Crystal structure of human jak3 kinase domain complex and binding pockets thereof

ABSTRACT

The present invention relates to human Janus Kinase 3 (JAK3) and JAK3-like binding pockets. The present invention provides a computer comprising a data storage medium encoded with the structure coordinates of such binding pockets. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to JAK3 protein or JAK3 protein homologues, or complexes thereof. The invention also relates to crystallizable compositions and crystals comprising JAK3 kinase domain and JAK3 kinase domain complexes with AMP-PNP.

This application claims the benefit under 35 U.S.C. §119 of U.S.Provisional Application No. 60/566,393, filed Apr. 28, 2004, and U.S.Provisional Application titled “CRYSTAL STRUCTURE OF HUMAN JAK3 KINASEDOMAIN COMPLEX AND BINDING POCKETS THEREOF” and filed Apr. 8, 2005, thedisclosures of which is incorporated herein by reference.

TECHNICAL FIELD OF INVENTION

The present invention relates to human Janus Kinase 3 (JAK3) andJAK3-like binding pockets. The present invention provides a computercomprising a data storage medium encoded with the structure coordinatesof such binding pockets. This invention also relates to methods of usingthe structure coordinates to solve the structure of homologous proteinsor protein complexes. In addition, this invention relates to methods ofusing the structure coordinates to screen for and design compounds,including inhibitory compounds, that bind to JAK3 protein or JAK3protein homologues, or complexes thereof. The invention also relates tocrystallizable compositions and crystals comprising JAK3 kinase domainand JAK3 kinase domain complexes with AMP-PNP.

BACKGROUND OF THE INVENTION

Janus kinases (JAKs) are non-receptor tyrosine kinases that play anessential role in cytokine signaling (Darnell et al., Science 264:1415-1421 (1994); Ihle, Adv. Immunol. 60: 1-35 (1995)). The JAK familyconsists of four evolutionary-conserved mammalian JAK proteins JAK1,JAK2, JAK3 and TYK2, which are each approximately 120 kDa in molecularmass, and homologues in other vertebrates such as chicken, and zebrafishand drosophila. These kinases appear to be responsible for thetransmission of signal by most cytokines and neurokines (Rane and Reddy,Oncogene 19: 5662-5679 (2000)). Accumulated evidence suggests thatbinding of cytokines to their receptors induces receptoroligomerization, which results in an increased affinity of thecytoplasmic domain of the receptor for the JAK kinases. As a consequenceof this increased affinity, the JAK kinases are recruited to thereceptors resulting in their phosphorylation and subsequent activation.The activated JAKs then phosphorylate the cytoplasmic tails of thereceptors on target tyrosines residues, which in turn serve as thedocking sites for the Src-homology-2 (SH2) domains of signal transducerand activation of transcription (STAT) proteins. The recruited STATs arephosphorylated by JAKs on specific tryosine residues, which causes theirrelease from the receptor and finally dimerization through a reciprocalphosphotyrosine-SH2 domain interaction (Chen et al., Cell 93:827-839(1998); Becker et al., Nature 394: 145-151 (1998)). The dimerized STATproteins then translocate to the nucleus where they act as transcriptionfactors.

A unique feature of the domain-structure of JAKs that distinguishes themfrom other tryrosine kinases, a C-terminal catalytic domain and animmediately preceded pseudokinase domain (Ihle, supra). The pseudokinasedomain lacks canonical residues that are essential for catalyticfunction. Several lines of evidence suggest that this domain regulatescatalytic activity and autophosphorylation (Saharinen et al., Mol. Biol.Cell 14: 1448-1459 (2003); Saharinen et al., Mol. Cell. Biol. 20:3387-3395 (2000); Saharinen et al., J. Biol. Chem. 277: 47954-47963(2002); Chen et al., Mol. Cell. Biol. 20: 947-956 (2000)).

In addition to the two kinase domains, JAKs contain an N-terminal bandfour-point-one, erzin, radixin, moesin (FERM) homology domain and anSH2-like domain (Girault et al., Trends Biochem. Sci. 24: 54-57 (1999)).The FERM domain is a 300-amino acid protein-protein interaction modulethat mediates receptor interactions and is important for thepreservation of proper catalytic function (Terawaki et al., ActaCrystallog. D59: 177-179 (2003); Smith et al., J. Biol. Chem. 278:4949-4956 (2003); Hamada et al., EMBO J. 19: 4449-4462 (2000); Hamada etal., EMBO J. 22: 502-514 (2003); Pearson et al., Cell 101: 259-270(2000); Zhou et al., Mol. Cell. 8: 959-969 (2001)).

The activity of JAKs is also regulated by the two tyrosines in theactivation loop of the catalytic domain (Gauzzi et al., J. Biol. Chem.271: 20494-20500 (1996); Feng et al., Mol. Cell. Biol. 17: 2497-2501(1997); Zhou et al., Proc. Natl. Acad. Sci. USA 94: 13850-13855 (1997)).In JAK3, phosphorylation of Tyr980 and Tyr981 results in positive andnegative regulation of its enzymatic activity, respective (Zhou, supra).

JAK3 is predominantly expressed in lymphoid and myeloid cell lines andin hematopoietic tissues such as the thymus, bone marrow, spleen, andfetal liver (Rane and Reddy, Oncogene 21:3334-3358 (2002)). In contrast,other JAKs are ubiquitously expressed. JAK3 specifically associates withthe common γ chain (γc) of the cytokine receptors for interleukin-2(IL-2), IL-4, IL-7, IL-9, IL-15 and IL-21 (Kisseleva et al., Gene285:1-24 (2002); O'Shea et al., Cell 109 Suppl; S121-131 (2002)). Inhumans, mutations in JAK3 or γc result in sever combinedimmunodeficiency (SCID), which is characterized by the absence ofcirculating mature T cells and natural killer cells, but not B cells(TB⁺SCID) (Notarangelo et al., Hum. Mutat. 18: 255-263 (2001); Robertset al., Blood 103:2009-2018 (2004); Epub in November2003). JAK3−/− micealso exhibit severe immunodeficiency (Thomis et al., Science 270:794-797 (1995)).

Therapeutic targeting of JAK3 kinase has received particular attention,because the effects owing to the complete absence of JAK3 are limited tothe immune system. Several JAK3 inhibitors, such as JANEX-1, AG-490,WHI-P154 and PNU156804 have been reported (Sudbeck et al., Clin. CancerRes. 5: 1569-1582 (1999); Cetkovic-Cvrlje et al. Arzeneimittolforschung53: 648-654 (2003); Cetkovic-Cvrlje et al., Clin. Immunol. 106: 213-225(2003); Saemann et al., Transplantation 75: 1864-1874 (2003); Stepkowskiet al., Blood 99: 680-689 (2002)). More recently, Pfizer imported anorally active JAK3 selective inhibitor, CP-690,550 as animmunosuppressive agent in mouse and monkey transplant models(Changelian et al., Science 302: 875-878 (2003)). Collectively thesedata suggest that JAK3 is an attractive pharmacologic target for thetreatment of immune-mediated transplant rejection Kirken, TransplantProc. 33: 3268-3270 (2001)).

Despite its importance in SCID and as a clinical target forimmunosuppression, very little is known about the three-dimensionalstructure of JAK3. Drug design for human therapy has been hamperedbecause the structure of JAK3 was not previously known. Withoutstructural information of JAK3, the detailed knowledge of the mechanismis limited and progress of designing drugs as specific inhibitors isimpeded. Structural information on the unique features of the activesite of human JAK3 would facilitate drug discovery.

SUMMARY OF THE INVENTION

The present invention solves the problems identified above by providingfor the first time the crystal structure of JAK3-AMP-PNP complex. Thiscrystal structure of human JAK3 kinase domain in complex with AMP-PNPbound to its ATP-binding site provides important structural informationfor the development of novel JAK3 selective inhibitors.

The present invention also provides molecules comprising JAK3 bindingpockets, or JAK3-like binding pockets that have similarthree-dimensional shapes. In one embodiment, the molecules are JAK3kinase domain complexes. In another embodiment, the molecules are JAK3kinase domain homologues, or complexes thereof. In another embodiment,the molecules are in crystalline form.

The invention provides crystallizable compositions and crystalscomprising JAK3 kinase domain, complexes thereof, or homologues thereof.

The invention provides a computer comprising a machine-readable storagemedium, comprising a data storage material encoded with machine-readabledata, wherein the data defines the JAK3 or JAK3-like binding pocket ordomain according to the structure coordinates of Table 2. Such storagemedium when read and utilized by a computer programmed with appropriatesoftware can display, on a computer screen or similar viewing device, athree-dimensional graphical representation of such binding pockets. Inone embodiment, the structure coordinates of said binding pocket ordomain are produced by homology modeling of at least portion of thecoordinates of Table 2.

The invention also provides method for designing, selecting, evaluatingand identifying and/or optimizing compounds which bind to the moleculesor molecular complexes or their binding pockets. Such compounds arepotential inhibitors of JAK3, JAK3-like proteins or its homologues.

The invention also provides a method for determining at least a portionof the three-dimensional structure of molecules or molecular complexeswhich contain at least some structurally similar features to JAK3,particular JAK3 homologues. This is achieved by using at least some ofthe structure coordinates obtained from the JAK3 kinase domain.

The present invention provides a crystal comprising a human Janus Kinase3 kinase domain.

The present invention provides a crystal comprising a Janus Kinase 3kinase domain homologue.

The present invention provides a crystal comprising a human Janus Kinase3 kinase domain complex.

The present invention provides a crystal comprising a Janus Kinase 3kinase domain homologue complex.

The present invention also provides the crystal according to paragraph[0018], wherein said human Janus Kinase 3 kinase domain complexcomprises human Janus Kinase 3 kinase domain and a chemical entityselected from the group consisting of adenosine, ATP, an ATP analogue,AMP-PNP, a nucleotide triphosphate, a nucleotide diphosphate, phosphateand active site inhibitor.

The present invention also provides the crystal according to paragraph[0018], wherein said human Janus Kinase 3 kinase domain complexcomprises human Janus Kinase 3 kinase domain and AMP-PNP.

The present invention also provides the crystal according to any one ofparagraphs [0016], [0018], [0020] and [0021], wherein said human JanusKinase 3 kinase domain is selected from the group consisting of aminoacid residues 810-1100 of SEQ ID NO:1, amino acid residues 810-1104 ofSEQ ID NO:1, amino acid residues 810-1115 of SEQ ID NO:1, amino acidresidues 810-1124 of SEQ ID NO:1, and amino acid residues 813-1100 ofSEQ ID NO:1.

The present invention also provides the crystal according to any one ofparagraphs [0016], [0018], [0020] and [0021], wherein said human JanusKinase 3 kinase domain is amino acid residues 810-1115 of SEQ ID NO:1.

The present invention provides a crystallizable composition comprising ahuman Janus Kinase 3 kinase domain.

The present invention provides a crsytallizable composition comprising aJanus Kinase 3 kinase domain homologue.

The present invention provides a crystallizable composition comprising ahuman Janus Kinase 3 kinase domain complex.

The present invention provides a crystallizable composition comprising aJanus Kinase 3 kinase domain homologue complex.

The present invention also provides the crystallizable compositionaccording to paragraph [0026], wherein said human Janus Kinase 3 kinasedomain complex comprises human Janus Kinase 3 kinase domain and achemical entity selected from the group consisting of adenosine, ATP, anATP analogue, AMP-PNP, a nucleotide triphosphate, a nucleotidediphosphate, phosphate and active site inhibitor.

The present invention also provides the crystallizable compositionaccording to paragraph [0026], wherein said human Janus Kinase 3 kinasedomain complex comprises human Janus Kinase 3 kinase domain and AMP-PNP.

The present invention also provides the crystallizable compositionaccording to any one of paragraphs [0024], [0026], [0028] and [0029],wherein said human Janus Kinase 3 kinase domain is selected from thegroup consisting of amino acid residues 810-1100 of SEQ ID NO:1, aminoacid residues 813-1104 of SEQ ID NO:1, amino acid residues 810-1115 ofSEQ ID NO:1, amino acid residues 810-1124 of SEQ ID NO:1, and amino acidresidues 813-1100 of SEQ ID NO:1.

The present invention also provides the crystallizable compositionaccording to any one of paragraphs [0024], [0026], [0028 ] and [0029],wherein said human Janus Kinase 3 kinase domain is amino acid residues810-1115 of SEQ ID NO:1.

The present invention provides a computer comprising:

-   -   (a) a machine-readable data storage medium, comprising a data        storage material encoded with machine-readable data, wherein        said data defines a binding pocket or domain selected from the        group consisting of:        -   (i) a set of amino acid residues that are identical to human            Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,            Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,            Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,            Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902,            Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909,            Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951,            Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,            Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and            Trp 993 according to Table 2, wherein the root mean square            deviation of the backbone atoms between said set of amino            acid residues and said human Janus Kinase 3 amino acid            residues is not greater than about 2.5 Å; and        -   (ii) a set of amino acid residues that are identical to            human Janus Kinase 3 amino acid residues according to Table            2, wherein the root mean square deviation between said set            of amino acid residues and said human Janus Kinase 3 amino            acid residues is not more than about 3.0 Å;    -   (b) a working memory for storing instructions for processing        said machine-readable data;    -   (c) a central processing unit coupled to said working memory and        to said machine-readable data storage medium for processing said        machine-readable data and a means for generating        three-dimensional structural information of said binding pocket        or domain; and    -   (d) output hardware coupled to said central processing unit for        outputting three-dimensional structural information of said        binding pocket or domain, or information produced using said        three-dimensional structural information of said binding pocket        or domain.

The present invention also provides the computer according to paragraph[0032], wherein the binding pocket is produced by homology modeling ofthe structure coordinates of said Janus Kinase 3 amino acid residuesaccording to Table 2.

The present invention also provides the computer according to paragraph[0032], wherein said means for generating three-dimensional structuralinformation is provided by means for generating a three-dimensionalgraphical representation of said binding pocket or domain.

The present invention also provides the computer according to paragraph[0032], wherein said output hardware is a display terminal, a printer,CD or DVD recorder, ZIP™ or JAX™ drive, a disk drive or othermachine-readable data storage device.

The present invention provides a method of using a computer forselecting an orientation of a chemical entity that interacts favorablywith a binding pocket or domain selected from the group consisting of;

-   -   -   (i) a set of amino acid residues that are identical to human            Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,            Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,            Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,            Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902,            Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909,            Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951,            Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,            Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and            Trp 993 according to Table 2, wherein the root mean square            deviation of the backbone atoms between said set of amino            acid residues and said human Janus Kinase 3 amino acid            residues is not greater than about 2.5 Å; and        -   (ii) a set of amino acid residues that are identical to            human Janus Kinase 3 amino acid residues according to Table            2, wherein the root mean square deviation between said set            of amino acid residues and said human Janus Kinase 3 amino            acid residues is not more than about 3.0 Å;

said method comprising the steps of:

-   -   (a) providing the structure coordinates of said binding pocket        or domain thereof on a computer comprising the means for        generating three-dimensional structural information from said        structure coordinates;    -   (b) employing computational means to dock a first chemical        entity in the binding pocket or domain;    -   (c) quantifying the association between said chemical entity and        all or part of the binding pocket or domain for different        orientation of the chemical entity; and    -   (d) selecting the orientation of the chemical entity with the        most favorable interaction based on said quantified association.

The present invention also provides the method according to paragraph[0036], further comprising generating a three-dimensional graphicalrepresentation of the binding pocket or domain prior to step (b).

The present invention also provides the method according to paragraph[0036], wherein energy minimization, molecular dynamics simulations, orrigid-body minimizations are performed simultaneously with or followingstep (b).

The present invention also provides the method according to paragraph[0036], further comprising the steps of:

-   -   (e) repeating steps (b) through (d) with a second chemical        entity; and    -   (f) selecting at least one of said first or second chemical        entity that interacts more favorably with said binding pocket or        domain based on said quantified association of said first or        second chemical entity.

The present invention provides a method of using a computer forselecting an orientation of a chemical entity with a favorable shapecomplementarity in a binding pocket consisting of a set of amino acidresidues that are identical to human Kinase 3 amino acid residuesGln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835,Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857,Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905,Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949,Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and Trp 993according to Table 2, wherein the root mean square deviation of thebackbone atoms between said set of amino acid residues and said humanJanus Kinase 3 amino acid residues is not greater than about 2.5 Å;

said method comprising the steps of:

-   -   (a) providing the structure coordinates of said binding pocket        and all or part of the ligand bound therein on a computer        comprising the means for generating three-dimensional structural        information from said structure coordinates;    -   (b) employing computational means to dock a first chemical        entity in the binding pocket;    -   (c) quantitating the contact score of said chemical entity in        different orientations; and    -   (d) selecting an orientation with the highest contact score.

The present invention also provides the method according to paragraph[0040], further comprising generating a three-dimensional graphicalrepresentation of the binding pocket and all or part of the ligand boundtherein prior to step (b).

The present invention also provides the method according to paragraph[0040], further comprising the steps of:

-   -   (e) repeating steps (b) through (d) with a second chemical        entity; and    -   (f) selecting at least one of said first or second chemical        entity that has a higher contact score based on said quantitated        contact score of said first or second chemical entity.

The present invention provides a method for identifying a candidateinhibitor of a molecule or molecular complex comprising a binding pocketor domain selected from the group consisting of:

-   -   (i) a set of amino acid residues that are identical to human        Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,        Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837,        Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884,        Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905,        Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947,        Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956,        Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989,        Pro990 and Trp 993 according to Table 2, wherein the root mean        square deviation of the backbone atoms between said set of amino        acid residues and said human Janus Kinase 3 amino acid residues        is not greater than about 2.5 Å; and    -   (ii) a set of amino acid residues that are identical to human        Janus Kinase 3 amino acid residues according to Table 2, wherein        the root mean square deviation between said set of amino acid        residues and said human Janus Kinase 3 amino acid residues is        not more than about 3.0 Å;

comprising the steps of:

-   -   (a) using a three-dimensional structure of the binding pocket or        domain to design, select or optimize a plurality of chemical        entities;    -   (b) contacting each chemical entity with the molecule or the        molecular complex;    -   (c) monitoring the inhibition to the catalytic activity of the        molecule or molecular complex by each chemical entity; and    -   (d) selecting a chemical entity based on the inhibitory effect        of the chemical entity on the catalytic activity of the molecule        or molecular complex.

The present invention provides a method of designing a compound orcomplex that interacts with a binding pocket or domain selected from thegroup consisting of:

-   -   (i) a set of amino acid residues that are identical to human        Janus kinase 3 amino acid residues Gln827, Leu828, Gly829,        Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837,        Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884,        Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905,        Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947,        Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956,        Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989,        Pro990 and Trp 993 according to Table 2, wherein the root mean        square deviation of the backbone atoms between said set of amino        acid residues and said human Janus Kinase 3 amino acid residues        is not greater than about 2.5 Å; and    -   (ii) a set of amino acid residues that are identical to human        Janus Kinase 3 amino acid residues according to Table 2, wherein        the root mean square deviation between said set of amino acid        residues and said human Janus Kinase 3 amino acid residues is        not more than about 3.0 Å;    -   comprising the steps of:    -   (a) providing the structure coordinates of said binding pocket        or domain on a computer comprising the means for generating        three-dimensional structural information from said structure        coordinates;    -   (b) using the computer to dock a first chemical entity in part        of the binding pocket or domain;    -   (c) docking at least a second chemical entity in another part of        the binding pocket or domain;    -   (d) quantifying the association between the first or second        chemical entity and part of the binding pocket or domain;    -   (e) repeating steps (b) to (d) with another first and second        chemical entity, selecting a first and a second chemical entity        based on said quantified association of all of said first and        second chemical entity;    -   (f) optionally, visually inspecting the relationship of the        first and second chemical entity to each other in relation to        the binding pocket or domain on a computer screen using the        three-dimensional graphical representation of the binding pocket        or domain and said first and second chemical entity; and    -   (g) assembling the first and second chemical entity into a        compound or complex that interacts with said binding pocket or        domain by model building.

The present invention provides a method of utilizing molecularreplacement to obtain structural information about a molecule ormolecular complex of unknown structure, wherein the molecule issufficiently homologous to human Janus Kinase 3 kinase domain,comprising the steps of:

-   -   (a) crystallizing said molecule or molecular complex;    -   (b) generating an X-ray diffraction pattern from said        crystallized molecule or molecular complex; and    -   (c) applying at least a portion of the structure coordinates set        forth in Table 2 or homology model thereof to the X-ray        diffraction pattern to generate a three-dimensional electron        density map of at least a portion of the molecule or molecular        complex whose structure is unknown; and    -   (d) generating a structural model of the molecule or molecular        complex from the three-dimensional electron density map.

The present invention also provides the method according to paragraph[0045], wherein the molecule is selected from the group consisting of aJanus Kinase 3 protein and a protein comprising a Janus Kinase 3 kinasedomain homologue.

The present invention also provides the method according to paragraph[0045], wherein the molecular complex is selected from the groupconsisting of a Janus Kinase 3 protein complex, a Janus Kinase 3 kinasedomain complex, and a Janus Kinase 3 kinase domain homologue complex.

The present invention also provides a method for identifying a candidateinhibitor that interacts with a binding site of a human Janus Kinase 3kinase protein or a homologue thereof, comprising the steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3        kinase protein or said homologue thereof, wherein the crystal is        characterized with space group P2₁ and has unit cell parameters        of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5°;    -   (b) obtaining the structure coordinates of amino acids of the        crystal of step (a), wherein the structure coordinates are set        forth in Table 1;    -   (c) generating a three-dimensional model of said human Janus        Kinase 3 kinase protein or said homologue thereof using the        structure coordinates of the amino acids obtained in step (b), a        root mean square deviation from backbone atoms of said amino        acids of not more than ±2.0 Å;    -   (d) determining a binding site of said human Janus Kinase 3        kinase protein or said homologue thereof from said        three-dimensional model; and    -   (e) performing computer fitting analysis to identify the        candidate inhibitor which interacts with said binding site.

The present invention also provides the method according to paragraph[0048], further comprising the step of:

-   -   (f) contacting the identified candidate inhibitor with said        human Janus Kinase 3 kinase protein or said homologue thereof in        order to determine the effect of the inhibitor on human Janus        Kinase 3 kinase protein activity.

The present invention also provides the method according to paragraph[0048], wherein the binding site said human Janus Kinase 3 kinaseprotein or said homologue thereof determined in step (d) comprises thestructure coordinates according to Table 1 of amino acid residues thatare identical to human Janus Kinase 3 amino acid residues Gln827,Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884,Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906,Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950,Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967,Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and Trp 993, wherein theroot mean square deviation from the backbone atoms of said amino acidsis not more than ±2.0 Å.

The present invention also provides a method for identifying a candidateinhibitor that interacts with a binding site of a human Janus Kinase 3kinase protein or a homologue thereof, comprising the steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3        kinase protein or said homologue thereof, wherein the crystal is        characterized with space group P2₁ and has unit cell parameters        of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5°;    -   (b) obtaining the structure coordinates of amino acids of the        crystal of step (a);    -   (c) generating a three-dimensional model of said human Janus        Kinase 3 kinase protein or said homologue thereof using the        structure coordinates of the amino acids obtained in step (b), a        root mean square deviation from backbone atoms of said amino        acids of not more than ±2.0 Å;    -   (d) determining a binding site of said human Janus Kinase 3        kinase protein or said homologue thereof from said        three-dimensional model; and    -   (e) performing computer fitting analysis to identify the        candidate inhibitor which interacts with said binding site.

The present invention also provides the method according to paragraph[0051], further comprising the step of:

-   -   (f) contacting the identified candidate inhibitor with said        human Janus Kinase 3 kinase protein or said homologue thereof in        order to determine the effect of the inhibitor on human Janus        Kinase 3 kinase protein activity.

The present invention also provides the method according to paragraph[0051], wherein the binding site of said human Janus Kinase 3 kinaseprotein or said homologue thereof determined in step (d) comprises thestructure coordinates according to Table 1 of a set of amino acidresidues that are identical to human Janus Kinase 3 amino acid residuesGln827, Leu828, Gly829, Lys830, Gly831, Asn832, Phe833, Gly834, Ser835,Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857,Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905,Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949,Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,Asp967, Leu970, Glu985, Glu988, Ser989, Pro990 and Trp 993, wherein theroot mean square deviation from the backbone atoms of said amino acidsis not more than ±2.0 Å.

The present invention also provides the method for identifying acandidate inhibitor that interacts with a binding site of a human JanusKinase 3 kinase protein or a homologue thereof, comprising the step ofdetermining a binding site of said human Janus Kinase 3 kinase proteinor the homologue thereof from a three-dimensional model to design oridentify the candidate inhibitor which interacts with said binding site.

The present invention also provides the method according to paragraph[0054], wherein the binding site of said human Janus Kinase 3 kinaseprotein or said homologue thereof determined comprises the structurecoordinates according to Table 1 of a set of amino acid residues thatare identical to human Janus Kinase 3 amino acid residues Gln827,Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884,Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906,Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950,Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967,Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and Trp 993, wherein theroot mean square deviation from the backbone atoms of said amino acidsis not more than ±2.0 Å.

The present invention also provides a method for identifying a candidateinhibitor of a molecule or molecular complex comprising a binding pocketor domain selected from the group consisting of:

-   -   (i) a set of amino acid residues which are identical to human        Janus Kinase 3 kinase a set of amino acid resides that are        identical to human Janus Kinase 3 amino acid residues Gln827,        Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835,        Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,        Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903,        Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911,        Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954,        Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985,        Gln988, Ser989, Pro990 and Trp 993 according to Table 1, wherein        the root mean square deviation of the backbone atoms between        said set of amino acid residues and said human Janus Kinase 3        amino acid residues is not greater than about 2.0 Å; and    -   (ii) a set of amino acid residues that are identical to human        Janus Kinase 3 kinase amino acid residues according to Table 1,        wherein the root mean square deviation between said set of amino        acid residues and said human Janus Kinase 3 kinase amino acid        residues is not more than about 3.0 Å; comprising the steps of:    -   (a) using a three-dimensional structure of the binding pocket or        domain to design, select or optimize a plurality of chemical        entities; and    -   (b) selecting said candidate inhibitor based on the inhibitory        effect of said chemical entities a human Janus Kinase 3 kinase        protein or a human Janus Kinase 3 kinase protein homologue on        the catalytic activity of the molecule or molecular complex.

The present invention also provides a method of using the crystal ofparagraphs [0016] and [0017] in an inhibitor screening assay comprising:

-   -   (a) selecting a potential inhibitor by performing rational drug        design with a three-dimensional structure determined for the        crystal, wherein said selecting is performed in conjunction with        computer modeling;    -   (b) contacting the potential inhibitor with a kinase; and    -   (c) detecting the ability of the potential inhibitor for        inhibiting the kinase.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 depicts a ribbon diagram of the overall fold of the JAK3-AMP-PNPcomplex. The N-terminal and the C-terminal domains are colored lightgray and dark gray, respectively. The N-terminal domain, the C-terminaldomain, the glycine-rich loop or P-loop which contains the G-X-G-X-X-Gmotif (SEQ ID NO: 7) in the N-terminal lobe, the hinge region betweenthe N- and C-terminal domains, and the activation loop or A-loop in theC-terminal domain are labeled. The AMP-PNP is shown in a stickrepresentation, and the magnesium ion is represented by a sphere. Thetwo tyrosines which have been shown to be phosphorylated (Y980 and Y981)are on the A-loop and are shown in sticks representation and labeled.

FIG. 2 depicts the overall structure of the Jak3-AMP-PNP complex. Thestructure is shown with β-sheets as arrows and the α-helices arecylinders. The N-terminal lobe is shown with the glycine rich loop. TheC-terminal lobe is shown with the activation loop. The α-FG helix islabeled. The non-hydrolyzable ATP analogue, AMP-PNP, is shown asball-and-stick format, in the active site. The sites of phosphorylationlocated in the activation loop, Tyr980 and Tyr981, are shown. Allstructural figures were prepared with Pymol (DeLano W. L. (2002), DeLanoScientific, San Carlos, Calif., USA).

FIG. 3 shows a detailed representation of the active site of JAK3 withAMP-PNP depicting some of the hydrogen bonds formed between the AMP-PNPand amino acid sidechains of JAK3 as dashed-lines. The bond between thecatalytic amino acid residue K855 and D967 is also shown as adashed-line.

FIG. 4 shows αF and αG of Jak3 were superimposed on c-Src. The I1 and I3regions jut out from this area. This is perhaps an area for either intraor inter protein-protein interactions. The proximity of the α-FG regionto the activation loop suggests that it may play a role in theactivation of Jak3.

FIG. 5 shows the α-FG region is unique to Janus kinases. The sequencebetween αF and αG is conserved in the janus kinases and unique among theother tyrosine kinases. The aligned sequences of Jak3 (amino acidresidues 967-1052 of SEQ ID NO: 1) with a variety of other tyrosinekinases, including Ack (SEQ ID NO: 2); MuSK (SEQ ID NO: 3); Insr (SEQ IDNO: 4); FGFR1 (SEQ ID NO: 5); c-Src (SEQ ID NO: 6). The sequences werealigned using the “Align and Superpose” option in Quanta, and thenmanually aligned based on the resultant structural superposition. Thebold black residue corresponds to the residue in the P+1 loop that istypical an arginine or lysine in all tyrosine kinases except the fourmammalian Jaks and the closely related 2 Ack kinases, Ack1 and Tnk1.

FIG. 6 shows interactions between inactivated Jak3 and AMP-PNP in theATP-binding site. Interactions between Jak3 and AMP-PNP in theATP-binding site. The protein backbone is depicted as a thin coil. Fo-Fcexperimental electron density for the inhibitor is shown in a wirelines, contoured at 2.0σ at 2.5 Å resolution.

FIG. 7 shows the location of SCID mutation L910S. Leucine 910 is locatedat the beginning of the αD helix and is surrounded by a number of otherhydrophobic residues from adjoining parts of the C-lobe. Burying a polarsidechain, serine 910, in this hydrophobic pocket would probably lead todisruption of this region of the protein. The results could be thedisruption of ATP, substrate binding, or both, resulting in anonfunctioning kinase. The sidechains of L910 and the surroundingresidues are shown.

FIG. 8 shows a diagram of a system used to carry out the instructionsencoded by the storage medium of FIGS. 9 and 10.

FIG. 9 shows a cross section of a magnetic storage medium.

FIG. 10 shows a cross section of a optically-readable data storagemedium.

DESCRIPTION OF THE INVENTION

In order that the invention described herein may be more fullyunderstood, the following detailed description is set forth.

Throughout the specification, the word “comprise”, or variations such as“comprises” or “comprising” will be understood to imply the inclusion ofa stated integer or groups of integers but not exclusion of any otherinteger or groups of integers.

The following abbreviations are used throughout the application:

A = Ala = Alanine T = Thr = Threonine V = Val = Valine C = Cys =Cysteine L = Leu = Leucine Y = Tyr = Tyrosine I = Ile = Isoleucine N =Asn = Asparagine P = Pro = Proline Q = Gln = Glutamine F = Phe =Phenylalanine D = Asp = Aspartic Acid W = Trp = Tryptophan E = Glu =Glutamic Acid M = Met = Methionine K = Lys = Lysine G = Gly = Glycine R= Arg = Arginine S = Ser = Serine H = His = HistidineOther abbreviations that are used throughout the application include:ANP (for AMP-PNP).

As used herein, the following definitions shall apply unless otherwiseindicated.

The term “about” when used in the context of root mean square deviation(RMSD) values takes into consideration the standard error of the RMSDvalue, which is ±0.1 Å.

The term “associating with” refers to a condition of proximity between achemical entity or compound, or portions thereof, and a binding pocketor binding site on a protein. The association may benon-covalent—wherein the juxtaposition is energetically favored byhydrogen bonding, hydrophobic, van der Waals or electrostaticinteractions—or it may be covalent.

The term “ATP analogue” refers to a compound derived fromadenosine-5′-triphosphate (ATP). The compound can be adenosine, AMP,ADP, or a non-hydrolyzable analogue, such as, but not limited toAMP-PNP. The analogue may be in complex with magnesium or manganeseions.

The term “binding pocket” refers to a region of a molecule or molecularcomplex, that, as a result of its shape, favorably associates withanother chemical entity. The term “pocket” includes, but is not limitedto, a cleft, channel or site. JAK3, JAK3-like molecules or homologuesthereof may be binding pockets which include, but are not limited to,peptide or substrate binding sites, and ATP-binding sites. The shape ofa binding pocket may be largely pre-formed before binding of a chemicalentity, may be formed simultaneously with binding of a chemical entity,or may be formed by the binding of another chemical entity to adifferent binding pocket of the molecule, which in turn induces a changein shape of the binding pocket.

The term “catalytic active site” or “active site” refers to the portionof the protein kinase to which nucleotide substrates bind. For example,the catalytic active site of JAK3 is at the interface between theN-terminal and C-terminal domains.

The term “chemical entity” refers to chemical compounds, complexes of atleast two chemical compounds, and fragments of such compounds orcomplexes. The chemical entity can be, for example, a ligand, substrate,nucleotide triphosphate, nucleotide diphosphate, phosphate, nucleotide,agonist, antagonist, inhibitor, antibody, peptide, protein or drug. Inone embodiment, the chemical entity is an inhibitor or substrate for theactive site.

The term “conservative substitutions” refers to residues that arephysically or functionally similar to the corresponding referenceresidues. That is, a conservative substitution and its reference residuehave similar size, shape, electric charge, chemical properties includingthe ability to form covalent or hydrogen bonds, or the like. Preferredconservative substitutions are those fulfilling the criteria defined foran accepted point mutation in Dayhoff et al., Atlas of Protein Sequenceand Structure, 5: 345-352 (1978 & Supp.), which is incorporated hereinby reference. Examples of conservative substitutions are substitutionsincluding but not limited to the following groups: (a) valine, glycine;(b) glycine, alanine; (c) valine, isoleucine, leucine; (d) asparticacid, glutamic acid; (e) asparagine, glutamine; (f) serine, threonine;(g) lysine, arginine, methionine; and (h) phenylalanine, tyrosine.

The term “contact score” refers to a measure of shape complementaritybetween the chemical entity and binding pocket, which is correlated withan RMSD value obtained from a least square superimposition between allor part of the atoms of the chemical entity and all or part of the atomsof the ligand bound (for example, AMP-PNP) in the binding pocketaccording to Table 2. The docking process may be facilitated by thecontact score or RMSD values. For example, if the chemical entity movesto an orientation with high RMSD, the system will resist the motion. Aset of orientations of a chemical entity can be ranked by contact score.A lower RMSD value will give a higher contact score. See Meng et al. J.Comp. Chem. 4: 505-524 (1992).

The term “corresponds to” to “corresponding amino acid” when used in thecontext of amino acid residues that correspond to JAK3 amino acidresidues refers to particular amino acid residues or analogues thereofin a JAK3 kinase domain homologue that corresponds to amino acidresidues in the human JAK3 kinase domain. The corresponding amino acidmay be an identical, mutated, chemically modified, conserved,conservatively substituted, functionally equivalent or homologous aminoacid residue when compared to the JAK3 amino acid residue to which itcorresponds.

Methods for identifying a corresponding amino acid are known in the artand are based upon are sequence, structural alignment, its functionalposition, or a combination thereof as compared to the JAK3 kinase. Forexample, corresponding amino acids may be identified by superimposingthe backbone atoms of the amino acids in JAK3 and the protein using wellknown software applications, such as QUANTA (Accelrys, San Diego, Calif.©2001, 2002). The corresponding amino acids may also be identified usingsequence alignment programs such as the “bestfit” program or CLUSTAL WAlignment Tool (Higgins et al., Methods Enzymol. 266: 383-402 (1996)).

The term “crystallization solution” refers to a solution that promotescrystallization comprising at least one agent, including a buffer, oneor more salts, a precipitating agent, one or more detergents, sugars ororganic compounds, lanthanide ions, a poly-ionic compound and/or astabilizer.

The term “docking” refers to orienting, rotating, translating a chemicalentity in the binding pocket, domain, molecule or molecular complex orportion thereof based on distance geometry or energy. Docking may beperformed by distance geometry methods that find sets of atoms of achemical entity that match sets of sphere centers of the binding pocket,domain, molecule or molecular complex or portion thereof. See Meng etal., J. Comp. Chem. 4: 505-524 (1992). Sphere centers are generated byproviding an extra radius of given length from the atoms (excludinghydrogen atoms) in the binding pocket, domain, molecule or molecularcomplex or portion thereof. Real-time interaction energy calculations,energy minimizations or rigid-body minimizations (Gschwend et al., J.Mol. Recognition 9:175-186 (1996)) can be performed while orienting thechemical entity to facilitate docking. For example, interactive dockingexperiments can be designed to follow the path of least resistance. Ifthe user in an interactive docking experiment makes a move to increasethe energy, the system will resist that move. However, if that usermakes a move to decrease energy, the system will favor that move byincreased responsiveness. (Cohen et al., J. Med. Chem. 33:889-894(1990)). Docking can also be performed by combining a Monte Carlo searchtechnique with rapid energy evaluation using molecular affinitypotentials. See Goodsell and Olsen, Proteins: Structures, Function andGenetics 8:195-202 (1990). Software programs that carry out dockingfunctions include but are not limited to MATCHMOL (Cory et al., J. Mol.Graphics 2: 39 (1984); MOLFIT (Redington, Comput. Chem. 16 216 (1992))and DOCK (Meng et al., supra).

The term “full-length JAK3” refers to the complete human JAK3 protein(amino acid residues 1 to 1124; SEQ ID NO:1).

The term “generating a three-dimensional structure” or “generating athree-dimensional representation” refers to converting the lists ofstructure coordinates into structural models or graphical representationin three-dimensional space. This can be achieved through commercially orpublicly available software. A model of a three-dimensional structure ofa molecule or molecular complex can thus be constructed on a computerscreen by a computer that is given the structure coordinates and thatcomprises the correct software. The three-dimensional structure may bedisplayed or used to perform computer modeling or fitting operations. Inaddition, the structure coordinates themselves, without the displayedmodel, may be used to perform computer-based modeling and fittingoperations.

The term “homologue of JAK3 kinase domain” or “JAK3 kinase domainhomologue” refers to a domain that retains JAK3 kinase activity and thathas mutations, conservative substitutions, or both, as compared to thehuman JAK3 kinase domain. In one embodiment, the homologue is at least95%, 96%, 97%, 98% or 99% identical in sequence to amino acid residues810-1124 of SEQ ID NO:1, and has conservative substitutions as comparedto the JAK3 kinase domain. In another embodiment, the homologue is atleast 95%, 96%, 97%, 98% or 99% identical in sequence to amino acidresidues 813-1100 of SEQ ID NO:1, and has conservative substitutions ascompared to the JAK3 kinase domain. Examples of homologues include butare not limited to the following: the kinase domains of JAK3 fromanother species or the foregoing, with mutations, conservativesubstitutions, or both. Such animal species include, but are not limitedto, mouse, rat, a primate such as monkey or other primates.

The term “homology model” refers to a structural model derived from knowthree-dimensional structure(s). Generation of the homology model, termed“homology modeling”, can include sequence alignment, residuereplacement, residue conformation adjustment through energyminimization, or a combination thereof.

The term “interaction energy” refers to the energy determined for theinteraction of a chemical entity and a binding pocket, domain, moleculeor molecular complex or portion thereof. Interactions include but arenot limited to one or more of covalent interactions, non-covalentinteractions such as hydrogen bond, electrostatic, hydrophobic,aromatic, van der Waals interactions, and non-complementaryelectrostatic, interactions such as repulsive charge-charge,dipole-dipole and charge-dipole interactions. As interactions energiesare measured in negative values, the lower the value the more favorablethe interaction.

The term “JAK” refers to the kinases from the JAK kinase family.Examples of this family of kinases include but are not limited to JAK3,JAK2, JAK1 and TYK2.

The term “JAK3 ATP-binding pocket” refers to a binding pocket of amolecule or molecular complex defined by the structure coordinates of acertain set of amino acid residues present in the JAK3 structure, asdescribed below. In general, the ligand for the ATP-binding pocket is anucleotide such as ATP. This binding pocket is in the catalytic activesite of the catalytic domain. In the protein kinase family, theATP-binding pocket is generally located at the interface of theN-terminal and C-terminal domains, and is bordered by the glycine richloop and the hinge (see, Xie et al., Structure 6: 983-991 (1998),incorporated herein by reference).

The term “JAK3 catalytic domain”, “JAK3 kinase catalytic domain”, “JAK3protein kinase catalytic domain”, “JAK3 catalytic kinase domain” or“JAK3 kinase domain” refers to human JAK3 amino acid residues 810-1115of SEQ ID NO:1, or the foregoing with additions and deletions of up to 9amino acid residues at the C-terminal and/or 20 amino acids at theN-terminal of these amino acid residues. The kinase domain includes thecatalytic active site.

The term “JAK3 inhibitor-binding pocket” refers to that portion of theJAK3 enzyme active site to which the inhibitor binds. Theinhibitor-binding pocket is defined by the structure coordinates of acertain set of amino acid residues present in the JAK3-inhibitorstructure.

The term “JAK3-like” refers to all or a portion of a molecule ormolecular complex that has a commonality of shape to all or a portion ofthe JAK3 protein. For example, in the JAK3-like ATP-binding pocket, thecommonality of shape is defined by a root mean square deviation of thestructure coordinates of the backbone atoms between the amino acids inthe JAK3-like ATP-binding pocket and the JAK3 amino acids of the JAK3ATP-binding pocket, the corresponding amino acid residues in theJAK3-like binding pocket may or may not be identical. Depending on theset of JAK3 amino acid residues that define the JAK3 ATP-binding pocket,one skilled in the art would be able to locate the corresponding aminoacid residues, that define a JAK3-like binding pocket in a protein basedon sequence or structural homology.

The term “JAK3 protein complex” or “JAK3 homologue complex” refers to amolecular complex formed by associating the JAK3 protein or JAK3homologue with a chemical entity, for example, a ligand, a substrate,nucleotide triphosphate, nucleotide diphosphate, phosphate, an agonistor antagonist, inhibitor, antibody, drug or compound.

The term “motif” refers to a group of amino acid residues in the JAK3kinase or homologue that defines a structural compartment or carries outa function in the protein, for example, catalysis, structuralstabilization or phosphorylation. The motif may be conserved insequence, structure and function. The motif can be contiguous in primarysequence or three-dimensional space. Examples of a motif include, butare not limited to, a binding pocket, activation loop, the glycine-richloop, and the DFG loop (See, Xie et al., Structure 6: 983-991 (1998).

The term “part of a binding pocket” refers to less than all of the aminoacid residues that define the binding pocket. The structure coordinatesof amino acid residues that constitute part of a binding pocket may bespecific for defining the chemical environment of the binding pocket, oruseful in designing fragments of an inhibitor that may interact withthose residues. For example, the portion of amino acid residues may bekey residues that play a role in ligand binding, or may be residues thatare spatially related and define a three-dimensional compartment of thebinding pocket. The amino acid residues may be contiguous ornon-contiguous in primary sequence. In one embodiment, part of thebinding pocket has at least two amino acid residues, preferably at leastthree, six, eight, ten, fourteen or fifteen amino acid residues.

The term “part of a JAK3 kinase domain” or “part of a JAK3 kinase domainhomologue” refers to less than all of the amino acid residues of a JAK3kinase domain or kinase domain homologue. In one embodiment part of theJAK3 kinase domain or kinase domain homologue defines the bindingpockets, sub-domains, and motifs. The structure coordinates of aminoacid residues that constitute part of a JAK3 kinase domain or JAK3kinase domain homologue may be specific for defining the chemicalenvironment of the protein, or useful in designing fragments of aninhibitor that interact with those residues. The portion of amino acidresidues may also be residues that are spatially related and define athree-dimensional compartment of the binding pocket or motif. The aminoacid residues may be contiguous or non-contiguous in primary sequence.For example, the portion of amino acid residues may be key residues thatplay a role in ligand or substrate binding, peptide binding, antibodybinding, catalysis, structural stabilization or degradation.

The term “quantified association” refers to calculations of distancegeometry and energy. Energy can include but is not limited tointeraction energy, free energy and deformation energy. See Cohen,supra.

The term “root mean square deviation” or “RMSD” means the square root ofthe arithmetic mean of the squares of the deviations from the mean. Itis a way to express the deviation or variation from a trend or object.For purposes of the invention, the “root means square deviation” definesthe variation in the backbone atoms of JAK3, a binding pocket, a motif,a domain, or portion thereof, as defined by the structure coordinates ofJAK3 described herein. It would be apparent to the skilled worker thatthe calculation of RMSD involves a standard error of a ±0.1 Å.

The term “soaked” refers to a process in which the crystal istransferred to a solution containing the compound of interest.

The term “structure coordinates” refers to Cartesian coordinates derivedfrom mathematical equations related to the patterns obtained ondiffraction of a monochromatic beam of X-rays by the atoms (scatteringcenters) of a protein or protein complex in crystal form. Thediffraction data are used to calculate an electron density map of therepeating unit of the crystal. The electron density maps are then usedto establish the positions of the individual atoms of the molecule ormolecular complex.

The term “sub-domain” refers to a portion of the domain.

The term “substantially all of a JAK3 binding pocket” or “substantiallyall of a JAK3 kinase domain” refers to all or almost all of the aminoacids in the JAK3 binding pocket or kinase domain. For example,substantially all of a JAK3 binding pocket can be 100%, 95%, 90%, 80%,or 70% of the residues defining the JAK3 binding pocket.

The term “substrate binding pocket” refers to the binding pocket for asubstrate of JAK3 or homologue thereof. A substrate is generally definedas the molecule upon which an enzyme performs catalysis. Naturalsubstrates, synthetic substrates or peptides, or mimics of a naturalsubstrate of JAK3 or homologue thereof may associate with the substratebinding pocket.

The term “sufficiently homologous to JAK3” kinase domain refers to aprotein that has a sequence identity of at least 25% compared to JAK3kinase domain. In other embodiments, the sequence identity is at least40%. In other embodiments, the sequence identity is at least 50%, 60%,70%, 80%, 90%, 95% 96%, 97%, 98% or 99%.

The term “three-dimensional structural information” refers toinformation obtained from the structure coordinates. Structuralinformation generated can include the three-dimensional structure orgraphical representation of the structure. Structural information canalso be generated when subtracting distances between atoms in thestructure coordinates, calculating chemical energies for a JAK3 moleculeor molecular complex or homologues thereof, calculating or minimizingenergies for an association of a JAK3 molecule or molecular complex orhomologues thereof to a chemical entity.

Crystallizable Compositions and Crystals of JAK3 Kinase Domain andComplexes Thereof

According to one embodiment, the invention provides a crystal orcrystallizable composition comprising a JAK3 kinase domain, a JAK3kinase domain homologue, a JAK3 kinase domain complex, or a JAK3 kinasedomain homologue complex. In one embodiment, the chemical entry is anATP analogue, nucleotide triphosphate, nucleotide diphosphate,phosphate, adenosine or AMP-PNP. In a certain embodiment, the chemicalentity is AMP-PNP.

The JAK3 kinase domain in the crystal or crystallizable composition maybe amino acid residues 810-1124 of SEQ ID NO:1, amino acid residues810-1115 of SEQ ID NO:1, amino acid residues 810-1104 of SEQ ID NO:1,amino acid residues 810-1100 of SEQ ID NO:1 or amino acid residues813-1100 of SEQ ID NO:1, the JAK3 kinase domain homologue may be theforegoing with conservative substitutions.

SEQ ID NO: 1         10         20         30         40         MAPPSEETPL IPQRSCSLLS TEAGALHVLL PARGPGFFQR         50         60         70         80LSFSFGDHLA EDLCVQAAKA SGILPVYHSL FALATEDLSC        90        100        110        120WFPPSHIFSV EDASTQVLLY RIRFYFPNWF GLEKCHRFGL       130        140        150        160RKDLASAILD LPVLEHLFAQ HRSDLVSGRL PVGLSLKEQG       170        180        190        200ECLSLAVLDL ARMAREQAQR PGELLKTVSY KACLPPSLRD       210        220        230        240        LIQGLSFVTR RRIRRTVRRA LRRVAACQAD RHSLMAKYTM        250        260        270        280DLERLDPAGA AETFHVGLPG ALGGHDGLGL LRVAGDGGIA       290        300        310        320WTQGEQEVLQ PFCDFPEIVD ISIKQAPRVG PAGEHRLVTV       330        340        350        360TRTDNQILEA EFPGLPEALS FVALVDGYFR LTTDSQHFFC       370        380        390        400KEVAPPRLLE EVAEQCHGPI TLDFAINKLK TGGSRPGSYV       410        420        430        440LRRSPQDFDS FLLTVCVQNP LGPDYKGCLI RRSPTGTFLL        450        460        470        480VGLSRPHSSL RELLATCWDG GLHVDGVAVT LTSCCIPRPK       490        500        510        520EKSNLIVVQR GHSPPTSSLV QPQSQYQLSQ MTFHKIPADS       530        540        550        560LEWHENLGHG SFTKIYRGCR HEVVDGEARK TEVLLKVMDA       570        580        590        600KHKNCMESFL EAASLMSQVS YRHLVLLHGV CMAGDSTMVQ       610        620        630        640        EPVHLGAIDM YLRKRGHLVP ASWKLQVVKQ LAYALNYLED        650        660        670        680        KGLPHGNVSA RKVLLAREGA DGSPPFIKLS DPGVSPAVLS        690        700        710        720        LEMLTDRIPW VAPECLREAQ TLSLEADKWG FGATVWEVFS        730        740        750        760        GVTMPISALD PAKKLQFYED RQQLPAPKWT ELALLIQQCM        770        780        780        800AYEPVQRPSF RAVIRDLNSL ISSDYELLSD PTPGALAPRD       810        820        830        840        GLWNGAQLYA CQDPTIFEER HLKYISQLGK GNFGSVELCR        850        960        870        880        YDPLGDNTGA LVAVKQLQHS GPDQQRDFQR EIQILKALHS        890        900        910        920               DFIVKYRGVS YGPGRQSLRL VMEYLPSGCL RDFLQRHRAR         930        940        950        960               LDASRLLLYS SQICKGMEYL GSRRCVHRDL AARNILVESE         970        980        990       1000              AHVKIADFGL AKLLPLDKDY YVVREPGQSP IFWYAPESLS       1010       1020       1030       1040DINFSRQSDV WSFGVVLYEL FTYCDKSCSP SAEFLRMMGC      1050       1060       1070       1080             ERDVPALCRL LELLEEGQRL PAPPACPAEV HELMKLCWAP        1090       1100       1110       1120SPQDRPSFSA LGPQLDMLWS GSRGCETHAF TAHPEGKHHS LSFS

In one embodiment, the a crystallizable composition comprises acrystallization solution of equal volumes of JAK3 protein (7.5-30mg/ml), a salt, a buffer between pH 5.0 and 7.0, 0-10 mM DTT and apolyethylene glycol. The salt includes, but is not limited to KCl, NaCland (NH₄)₂SO₄. The polyethylene glycol includes, but is limited to,PEGMME 550, PEGMME2000, PEG4000, PEG6000. If the crystals are derivedfrom seeding techniques, the concentration of the polyethylene glycolmay be less than 20%. In another embodiment, the crystallizablecomposition comprises a crystallization solution of equal volumes ofJAK3 protein (10-15 mg/mL in 50 mM Hepes at pH 8.0, 500 mM NaCl, 20%(v/v) glycerol, 5 mM DTT, and 0.05% (w/v) β-octylglucopyranosideand asolution of 20-26% PEG 3350, 200-260 mM KCl, 20 mM spermine, 10 mM DTTand 100 mM bis-Tris pH 6.0. In one embodiment, the volume of proteinused is 0.5 μL. In another embodiment, the volume of protein used in 1.0μL. In another embodiment, the volume of protein used in 2.0 μL.

Crystals can be grown using sitting drop or hanging drop vapourdiffusion techniques, such as, but not limited to techniques describedin Example 3. Crystals can be grown in the Corning® 384 Well plate(available from Fisher Scientific), Greiner crystallization low profileplates (available from Hampton Research (Aliso Veijo, Calif.)), both the96-well CrystalQuick™ standard profile round and flat bottom plates(available from Hampton Research (Aliso Viejo, Calif.)), and the 24 wellVDX plates (available from Hampton Research (Aliso Viejo, Calif.)). Thevolume of the reservoir for the 384-well plate can be 50 μL. The volumeof the reservoir for the 96-well low profile plate can be 100 μL, andfor the CrystalQuick™ plates it can be varied between 70-100 μL.Crystals can also be grown in 72-well terasaki plates using themicrobatch method. They also can be grown in 96-well Corning® (availablefrom Hampton Research (Aliso Viejo, Calif.)) with a reservoir of 50 μL.

According to one embodiment, the invention provides for a crystal withunit cell dimensions of a=59.98 Å b=90.19 Å, c=69.00 Å, α=γ=90, β=11.5°and space group P2₁ with 2 molecules in the asymmetric unit. Preferably,the crystal comprises the JAK3-AMP-PNP complex.

According to another embodiment, the invention provides for a crystalwith unit cell dimensions of a=72.36 Å b=90.04 Å, c=105.60 Å, α=β=γ=90°and a space P2₁2₁2₁ with 2 molecules in the symmetric unit. Preferably,the crystal comprises the JAK3-AMP-PNP complex.

It will be readily apparent to those skilled in the art that the unitcells of the crystal compositions may deviate up to ±1-4 Å in celllength (and 7-8° in β angle in the P2₁ space group) from the above celldimensions depending on the deviation in the unit calculations orconformational change in the protein.

The JAK3 kinase domain or homologue thereof may be produced by anywell-known method, including synthetic methods, such as solid phase,liquid phase and combination solid phase/liquid phase syntheses;recombinant DNA methods, including cDNA cloning, optionally combinedwith site directed mutagenesis; and/or purification of the naturalproducts. In one embodiment, the protein is overexpressed in baculovirussystem.

Methods of Obtaining Crystals of JAK3 Kinase Domain, Complexes Thereofor Homologues Thereof

The invention also relates to a method of obtaining a crystal of JAK3kinase domain of JAK3 homologue thereof, comprising the steps of:

-   -   a) producing and purifying a JAK3 kinase domain or homologue        thereof;    -   b) combining a crystallizable solution with said JAK3 kinase        domain or homologue thereof to produce a crystallizable        composition; and    -   c) subjecting said crystallizable composition to conditions        which promote crystallization and obtaining said crystals.

The invention also relates to a method of obtaining a crystal of a JAK3kinase domain complex or JAK3 kinase domain homologue complex, furthercomprising the step of:

-   -   d) soaking said crystal in a buffer solution comprising a        chemical entity.

The invention also relates to a method of obtaining a crystal of JAK3kinase domain complex or JAK3 kinase domain homologue complex,comprising the steps of:

-   -   a) producing and purifying a JAK3 kinase domain or homologue        thereof;    -   b) b) combining a crystallizable solution with said JAK3 kinase        domain or homologue thereof in the presence of a chemical entity        to produce a crystallizable composition; and    -   c) subjecting said crystallizable composition to conditions        which promote crystallization and obtaining said crystals.

In one embodiment, the chemical entity is selected from the groupconsisting of an ATP analogue, nucleotide triphosphate, nucleotidediphosphate, phosphate, adenosine, AMP-PNP, substrate inhibitor, oractive site inhibitor. In another embodiment, the crystallizationsolution is as described previously. In another embodiment, thecomposition is treated with micro-crystals of JAK3 kinase domain or JAK3kinase domain homologues, or complexes thereof.

In certain embodiments, the method of making crystals of JAK3 kinasedomain. JAK3 kinase domain homologues, or complexes thereof, includesthe use of a device for promoting crystallizations. Devices forpromoting crystallization can include but are not limited to thehanging-drop, sitting drop, dialysis or microtube batch devices. (U.S.Pat. Nos. 4,886,646, 5,096,676, 5,130,105, 5,221,410 and 5,400, 741; Pavet al., Proteins: Structure, Function, and Genetics 20: 98-102 (1994),incorporated herein by reference). The hanging-drop, sitting-drop, andsome adaptations of the microbatch methods (D'Arcy et al., J. Cryst.Growth 168: 175-180 (1996) and Chayen, J. Appl. Cryst. 30: 198-202(1997)) produce crystals by vapor diffusion. The hanging drop andsitting drop containing the crystallizable composition is equilibratedin a reservoir containing a higher or lower concentration of theprecipitant. As the drop approaches equilibrium with the reservoir, thesaturation of protein in the solution leads to the formation ofcrystals.

Microseeding or seeding may be used to increase the size and quality ofcrystals. In this instance, micro-crystals are crushed to yield a stockseed solution. The stock seed solution is diluted in series. Using aneedle, glass rod, micro-pipet, micro-loop or strand of hair, a smallsample from each diluted solution is added to a set of equilibrateddrops containing a protein concentration equal to or less than aconcentration needed to create crystals without the presence of seeds.The aim is to end up with a single seed crystal that will act tonucleate crystal growth in the drop.

In would be readily apparent to one of skill the art to vary thecrystallization conditions disclosed above to identify othercrystallization conditions that would produce crystals of a JAK3 kinasedomain homologue, a JAK3 kinase domain homologue complex, a JAK3 kinasedomain or another JAK3 kinase domain complex. Such variations include,but are not limited to, adjusting pH, protein concentration and/orcrystallization temperature, changing the identity or concentration ofsalt and/or precipitant used, using a different method ofcrystallization, or introducing additives such as detergents (e.g.,TWEEN 20 (monolaurate), LDAO, Brij 30 (4 lauryl ether)), sugars (e.g.,glucose, maltose), organic compounds (e.g., dioxane, dimethylformamide),lanthanide ions or polyionic compounds that aid in crystallization. Highthroughput crystallization assays may also be used to assist in findingor optimizing the crystallization condition.

Binding Pockets of JAK3 Kinase Domain or Homologue Thereof

As disclosed herein, applicants have provided the three-dimensionalX-ray structure of JAK3-AMP-PNP complex. The atomic coordinates for thestructures of JAK3-AMP-PNP complex are presented in Table 2.

To use the structure coordinates generated for the JAK3 complex or oneof its binding pockets or homologues thereof, it may be necessary toconvert the structure coordinates, or portions thereof, into athree-dimensional shape (i.e., a three-dimensional representation ofthese complexes or binding pockets). This is achieved through the use ofa computer and commercially available software that is capable ofgenerating the three-dimensional representations or structures ofmolecules or molecular complexes, or portions thereof, from a set ofstructural coordinates. These three-dimensional representations may bedisplayed on a computer screen.

Binding pockets, also referred to as binding sites in the presentinvention, are of significant utility in fields such as drug discovery.The association of natural ligands or substrates with the bindingpockets of their corresponding receptors or enzymes is the basis of manybiological mechanisms of action. Similarly, many drugs exert theirbiological effects through association with the binding pockets ofreceptors and enzymes. Such associations may occur with all or part ofthe binding pocket. An understanding of such associations will help leadto the design of drugs having more favorable associations with theirtarget receptor or enzyme, and thus, improved biological effects.Therefore, this information is valuable in designing potentialinhibitors of the binding pockets of biologically important targets. Thebinding pockets of this invention will be important for drug design.

The conformations of JAK3 and other proteins at a particular amino acidsite, along the polypeptide backbone, can be compared using well-knownprocedures for performing sequence alignments of the amino acids. Suchsequence alignments allow for the equivalent sites on these proteins tobe compared. Such methods for performing sequence alignment include, butare not limited to, the “bestfit” program and CLUSTAL W Alignment Tool,Higgins et al., supra.

In one embodiment, the ATP-binding pocket comprises amino acid residuesLeu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,Ala853, Lys855, Val884, Met902, Glu903, Tyr904, Leu905, Pro906, Cys909,Arg911, Asp949, Arg953, Asn954, Leu956, Asp967, and Gln988 according tothe structure of the JAK3-AMP-PNP complex in Table 2. These amino acidresidues are within 5 Å (“5 Å sphere of amino acids”) of AMP-PNP boundin the ATP-binding pocket as identified using the program QUANTA(Accelrys, San Diego, Calif. ©2001, 2002).

In another embodiment, the ATP-binding pocket comprises amino acidresidues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833,Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855,Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903,Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912,His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956,Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990and Trp 993 according to the structure of the JAK3-AMP-PNP complex inTable 2. These amino acid residues are within 8 Å (“8 Å sphere of aminoacids”) of AMP-PNP bound in the ATP-binding pockets as identified usingthe program QUANTA (Accelrys, San Diego, Calif. ©2001, 2002).

It will be readily apparent to those of skill in the art that thenumbering of amino acid residues in homologues of human JAK3 may bedifferent than that set forth for human JAK3. Corresponding amino acidsin JAK3 homologues are easily identified by visual inspection of theamino acid sequences or by using commercially available homologysoftware programs. Homologues of JAK3 include, for example, JAK3 fromother species, such as non-humans primates, mouse, rat, etc.

Those of skill in the art understand that set of structure coordinatesfor an enzyme or an enzyme-complex, or a portion thereof, is a relativeset of points that define a shape in three dimensions. Thus, it ispossible that an entirely different set of coordinates could define asimilar or identical shape. Moreover, slight variations in theindividual coordinates will have little effect on overall shape. Interms of binding pockets, these variations would not be expected tosignificantly alter the nature of ligands that could associate withthose pockets.

The variations in coordinates discussed above may be generated becauseof mathematical manipulations of the JAK3-AMP-PNP structure coordinates.For example, the structure coordinates set forth in Table 2 may undergocrystallographic permutations of the structure coordinates,fractionalization of the structure coordinates, integer additions orsubtractions to sets of the structure coordinates, inversion of thestructure coordinates or any combinations of the above.

Alternatively, modifications in the crystal structure due to mutations,additions, substitutions, and/or deletions of amino acids, or otherchanges in any of the components that make up the crystal may alsoaccount for variations in structure coordinates. If such variations arewithin a certain root mean square deviation as compared to the originalcoordinates, the resulting three-dimensional shape is consideredencompassed by this invention. Thus, for example, a ligand that bound tothe ATP-binding pocket of JAK3 would also be expected to bind to anotherbinding pocket whose structure coordinates defined a shape that fellwithin the RMSD value.

Various computational analyses may be necessary to determine whether amolecule or binding pocket, or portion thereof, is sufficiently similarto the binding pockets above-described. Such analyses may be carried outin well known software applications, such as ProFit (A.C.R. Martin,ProFit version 1.8, http://www.bioinf.org.uk/software), Swiss-Pdb Viewer(Guex and Peitsch, Electrophoresis 18: 2714-2723 (1997)), the MolecularSimilarity application of QUANTA (Accelrys, San Diego, Calif. ©2001,2002) and as described in the accompanying User's Guide, which areincorporated herein by reference.

The above programs permit comparisons between different structures,different conformations of the same structure, and different parts ofthe same structure. The procedure used in QUANTA (Accelrys, San Diego,Calif. ©2001, 2002) and Swiss-Pdb Viewer (Guex and Peitsch,Electrophoresis 18: 2714-2723 (1997) to compare structures is dividedinto four steps: 1) load the structures to be compared; 2) define theatom equivalences in these structures; 3) perform a fitting operation onthe structures; and 4) analyze the results.

The procedure used in ProFit to compare structures includes thefollowing steps: 1) load the structures to be compared; 2) specifyselected residues of interest; 3) define the atom equivalences in theselected residues; 4) perform a fitting operation on the selectedresidues; and 5) analyze the results.

Each structure in the comparison is identified by a name. One structureis identified as the target (i.e., the fixed structure); all remainingstructures are working structures (i.e., moving structures). Since atomequivalency within QUANTA (Accelrys, San Diego, Calif. ©2001, 2002) isdefined by user input, for the purposes of this invention, we willdefine equivalent atoms as protein backbone atoms N, O, C and Cα for allcorresponding amino acid residues between two structures being compared.

The corresponding amino acids may be identified by sequence alignmentprograms such as the “bestfit” program available from the GeneticsComputer Group which uses the local homology algorithm described bySmith and Waterman in Advances in Applied Mathematics 2: 482 (1981),which is incorporated herein by reference. A suitable amino acidsequence alignment will require that the proteins being aligned shareminimum percentage of identical amino acids. Generally, a first proteinbeing aligned with a second protein should share in excess of about 35%identical amino acids (Hanks et al., Science 241: 42 (1988); Hanks andQuinn, Methods in Enzymology 200: 38 (1991)). The identification ofequivalent residues can also be assisted by secondary structurealignment, for example, aligning the α-helices, β-sheets in thestructure. The program Swiss-Pdb viewer (Guex and Peitsch,Electrophoresis 18: 2714-2723 (1997) utilizes a best fit algorithm thatis based on secondary sequence alignment.

When a rigid fitting method is used, the working structure is translatedand rotated to obtain an optimum fit with the target structure. Thefitting operation uses an algorithm that computes the optimumtranslation and rotation to be applied to the moving structure, suchthat the root mean square difference of the fit over the specified pairsof equivalent atom is an absolute minimum. This number, given inangstroms, is reported by the above programs. The Swiss-Pdb Viewerprogram (Guex and Peitsch, Electrophoresis 18: 2714-2723 (1997) sets anRMSD cutoff for eliminating pairs of equivalent atoms that have highRMSD values. An RMSD cutoff value can be used to exclude pairs ofequivalent atoms with extreme individual RMSD values. In the programProFit, the RMSD cutoff value can be specified by the user.

For the purpose of this invention, any molecule, molecular complex,binding pocket, motif, domain thereof or portion thereof that is withina root mean square deviation for backbone atoms (N, Cα, C, O) whensuperimposed on the relevant backbone atoms described by structurecoordinates listed in Table 2 are encompassed by this invention.

One embodiment of this invention provides a crystalline moleculecomprising a protein defined by structure coordinates of a set of aminoacid residues that are identical to JAK3 amino acid residues accordingto Table 2, wherein the RMSD between backbone atoms of said set of aminoacid residues and said JAK3 amino acid residues is not more than about3.0 Å. In other embodiments, the RMSD between backbone atoms of said setof amino acid residues and said JAK3 amino acid residues is not greaterthan about 2.0 Å, not greater than about 1.5 Å, not greater than about1.1 Å, not greater than about 1.0 Å, not greater than about 0.9 Å, notgreater than about 0.8 Å, not greater than about 0.7 Å, not greater thanabout 0.6 Å, or not greater than about 0.5 Å. Calculations of RMSDvalues were done with Swiss Pdb Viewer (Guex Peitsch, Electrophoresis18: 2714-2723 (1997)).

In one embodiment, the present invention provides a crystalline moleculecomprising all or part of a binding pocket defined by a set of aminoacid residues comprising amino acid residues which are identical tohuman JAK3 amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831,Asn 832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853,Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901,Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910,Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954,Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988,Ser989, Pro990 and Trp 993 according to Table 2, wherein the RMSD of thebackbone atoms between said JAK3 amino acid residues and said amino acidresidues which are identical is not greater than about 2.5 Å. In otherembodiments, the RMSD is not greater than about 2.4 Å, 2.2 Å, 2.0 Å, 1.8Å, 1.6 Å, 1.4 Å, 1.2 Å, 1.0 Å, 0.8 Å, 0.5 Å, 0.3 Å, or 0.2 Å. In otherembodiments, the binding pocket is defined by a set of amino acidresidues comprising at least four, six, eight, ten, twelve, fifteen,twenty, twenty-five, thirty, thirty-five, forty, forty-five or fiftyamino acid residues which are identical to said JAK3 amino acidresidues.

Computer Systems

According to another embodiment, this invention provides amachine-readable data storage medium, comprising a data storage materialencoded with machine-readable data, wherein said data defines theabove-mentioned molecules or molecular complexes. In one embodiment, thedata defines the above-mentioned binding pockets by comprising thestructure coordinates of said amino acid residues according to Table 2.To use the structure coordinates generated for JAK3 homologues thereof,or one of its binding pockets, it is at times necessary to convert theminto a three-dimensional shape or to extract three-dimensionalstructural information from them. This is achieved through the use ofcommercially or publicly available software that is capable ofgenerating a three-dimensional structure or a three-dimensionalrepresentation of molecules or portions thereof from a set of structurecoordinates. In one embodiment, three-dimensional structure orrepresentation may be displayed graphically.

Therefore, according to another embodiment, this invention provides amachine-readable data storage medium comprising a data storage materialencoded with machine readable data. In one embodiment, a machineprogrammed with instructions for using said data is capable ofgenerating a three-dimensional structure or three-dimensionalrepresentation of any of the molecules, or molecular complexes orbinding pockets thereof, that are described herein.

This invention also provides a computer comprising:

-   -   (a) a machine-readable data storage medium, comprising a data        storage material encoded with machine-readable data, wherein        said data defines any one of the above molecules or molecular        complexes;    -   (b) a working memory for storing instructions for processing        said machine-readable data;    -   (c) a central processing unit (CPU) coupled to said working        memory and to said machine-readable data storage medium for        processing said machine readable data and means for generating        three-dimensional structural information of said molecule or        molecular complex; and    -   (d) output hardware coupled to said central processing unit for        outputting three-dimensional structural information of said        molecule or molecular complex, or information produced by using        said three-dimensional structural information of said molecule        or molecular complex.

In one embodiment, the data defines the binding pocket of the moleculeor molecular complex.

Three-dimensional data generation may be provided by an instruction orset of instructions such as a computer program or commands forgenerating a three-dimensional structure or graphical representationfrom structure coordinates, or by subtracting distances between atoms,calculating chemical energies for a JAK3 molecule or molecular complexor homologues thereof, or calculating or minimizing energies for anassociation of a JAK3 molecule or molecular complex or homologuesthereof to a chemical entity. The graphical representation can begenerated or displayed by commercially available software programs.Examples of software programs include but are not limited to QUANTA(Accelrys, San Diego, Calif. ©2001, 2002), O (Jones et al., ActaCrystallogr. A47: 110-119 (1991)) and RIBBONS (Carson, J. Appl.Crystallogr. 24: 958-961 (1991)), which are incorporated herein byreference. Certain software programs may imbue this representation withphysico-chemical attributes which are know from the chemical compositionof the molecule, such as residue charge, hydrophobicity, torsional androtational degrees of freedom for the residue or segment, etc. Examplesof software programs for calculating chemical energies are described inthe Rational Drug Design section.

Information of said binding pocket or information produced by using saidbinding pocket can be outputted through display terminals, touchscreens,facsimile machines, modems, CD-ROMS, printers, a CD or DVD recorder,ZIP™ or JAZ™ drives or disk drives. The information can be in graphicalor alphanumeric form.

In one embodiment, the computer is executing an instruction such as acomputer program for generating three-dimensional structure or docking.In another embodiment, the computer further comprises a commerciallyavailable software program to display the information as a graphicalrepresentation. Examples of software programs include but as not limitedto, QUANTA (Accelrys, San Diego, Calif. ©2001, 2002), O (Jones et al.,Acta Crystallogr. A47: 110-119 (1991)) and RIBBONS (Carson, J. Appl.Crystallogr. 24: 958-961 (1991)), all of which are incorporated hereinby reference.

FIG. 8 demonstrates one version of these embodiments. System (10)includes a computer (11) comprising a central processing unit (“CPU”)(20), a working memory (22) which may be, e.g., RAM (random-accessmemory) or “core” memory, mass storage memory (24) (such as one or moredisk drives, CD-ROM drives or DVD-ROM drives), one or more cathode-raytube (“CRT”) display terminals (26), one or more keyboards (28), one ormore input lines (30), and one or more output lines (40), all of whichare, interconnected by a conventional bi-directional system bus (50).

Input hardware (35), coupled to computer (11) by input lines (30), maybe implemented in a variety of ways. Machine-readable data of thisinvention may be inputted via the use of a modem or modems (32)connected by a telephone line or dedicated data line (34). Alternativelyor additionally, the input hardware (35) may comprise CD-ROM or DVD-ROMdrives or disk drives (24). In conjunction with display terminal (26),keyboard (28) may also be used as an input device.

Output hardware (46), coupled to computer (11) by output lines (40), maysimilarly be implemented by conventional devices. By way of example,output hardware (46) may include CRT display terminal (26) fordisplaying a graphical representation of a binding pocket of thisinvention using a program such as QUANTA (Accelrys, San Diego, Calif.©2001, 2002) as described herein. Output hardware may also include aprinter (42), so that hard copy output may be produced, or a disk drive(24), to store system output for later use. Output hardware may alsoinclude a display terminal, touchscreens, facsimile machines, modems, aCD or DVD recorder, ZIP™ or JAZ™ drives, disk drives, or othermachine-readable data storage device.

In operation, CPU (20) coordinates the use of the various input andoutput devices (35), (46), coordinates data accesses from mass storage(24) and accesses to and from working memory (22), and determines thesequence of data processing steps. A number of programs may be used toprocess the machine-readable data of this invention. Such programs arediscussed in reference to the computational methods of drug discovery asdescribed herein. Specific references to components of the hardwaresystem (10) are included as appropriate throughout the followingdescription of the data storage medium.

FIG. 9 shows a cross section of a magnetic data storage medium (100)which can be encoded with a machine-readable data that can be carriedout by a system such as system (10) of FIG. 8. Medium (100) can be aconventional floppy diskette or hard disk, having a suitable substrate(101), which may be conventional, and a suitable coating (102), whichmay be conventional, on one or both sides, containing magnetic domains(not visible) whose polarity or orientation can be altered magnetically.Medium (100) may also have an opening (not shown) for receiving thespindle of a disk drive or other data storage device (24).

The magnetic domains of coating (102) of medium (100) are polarized ororiented so as to encode in manner which may be conventional, machinereadable data such as that described herein, for execution by a systemsuch as system (10) of FIG. 8.

FIG. 10 shows a cross-section of an optically-readably data storagemedium (110) which also can be encoded with such a machine-readabledata, or set of instructions, which can be carried out by a system suchas system (10) or FIG. 8. Medium (110) can be a conventional compactdisk read only memory (CD-ROM) or a rewritable medium such as amagneto-optical disk which is optically readable and magneto-opticallywritable. Medium (100) preferably has a suitable substrate (111), whichmay be conventional, and a suitable coating (112), which may beconventional, usually of one side of substrate (111).

In the case of CD-ROM, as is well known, coating (112) is reflective andis impressed with a plurality of pits (113) to encode themachine-readable data. The arrangement of pits is read by reflectinglaser light off the surface of coating (112). A protective coating(114), which preferably is substantially transparent, is provided on topof coating (112).

In the case of a magneto-optical disk, as is well known, coating (112)has no pits (113), but has a plurality of magnetic domains whosepolarity or orientation can be changed magnetically when heated above acertain temperature, as by a laser (not shown). The orientation of thedomains can be read by measuring the polarization of laser lightreflected from coating (112). The arrangement of the domains encodes thedata as described above.

In one embodiment, the structure coordinates of said molecules ormolecular complexes are provided by homology modeling of at least aportion of the structure coordinates of Table 2. Homology modeling canbe used to generate structural models of JAK3 homologues or otherhomologues proteins based on the known structure of JAK3. This can beachieved by performing one or more of the following steps: performingsequence alignment between the amino acid sequence of a molecule(possibly an unknown molecule) against the amino acid sequence of JAK3;identifying conserved and variable regions by sequence or structure;generating structure coordinates for structurally conserved residues ofthe unknown structure from those of JAK3; generating conformation forthe structurally variable residues in the unknown structure; replacingthe non-conserved residues of JAK3 with residues in the unknownstructure; building side chain conformations; and refining and/orevaluating the unknown structure.

Software programs that are useful in homology modeling include XALIGN(Wishart et al., Comput. Appl. Biosci. 10: 687-688 (1994)) and CLUSTAL WAlignment Tool, Higgins et al., supra. See also, U.S. Pat. No.5,884,230. These references are incorporated herein by reference.

To perform the sequence alignment, programs such as the “bestfit”program available from the Genetics Computer Group (Waterman in Advancesin Applied Mathematics 2: 482 (1981), which is incorporated herein byreference) and CLUSTAL W Alignment Tool (Higgins et al., supra, which isincorporated by reference) can be used. To model the amino acid sidechains of homologous molecules, the amino acid residues in JAK3 can bereplaced, using a computer graphics program such as “O” (Jones et al.,Acta Cryst. Sect. A 47: 110-119 (1997)), by those of the homologousprotein, where they differ. The same orientation or a differentorientation of the amino acid can be used. Insertions and deletions ofamino acid residues may be necessary where gaps occur in the sequencealignment. However, certain portions of the active site of JAK3 and itshomologues are highly conserved with essentially no insertions anddeletions.

Homology modeling can be performed using, for example, the computerprograms SWISS-MODEL available through Glaxo Wellcome ExperimentalResearch in Geneva, Switzerland; WHATIF available on EMBL servers;Schnare et al., J. Mol. Biol. 256: 701-719 (1996); Blundell et al.,Nature 326: 347-352 (1987); Fetrow and Bryant, Bio/Technology 11:479-484(1993); Greer, Methods in Enzymology 202:239-252 (1991); and Johnson etal., Crit. Rev. Biochem. Mol Biol. 29: 1-68 (1994). An example ofhomology modeling can be found, for example, in Szklarz, Life Sci. 61:2507-2520 (1997). These references are incorporated herein by reference.

Thus, in accordance with the present invention, data capable ofgenerating the three-dimensional structure or three-dimensionalrepresentation of the above molecules or molecular complexes, or bindingpockets thereof, can be stored in a machine-readable storage medium,which is capable of displaying structural information or a graphicalthree-dimensional representation of the structure. In one embodiment,the means of generating a three-dimensional is provided by the means forgenerating a three-dimensional structural representation of the bindingpocket or protein of a molecule or molecular complex.

Rational Drug Design

The JAK3 structure coordinates or the three-dimensional graphicalrepresentation generated from these coordinates may be used inconjunction with a computer for a variety of purposes, including drugdiscovery.

For example, the structure encoded by the data may be computationallyevaluated for its ability to associate with chemical entities. Chemicalentities that associate with JAK3 may inhibit or activate JAK3 or itshomologues, and are potential drug candidates. Alternatively, thestructure encoded by the data may be displayed in a graphicalthree-dimensional representation on a computer screen. This allowsvisual inspection of the structure, as well as visual inspection of thestructure's association with chemical entities.

In one embodiment, the invention provides for a method of using acomputer for selecting an orientation of a chemical entity thatinteracts favorably with a binding pocket or domain comprising the stepsof:

-   -   (a) providing the structure coordinates of said binding pocket        or domain on a computer comprising the means for generating        three-dimensional structural information from said structure        coordinates;    -   (b) employing computational means to dock a first chemical        entity in the binding pocket or domain;    -   (c) quantifying the association between said chemical entity and        all or part of the binding pocket or domain for different        orientations of the chemical entity; and    -   (d) selecting the orientation of the chemical entity with the        most favorable interaction based on said quantified association.

In one embodiment, the docking is facilitated by said quantifiedassociation.

In one embodiment, the above method further comprises the followingsteps before step (a):

-   -   (e) producing a crystal of a molecule or molecular complex        comprising JAK3 kinase domain or homologue thereof;    -   (f) determining the three-dimensional structure coordinates of        the molecule or molecular complex by X-ray diffraction of the        crystal; and    -   (g) identifying all or part of a binding pocket that corresponds        to said binding pocket.

Three-dimensional structural information in step (a) may be generated byinstructions such as a computer program or commands that can generate athree-dimensional representation; subtract distances between atoms;calculate chemical energies for a JAK3 molecule, molecular complex orhomologues thereof; or calculate or minimize the chemical energies of anassociation of JAK3 molecule, molecular complex or homologues thereof toa chemical entity. These types of computer programs are known in theart. The graphical representation can be generated or displayed bycommercially available software programs. Examples of software programsinclude but are not limited to QUANTA (Accelrys, San Diego, Calif.©2001, 2002), O (Jones et al., Acta Crystallogr. A47: 110-119 (1991))and RIBBONS (Carson, J. Appl. Crystallogr. 24: 958-961 (1991)), whichare incorporated herein by reference. Certain software programs mayimbue this representation with physico-chemical attributes which areknown from the chemical composition of the molecule, such as residuecharge, hydrophobicity, torsional and rotational degrees of freedom forthe residue or segment, etc. Examples of software programs forcalculating chemical energies are described below.

The above method may further comprise the following step after step (d):outputting said quantified association to a suitable output hardware,such as a CRT display terminal, a CD or DVD recorder, ZIP™ or JAZ™drive, a disk drive, or other machine-readable data storage device, asdescribed previously. The method may further comprise generating athree-dimensional structure, graphical representation thereof, or both,of the molecule or molecular complex prior to step (b).

One embodiment of this invention provides for the above method, whereinenergy minimization, molecular dynamics simulations, or rigid bodyminimizations are performed simultaneously with or following step (b).

The above method may further comprise the steps of:

-   -   (e) repeating steps (b) through (d) with a second chemical        entity; and    -   (f) selecting at least one of said first or second chemical        entity that interacts more favorably with said binding pocket or        domain based on said quantified association of said first or        second chemical entity.

In another embodiment, the invention provides for the method of using acomputer for selecting an orientation of a chemical entity with afavorable shape complementarity in a binding pocket comprising the stepsof:

-   -   (a) providing the structure coordinates of said binding pocket        and all or part of the ligand bound therein on a computer        comprising the means for generating three-dimensional structural        information from said structure coordinates;    -   (b) employing computational means to dock a first chemical        entity in the binding pocket;    -   (c) quantiating the contact score of said chemical entity in        different orientations; and    -   (d) selecting an orientation with the highest contact score.

In one embodiment, the docking is facilitated by the contact score.

The method above may further comprise the step of generating athree-dimensional graphical representation of the binding pocket and allor part of the ligand bound therein prior to step (b).

The method above may further comprise the steps of:

-   -   (e) repeating steps (b) through (d) with a second chemical        entity; and    -   (f) selecting at least one of said first or second chemical        entity that has a higher contact score based on said quantitated        contact score of said first or second chemical entity.

In another embodiment, the invention provides a method for screening aplurality of chemical entities to associate at a deformation energy ofbinding of less than −7 kcal/mol with said binding pocket;

-   -   (a) employing computational means, which utilize said structure        coordinates to dock one of said plurality of chemical entities        in said binding pocket;    -   (b) quantifying the deformation energy of binding between the        chemical entity and the binding pocket;    -   (c) repeating steps (a) and (b) for each remaining chemical        entity; and    -   (d) outputting a set of chemical entities that associate with        the binding pocket at a deformation energy of binding of less        than −7 kcal/mol to a suitable output hardware.

In another embodiment, the method comprises the steps of:

-   -   (a) constructing a computer model of the binding pocket of said        molecule or molecular complex;    -   (b) selecting a chemical entity to be evaluated by a method        selected from the group consisting of assembling said chemical        entity; selecting a chemical entity from a small molecule        database; de novo ligand design of said chemical entity; and        modifying a known agonist or inhibitor, or a portion thereof, of        a JAK3 kinase domain, or homologue thereof;    -   (c) employing computational means to dock said chemical entity        to be evaluated in said binding pocket in order to provide an        energy-minimized configuration of said chemical entity in the        binding pocket; and    -   (d) evaluating the results of said docking to quantify the        association between said chemical entity and the binding pocket.

Alternatively, the structure coordinates of the JAK3 binding pocket maybe utilized in a method for identifying a candidate inhibitor of amolecule or molecular complex comprising a binding pocket of JAK3. Thismethod comprises the steps of:

-   -   (a) using a three-dimensional structure of the binding pocket or        domain to design, select or optimize a plurality of chemical        entities;    -   (b) contacting each chemical entity with the molecule said        molecular complex;    -   (c) monitoring the inhibition to the catalytic activity of the        molecule or molecular complex by the chemical entity; and    -   (d) selecting a chemical entity based on the effect of the        chemical entity on the activity of the molecule or molecular        complex.

In one embodiment, the three-dimensional structure is displayed as agraphical representation.

In another embodiment, the method comprises the steps of:

-   -   (a) constructing a computer model of a binding pocket of the        molecule or molecular complex;    -   (b) selecting a chemical entity to be evaluated by a method        selected from the group consisting of assembling said chemical        entity; selectign a chemical entity from a small molecule        database; de novo ligand design of said chemical entity; and        modifying a known agonist or inhibitor, or a portion thereof, of        a JAK3 kinase domain or homologue thereof;    -   (c) employing computation means to dock said chemical entity to        be evaluated and said binding pocket in order to provide an        energy-minimized configuration of said chemical entity in the        binding pocket; and    -   (d) evaluating the results of said docking to quantify the        association between said chemical entity and the binding pocket;    -   (e) synthesizing said chemical entity; and    -   (f) contacting said chemical entity with said molecule or        molecular complex to determine the ability of said chemical        entity to activate or inhibit said molecule.

In one embodiment, the invention provides a method of designing acompound or complex that associates with all or part of the bindingpocket comprising the steps of:

-   -   (a) providing the structure coordinates of said binding pocket        or domain on a computer comprising the means for generating        three-dimensional structural information from said structure        coordinates;    -   (b) using the computer to dock a first chemical entity in part        of the binding pocket or domain;    -   (c) docking a second chemical entity in another part of the        binding pocket or domain;    -   (d) quantifying the association between the first and second        chemical entity and part of the binding pocket or domain;    -   (e) repeating steps (b) to (d) with another first and second        chemical entity, selecting a first and a second chemical entity        based on said quantified association of all of said first and        second chemical entity;    -   (f) optionally, visually inspecting the relationship of the        first and second chemical entity to each other in relation to        the binding pocket or domain on a computer screen using the        three-dimensional graphical representation of the binding pocket        or domain and said first and second chemical entity; and    -   (g) assembling the first and second chemical entity into a        compound or complex that interacts with said binding pocket by        modeling building.

For the first time, the present invention permits the use of moleculardesign techniques to identify, select and design chemical entities,including inhibitory compounds, capable of binding to JAK3 or JAK3-likebinding pockets, motifs and domains.

Applicant's elucidation of binding pockets on JAK3 provides thenecessary information for designing new chemical entities and compoundsthat may interact with JAK3 substrate, active site, in whole or in part.

Throughout this section, discussions about the ability of a chemicalentity to bind to, interact with or inhibit JAK3 binding pockets referto features of the entity alone.

The design of compounds that bind to or inhibit JAK3 binding pocketsaccording to this invention generally involves consideration of twofactors. First, the chemical entity must be capable of physically andstructurally associating with parts or all of the JAK3 binding pockets.Non-covalent molecular interactions important in this associationinclude hydrogen bonding, van der Waals interactions, hydrophobicinteractions and electrostatic interactions.

Second, the chemical entity must be able to assume a conformation thatallows it to associate with the JAK3 binding pockets directly. Althoughcertain positions of the chemical entity will not directly participatein these associations, those portions of the chemical entity may stillinfluence the overall conformation of the molecule. This, in turn, mayhave a significant impact on potency. Such conformational requirementsinclude the overall three-dimensional structure and orientation of thechemical entity in relation to all or a portion of the binding pocket,or the spacing between functional groups of a chemical entity comprisingseveral chemical entities that directly interact with the JAK3 orJAK3-like binding pockets.

The potential inhibitory or binding effect of a chemical entity on JAK3binding pockets may be analyzed prior to its actual synthesis andtesting by the use of computer modeling techniques. If the theoreticalstructure of the given entity suggests insufficient interaction andassociation between it and the JAK3 binding pockets, testing of theentity is obviated. However, if computer modeling indicates a stronginteraction, the molecule may then be synthesized and tested for itsability to bind to a JAK3 binding pocket. This may be achieved bytesting the ability of the molecule to inhibit JAK3 using the assaydescribed in Example 9.

A potential inhibitor of a JAK3 binding pocket may be computationallyevaluated by means of a series of steps in which chemical entities orfragments are screened and selected for their ability to associate withthe JAK3 binding pockets.

One skilled in the art may use one of several methods to screen chemicalentities or fragments or moieties thereof for their ability to associatewith the binding pockets described herein. This process may begin byvisual inspection of, for example, any of the binding pockets on thecomputer screen based on the JAK3 structure coordinates Table 2 or othercoordinates which define a similar shape generated from themachine-readable storage medium. Selected chemical entities, orfragments or moieties thereof may then be positioned in a variety oforientations, or docked, within that binding pocket as defined supra.Docking may be accomplished using software such as QUANTA (Accelrys, SanDiego, Calif. ©2001,2002) and Sybyl (Tripos Associates, St. Louis, Mo.),followed by, or performed simultaneously with, energy minimization,rigid-body minimization (Gshwend, supra) and molecular dynamics withstandard molecular mechanics force fields, such as CHARMM and AMBER.

Specialized computer programs may also assist in the process ofselecting fragments or chemical entities. These include:

-   -   1. GRID (Goodford, P. J., “A Computational Procedure for        Determining Energetically Favorable Binding Sites on        Biologically Important Macromolecules”, J. Med. Chem. 28:        849-857 (1985)). GRID is available from Oxford University,        Oxford, UK.    -   2. MCSS (Miranker et al., “Functionality Maps of Binding Sites:        A Multiple Copy Simultaneous Search Method,” Proteins Struct.        Funct. Genet. 11: 29-34 (1991)). MCSS is available from        Molecular Simulations, San Diego, Calif.    -   3. AUTODOCK (Goodsell, et al., “Automated Docking of Substrates        to Proteins by Simulated Annealing”, Proteins Struct. Funct. and        Genet. 8: 195-202 (1990)). AUTODOCK is available from Scripps        Research Institute, La Jolla, Calif.    -   4. DOCK (Kuntz et al., “A Geometric Approach to        Macromolecule-Ligand Interactions”, J. Mol. Biol. 161: 269-288        (1982)). DOCK is available from University of California, San        Francisco, Calif.

Once suitable chemical entities or fragments have been selected, theycan be assembled into single compound or complex. Assembly may bepreceded by visual inspection of the relationship of the fragments toeach other on the three-dimensional image displayed on a computer screenin relation to the structure coordinates of JAK3. This would be followedby manual model building using software such as QUANTA (Accelrys, SanDiego, Calif. ©2001, 2002) or Sybyl (Tripos Associates, St. Louis, Mo.).

Useful programs to aid one of skill in the art in connecting theindividual chemical entities or fragments include:

-   -   1. CAVEAT (Bartlett et al., “CAVEAT: A Program to Facilitate the        Structure-Derived Design of Biologically Active Molecules”, in        Molecular Recognition in Chemical and Biological Problems, S. M.        Roberts, Ed., Royal Society of Chemistry, Special Publication        No. 78: 182-196 (1989); Lauri, G. and Bartlett, P. A., “CAVEAT:        A Program to Facilitate the Design of Organic Molecules”, J.        Comp. Aid. Molec. Design 8: 51-66 (1994)), CAVEAT is available        from the University of California, Berkeley, Calif.    -   2. 3D Database systems such as ISIS (MDL Information Systems,        San Leandro, Calif.). This area is reviewed in Martin, Y. C.,        “3D Database Searching in Drug Design”, J. Med. Chem. 35:        2145-2154 (1992).    -   3. HOOK (Eisen et al., “HOOK: A program for Finding Novel        Molecular Architectures that Satisfy the Chemical and Steric        Requirements of a Macromolecule Binding Site”, Proteins Struct.        Funct. Genet. 19: 199-221 (1994)). HOOK is available from        Molecular Simulations, San Diego, Calif.

Instead of proceeding to build an inhibitor of a JAK3 binding pocket ina step-wise fashion one fragment or chemical entity at a time asdescribed above, inhibitory or other JAK3 binding compounds may bedesigned as a whole or “de novo” using either an empty binding pocket oroptionally including some portion(s) of a known inhibitor(s). There aremany de novo ligand design methods including:

-   -   1. LUDI (Böhm, J.-J., “The Computer Program LUDI: A New Method        for the De Novo Design of Enzyme Inhibitors”, J. Comp. Aid.        Molec. Design 6: 61-78 (1992)). LUDI is available from Molecular        Simulations Incorporated, San Diego, Calif.    -   2. LEGEND (Nishibata et al., Tetrahedron 47: 8985-8990 (1991)).        LEGEND is available from Molecular Simulations Incorporated, San        Diego, Calif.    -   3. LeapFrog (available from Tripos Associates, St. Louis, Mo.).    -   4. SPROUT (Gillet et al., “SPROUT: A program for Structure        Generation)”, J. Comp. Aid. Molec. Design 7: 127-153 (1993)).        SPROUT is available from the University of Leeds, UK.

Other molecular modeling techniques may also be employed in accordancewith this invention (see, e.g., Cohen et al., “Molecular ModelingSoftware and Methods for Medicinal Chemistry, J. Med. Chem. 33: 883-894(1990); see also, Navia, M. A. and Murcko, M. A., “The Use of StructuralInformation in Drug Design”, Current Opinions in Structural Biology 2:202-210 (1992); Balbes et al., “A Perspective of Modern Methods inComputer-Aided Drug Design”, in Reviews in Computational Chemistry, K.B. Lipkowitz and D. B. Boyd, Eds., VCH Publishers, New York, 5: 337-379(1994); see also, Guida, W. C., “Software For Structure-Based DrugDesign”, Curr. Opin. Struct. Biology 4: 777-781 (1994)).

Once a chemical entity has boon designed or selected by the abovemethods, the efficiency with which that entity may bind to any of theabove binding, pockets may be tested and optimized by computationalevaluation. For example, an effective binding pocket inhibitor mustpreferably demonstrate a relatively small difference in energy betweenits bound and free states (i.e., a small deformation energy of binding).Thus, the most efficient binding pocket inhibitors should preferably bedesigned with a deformation energy of binding of not greater than about10 kcal/mole, more preferably, not greater than 7 kcal/mole. Bindingpocket inhibitors may interact with the binding pocket in more than oneconformation that is similar in overall binding energy. In those cases,the deformation energy of binding is taken to be the difference betweenthe energy of the free entity and the average energy of the conformationobserved when the inhibitor binds to the protein.

A chemical entity designed or selected as binding to any one of theabove binding pocket may be further computationally optimized so that inits bound state it would preferably lack repulsive electrostaticinteraction with the target enzyme and with the surrounding watermolecules. Such non-complementary electrostatic interactions includerepulsive charge-charge, dipole-dipole and charge-dipole interactions.

Specific computer software is available in the art to evaluate compounddeformation energy and electrostatic interactions. Examples of programsdesigned for such uses include: Gaussian 94, revision C (M. J. Frisch,Gaussian, Inc., Pittsburgh, Pa. ©1995); AMBER version 4.1 (P. A.Kollman, University of California at San Francisco, ©1995); QUANT/CHARMM(Accelrys, San Diego, Calif. ©2001, 2002); Insight II/Discover(Molecular Simulations, Inc., San Diego, Calif. ©1998); DelPhi(Molecular Simulations, Inc., San Diego, Calif. ©1998); and AMSOL(Quantum Chemistry Program Exchange, Indiana University). These programsmay be implemented, for instance, using a Silicon Graphics workstationsuch as an Indigo2 with “IMPACT” graphics. Other hardware systems andsoftware packages will be known to those skilled in the art.

Another approach enabled by this invention is the computationalscreening of small molecule databases for chemical entities or compoundsthat can bind in whole, or in part, to any of the above binding pocket.In this screening, the quality of fit of such entities to the bindingpocket may be judged either by shape complementarity or by estimatedinteraction energy (Meng et al., J. Comp. Chem. 13: 505-524 (1992)).

Another particularly useful drug design technique enabled by thisinvention is iterative drug design. Iterative drug design is a methodfor optimizing associations between a protein and a chemical entity bydetermining and evaluating the three-dimensional structures ofsuccessive sets protein/chemical entity complexes.

In iterative drug design, crystals of a series of protein or proteincomplexes are obtained and then the three-dimensional structures of eachcrystal is solved. Such an approach provides insight into the associatedbetween the proteins and compounds of each complex. This is accomplishedby selecting compounds with inhibitory activity, obtaining crystals ofthis new protein/compound complex, solving the three-dimensionalstructure of the complex, and comparing the associations between the newprotein/compound complex and previously solved protein/compoundcomplexes. By observing how changes in compound affected theprotein-compound associations, these associations may be optimized.

In some cases, iterative drug design is carried out by formingsuccessive protein-compound complexes and then crystallizing each newcomplex. High throughput crystallization assays may be used to find anew crystallization condition or to optimize the original proteincrystallization condition for the new complex. Alternatively, apre-formed protein crystal may be soaked in the presence of aninhibitor, thereby forming a protein/compound complex and obviating theneed to crystallize each individual protein/compound complex.

In one embodiment, this invention provides a method for identifying acandidate inhibitor that interacts with a binding site of a Janus Kinase3 kinase protein or a homologue thereof, comprising the steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3        kinase protein or said homologue thereof, wherein the crystal is        characterized with space group P2₁ and has unit cell parameters        of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5°;    -   (b) obtaining the structure coordinates of amino acids of the        crystal step (a), wherein the structure coordinates are set        forth in Table 1;    -   (c) generating a three-dimensional model of said human Janus        Kinase 3 kinase protein or said homologue thereof using the        structure coordinates of the amino acids obtained in step (b), a        root mean square deviation from backbone atoms of said amino        acids of not more than ±2.0 Å;    -   (d) determining a binding site of said human Janus Kinase 3        kinase protein or said homologue thereof from said        three-dimensional model; and    -   (e) performing computer fitting analysis to identify the        candidate inhibitor which interacts with said binding site.

In one embodiment, this method further comprising the step of:

-   -   (f) contacting the identified candidate inhibitor with said        human Janus Kinase 3 kinase protein or said homologue thereof in        order to determine the effect of the inhibitor on human Janus        Kinase 3 kinase protein activity.

In another embodiment, the binding site of said human Janus Kinase 3kinase protein or said homologue thereof determined in step (d)comprises the structure coordinates according to Table 1 of amino acidresidues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833,Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855,Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903,Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912,His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956,Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990and Trp 993, wherein the root mean square deviation from the backboneatoms of said amino acids is not more than ±2.0 Å.

In one embodiment, this invention provides for a method of foridentifying a candidate inhibitor that interacts with a binding site ofa human Janus Kinase 3 kinase protein or a homologue thereof, comprisingthe steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3        kinase protein or said homologue thereof, wherein the crystal is        characterized with space group P2₁ and has unit cell parameters        of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5°;    -   (b) obtaining the structure coordinates of amino acids of the        crystal of step (a);    -   (c) generating a three-dimensional model of said human Janus        Kinase 3 kinase protein or said homologue thereof using the        structure coordinates of the amino acids generated in step (b),        a root mean square deviation from backbone atoms of said amino        acids of not more than ±2.0 Å;    -   (d) determining a binding site of said human Janus Kinase 3        kinase protein or said homologue thereof from said        three-dimensional model; and    -   (e) performing computer fitting analysis to identify the        candidate inhibitor which interacts with said binding site.

In one embodiment, this method further comprising the step of:

-   -   (f) contacting the identified candidate inhibitor with said        human Janus Kinase 3 kinase protein or said homologue thereof in        order to determine the effect of the inhibitor on human Janus        Kinase 3 kinase protein activity.

In another embodiment, the binding site of said human Janus Kinase 3kinase protein or said homologue thereof determined in step (d)comprises the structure coordinates according to Table 1 of amino acidresidues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833,Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855,Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903,Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912,His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956,Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990and Trp 993, wherein the root mean square deviation from the backboneatoms of said amino acids is not more than ±2.0 Å.

In another embodiment, this invention provides a method for identifyinga candidate inhibitor that interacts with a binding site of a humanJanus Kinase 3 kinase protein or a homologue thereof, comprising thestep of determining a binding site said human Janus Kinase 3 kinaseprotein or the homologue thereof from a three-dimensional model todesign or identify the candidate inhibitor which interacts with saidbinding site.

In another embodiment, the binding site of said human Janus Kinase 3kinase protein or said homologue thereof determined in step (d)comprises the structure coordinates according to Table 1 of amino acidresidues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833,Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855,Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903,Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912,His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956,Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990and Trp 993, wherein the root mean square deviation from the backboneatoms of said amino acids is not more than ±2.0 Å.

In one embodiment, this invention provides a method for identifying acandidate inhibitor of a molecule or molecular complex comprising abinding pocket or domain selected from the group consisting of:

-   -   (i) a set of amino acid residues which are identical to human        Janus Kinase 3 kinase a set of amino acid residues that are        identical to human Janus Kinase 3 amino acid residues Gln827,        Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835,        Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,        Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903,        Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911,        Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954,        Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985,        Gln988, Ser989, Pro990 and Trp 993, according to Table 1,        wherein the root mean square deviation from the backbone atoms        of said amino acid residues and said human Janus Kinase 3 kinase        amino residues is not greater than about ±2.0 Å; and    -   (ii) a set of amino acid residues that are identical to Janus        Kinase 3 kinase amino acid residues according to Table 1,        wherein the root mean square deviation between said set of amino        acid residues and said human Janus Kinase 3 kinase amino acid        residues is not more than about 3.0 Å;    -   comprising the steps of:    -   (a) using a three-dimensional structure of the binding pocket or        domain to design, select or optimize a plurality of chemical        entities; and    -   (b) selecting said candidate inhibitor based on the inhibitory        effect of said chemical entities on a human Janus Kinase 3        kinase protein or a human Janus Kinase 3 kinase protein        homologue on the catalytic activity of the molecule or molecular        complex.

In another embodiment, this invention provides a method of using acrystal of this invention in an inhibitor screening assay comprising:

-   -   (a) selecting a potential inhibitor by performing rational drug        design with a three-dimensional structure determined for the        crystal, wherein said selecting is performed in conjunction with        computer modeling;    -   (b) contacting the potential inhibitor with a kinase; and    -   (c) detecting the ability of the potential inhibitor for        inhibiting the kinase.

Any of the above methods may be used to design peptide or small moleculemimics of the a ligand which may have inhibitory effects on full-lengthJAK3 protein or fragments thereof, or on full-length JAK3 protein whichis mutated in or fragments of the mutated protein thereof.

Structure Determination of Other Molecules

The structure coordinates set forth in Table 2 can also be used inobtaining structural information about other crystallized molecules ormolecular complexes. This may be achieved by any of a number ofwell-known techniques, including molecular replacement.

According to one embodiment, the machine-readable data storage mediumcomprises a data storage material encoded with a first set of machinereadable data which comprises the Fourier transform of at least aportion of the structure coordinates set forth in Table 2 or homologymodel thereof, and which, when using a machine programmed withinstructions for using said data, can be combined with a second set ofmachine readable data comprising the X-ray diffraction pattern of amolecule or molecular complex to determine at least a portion of thestructure coordinates corresponding to the second set of machinereadable data.

In another embodiment, the invention provides a computer for determiningat least a portion of the structure coordinates corresponding to X-raydiffraction data obtained from a molecule or molecular complex having anunknown structure, wherein said computer comprises:

-   -   (a) a machine-readable data storage medium comprising a data        storage material encoded with machine-readable data, wherein        said data comprises at least a portion of the structure        coordinates of JAK3 according to Table 2 or homology model        thereof;    -   (b) a machine-readable data storage medium comprising a data        storage material encoded with machine-readable data, wherein        said data comprises X-ray diffraction data obtained from said        molecule or molecular complex having an unknown structure; and    -   (c) instructions for performing a Fourier transform of the        machine-readable data of (a) and for processing said        machine-readable data of (b) into structure coordinates.

For example, the Fourier transform of at least a portion of thestructure coordinates set forth in Table 2 or homology model thereof maybe used to determine at least a portion of the structure coordinates ofthe molecule or molecular complex.

Therefore, in another embodiment this invention provides a method ofutilizing molecular replacement to obtain structural information about amolecule or molecular complex of unknown structure wherein the moleculeor molecular complex is sufficiently homologous to JAK3 kinase domain,comprising the steps of:

-   -   (a) crystallizing said molecule or molecular complex of unknown        structure;    -   (b) generating X-ray diffractions data from said crystallized        molecule or molecular complex;    -   (c) applying at least a portion of the JAK3 structure        coordinates set forth in one of Table 2 or a homology model        thereof to the X-ray diffraction data to generate a        three-dimensional electron density map of at least a portion of        the molecule or molecular complex whose structure is unknown;        and    -   (d) generating a structural model of the model or molecular        complex from the three-dimensional electron density map.

In one embodiment, the methods is performed using a computer. In anotherembodiment, the molecule is selected from the group consisting of JAK3kinase domain and a JAK3 kinase domain homologue. In another embodiment,the molecular complex is a JAK3 kinase domain complex or a JAK3 kinasedomain homologue complex.

By using molecular replacement, all or part of the structure coordinatesof JAK3 as provided by this invention (and set forth in Table 2) can beused to determine the structure of a crystallized molecule or molecularcomplex whose structure is unknown more quickly and efficiently thanattempting to determine such information ab initio.

Molecular replacement provides an accurate estimation of the phases foran unknown structure. Phases are a factor in equations used to solvecrystal structures that can not be determined directly. Obtainingaccurate values for the phases, by methods other than molecularreplacement, is a time-consuming process that involves iterative cyclesof approximations and refinements and greatly hinders the solution ofcrystal structures. However, when the crystal structure of a proteincontaining at least a homologous portion has been solved, the phasesfrom the known structure may provide a satisfactory estimate of thephases for the unknown structure.

Thus, this method involves generating a preliminary model of a moleculeor molecular complex whose structure coordinates are unknown, byorienting and positioning the relevant portion of JAK3 kinase domainaccording to Table 2 within the unit cell of the crystal of the unknownmolecule or molecular complex so as best to account for the observedX-ray diffraction pattern of the crystal of the molecule or molecularcomplex whose structure is unknown. Phases can then be calculated fromthis model and combined with the observed X-ray diffraction patternamplitudes to generate an electron density map of the structure whosecoordinates are unknown. This, in turn, can be subjected to anywell-known model building and structure refinement techniques to providea final, accurate structure of the unknown crystallized molecule ormolecular complex (E. Littman, “Use of the Rotation and TranslationFunctions”, in Meth. Enzymol. 115: 55-77 (1985); M. G. Rossmann, ed.,“The Molecular Replacement Method”, Int. Sci. Rev. Ser. No. 13, Gordon &Breach, New York (1972)).

The structure of any portion of any crystallized molecule or molecularcomplex that is sufficiently homologous to any portion of the structureof human JAK3 kinase domain can be resolved by this method.

In one embodiment, the method of molecular replacement is utilized toobtain structural information about a JAK3 homologue. The structurecoordinates of JAK3 as provided by this invention are particularlyuseful in solving the structure of JAK3 complexes that are bound byligands, substrates and inhibitors.

Furthermore, the structure coordinates of JAK3 kinase domain as providedby this invention are useful in solving the structure of JAK3 kinasedomains that have amino acid substitutions, additions and/or deletions(referred to collectively as “JAK3 mutants”, as compared to naturallyoccurring JAK3). These JAK3 mutants may optionally be crystallized inco-complex with a chemical entity. The crystal structures of a series ofsuch complexes may then be solved by molecular replacement and comparedwith that of wild-type JAK3. Potential sites for modification within thevarious binding pockets of the enzyme may thus be identified. Thisinformation provides an additional tool for determining the mostefficient binding interactions, for example, increased hydrophobicinteractions, between JAK3 and a chemical entity or compound.

The structure coordinates are also particularly useful in solving thestructure of crystals of the kinase domain of JAK3 or homologuesco-complexes with a variety of chemical entities. This approach enablesthe determination of the optimal sites for interaction between chemicalentities, including candidate JAK3 inhibitors. For example, highresolution X-ray diffraction data collected from crystals exposed todifferent types of solvent allows the determination of where each typeof solvent molecule resides. Small molecules that bind tightly to thosesites can then be designed and synthesized and tested for their JAK3inhibition activity.

All of the complexes referred to above may be studied using well-knownX-ray diffraction techniques and may be refined using 1.5-3.4 Åresolution X-ray data to an R value of about 0.30 or less using computersoftware, such as X-PLOR (Yale University, ©1992, distributed byMolecular Simulations, Inc.; see, e.g., Blundell & Johnson, supra; Meth.Enzymol. vol. 114 & 115, H. W. Wyckoff et al., eds. Academic Press(1985)) or CNS (Brunger et al., Acta Cryst. D54: 905-921, (1998)).

In order that this invention be more fully understood, the followingexamples are set forth. These examples are for the purpose ofillustration only and are not to be construed as limiting the scope ofthe invention in any way.

Example 1

Cloning and Expression of JAK3

The full-length JAK3 cDNA (GenBank accession number AAD22741) wasobtained by RT-PCR from human bone marrow mRNA (Clontech). A kinasedomain JAK3 (A810-E1115) was cloned by PCR from the previously isolatedfull-length JAK3 cDNA. The PCR product of the kinase domain was clonedinto the baculoviral transfer vector pBEV10 for insect cell expression.The recombinant virus was plaque purified and amplified to obtain ahigh-titer clonal viral stock. For production, High-5 insect cells weregrown to 2×10⁶ cells/ml in Excell-405 medium (JRH Bioscience, KS, US)and infected with virus at a multiplicity of infection of 2.5 andincubated for 72-96 hours at 27° C.

Using the same procedure above, the following kinase domains of humanJAK3 were also cloned and expressed: amino acid residues 810-1124, aminoacid residues 810-1104, and amino acid residues 810-1100.

Example 2 Purification of JAK3

Frozen cell paste was thawed in 5 volumes of Buffer A (50 mM Hepes at pH8.0, 500 mM NaCl, 20% (v/v) glycerol, 0.2% (v/v) Tween 20, 0.05% (v/v)mM β-mercaptoethanol, 5 mM imidazole, 1 mM PMSF, 5 μg/ml leopeptin, 3 mMbenzamidine, and 25 μl/L Benzonase (Novagen, Madison, Wis.) andmechanically lysed in a microfluidizer (Microfluidics, Newton, Mass.).The lysate was centrifuged at 54,000×g for 1 hour, and the supernatantincubated with Talon metal affinity resin (Clonetech, Palo Alto, Calif.)overnight at 4° C. After extensive washing with 20 column volumes ofBuffer A, the kinase domain was eluted with Buffer A containing 100 mMimidazole with the pH readjusted to 8.0.

The elution pool was concentrated by ultrafiltration (30 KDa MWCO) in anAmicon stirred cell concentrator (Millipore, Billerica, Mass.) andloaded onto a HR 16/60 Superdex-200 size-exclusion column (AmershamBiosciences, Uppsala, Sweden) equilibrated in Buffer B (50 mM Hepes atpH 8.0, 500 mM NaCl, 20% (v/v) glycerol, 5 mM DTT, and 0.05% (w/v)β-octylglucopyranoside). The JAK3 kinase domain was pooled based onSDS-PAGE analysis and MgCl₂ was added to give a final concentration of20 mM MgCl₂.

The JAK3 kinase domain was loaded onto a γ-phenyl ATP-Sepharose column(Haystead et al., Eur. J. Biochem. 214: 459-467 (1993)) pre-equilibratedwith Buffer C (50 mM Hepes at pH 8.0, 20% (v/v) glycerol, 0.5 M NaCl, 20mM MgCl₂, 0.05% β-octylglucopyranoside, and 5 mM DTT). After washingwith two column volumes of Buffer C, JAK3 kinase domain was eluted fromthe column with 10 mM ADP in Buffer C and the fractions containing JAK3kinase domain were pooled based on SDS-PAGE analysis.

The hexahistidine tag was cleaved by incubating the protein with 4units/ml thrombin (Calbiochem, La Jolla, Calif.) at room temperature fortwo hours. The completion of the cleavage was confirmed by SDS-PAGE andthrombin was removed by treating the protein with benzamidine Sepharose™6B (Amersham Biosciences, Uppsala, Sweden) for 30 minutes at roomtemperature.

The buffer was exchanged to Buffer B using a HR 16/60 Superdex-200 sizeexclusion column (Amersham Biosciences, Uppsala, Sweden). The kinasedomain containing fractions were pooled and concentrated to 15 mg/mlusing a 10 KDa MWCO Vivaspin concentrator (Vivascience, Hanover,Germany) in the presence of 2 mM AMP-PNP (ANP) and 4 mM MgCl₂. Sampleswere subjected to ultracentrifugation at 90,000×g for 10 minutes priorto freezing for storage at −80° C.

Example 3 Crystallization of JAK3-Adenosine Complex

The concentrated protein stored at −80° C. from Example 2 above wasthawed on ice and centrifuged in a microcentrifuge for 5 minutes priorto crystallization. The protein (10-15 mg/mL in 50 mM Hepes at pH 8.0,500 mM NaCl, 20% (v/v) glycerol, 5 mM DTT, and 0.05% (w/v)β-octylglucopyranoside) was crystallized by the vapor diffusion methodin sitting drop or hanging drop plates using 20-26% PEG 3350 as theprecipitant, 200-260 mM KCl, 20 mM spermine, 10 mM DTT and 100 mMbis-tris pH 6.0. Equal volumes of protein and reservoir solution (0.5μL) were used to form drops. Bigger drops would also grow from 1.0 μL ofprotein and 1.0 μL of reservoir solution. Crystals usually grewovernight as extremely thin (150×50×<10 μm) highly malleable plates.

Crystals were grown in the Corning® 384 Well plate (available fromFisher Scientific), Greiner crystallization low profile plates(available from Hampton Research (Aliso Viejo, Calif.)), both the96-well CrystalQuick™ standard profile round and flat bottom plates(available from Hampton Research (Aliso Viejo, Calif.)), and the 24 wellVDX plates (available from Hampton Research Aliso Viejo, Calif.)). Thevolume of the reservoir for the 384-well plate was 50 μL. The volume ofthe reservoir for the 96-well low profile plate was 100 μL, and for theCrystalQuick™ plates, it was varied between 70-100 μL.

Crystals were obtained for JAK3 protein constructs comprising amino acidresidues 810-1100, amino acid residues 810-1104, amino acid residues810-1115 and amino acid residues 810-1124.

Example 4 X-Ray Data Collection and Structure Determination

Data was collected from crystals of the protein constructs comprisingamino acid residues 810-1115 and 810-1124. The details described below,which generated the final data sets used to solve the structure of humanJAK3 kinase domain, are for the protein construct comprising amino acidresidues 810-1115.

Cryosolvent (reservoir solution containing 25% glycerol) was slowlymixed with the protein drop until no further mixing was observed. Thecrystals were mounted in nylon loops and flash frozen directly in thenitrogen stream and then stored in liquid nitrogen until the time ofdata collection. Flash freezing in the nitrogen stream caused lessdamage to the crystals than freezing directly into liquid nitrogen. Thecrystals diffracted to greater than 2.1 Å resolution, but the spot shapewas distorted at higher than 2.5 Å resolution, and the data sufferedfrom severe anisotropy. Therefore, although the crystals diffracted togreater than 2.1 Å, data were only useable to 2.5 Å.

The data were collected at the beamline 5.0.2 at the Advanced LightSource (ALS) Berkeley, Calif. using 1.0 Å X-rays and an ADSC CCDdetector. The data from the crystal were integrated and scaled usingd*TREK (Pflugrath, Acta Crystallogr. D55: 1718-1725 (1999)). Structurefactors were calculated using TRUNCATE (Bailey, Acta Crystallogr. D50:760-763). Table 1 summarizes data collection.

The crystal belonged to spacegroup P2₁ with unit cell dimensions a=59.98Å, b=90.19 Å, c=69.00 Å, α=90°, β=111.5°, γ=90° with 2 molecules in theasymmetric unit. A second crystal form that belonged to spacegroupP2₁2₁2₁ with unit cell dimensions a=72.36 Å, b=90.04 Å, c=105.60 Å,α=β=γ=90° also formed. The discussions below will be limited to thecrystals belonging to the P2₁ spacegroup.

The orientation and position of JAK3 within the asymmetric unit wasachieved by molecular replacement using BEAST (Read, Acta Crystallogr.D547: 1373-1382 (2001)). BEAST uses maximum likelihood targets for therotation and translation functions, and allows the use of multiplemodels, allowing the creation of a statically-weighted set of averagedstructure factors. The use of BEAST was essential in solving thestructure. Protein kinases are very flexible molecules in their inactivestate (Huse and Kuriyan, Cell 109: pp. 275-282 (20002)). Whileconventional molecular replacement methods failed, BEAST, which usesmaximum likelihood targets for the rotation and translation functions,allowed the use of multiple models, and created from these models astatistically-weighted set of averaged structure factors.

Multiple superimposed kinase domains with the activation loop removedwere used as the search model (Protein Data Bank (PDB) accession codes1M17, 1LUF, 1FVR, 1IEP, 1JPA, 1AGW, 1IR3, 1QPC, and 1GJO). Thesuperposition of the structures was done using the program DeepView(Guex and Peitsch, Electrophoresis 18: 2714-2723). The initial set ofstructures chosen represented molecules with high sequence homology toJAK3, and were in a variety of conformations. The BEAST rotationfunction yielded two distinct peaks, which were related by the observednon-crystallographic symmetric. Of the kinase domains used, epidermalgrown factor receptor (1M17), had the highest sequence homology to JAK3,therefore, EGFR was used as the initial model for rigid body refinementin CNX (Accelrys, San Diego, Calif.).

Initial calculated electron density maps revealed that the C-terminaldomain was positioned correctly, but the N-terminal domain was not. Inorder to find the proper orientation of the N-terminal domain, severalhybrid molecules were created. The C-terminal domain of another tyrosinekinase was superimposed onto the C-terminal domain of EGFR. The newmolecule used for rigid body refinement consisted of the C-terminaldomain of EGFR and the newly positioned N-terminal domain of the otherkinase. Of the hybrid kinases created, the molecule with the N-terminaldomain of src kinase (PDB accession code 2SRC) and the C-terminal domainof EGFR yielded an easily interpretable electron density map in bothdomains.

The position of the ANP ligand could be clearly seen in the initialelectron density maps. The structure was refined using CNX (Accelrys,San Diego, Calif.). Initial rigid-body refinement of the hybrid Src-EGFRkinase domain was followed by mutation of the necessary side chains inorder to reflect the human JAK3 sequence, and proper placement of thoseside chains into the initial electron density maps. Subsequentrefinement consisted of rounds of energy minimization, simulatedannealing, and B factor refinement using NCS restraints, which werealternated with manual rebuilding of the structure in QUANTA (Accelrys,San Diego, Calif. ©2001, 2002).

Table 1 summarizes refinement statistics. Poor electron density wasobserved for the extreme N-terminus of the molecule (residues 810-812)and no electron density was observed for the extreme C-terminus(residues 1102-1115). A glycerol molecule was modeled into unaccountedelectron density near the surface of the molecule. The final refinedstructure model includes human JAK3 kinase amino acid residues 813-1100of SEQ ID NO:1.

The asymmetric unit contains two molecules of human JAK3 (labeled as molA and B in FIG. 1). The overall RMSD for 288 Cα atoms between the twostructures is 0.20 Å, and the overall RMSSD for 1152 backbone atoms is0.23 Å. Throughout the refinement non-crystallographic restraints wereused. The largest area of difference between the two molecules is theactivation loop. If Molecule B is the fixed molecule and Molecule A isthe moving molecule, then the relationship between A and B is thefollowing:

ROTATION MATRIX: −0.54749 −0.00940 0.83676 0.00861 −0.99995 −0.005600.83677 0.00414 0.54754 TRANSLATION VECTOR IN AS 4.32576 73.988686.79225

The overall R-factor and R_(free) of the final model were 24.5% and31.1%, respectively. The test set was composed of 7.9% of the totalreflections.

Table 2 lists the atomic structure coordinates in Protein Data Bank(PDB)-like format and header for human JAK3 in complex with AMP-PNP(JAK3-AMP-PNP complex), as derived by X-ray diffraction from a crystalof the complex. The structure model includes human JAK3 kinase aminoacid residues 813-1100 of SEQ ID NO:1).

The following abbreviations are used in Table 2:

“Atom type” refers to the element whose coordinates are measured. Thefirst letter in the column defines the element.

“Resid” refers to the amino acid residue in the molecular model.

“X, Y, Z” define the atomic position of the element measured.

“B” is a thermal factor that measures movement of the atom around itsatomic center.

“Occ” is an occupancy factor that refers to the fraction of themolecules in which each atom occupies the position specified by thecoordinates. A value of “1” indicates that each atom has the sameconformation, i.e., the same position, in the molecules.

“Mol” refers to a molecule in the asymmetric unit. Mol A and Mol B areJAK3 protein molecules. Mol Y and Mol Z are AMP-PNP. Mol Y and Mol Zbinds to Mol A and Mol B of JAK3 protein, respectively. Mol W is water.

Residue “AMP” represents AMP-PNP.

Example 8 Overview of Crystal Structure of JAK3-AMP-PNP Complex

FIG. 1 shows the overall fold of the JAK3 kinase domain. The overallstructure of the unactivated JAK3 kinase domain is similar to thetypical kinase-fold found in both serine-threonine and tyrosine kinases.The protein structure is composed of two domains connected by a flexiblelinker or hinge (residues 898-905). The smaller N-terminal domain ismostly β-sheet structure (β1-β5), with the exception of a predominanthelix, called the αC helix. The C-terminal domain is composed of twoβ-strands (β and β8) and seven conserved helices (αD, αE, αEF, andαF-αI), which are found in all protein kinases. However, the JAK3C-terminal domain also contains structural insertions including an extrahelix between αF and αG, referred to herein as αFG.

The JAK3 C-terminal domain region between αF and αG contains a total ofthree structural insertions when compared to other tyrosine kinases. Thefirst insertion (I1) is between amino acid residues 1024 and 1029. Herethe chain juts out away from the C-terminal domain as compared to thatof other tyrosine kinases. The structure briefly returns to registerwith other tyrosine kinases at P1030. The second structural insertion isthe short αFG helix (1030-1038). In the αFG helix the side chain ofamino acid residue F1034 is in the approximate position of the phenylring of a conserved tyrosine found in other tyrosine kinases. The finalinsertion (I3), amino acid residues 1039-1046, like I1, extends awayfrom The C-terminal domain.

Comparisons of Structures of JAK3-Inhibitor Complexes to Structures ofOther Kinases

Comparison of the JAK3 with other protein kinases reveals that theoverall orientation of the N- and C-terminal domains is related to thatof the Src-2 structure (Xu et al., Mol. Cell 3: pp. 629-638 (1999)). Theroot mean square deviation between Src-2 and JAK3 using 260 equivalentCα positions is 3.4 Å. Both structures are in an inactive conformation.Like Src-2 and the unactivated CDK2/ATP structure (Schulze-Gahmen etal., J. Med. Chem. 39: pp. 4540-4546 (1996)), the position of theC-helix results in a nonproductive alignment of the AMP-PNP phosphategroups. The major difference in the overall architecture of the JAK3structure and the structures of the inactive forms of Src-2 and CDK2/ATPis the αFG helix region and the conformation of the activation loop. Inaddition, CDK2 is a Serine/Threonine kinase, not a Tyrosine kinase asare Src-2 and JAK3, and as such it has a large insertion region betweenthe G and H helices.

While the N-terminus of the activation loop of JAK3 is similar to thatof Src-2 structure, the C-terminus of the activation loop is kinkedsimilar to the activation loops of the FGF-1 receptor/ACP and CDK2/ATPcomplex structures. This kink effectively blocks the peptide substratesite. In the FGF-1 receptor, although the C-terminus of the activationloop is kinked, the overall structure is in a more open conformation andthe activation loop does not reach the glycine-rich loop. However, inthe unactivated CDK2/ATP structure, the activation loops does interactwith the glycine-rich loop (Schulze-Gahmen et al., J. Med. Chem. 39: pp.4540-4546 (1996)). In JAK3, N832 of the glycine-rich loop makes twohydrogen bonds to the activation loop. The main chain carbonyl group ishydrogen bonded to the Nζ group of K978 and the Nδ of the side chain ishydrogen bonded to the main chain carbonyl group of E988. Theinteraction network also includes the γ-phosphate of the ATP analogue.

The active site, which contains the non-hydrolyzable ATP analogue,AMP-PNP, is formed by a groove at the interface between the N andC-terminal lobes. The hinge region, the glycine rich loop (residues829-834), and the activation loop (residues 967-990) enclose the ligand.The NH2 of the purine ring is hydrogen bonded to the backbone oxygen ofGlu 903 (FIG. 6). The phosphates of the AMP-PNP participate in anextensive hydrogen bonding network that includes both the activation andglycine-rich loops (FIG. 6).

The orientation of the N and C-terminal lobes of Jak3 KD1 structure ismost similar to that of the unactivated Src kinase (Xu, W., Doshi, A.,Lei, M., Eck, M. J. and Harrison, S. C. (1999) Mol Cell 3, 629-638),Cdk-2 (Schulze Gahmen, U. Brandsen, J., Jones, H. D., Morgan, D. O.Meijer, L., Vesely, J., and Kim, S. H. (1995) Proteins 22, 378-391), andthe recently solved structures of Mek1 and Mek2 (Ohren, J. F., Chen, H.,Pavlovsky, A., Whitehead, C., Zhang, E., Kuffa, P., Yan, C., McConnell,P., Spessard, C., Banotai, C., Mueller, W. T., Delaney, A., Omer, C.,Sebolt-Leopold, J. Dudley, D. T., Leung, I. K. Flamme, C., Warmus J.,Kaufman, M., Barrett, S., Tecle, H., and Hasemann, C. A. (2004) NatStruct Mol Biol 11, 1192-1197). The root mean square deviation(r.m.s.d.) between Jak3 and the Src-2, Cdk-2, Mek-1, and Mek-2structures is 1.15 Å (using 215 equivalent Cα positions), 1.36 Å (using186 equivalent Cα positions), 1.56 Å (using 190 equivalent Cαpositions), and 1.63 Å (using 191 equivalent Cα positions) respectively.As in the previously mentioned structures, the αC-helix which containsthe conserved glutamic acid, Glu 871, is swung out, away from the activesite preventing the formation of the salt bridge between Glu 871 and theconserved catalytic lysine, Lys 855, which in activated kinasescoordinates the α and β phosphates of the ATP. Instead Lys 855 ishydrogen bonded to the α-phosphate of the AMP-PNP, and the asparticacid, Asp 967, at the beginning of the activation loop. The conformationof the AMP-PNP, the coordination of the Mg²⁺ ion, and the interactionwith the catalytic lysine, Lys 855, are all very similar to that seen inthe inactive Cdk-2/ATP (Schulze Gahmen, U., De Bondt, H. L., and Kim, S.H. (1996) J Med Chem 39, 4540-4546) and Src-2 structures (Xu, W. Doshi,A., Lei, M., Eck, M. J., and Harrison, S. C. (1999) Mol Cell 3,629-638).

The beginning of the activation loop, containing the conserved DFGsequence (residues 967-968), is almost identical in conformation to thatin the Src-2 and unactivated Cdk-2 structures. However, the Jak3 KD1activation loop notably diverges from the previously mentionedstructures, Src-2 and Cdk-2, as it kinks toward the glycine-rich loop.Superposition of Jak3 on insulin receptor kinase with a bound peptidesubstrate (PDB #IIR3) clearly showed the kink in the activation loop(residues 978-989) blocks the protein substrate binding site, similar tothat seen in unactivated Cdk-2 (PDB #1HCK) (Schulze-Gahmen, U., DeBondt, H.L., and Kim, S. H. (1996) J Med Chem 39, 4540-4546) andfibroblast growth factor receptor kinase (PDB #1FGK (Mohammadi, M.,Schlessinger, J., and Hubbard, S. R. (1996) Cell 86, 577-587). Thisregion of the activation loop includes the potential autophosphorylationtyrosines, Tyr 980 and Tyr 981.

Regulation of the Catalytic Domain of JAK3

Regulation of the catalytic domain of Janus kinases takes place throughinteractions with domains N-terminal to the kinase domain. Both thepseudokinase domain and the FERM domain play pivotal roles incontrolling activity of the catalytic domain. Furthermore, it has beenshown that both of these domains can interact with the kinase domain.Previous studies in JAK3 have focused on naturally occurring mutationsin the FERM domain and pseudokinase domain that have been found in SCIDpatients. Unique region around αFG is a possible site for interactionwith the other JAK3 domains.

Some known SCID mutations affect the kinase domain. There are two knownSCID mutations that prematurely terminate the kinase domain. Thesepremature stops remove the αFG-α1 helices. These prematurely terminatedkinases probably result in an unstable kinase domain, which may berapidly degraded in cells. This would explain the undetectable levels ofprotein expressed in cells containing these mutations. The onlynaturally occurring point mutation in the catalytic domain resulting inSCID known is the mutation of a leucine at position 910 (L910) toserine. L910 occurs at the beginning of the αD helix. The side chain ofL910 contributes to the hydrophobic core of the C-terminal domain. Thisresidue is only five residues away from L905, which is involved inpositioning the purine ring of the ATP substrate, and one residue awayfrom R911, R918, have been implicated in binding the peptide substrateat the P-1, P-2 and P-3 positions. The replacement of a highly conservedhydrophobic residue, leucine, with a polar residue, serine, may resultin the disruption or distortion of the αD helix, which may affect thebinding of either the ATP substrate and/or the peptide substrate.

The invention between αF and αG appears to be a unique feature of theJAK family when compared to the same region in other receptor andnon-receptor tyrosine kinases. This insertion structurally encompasses arather large region on the surface of the kinase domain as compared toother kinases, such as c-scr. The αFG insertion region creates a largepotential binding surface for recognition by another domain of the JAKkinases, specifically, the N-terminal FERM domain or the pseudokinasedomain or perhaps another protein. In fact, it has been suggested thatmessages in other domains affect the function of the kinase domain. Thisregion may be docking site for either another domain within the JAKkinase or for an exogenous protein substrate.

Example 9 Activity Assay

To each well of a 96-well polycarbonate plate is added 1.5 μL of acandidate JAK3 inhibitor along with 50 μL of kinase buffer (100 mM Hepesat pH 7.4, 1 mM DTT, 10 mM MgCl₂, 25 mM NaCl and 0.01% BSA) containing 2uM poly(Glu)₄Tyr and 10 μM ATP. This is then mixed and 50 μL of kinasebuffer containing 2 nM JAK3 enzyme is added to start the reaction. After20 minutes at room temperature (25° C.), the reaction is stopped with 50μL of 20% trichloroacetic acid (TCA) that also contains 0.4 mM ATP. Theentire contents of each well is then transferred to a 96-well glassfiber filter plate using a TomTek Cell Harvester. After washing, 60 μLof scintillation fluid is added and ³³P incorporated is detected on aPerkin Elmer® TopCount instrument.

JAK2 activity can be assayed as above, except that final poly(Glu)₄Tyrconcentration is 15 μM and final ATP concentration is 12 μM.

While we have described a number of embodiments of this invention, it isapparent that our basic constructions may be altered to provide otherembodiments which utilize the products, processes and methods of thisinvention.

TABLE 1 Data Collection and Refinement Statistics Data set AMP-PNP Datacollection X-ray source ALS 5.0.2 Space group P2₁ Unit cell parameters(Å) a = 59.98 Å, b = 90.19 Å, c = 69.00 Å, β = 111.5° Resolution (Å)45.54-2.50 (2.59-2.50) Unique reflections 23427 Redundancy 3.23 (3.12)Completeness (%)* 98.6 (94.2) R_(merge)* 0.124 (0.393) <I/σ>* 5.4 (2.2)Refinement Reflections used 22832 Test reflections 1806 R-factor 24.5%(28.5%) Free R-factor (% data) 31.1% (36.1%) RMS deviation Bond lengths(Å) 0.009 Bond angles (°) 1.4 Dihedral angles (°) 22.4 Protein atoms4612 Solvent atoms 176 *Values for the highest resolution shell areshown in parentheses, R_(merge) = Σ_(hkl )Σ_(i)|I(hkl)_(i )− I(hkl)

|/Σ_(hkl) Σ_(i )

I(hkl)_(i )

 over i observations of reflection hkl. R-factor = Σ||F_(obs)| −|F_(calc)||/Σ|F_(obs)| where F_(obs )and F_(calc )are the observed andcalculated structure factors, respectively. Free R-factor is calculatedfrom a randomly chosen subset of reflections not used for refinement.

TABLE 2 REMARK REMARK 3 REFINEMENT. REMARK 3  PROGRAM : CNX 2002 REMARK3  AUTHORS : Brunger, Adams, Clore, Delano, REMARK 3   Gros,Grosse-Kunstleve, Jiang, REMARK 3   Kuszewski, Nilges, Pannu, Read,REMARK 3   Rice, Simonson, Warren REMARK 3  And REMARK 3 Accelrys Inc.,REMARK 3    (Badger, Berard, Kumar, Szalma, REMARK 3  Yip, Dzakula).REMARK 3 REMARK 3  DATA USED IN REFINEMENT. REMARK 3  RESOLUTION RANGEHIGH (ANGSTROMS) : 2.50 REMARK 3  RESOLUTION RANGE LOW (ANGSTROMS) : 19.83 REMARK 3  DATA CUTOFF (SIGMA(F)) : 1.0 REMARK 3  DATA CUTOFF HIGH(ABS(F)) :  1153422.38 REMARK 3  DATA CUTOFF LOW (ABS(F)) :   0.000000REMARK 3  COMPLETENESS (WORKING + TEST) (%) : 96.2 REMARK 3  NUMBER OFREFLECTIONS : 22832 REMARK 3 REMARK 3  FIT TO DATA USED IN REFINEMENT.REMARK 3  CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3  FREE R VALUETEST SET SELECTION : RANDOM REMARK 3  R VALUE (WORKING SET) : 0.245REMARK 3  FREE R VALUE : 0.311 REMARK 3  FREE R VALUE TEST SET SIZE (%):  7.9 REMARK 3  FREE R VALUE TEST SET COUNT :  1806 REMARK 3  ESTIMATEDERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3  FIT IN THE HIGHESTRESOLUTION BIN. REMARK 3  TOTAL NUMBER OF BINS USED :   6 REMARK 3  BINRESOLUTION RANGE HIGH (A) : 2.50 REMARK 3  BIN RESOLUTION RANGE LOW (A): 2.66 REMARK 3  BIN COMPLETENESS (WORKING + TEST) (%) : 94.7 REMARK 3 REFLECTIONS IN BIN (WORKING SET) :  3423 REMARK 3  BIN R VALUE (WORKINGSET) : 0.285 REMARK 3  BIN FREE R VALUE : 0.361 REMARK 3  BIN FREE RVALUE TEST SET SIZE (%) :  7.7 REMARK 3  BIN FREE R VALUE TEST SET COUNT:   286 REMARK 3  ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3REMARK 3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4612 REMARK 3  NUCLEIC ACID ATOMS :   0 REMARK 3 HETEROGEN ATOMS :  64 REMARK 3  SOLVENT ATOMS :  176 REMARK 3 REMARK 3 B VALUES. REMARK 3  FROM WILSON PLOT (A**2) : 24.1 REMARK 3  MEAN BVALUE (OVERALL, A**2) : 33.3 REMARK 3  OVERALL ANISOTROPIC B VALUE.REMARK 3   B11 (A**2) : 5.72 REMARK 3   B22 (A**2) : 0.10 REMARK 3   B33(A**2) : −5.81 REMARK 3   B12 (A**2) : 0.00 REMARK 3   B13 (A**2) :−4.61 REMARK 3   B23 (A**2) : 0.00 REMARK 3 REMARK 3  BULK SOLVENTMODELING. REMARK 3  METHOD USED : FLAT MODEL REMARK 3  KSOL : 0.398536REMARK 3  BSOL : 68.0347 (A**2) REMARK 3 REMARK 3  ESTIMATED COORDINATEERROR. REMARK 3  ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3  ESD FROMSIGMAA (A) : 0.35 REMARK 3  LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3REMARK 3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3  ESD FROMC-V LUZZATI PLOT (A) : 0.45 REMARK 3  ESD FROM C-V SIGMAA (A) : 0.42REMARK 3 REMARK 3  RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3  BONDLENGTHS (A) : 0.009 REMARK 3  BOND ANGLES (DEGREES) : 1.4 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.4 REMARK 3  IMPROPER ANGLES (DEGREES) :0.82 REMARK 3 REMARK 3  ISOTROPIC THERMAL MODEL: RESTRAINED REMARK 3REMARK 3  ISOTROPIC THERMAL FACTOR RESTRAINTS.  RMS  SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) :  1.38 ;  1.50 REMARK 3  MAIN-CHAIN ANGLE(A**2) :  2.29 ;  2.00 REMARK 3  SIDE-CHAIN BOND (A**2) :  2.01 ;  2.00REMARK 3  SIDE-CHAIN ANGLE (A**2) :  2.92 ;  2.50 REMARK 3 REMARK 3  NCSMODEL: CONSTR REMARK 3 REMARK 3  NCS RESTRAINTS.  RMS SIGMA/WEIGHTREMARK 3  GROUP  1  POSITIONAL (A) : NULL ; NULL REMARK 3  GROUP  1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3  PARAMETER FILE  1 :ACCELRYS_CNX: libraries/toppar/protein_rep.param REMARK 3  PARAMETERFILE  2 : ACCELRYS_CNX: libraries/toppar/water_rep.param REMARK 3 PARAMETER FILE  3 : parm/missing.dat REMARK 3  PARAMETER FILE  4 :parm/parmxray.xpl REMARK 3  PARAMETER FILE  5 : ACCELRYS_CNX:libraries/toppar/ion.param REMARK 3  TOPOLOGY FILE  1   : ACCELRYS_CNX:libraries/toppar/protein.top REMARK 3  TOPOLOGY FILE  2   :parm/mass1.dat REMARK 3  TOPOLOGY FILE  3   : ACCELRYS_CNX:libraries/toppar/water.top REMARK 3  TOPOLOGY FILE  4   : inhib.gol.rtfREMARK 3  TOPOLOGY FILE  5   : ACCELRYS_CNX: libraries/toppar/ion.topREMARK 3 REMARK 3  OTHER REFINEMENT REMARKS: NULL SEQRES 1 A 288 ASP PROTHR ILE PHE GLU GLU ARG HIS LEU LYS TYR ILE SEQRES 2 A 288 SER GLN LEUGLY LYS GLY ASN PHE GLY SER VAL GLU LEU SEQRES 3 A 288 CYS ARG TYR ASPPRO LEU GLY ASP ASN THR GLY ALA LEU SEQRES 4 A 288 VAL ALA VAL LYS GLNLEU GLN HIS SER GLY PRO ASP GLN SEQRES 5 A 288 GLN ARG ASP PHE GLN ARGGLU ILE GLN ILE LEU LYS ALA SEQRES 6 A 288 LEU HIS SER ASP PHE ILE VALLYS TYR ARG GLY VAL SER SEQRES 7 A 288 TYR GLY PRO GLY ARG GLN SER LEUARG LEU VAL MET GLU SEQRES 8 A 288 TYR LEU PRO SER GLY CYS LEU ARG ASPPHE LEU GLN ARG SEQRES 9 A 288 HIS ARG ALA ARG LEU ASP ALA SER ARG LEULEU LEU TYR SEQRES 10 A 288 SER SER GLN ILE CYS LYS GLY MET GLU TYR LEUGLY SER SEQRES 11 A 288 ARG ARG CYS VAL HIS ARG ASP LEU ALA ALA ARG ASNILE SEQRES 12 A 288 LEU VAL GLU SER GLU ALA HIS VAL LYS ILE ALA ASP PHESEQRES 13 A 288 GLY LEU ALA LYS LEU LEU PRO LEU ASP LYS ASP TYR TYRSEQRES 14 A 288 VAL VAL ARG GLU PRO GLY GLN SER PRO ILE PHE TRP TYRSEQRES 15 A 288 ALA PRO GLU SER LEU SER ASP ASN ILE PHE SER ARG GLNSEQRES 16 A 288 SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEUSEQRES 17 A 288 PHE THR TYR CYS ASP LYS SER CYS SER PRO SER ALA GLUSEQRES 18 A 288 PHE LEU ARG MET MET GLY CYS GLU ARG ASP VAL PRO ALASEQRES 19 A 288 LEU CYS ARG LEU LEU GLU LEU LEU GLU GLU GLY GLN ARGSEQRES 20 A 288 LEU PRO ALA PRO PRO ALA CYS PRO ALA GLU VAL HIS GLUSEQRES 21 A 288 LEU MET LYS LEU CYS TRP ALA PRO SER PRO GLN ASP ARGSEQRES 22 A 288 PRO SER PHE SER ALA LEU GLY PRO GLN LEU ASP MET LEUSEQRES 23 A 288 TRP SER SEQRES 1 B 288 ASP PRO THR ILE PHE GLU GLU ARGHIS LEU LYS TYR ILE SEQRES 2 B 288 SER GLN LEU GLY LYS GLY ASN PHE GLYSER VAL GLU LEU SEQRES 3 B 288 CYS ARG TYR ASP PRO LEU GLY ASP ASN THRGLY ALA LEU SEQRES 4 B 288 VAL ALA VAL LYS GLN LEU GLN HIS SER GLY PROASP GLN SEQRES 5 B 288 GLN ARG ASP PHE GLN ARG GLU ILE GLN ILE LEU LYSALA SEQRES 6 B 288 LEU HIS SER ASP PHE ILE VAL LYS TYR ARG GLY VAL SERSEQRES 7 B 288 TYR GLY PRO GLY ARG GLN SER LEU ARG LEU VAL MET GLUSEQRES 8 B 288 TYR LEU PRO SER GLY CYS LEU ARG ASP PHE LEU GLN ARGSEQRES 9 B 288 HIS ARG ALA ARG LEU ASP ALA SER ARG LEU LEU LEU TYRSEQRES 10 B 288 SER SER GLN ILE CYS LYS GLY MET GLU TYR LEU GLY SERSEQRES 11 B 288 ARG ARG CYS VAL HIS ARG ASP LEU ALA ALA ARG ASN ILESEQRES 12 B 288 LEU VAL GLU SER GLU ALA HIS VAL LYS ILE ALA ASP PHESEQRES 13 B 288 GLY LEU ALA LYS LEU LEU PRO LEU ASP LYS ASP TYR TYRSEQRES 14 B 288 VAL VAL ARG GLU PRO GLY GLN SER PRO ILE PHE TRP TYRSEQRES 15 B 288 ALA PRO GLU SER LEU SER ASP ASN ILE PHE SER ARG GLNSEQRES 16 B 288 SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEUSEQRES 17 B 288 PHE THR TYR CYS ASP LYS SER CYS SER PRO SER ALA GLUSEQRES 18 B 288 PHE LEU ARG MET MET GLY CYS GLU ARG ASP VAL PRO ALASEQRES 19 B 288 LEU CYS ARG LEU LEU GLU LEU LEU GLU GLU GLY GLN ARGSEQRES 20 B 288 LEU PRO ALA PRO PRO ALA CYS PRO ALA GLU VAL HIS GLUSEQRES 21 B 288 LEU MET LYS LEU CYS TRP ALA PRO SER PRO GLN ASP ARGSEQRES 22 B 288 PRO SER PHE SER ALA LEU GLY PRO GLN LEU ASP MET LEUSEQRES 23 B 288 TRP SER CRYST1 59.979   90.191   68.998  90.00 111.49  90.00 P 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.0000001.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000SCALE1 0.016672 0.000000 0.006563 0.00000 SCALE2 0.000000 0.0110880.000000 0.00000 SCALE3 0.000000 0.000000 0.015576 0.00000 ATOM 1 CB ASPA 813 0.580 50.367 −0.785 1.00 41.79 A C ATOM 2 CG ASP A 813 1.99849.832 −0.801 1.00 43.65 A C ATOM 3 OD1 ASP A 813 2.838 50.329 −0.0161.00 46.37 A O ATOM 4 OD2 ASP A 813 2.273 48.916 −1.599 1.00 42.84 A OATOM 5 C ASP A 813 1.327 52.295 −2.160 1.00 40.95 A C ATOM 6 O ASP A 8131.392 51.562 −3.146 1.00 42.84 A O ATOM 7 N ASP A 813 −0.881 52.355−1.021 1.00 40.53 A N ATOM 8 CA ASP A 813 0.529 51.886 −0.931 1.00 41.34A C ATOM 9 N PRO A 814 1.959 53.476 −2.104 1.00 39.43 A N ATOM 10 CD PROA 814 1.808 54.433 −0.997 1.00 38.58 A C ATOM 11 CA PRO A 814 2.77554.055 −3.176 1.00 37.23 A C ATOM 12 CB PRO A 814 3.106 55.453 −2.6541.00 37.73 A C ATOM 13 CG PRO A 814 1.992 55.748 −1.708 1.00 39.50 A CATOM 14 C PRO A 814 4.044 53.287 −3.480 1.00 35.24 A C ATOM 15 O PRO A814 4.660 52.693 −2.598 1.00 34.89 A O ATOM 16 N THR A 815 4.424 53.332−4.748 1.00 34.06 A N ATOM 17 CA THR A 815 5.634 52.702 −5.241 1.0031.98 A C ATOM 18 CB THR A 815 5.350 51.911 −6.492 1.00 30.59 A C ATOM19 OG1 THR A 815 4.429 50.863 −6.172 1.00 30.79 A O ATOM 20 CG2 THR A815 6.637 51.342 −7.065 1.00 26.89 A C ATOM 21 C THR A 815 6.534 53.867−5.604 1.00 32.10 A C ATOM 22 O THR A 815 7.705 53.702 −5.925 1.00 30.98A O ATOM 23 N ILE A 816 5.945 55.054 −5.552 1.00 32.69 A N ATOM 24 CAILE A 816 6.628 56.297 −5.858 1.00 33.81 A C ATOM 25 CB ILE A 816 6.00356.976 −7.097 1.00 35.98 A C ATOM 26 CG2 ILE A 816 6.212 58.473 −7.0381.00 36.08 A C ATOM 27 CG1 ILE A 816 6.586 56.359 −8.378 1.00 38.71 A CATOM 28 CD1 ILE A 816 6.128 54.918 −8.667 1.00 37.14 A C ATOM 29 C ILE A816 6.482 57.205 −4.645 1.00 32.03 A C ATOM 30 O ILE A 816 5.380 57.406−4.146 1.00 33.36 A O ATOM 31 N PHE A 817 7.603 57.736 −4.174 1.00 29.99A N ATOM 32 CA PHE A 817 7.628 58.601 −3.011 1.00 28.59 A C ATOM 33 CBPHE A 817 8.362 57.897 −1.863 1.00 28.20 A C ATOM 34 CG PHE A 817 7.52856.863 −1.149 1.00 25.21 A C ATOM 35 CD1 PHE A 817 6.790 57.203 −0.0331.00 25.13 A C ATOM 36 CD2 PHE A 817 7.481 55.556 −1.593 1.00 23.71 A CATOM 37 CE1 PHE A 817 6.022 56.258 0.630 1.00 22.04 A C ATOM 38 CE2 PHEA 817 6.712 54.609 −0.928 1.00 21.29 A C ATOM 39 CZ PHE A 817 5.98754.965 0.181 1.00 19.64 A C ATOM 40 C PHE A 817 8.303 59.927 −3.324 1.0028.82 A C ATOM 41 O PHE A 817 9.451 59.981 −3.778 1.00 27.53 A O ATOM 42N GLU A 818 7.575 61.001 −3.064 1.00 29.51 A N ATOM 43 CA GLU A 8188.067 62.344 −3.311 1.00 31.25 A C ATOM 44 CB GLU A 818 6.872 63.273−3.540 1.00 31.85 A C ATOM 45 CG GLU A 818 7.228 64.650 −4.033 1.0035.45 A C ATOM 46 CD GLU A 818 6.011 65.460 −4.446 1.00 36.12 A C ATOM47 OE1 GLU A 818 6.193 66.667 −4.710 1.00 36.77 A O ATOM 48 OE2 GLU A818 4.889 64.894 −4.510 1.00 34.70 A O ATOM 49 C GLU A 818 8.884 62.774−2.097 1.00 30.93 A C ATOM 50 O GLU A 818 8.411 62.680 −0.958 1.00 30.09A O ATOM 51 N GLU A 819 10.120 63.213 −2.342 1.00 30.52 A N ATOM 52 CAGLU A 819 11.017 63.635 −1.265 1.00 31.39 A C ATOM 53 CB GLU A 81912.291 64.276 −1.836 1.00 29.12 A C ATOM 54 CG GLU A 819 13.384 63.303−2.288 1.00 28.07 A C ATOM 55 CD GLU A 819 13.967 62.480 −1.138 1.0026.19 A C ATOM 56 OE1 GLU A 819 13.771 62.869 0.031 1.00 27.05 A O ATOM57 OE2 GLU A 819 14.632 61.455 −1.402 1.00 23.85 A O ATOM 58 C GLU A 81910.349 64.607 −0.297 1.00 33.23 A C ATOM 59 O GLU A 819 10.489 64.4770.923 1.00 34.49 A O ATOM 60 N ARG A 820 9.616 65.571 −0.843 1.00 34.22A N ATOM 61 CA ARG A 820 8.917 66.574 −0.042 1.00 35.27 A C ATOM 62 CBARG A 820 8.063 67.444 −0.973 1.00 36.97 A C ATOM 63 CG ARG A 820 7.37568.619 −0.321 1.00 41.68 A C ATOM 64 CD ARG A 820 5.891 68.350 −0.1061.00 46.06 A C ATOM 65 NE ARG A 820 5.539 68.200 1.306 1.00 49.53 A NATOM 66 CZ ARG A 820 5.588 69.176 2.213 1.00 51.16 A C ATOM 67 NH1 ARG A820 5.978 70.398 1.867 1.00 50.30 A N ATOM 68 NH2 ARG A 820 5.242 68.9263.471 1.00 51.02 A N ATOM 69 C ARG A 820 8.046 65.991 1.087 1.00 34.18 AC ATOM 70 O ARG A 820 7.749 66.681 2.060 1.00 35.87 A O ATOM 71 N HIS A821 7.638 64.730 0.964 1.00 32.13 A N ATOM 72 CA HIS A 821 6.809 64.0971.980 1.00 29.99 A C ATOM 73 CB HIS A 821 5.700 63.251 1.327 1.00 31.61A C ATOM 74 CG HIS A 821 4.699 64.054 0.547 1.00 35.95 A C ATOM 75 CD2HIS A 821 4.203 63.889 −0.703 1.00 35.71 A C ATOM 76 ND1 HIS A 821 4.12165.205 1.038 1.00 35.92 A N ATOM 77 CE1 HIS A 821 3.319 65.719 0.1221.00 35.31 A C ATOM 78 NE2 HIS A 821 3.351 64.940 −0.943 1.00 34.98 A NATOM 79 C HIS A 821 7.630 63.228 2.937 1.00 30.47 A C ATOM 80 O HIS A821 7.084 62.609 3.845 1.00 31.60 A O ATOM 81 N LEU A 822 8.938 63.1552.746 1.00 29.14 A N ATOM 82 CA LEU A 822 9.734 62.357 3.669 1.00 30.38A C ATOM 83 CB LEU A 822 10.779 61.516 2.911 1.00 28.09 A C ATOM 84 CGLEU A 822 10.229 60.403 1.992 1.00 27.43 A C ATOM 85 CD1 LEU A 82211.359 59.787 1.205 1.00 25.73 A C ATOM 86 CD2 LEU A 822 9.504 59.3222.811 1.00 24.78 A C ATOM 87 C LEU A 822 10.402 63.296 4.678 1.00 30.74A C ATOM 88 O LEU A 822 11.342 64.017 4.353 1.00 31.28 A O ATOM 89 N LYSA 823 9.893 63.305 5.903 1.00 31.44 A N ATOM 90 CA LYS A 823 10.45564.169 6.934 1.00 31.93 A C ATOM 91 CB LYS A 823 9.367 64.596 7.917 1.0032.76 A C ATOM 92 CG LYS A 823 8.439 65.660 7.385 1.00 35.51 A C ATOM 93CD LYS A 823 7.557 65.135 6.284 1.00 37.19 A C ATOM 94 CE LYS A 8236.627 66.226 5.808 1.00 36.96 A C ATOM 95 NZ LYS A 823 7.411 67.3555.255 1.00 39.29 A N ATOM 96 C LYS A 823 11.601 63.513 7.700 1.00 30.88A C ATOM 97 O LYS A 823 11.407 62.522 8.405 1.00 29.92 A O ATOM 98 N TYRA 824 12.793 64.080 7.549 1.00 30.36 A N ATOM 99 CA TYR A 824 13.98663.584 8.225 1.00 31.67 A C ATOM 100 CB TYR A 824 15.169 64.521 7.9561.00 31.69 A C ATOM 101 CG TYR A 824 16.378 64.226 8.821 1.00 33.19 A CATOM 102 CD1 TYR A 824 17.277 63.221 8.476 1.00 34.10 A C ATOM 103 CE1TYR A 824 18.358 62.910 9.281 1.00 34.40 A C ATOM 104 CD2 TYR A 82416.598 64.921 10.006 1.00 34.17 A C ATOM 105 CE2 TYR A 824 17.681 64.61310.822 1.00 36.17 A C ATOM 106 CZ TYR A 824 18.555 63.603 10.452 1.0036.25 A C ATOM 107 OH TYR A 824 19.612 63.258 11.263 1.00 37.45 A O ATOM108 C TYR A 824 13.788 63.481 9.738 1.00 32.15 A C ATOM 109 O TYR A 82413.279 64.406 10.369 1.00 29.97 A O ATOM 110 N ILE A 825 14.190 62.35610.321 1.00 33.67 A N ATOM 111 CA ILE A 825 14.065 62.188 11.762 1.0034.78 A C ATOM 112 CB ILE A 825 13.177 60.959 12.123 1.00 34.51 A C ATOM113 CG2 ILE A 825 13.321 60.619 13.600 1.00 32.74 A C ATOM 114 CG1 ILE A825 11.703 61.262 11.801 1.00 33.78 A C ATOM 115 CD1 ILE A 825 10.73560.128 12.156 1.00 31.83 A C ATOM 116 C ILE A 825 15.458 62.040 12.3801.00 36.16 A C ATOM 117 O ILE A 825 15.781 62.696 13.377 1.00 36.26 A OATOM 118 N SER A 826 16.284 61.194 11.770 1.00 36.00 A N ATOM 119 CA SERA 826 17.645 60.963 12.247 1.00 37.27 A C ATOM 120 CB SER A 826 17.63760.362 13.653 1.00 37.84 A C ATOM 121 OG SER A 826 17.216 59.011 13.6151.00 41.26 A O ATOM 122 C SER A 826 18.383 60.017 11.312 1.00 36.08 A CATOM 123 O SER A 826 17.785 59.401 10.433 1.00 36.11 A O ATOM 124 N GLNA 827 19.693 59.914 11.499 1.00 35.73 A N ATOM 125 CA GLN A 827 20.49559.034 10.672 1.00 35.07 A C ATOM 126 CB GLN A 827 21.853 59.660 10.3721.00 36.39 A C ATOM 127 CG GLN A 827 21.839 60.555 9.144 1.00 41.54 A CATOM 128 CD GLN A 827 23.123 61.333 8.970 1.00 44.27 A C ATOM 129 OE1GLN A 827 23.527 62.094 9.852 1.00 46.01 A O ATOM 130 NE2 GLN A 82723.773 61.147 7.830 1.00 46.06 A N ATOM 131 C GLN A 827 20.685 57.70611.362 1.00 34.12 A C ATOM 132 O GLN A 827 20.851 57.646 12.579 1.0032.64 A O ATOM 133 N LEU A 828 20.644 56.639 10.568 1.00 32.89 A N ATOM134 CA LEU A 828 20.818 55.294 11.084 1.00 30.70 A C ATOM 135 CB LEU A828 19.852 54.338 10.380 1.00 29.69 A C ATOM 136 CG LEU A 828 18.37154.593 10.675 1.00 30.57 A C ATOM 137 CD1 LEU A 828 17.500 53.653 9.8511.00 28.22 A C ATOM 138 CD2 LEU A 828 18.107 54.400 12.174 1.00 27.72 AC ATOM 139 C LEU A 828 22.253 54.793 10.937 1.00 28.35 A C ATOM 140 OLEU A 828 22.695 53.966 11.716 1.00 27.97 A O ATOM 141 N GLY A 82922.981 55.293 9.945 1.00 29.46 A N ATOM 142 CA GLY A 829 24.354 54.8539.756 1.00 28.42 A C ATOM 143 C GLY A 829 24.780 54.760 8.302 1.00 27.74A C ATOM 144 O GLY A 829 23.968 54.944 7.394 1.00 25.98 A O ATOM 145 NLYS A 830 26.064 54.472 8.092 1.00 27.82 A N ATOM 146 CA LYS A 83026.658 54.339 6.765 1.00 28.70 A C ATOM 147 CB LYS A 830 27.716 55.4186.542 1.00 31.68 A C ATOM 148 CG LYS A 830 28.729 55.005 5.483 1.0038.00 A C ATOM 149 CD LYS A 830 30.008 55.815 5.517 1.00 42.10 A C ATOM150 CE LYS A 830 31.047 55.190 4.587 1.00 44.14 A C ATOM 151 NZ LYS A830 32.187 56.113 4.301 1.00 46.55 A N ATOM 152 C LYS A 830 27.32752.968 6.636 1.00 27.26 A C ATOM 153 O LYS A 830 28.028 52.535 7.5461.00 27.49 A O ATOM 154 N GLY A 831 27.131 52.300 5.501 1.00 25.76 A NATOM 155 CA GLY A 831 27.716 50.985 5.302 1.00 24.03 A C ATOM 156 C GLYA 831 28.751 50.940 4.196 1.00 23.33 A C ATOM 157 O GLY A 831 29.55751.861 4.063 1.00 23.56 A O ATOM 158 N ASN A 832 28.704 49.869 3.4011.00 23.05 A N ATOM 159 CA ASN A 832 29.613 49.614 2.278 1.00 21.30 A CATOM 160 CB ASN A 832 29.756 48.104 2.063 1.00 19.33 A C ATOM 161 CG ASNA 832 30.556 47.424 3.150 1.00 18.24 A C ATOM 162 OD1 ASN A 832 31.73147.712 3.315 1.00 18.72 A O ATOM 163 ND2 ASN A 832 29.927 46.511 3.8901.00 13.29 A N ATOM 164 C ASN A 832 29.182 50.222 0.946 1.00 22.90 A CATOM 165 O ASN A 832 29.986 50.315 0.018 1.00 22.04 A O ATOM 166 N PHE A833 27.913 50.604 0.829 1.00 24.50 A N ATOM 167 CA PHE A 833 27.43951.157 −0.434 1.00 25.47 A C ATOM 168 CB PHE A 833 26.633 50.109 −1.1971.00 24.25 A C ATOM 169 CG PHE A 833 27.366 48.819 −1.401 1.00 24.66 A CATOM 170 CD1 PHE A 833 27.226 47.778 −0.497 1.00 24.28 A C ATOM 171 CD2PHE A 833 28.215 48.650 −2.485 1.00 23.57 A C ATOM 172 CE1 PHE A 83327.919 46.591 −0.672 1.00 23.07 A C ATOM 173 CE2 PHE A 833 28.910 47.464−2.662 1.00 23.02 A C ATOM 174 CZ PHE A 833 28.761 46.437 −1.755 1.0021.21 A C ATOM 175 C PHE A 833 26.618 52.426 −0.333 1.00 26.66 A C ATOM176 O PHE A 833 26.543 53.175 −1.299 1.00 29.44 A O ATOM 177 N GLY A 83426.002 52.667 0.822 1.00 26.24 A N ATOM 178 CA GLY A 834 25.199 53.8590.986 1.00 26.25 A C ATOM 179 C GLY A 834 24.949 54.274 2.428 1.00 29.49A C ATOM 180 O GLY A 834 25.604 53.809 3.370 1.00 30.21 A O ATOM 181 NSER A 835 23.990 55.171 2.610 1.00 29.04 A N ATOM 182 CA SER A 83523.665 55.644 3.938 1.00 30.18 A C ATOM 183 CB SER A 835 24.092 57.1044.099 1.00 29.43 A C ATOM 184 OG SER A 835 24.164 57.744 2.840 1.0032.95 A O ATOM 185 C SER A 835 22.178 55.480 4.138 1.00 29.88 A C ATOM186 O SER A 835 21.420 55.418 3.166 1.00 31.77 A O ATOM 187 N VAL A 83621.770 55.404 5.400 1.00 28.84 A N ATOM 188 CA VAL A 836 20.373 55.2015.752 1.00 27.14 A C ATOM 189 CB VAL A 836 20.167 53.788 6.323 1.0026.52 A C ATOM 190 CG1 VAL A 836 18.684 53.558 6.635 1.00 26.80 A C ATOM191 CG2 VAL A 836 20.697 52.747 5.336 1.00 26.73 A C ATOM 192 C VAL A836 19.874 56.195 6.783 1.00 28.59 A C ATOM 193 O VAL A 836 20.55956.489 7.771 1.00 27.84 A O ATOM 194 N GLU A 837 18.666 56.698 6.5501.00 28.68 A N ATOM 195 CA GLU A 837 18.032 57.646 7.460 1.00 29.30 A CATOM 196 CB GLU A 837 17.847 58.998 6.780 1.00 29.51 A C ATOM 197 CG GLUA 837 19.100 59.647 6.279 1.00 29.26 A C ATOM 198 CD GLU A 837 18.83661.075 5.896 1.00 28.21 A C ATOM 199 OE1 GLU A 837 17.661 61.375 5.6021.00 29.43 A O ATOM 200 OE2 GLU A 837 19.781 61.890 5.880 1.00 29.52 A OATOM 201 C GLU A 837 16.656 57.143 7.902 1.00 30.42 A C ATOM 202 O GLU A837 16.020 56.341 7.206 1.00 30.43 A O ATOM 203 N LEU A 838 16.20157.618 9.061 1.00 30.98 A N ATOM 204 CA LEU A 838 14.886 57.253 9.5841.00 30.21 A C ATOM 205 CB LEU A 838 14.921 57.034 11.100 1.00 30.08 A CATOM 206 CG LEU A 838 13.571 56.846 11.822 1.00 30.36 A C ATOM 207 CD1LEU A 838 12.825 55.640 11.294 1.00 29.07 A C ATOM 208 CD2 LEU A 83813.812 56.679 13.297 1.00 29.13 A C ATOM 209 C LEU A 838 14.002 58.4379.271 1.00 31.11 A C ATOM 210 O LEU A 838 14.210 59.528 9.804 1.00 33.21A O ATOM 211 N CYS A 839 13.030 58.225 8.392 1.00 30.58 A N ATOM 212 CACYS A 839 12.113 59.282 7.996 1.00 31.03 A C ATOM 213 CB CYS A 83912.262 59.581 6.503 1.00 29.27 A C ATOM 214 SG CYS A 839 13.914 59.9935.930 1.00 27.80 A S ATOM 215 C CYS A 839 10.654 58.916 8.261 1.00 32.73A C ATOM 216 O CYS A 839 10.316 57.768 8.563 1.00 33.99 A O ATOM 217 NARG A 840 9.780 59.900 8.134 1.00 32.93 A N ATOM 218 CA ARG A 840 8.37259.642 8.312 1.00 34.97 A C ATOM 219 CB ARG A 840 7.820 60.439 9.4991.00 37.08 A C ATOM 220 CG ARG A 840 6.325 60.238 9.734 1.00 39.75 A CATOM 221 CD ARG A 840 5.744 61.214 10.764 1.00 42.91 A C ATOM 222 NE ARGA 840 6.009 60.817 12.145 1.00 45.02 A N ATOM 223 CZ ARG A 840 6.77961.492 12.995 1.00 46.42 A C ATOM 224 NH1 ARG A 840 7.378 62.617 12.6161.00 45.99 A N ATOM 225 NH2 ARG A 840 6.950 61.036 14.231 1.00 46.11 A NATOM 226 C ARG A 840 7.685 60.072 7.029 1.00 34.39 A C ATOM 227 O ARG A840 7.911 61.177 6.544 1.00 33.96 A O ATOM 228 N TYR A 841 6.885 59.1846.452 1.00 36.23 A N ATOM 229 CA TYR A 841 6.145 59.516 5.241 1.00 38.35A C ATOM 230 CB TYR A 841 5.696 58.246 4.511 1.00 38.71 A C ATOM 231 CGTYR A 841 4.982 58.516 3.206 1.00 38.68 A C ATOM 232 CD1 TYR A 841 5.49059.430 2.294 1.00 37.37 A C ATOM 233 CE1 TYR A 841 4.859 59.673 1.1011.00 36.58 A C ATOM 234 CD2 TYR A 841 3.811 57.848 2.878 1.00 39.63 A CATOM 235 CE2 TYR A 841 3.172 58.085 1.680 1.00 39.84 A C ATOM 236 CZ TYRA 841 3.703 58.998 0.798 1.00 38.61 A C ATOM 237 OH TYR A 841 3.06659.234 −0.397 1.00 41.90 A O ATOM 238 C TYR A 841 4.947 60.259 5.8011.00 40.68 A C ATOM 239 O TYR A 841 4.146 59.679 6.531 1.00 40.74 A OATOM 240 N ASP A 842 4.832 61.543 5.474 1.00 43.88 A N ATOM 241 CA ASP A842 3.755 62.370 6.009 1.00 46.15 A C ATOM 242 CB ASP A 842 4.326 63.2197.152 1.00 46.02 A C ATOM 243 CG ASP A 842 3.358 63.397 8.303 1.00 46.16A C ATOM 244 OD1 ASP A 842 2.749 62.395 8.730 1.00 46.36 A O ATOM 245OD2 ASP A 842 3.225 64.538 8.797 1.00 44.93 A O ATOM 246 C ASP A 8423.135 63.277 4.950 1.00 48.03 A C ATOM 247 O ASP A 842 3.262 64.5005.029 1.00 47.67 A O ATOM 248 N PRO A 843 2.453 62.688 3.948 1.00 50.40A N ATOM 249 CD PRO A 843 2.212 61.242 3.809 1.00 50.93 A C ATOM 250 CAPRO A 843 1.801 63.427 2.858 1.00 51.87 A C ATOM 251 CB PRO A 843 0.98062.348 2.154 1.00 51.29 A C ATOM 252 CG PRO A 843 1.792 61.125 2.3591.00 50.63 A C ATOM 253 C PRO A 843 0.923 64.556 3.389 1.00 53.34 A CATOM 254 O PRO A 843 0.848 65.633 2.798 1.00 54.36 A O ATOM 255 N LEU A844 0.263 64.295 4.511 1.00 54.96 A N ATOM 256 CA LEU A 844 −0.61265.273 5.144 1.00 56.98 A C ATOM 257 CB LEU A 844 −1.832 64.569 5.7451.00 57.16 A C ATOM 258 CG LEU A 844 −2.540 63.518 4.878 1.00 57.83 A CATOM 259 CD1 LEU A 844 −2.826 64.080 3.490 1.00 57.39 A C ATOM 260 CD2LEU A 844 −1.667 62.287 4.770 1.00 58.93 A C ATOM 261 C LEU A 844 0.15866.004 6.245 1.00 58.02 A C ATOM 262 O LEU A 844 1.173 65.510 6.736 1.0058.53 A O ATOM 263 N GLY A 845 −0.320 67.178 6.636 1.00 59.34 A N ATOM264 CA GLY A 845 0.366 67.926 7.676 1.00 60.48 A C ATOM 265 C GLY A 8450.607 67.135 8.956 1.00 61.50 A C ATOM 266 O GLY A 845 1.748 66.9869.400 1.00 61.55 A O ATOM 267 N ASP A 846 −0.471 66.631 9.551 1.00 61.30A N ATOM 268 CA ASP A 846 −0.383 65.862 10.785 1.00 61.54 A C ATOM 269CB ASP A 846 −1.731 65.199 11.100 1.00 63.49 A C ATOM 270 CG ASP A 846−2.244 64.334 9.960 1.00 64.35 A C ATOM 271 OD1 ASP A 846 −3.385 63.83510.056 1.00 66.21 A O ATOM 272 OD2 ASP A 846 −1.510 64.148 8.968 1.0065.16 A O ATOM 273 C ASP A 846 0.700 64.806 10.684 1.00 61.10 A C ATOM274 O ASP A 846 0.805 64.108 9.677 1.00 61.50 A O ATOM 275 N ASN A 8471.501 64.690 11.735 1.00 59.87 A N ATOM 276 CA ASN A 847 2.589 63.72311.763 1.00 57.70 A C ATOM 277 CB ASN A 847 3.512 64.038 12.924 1.0058.23 A C ATOM 278 CG ASN A 847 4.087 65.416 12.826 1.00 58.62 A C ATOM279 OD1 ASN A 847 4.999 65.663 12.039 1.00 59.48 A O ATOM 280 ND2 ASN A847 3.543 66.337 13.607 1.00 59.51 A N ATOM 281 C ASN A 847 2.083 62.30411.895 1.00 55.91 A C ATOM 282 O ASN A 847 2.803 61.426 12.374 1.0056.51 A O ATOM 283 N THR A 848 0.845 62.085 11.465 1.00 53.41 A N ATOM284 CA THR A 848 0.222 60.771 11.541 1.00 51.20 A C ATOM 285 CB THR A848 −1.273 60.836 11.136 1.00 50.55 A C ATOM 286 OG1 THR A 848 −1.39061.250 9.768 1.00 49.25 A O ATOM 287 CG2 THR A 848 −2.023 61.818 12.0231.00 49.29 A C ATOM 288 C THR A 848 0.920 59.735 10.663 1.00 50.05 A CATOM 289 O THR A 848 0.606 58.547 10.732 1.00 51.27 A O ATOM 290 N GLY A849 1.866 60.184 9.845 1.00 47.22 A N ATOM 291 CA GLY A 849 2.582 59.2748.965 1.00 44.27 A C ATOM 292 C GLY A 849 3.322 58.124 9.632 1.00 41.86A C ATOM 293 O GLY A 849 3.518 58.109 10.848 1.00 42.65 A O ATOM 294 NALA A 850 3.750 57.159 8.822 1.00 40.05 A N ATOM 295 CA ALA A 850 4.46755.984 9.315 1.00 37.02 A C ATOM 296 CB ALA A 850 3.994 54.730 8.5711.00 36.14 A C ATOM 297 C ALA A 850 5.979 56.103 9.188 1.00 36.11 A CATOM 298 O ALA A 850 6.501 56.891 8.397 1.00 35.06 A O ATOM 299 N LEU A851 6.682 55.309 9.982 1.00 34.16 A N ATOM 300 CA LEU A 851 8.130 55.3079.930 1.00 33.37 A C ATOM 301 CB LEU A 851 8.704 54.832 11.264 1.0035.31 A C ATOM 302 CG LEU A 851 9.165 55.901 12.257 1.00 36.20 A C ATOM303 CD1 LEU A 851 8.253 57.120 12.182 1.00 36.82 A C ATOM 304 CD2 LEU A851 9.181 55.297 13.664 1.00 34.32 A C ATOM 305 C LEU A 851 8.611 54.3948.806 1.00 31.96 A C ATOM 306 O LEU A 851 8.015 53.354 8.540 1.00 31.31A O ATOM 307 N VAL A 852 9.682 54.802 8.134 1.00 31.01 A N ATOM 308 CAVAL A 852 10.258 54.012 7.055 1.00 27.90 A C ATOM 309 CB VAL A 852 9.71554.441 5.672 1.00 26.77 A C ATOM 310 CG1 VAL A 852 8.205 54.243 5.6031.00 28.29 A C ATOM 311 CG2 VAL A 852 10.065 55.876 5.416 1.00 24.56 A CATOM 312 C VAL A 852 11.773 54.200 7.047 1.00 29.02 A C ATOM 313 O VAL A852 12.286 55.216 7.528 1.00 28.76 A O ATOM 314 N ALA A 853 12.48653.212 6.513 1.00 28.28 A N ATOM 315 CA ALA A 853 13.937 53.293 6.4041.00 27.51 A C ATOM 316 CB ALA A 853 14.564 51.949 6.642 1.00 27.05 A CATOM 317 C ALA A 853 14.218 53.749 4.985 1.00 28.18 A C ATOM 318 O ALA A853 13.746 53.132 4.016 1.00 28.55 A O ATOM 319 N VAL A 854 14.98354.828 4.857 1.00 26.18 A N ATOM 320 CA VAL A 854 15.297 55.366 3.5461.00 25.26 A C ATOM 321 CB VAL A 854 14.806 56.815 3.404 1.00 24.58 A CATOM 322 CG1 VAL A 854 15.175 57.355 2.020 1.00 25.67 A C ATOM 323 CG2VAL A 854 13.306 56.868 3.640 1.00 20.74 A C ATOM 324 C VAL A 854 16.77955.343 3.275 1.00 25.34 A C ATOM 325 O VAL A 854 17.523 56.142 3.8271.00 27.35 A O ATOM 326 N LYS A 855 17.211 54.430 2.418 1.00 24.66 A NATOM 327 CA LYS A 855 18.622 54.339 2.091 1.00 25.16 A C ATOM 328 CB LYSA 855 19.087 52.877 2.050 1.00 22.54 A C ATOM 329 CG LYS A 855 20.26452.682 1.088 1.00 20.44 A C ATOM 330 CD LYS A 855 20.761 51.253 0.9721.00 18.74 A C ATOM 331 CE LYS A 855 21.444 50.753 2.237 1.00 18.04 A CATOM 332 NZ LYS A 855 22.347 49.633 1.878 1.00 16.00 A N ATOM 333 C LYSA 855 18.944 54.987 0.746 1.00 26.42 A C ATOM 334 O LYS A 855 18.18554.861 −0.214 1.00 23.35 A O ATOM 335 N GLN A 856 20.071 55.693 0.7021.00 27.46 A N ATOM 336 CA GLN A 856 20.557 56.315 −0.522 1.00 29.59 A CATOM 337 CB GLN A 856 20.792 57.818 −0.325 1.00 29.19 A C ATOM 338 CGGLN A 856 21.044 58.568 −1.637 1.00 32.25 A C ATOM 339 CD GLN A 85621.048 60.101 −1.489 1.00 33.60 A C ATOM 340 OE1 GLN A 856 21.849 60.654−0.742 1.00 38.48 A O ATOM 341 NE2 GLN A 856 20.157 60.782 −2.213 1.0028.07 A N ATOM 342 C GLN A 856 21.882 55.624 −0.875 1.00 30.88 A C ATOM343 O GLN A 856 22.804 55.563 −0.054 1.00 31.97 A O ATOM 344 N LEU A 85721.967 55.088 −2.085 1.00 32.50 A N ATOM 345 CA LEU A 857 23.178 54.412−2.542 1.00 35.93 A C ATOM 346 CB LEU A 857 22.837 53.379 −3.620 1.0033.15 A C ATOM 347 CG LEU A 857 21.875 52.268 −3.202 1.00 31.85 A C ATOM348 CD1 LEU A 857 21.562 51.361 −4.379 1.00 31.75 A C ATOM 349 CD2 LEU A857 22.494 51.484 −2.072 1.00 31.93 A C ATOM 350 C LEU A 857 24.20255.386 −3.114 1.00 38.69 A C ATOM 351 O LEU A 857 23.845 56.347 −3.7961.00 37.21 A O ATOM 352 N GLN A 858 25.473 55.146 −2.814 1.00 43.02 A NATOM 353 CA GLN A 858 26.540 55.979 −3.347 1.00 48.51 A C ATOM 354 CBGLN A 858 27.899 55.516 −2.808 1.00 49.56 A C ATOM 355 CG GLN A 85829.091 56.039 −3.601 1.00 52.69 A C ATOM 356 CD GLN A 858 30.384 55.277−3.320 1.00 55.55 A C ATOM 357 OE1 GLN A 858 30.403 54.044 −3.301 1.0056.97 A O ATOM 358 NE2 GLN A 858 31.474 56.013 −3.113 1.00 56.46 A NATOM 359 C GLN A 858 26.465 55.749 −4.854 1.00 51.62 A C ATOM 360 O GLNA 858 26.836 54.687 −5.354 1.00 52.30 A O ATOM 361 N HIS A 859 25.96856.737 −5.579 1.00 56.16 A N ATOM 362 CA HIS A 859 25.827 56.591 −7.0191.00 59.85 A C ATOM 363 CB HIS A 859 24.361 56.781 −7.414 1.00 60.11 A CATOM 364 CG HIS A 859 24.025 56.251 −8.772 1.00 61.57 A C ATOM 365 CD2HIS A 859 23.561 56.872 −9.882 1.00 62.54 A C ATOM 366 ND1 HIS A 85924.157 54.921 −9.103 1.00 62.61 A N ATOM 367 CE1 HIS A 859 23.789 54.743−10.360 1.00 63.08 A C ATOM 368 NE2 HIS A 859 23.423 55.911 −10.855 1.0063.34 A N ATOM 369 C HIS A 859 26.699 57.605 −7.744 1.00 61.51 A C ATOM370 O HIS A 859 26.380 58.794 −7.795 1.00 62.00 A O ATOM 371 N SER A 86027.811 57.129 −8.291 1.00 63.34 A N ATOM 372 CA SER A 860 28.726 57.996−9.018 1.00 64.52 A C ATOM 373 CB SER A 860 30.132 57.916 −8.416 1.0065.20 A C ATOM 374 OG SER A 860 30.108 58.201 −7.025 1.00 65.35 A O ATOM375 C SER A 860 28.746 57.574 −10.480 1.00 65.06 A C ATOM 376 O SER A860 29.523 56.708 −10.886 1.00 64.96 A O ATOM 377 N GLY A 861 27.86258.198 −11.252 1.00 65.21 A N ATOM 378 CA GLY A 861 27.738 57.924−12.670 1.00 65.25 A C ATOM 379 C GLY A 861 26.374 58.427 −13.094 1.0065.25 A C ATOM 380 O GLY A 861 25.606 58.885 −12.245 1.00 65.70 A O ATOM381 N PRO A 862 26.032 58.368 −14.389 1.00 64.70 A N ATOM 382 CD PRO A862 26.713 57.725 −15.526 1.00 65.03 A C ATOM 383 CA PRO A 862 24.70758.854 −14.783 1.00 63.21 A C ATOM 384 CB PRO A 862 24.678 58.591−16.287 1.00 63.52 A C ATOM 385 CG PRO A 862 25.548 57.375 −16.425 1.0064.47 A C ATOM 386 C PRO A 862 23.598 58.107 −14.046 1.00 61.61 A C ATOM387 O PRO A 862 23.425 56.904 −14.232 1.00 61.26 A O ATOM 388 N ASP A863 22.865 58.823 −13.197 1.00 59.69 A N ATOM 389 CA ASP A 863 21.76358.228 −12.444 1.00 56.82 A C ATOM 390 CB ASP A 863 20.950 59.303−11.721 1.00 58.54 A C ATOM 391 CG ASP A 863 20.091 60.133 −12.680 1.0059.27 A C ATOM 392 OD1 ASP A 863 20.662 60.803 −13.574 1.00 60.57 A OATOM 393 OD2 ASP A 863 18.849 60.115 −12.541 1.00 58.02 A O ATOM 394 CASP A 863 20.859 57.574 −13.461 1.00 54.16 A C ATOM 395 O ASP A 86320.821 58.004 −14.612 1.00 54.94 A O ATOM 396 N GLN A 864 20.126 56.548−13.044 1.00 49.49 A N ATOM 397 CA GLN A 864 19.212 55.875 −13.953 1.0044.06 A C ATOM 398 CB GLN A 864 19.861 54.620 −14.509 1.00 46.96 A CATOM 399 CG GLN A 864 21.098 54.950 −15.309 1.00 49.97 A C ATOM 400 CDGLN A 864 20.834 56.024 −16.348 1.00 51.95 A C ATOM 401 OE1 GLN A 86421.748 56.732 −16.769 1.00 54.75 A O ATOM 402 NE2 GLN A 864 19.58056.149 −16.769 1.00 53.04 A N ATOM 403 C GLN A 864 17.883 55.553 −13.2971.00 39.54 A C ATOM 404 O GLN A 864 17.674 54.464 −12.767 1.00 37.98 A OATOM 405 N GLN A 865 16.995 56.540 −13.343 1.00 34.60 A N ATOM 406 CAGLN A 865 15.671 56.455 −12.766 1.00 30.90 A C ATOM 407 CB GLN A 86514.875 57.702 −13.173 1.00 29.99 A C ATOM 408 CG GLN A 865 13.395 57.657−12.845 1.00 27.24 A C ATOM 409 CD GLN A 865 12.635 56.758 −13.792 1.0025.91 A C ATOM 410 OE1 GLN A 865 12.783 56.867 −15.013 1.00 26.96 A OATOM 411 NE2 GLN A 865 11.815 55.866 −13.241 1.00 26.05 A N ATOM 412 CGLN A 865 14.937 55.178 −13.164 1.00 30.14 A C ATOM 413 O GLN A 86514.330 54.514 −12.317 1.00 29.46 A O ATOM 414 N ARG A 866 14.992 54.835−14.446 1.00 28.26 A N ATOM 415 CA ARG A 866 14.339 53.630 −14.939 1.0027.87 A C ATOM 416 CB ARG A 866 14.556 53.480 −16.442 1.00 30.08 A CATOM 417 CG ARG A 866 13.762 54.460 −17.277 1.00 31.40 A C ATOM 418 CDARG A 866 14.135 54.349 −18.744 1.00 30.86 A C ATOM 419 NE ARG A 86613.327 55.237 −19.577 1.00 31.25 A N ATOM 420 CZ ARG A 866 13.453 56.561−19.620 1.00 31.81 A C ATOM 421 NH1 ARG A 866 12.661 57.268 −20.410 1.0030.66 A N ATOM 422 NH2 ARG A 866 14.370 57.181 −18.883 1.00 30.91 A NATOM 423 C ARG A 866 14.843 52.386 −14.225 1.00 27.32 A C ATOM 424 O ARGA 866 14.039 51.559 −13.790 1.00 24.87 A O ATOM 425 N ASP A 867 16.16552.247 −14.111 1.00 29.27 A N ATOM 426 CA ASP A 867 16.762 51.096−13.420 1.00 30.55 A C ATOM 427 CB ASP A 867 18.287 51.202 −13.357 1.0031.56 A C ATOM 428 CG ASP A 867 18.961 50.950 −14.701 1.00 34.40 A CATOM 429 OD1 ASP A 867 18.384 50.263 −15.578 1.00 35.17 A O ATOM 430 OD2ASP A 867 20.094 51.439 −14.869 1.00 36.88 A O ATOM 431 C ASP A 86716.228 50.944 −12.001 1.00 31.08 A C ATOM 432 O ASP A 867 15.568 49.948−11.694 1.00 31.13 A O ATOM 433 N PHE A 868 16.508 51.919 −11.134 1.0031.00 A N ATOM 434 CA PHE A 868 16.018 51.844 −9.755 1.00 31.24 A C ATOM435 CB PHE A 868 16.192 53.180 −9.024 1.00 30.81 A C ATOM 436 CG PHE A868 17.597 53.467 −8.598 1.00 28.20 A C ATOM 437 CD1 PHE A 868 18.59153.669 −9.536 1.00 27.55 A C ATOM 438 CD2 PHE A 868 17.921 53.533 −7.2541.00 28.80 A C ATOM 439 CE1 PHE A 868 19.884 53.931 −9.143 1.00 28.47 AC ATOM 440 CE2 PHE A 868 19.207 53.793 −6.848 1.00 27.69 A C ATOM 441 CZPHE A 868 20.194 53.993 −7.792 1.00 29.38 A C ATOM 442 C PHE A 86814.536 51.487 −9.758 1.00 31.43 A C ATOM 443 O PHE A 868 14.076 50.687−8.950 1.00 32.47 A O ATOM 444 N GLN A 869 13.800 52.095 −10.676 1.0031.87 A N ATOM 445 CA GLN A 869 12.364 51.871 −10.814 1.00 33.84 A CATOM 446 CB GLN A 869 11.827 52.814 −11.901 1.00 34.67 A C ATOM 447 CGGLN A 869 10.323 52.847 −12.055 1.00 39.76 A C ATOM 448 CD GLN A 8699.621 53.521 −10.902 1.00 42.28 A C ATOM 449 OE1 GLN A 869 8.422 53.775−10.960 1.00 43.86 A O ATOM 450 NE2 GLN A 869 10.366 53.815 −9.842 1.0045.51 A N ATOM 451 C GLN A 869 12.053 50.405 −11.169 1.00 32.83 A C ATOM452 O GLN A 869 11.157 49.777 −10.593 1.00 30.45 A O ATOM 453 N ARG A870 12.807 49.868 −12.121 1.00 31.56 A N ATOM 454 CA ARG A 870 12.61948.490 −12.567 1.00 29.61 A C ATOM 455 CB ARG A 870 13.578 48.192−13.720 1.00 29.76 A C ATOM 456 CG ARG A 870 13.476 46.795 −14.306 1.0030.49 A C ATOM 457 CD ARG A 870 14.608 46.577 −15.294 1.00 27.79 A CATOM 458 NE ARG A 870 15.918 46.749 −14.671 1.00 26.84 A N ATOM 459 CZARG A 870 16.841 47.605 −15.098 1.00 27.83 A C ATOM 460 NH1 ARG A 87016.588 48.373 −16.152 1.00 24.51 A N ATOM 461 NH2 ARG A 870 18.02347.679 −14.485 1.00 25.65 A N ATOM 462 C ARG A 870 12.849 47.495 −11.4381.00 29.71 A C ATOM 463 O ARG A 870 12.092 46.535 −11.266 1.00 30.22 A OATOM 464 N GLU A 871 13.893 47.736 −10.658 1.00 30.06 A N ATOM 465 CAGLU A 871 14.244 46.851 −9.564 1.00 29.79 A C ATOM 466 CB GLU A 87115.625 47.219 −9.054 1.00 29.83 A C ATOM 467 CG GLU A 871 16.677 47.061−10.127 1.00 30.10 A C ATOM 468 CD GLU A 871 16.663 45.668 −10.734 1.0032.26 A C ATOM 469 OE1 GLU A 871 16.906 45.543 −11.956 1.00 33.53 A OATOM 470 OE2 GLU A 871 16.417 44.699 −9.985 1.00 32.71 A O ATOM 471 CGLU A 871 13.230 46.858 −8.435 1.00 32.02 A C ATOM 472 O GLU A 87112.617 45.829 −8.127 1.00 31.99 A O ATOM 473 N ILE A 872 13.035 48.016−7.822 1.00 33.05 A N ATOM 474 CA ILE A 872 12.081 48.115 −6.727 1.0033.73 A C ATOM 475 CB ILE A 872 11.839 49.581 −6.320 1.00 34.18 A C ATOM476 CG2 ILE A 872 10.647 49.683 −5.409 1.00 34.71 A C ATOM 477 CG1 ILE A872 13.055 50.096 −5.563 1.00 35.67 A C ATOM 478 CD1 ILE A 872 13.37749.261 −4.352 1.00 33.28 A C ATOM 479 C ILE A 872 10.753 47.453 −7.0611.00 32.84 A C ATOM 480 O ILE A 872 10.156 46.805 −6.200 1.00 33.81 A OATOM 481 N GLN A 873 10.286 47.594 −8.301 1.00 31.38 A N ATOM 482 CA GLNA 873 9.014 46.972 −8.669 1.00 31.13 A C ATOM 483 CB GLN A 873 8.55447.407 −10.060 1.00 31.19 A C ATOM 484 CG GLN A 873 8.194 48.867 −10.1191.00 33.73 A C ATOM 485 CD GLN A 873 7.213 49.198 −11.218 1.00 36.91 A CATOM 486 OE1 GLN A 873 6.858 50.366 −11.396 1.00 41.17 A O ATOM 487 NE2GLN A 873 6.761 48.181 −11.960 1.00 35.88 A N ATOM 488 C GLN A 873 9.12845.462 −8.614 1.00 30.57 A C ATOM 489 O GLN A 873 8.187 44.773 −8.2091.00 30.27 A O ATOM 490 N ILE A 874 10.291 44.961 −9.022 1.00 28.38 A NATOM 491 CA ILE A 874 10.571 43.538 −9.000 1.00 26.50 A C ATOM 492 CBILE A 874 11.906 43.224 −9.738 1.00 25.96 A C ATOM 493 CG2 ILE A 87412.444 41.878 −9.304 1.00 25.39 A C ATOM 494 CG1 ILE A 874 11.693 43.227−11.252 1.00 23.07 A C ATOM 495 CD1 ILE A 874 12.985 43.153 −12.033 1.0024.11 A C ATOM 496 C ILE A 874 10.693 43.093 −7.542 1.00 27.93 A C ATOM497 O ILE A 874 10.192 42.031 −7.157 1.00 27.66 A O ATOM 498 N LEU A 87511.361 43.922 −6.737 1.00 27.30 A N ATOM 499 CA LEU A 875 11.576 43.629−5.323 1.00 26.34 A C ATOM 500 CB LEU A 875 12.698 44.514 −4.769 1.0025.39 A C ATOM 501 CG LEU A 875 14.108 44.249 −5.324 1.00 23.64 A C ATOM502 CD1 LEU A 875 15.052 45.341 −4.844 1.00 23.64 A C ATOM 503 CD2 LEU A875 14.610 42.897 −4.876 1.00 22.26 A C ATOM 504 C LEU A 875 10.30843.802 −4.491 1.00 26.93 A C ATOM 505 O LEU A 875 10.068 43.056 −3.5411.00 27.40 A O ATOM 506 N LYS A 876 9.486 44.774 −4.862 1.00 26.36 A NATOM 507 CA LYS A 876 8.256 45.025 −4.134 1.00 27.17 A C ATOM 508 CB LYSA 876 7.669 46.380 −4.540 1.00 24.25 A C ATOM 509 CG LYS A 876 6.55146.819 −3.634 1.00 24.74 A C ATOM 510 CD LYS A 876 5.952 48.150 −4.0141.00 25.31 A C ATOM 511 CE LYS A 876 4.882 48.496 −3.008 1.00 24.35 A CATOM 512 NZ LYS A 876 4.120 49.691 −3.413 1.00 28.04 A N ATOM 513 C LYSA 876 7.227 43.917 −4.369 1.00 29.28 A C ATOM 514 O LYS A 876 6.21143.830 −3.666 1.00 32.41 A O ATOM 515 N ALA A 877 7.475 43.067 −5.3581.00 28.69 A N ATOM 516 CA ALA A 877 6.533 41.990 −5.629 1.00 29.42 A CATOM 517 CB ALA A 877 6.501 41.678 −7.130 1.00 27.23 A C ATOM 518 C ALAA 877 6.883 40.736 −4.814 1.00 29.56 A C ATOM 519 O ALA A 877 6.05339.841 −4.653 1.00 28.54 A O ATOM 520 N LEU A 878 8.107 40.694 −4.2881.00 29.51 A N ATOM 521 CA LEU A 878 8.585 39.573 −3.473 1.00 27.97 A CATOM 522 CB LEU A 878 10.094 39.691 −3.250 1.00 26.08 A C ATOM 523 CGLEU A 878 10.959 39.783 −4.503 1.00 27.63 A C ATOM 524 CD1 LEU A 87812.350 40.250 −4.135 1.00 27.67 A C ATOM 525 CD2 LEU A 878 10.991 38.444−5.209 1.00 26.13 A C ATOM 526 C LEU A 878 7.896 39.556 −2.117 1.0027.99 A C ATOM 527 O LEU A 878 7.899 40.560 −1.414 1.00 29.76 A O ATOM528 N HIS A 879 7.308 38.425 −1.745 1.00 29.32 A N ATOM 529 CA HIS A 8796.643 38.314 −0.451 1.00 31.36 A C ATOM 530 CB HIS A 879 5.130 38.240−0.630 1.00 32.39 A C ATOM 531 CG HIS A 879 4.550 39.450 −1.285 1.0039.51 A C ATOM 532 CD2 HIS A 879 3.661 39.582 −2.296 1.00 40.92 A C ATOM533 ND1 HIS A 879 4.907 40.732 −0.918 1.00 42.50 A N ATOM 534 CE1 HIS A879 4.266 41.599 −1.679 1.00 43.10 A C ATOM 535 NE2 HIS A 879 3.50440.929 −2.525 1.00 44.26 A N ATOM 536 C HIS A 879 7.103 37.131 0.4081.00 31.51 A C ATOM 537 O HIS A 879 6.948 35.968 0.022 1.00 31.05 A OATOM 538 N SER A 880 7.666 37.454 1.575 1.00 30.02 A N ATOM 539 CA SER A880 8.132 36.464 2.541 1.00 28.69 A C ATOM 540 CB SER A 880 9.564 36.0522.251 1.00 27.94 A C ATOM 541 OG SER A 880 10.046 35.269 3.324 1.0025.72 A O ATOM 542 C SER A 880 8.062 37.010 3.959 1.00 30.58 A C ATOM543 O SER A 880 8.201 38.211 4.170 1.00 31.38 A O ATOM 544 N ASP A 8817.848 36.132 4.933 1.00 31.77 A N ATOM 545 CA ASP A 881 7.762 36.5686.322 1.00 32.73 A C ATOM 546 CB ASP A 881 7.001 35.543 7.169 1.00 36.42A C ATOM 547 CG ASP A 881 5.539 35.439 6.786 1.00 41.67 A C ATOM 548 OD1ASP A 881 4.841 36.479 6.830 1.00 43.68 A O ATOM 549 OD2 ASP A 881 5.09034.318 6.446 1.00 43.38 A O ATOM 550 C ASP A 881 9.144 36.783 6.917 1.0032.05 A C ATOM 551 O ASP A 881 9.284 37.257 8.046 1.00 31.81 A O ATOM552 N PHE A 882 10.167 36.429 6.152 1.00 29.45 A N ATOM 553 CA PHE A 88211.538 36.573 6.611 1.00 27.95 A C ATOM 554 CB PHE A 882 12.195 35.1946.685 1.00 27.05 A C ATOM 555 CG PHE A 882 11.355 34.172 7.401 1.0025.73 A C ATOM 556 CD1 PHE A 882 11.060 34.318 8.741 1.00 24.96 A C ATOM557 CD2 PHE A 882 10.794 33.111 6.712 1.00 27.21 A C ATOM 558 CE1 PHE A882 10.209 33.427 9.388 1.00 26.21 A C ATOM 559 CE2 PHE A 882 9.94332.217 7.353 1.00 27.67 A C ATOM 560 CZ PHE A 882 9.650 32.378 8.6911.00 24.82 A C ATOM 561 C PHE A 882 12.281 37.472 5.639 1.00 28.22 A CATOM 562 O PHE A 882 13.422 37.210 5.282 1.00 27.42 A O ATOM 563 N ILE A883 11.608 38.533 5.203 1.00 28.53 A N ATOM 564 CA ILE A 883 12.18539.492 4.267 1.00 27.18 A C ATOM 565 CB ILE A 883 11.707 39.203 2.8251.00 27.90 A C ATOM 566 CG2 ILE A 883 11.013 40.427 2.239 1.00 27.92 A CATOM 567 CG1 ILE A 883 12.892 38.779 1.966 1.00 26.54 A C ATOM 568 CD1ILE A 883 13.414 37.448 2.314 1.00 23.32 A C ATOM 569 C ILE A 883 11.74940.898 4.661 1.00 26.07 A C ATOM 570 O ILE A 883 10.608 41.101 5.0701.00 26.87 A O ATOM 571 N VAL A 884 12.652 41.865 4.551 1.00 25.78 A NATOM 572 CA VAL A 884 12.327 43.245 4.900 1.00 25.41 A C ATOM 573 CB VALA 884 13.579 44.019 5.310 1.00 25.86 A C ATOM 574 CG1 VAL A 884 13.20945.438 5.667 1.00 25.61 A C ATOM 575 CG2 VAL A 884 14.244 43.327 6.4791.00 27.98 A C ATOM 576 C VAL A 884 11.677 43.928 3.701 1.00 25.52 A CATOM 577 O VAL A 884 12.314 44.168 2.680 1.00 24.56 A O ATOM 578 N LYS A885 10.398 44.246 3.851 1.00 26.64 A N ATOM 579 CA LYS A 885 9.60544.855 2.798 1.00 26.33 A C ATOM 580 CB LYS A 885 8.174 45.059 3.3011.00 27.25 A C ATOM 581 CG LYS A 885 7.258 43.868 3.055 1.00 29.12 A CATOM 582 CD LYS A 885 5.912 44.038 3.735 1.00 31.39 A C ATOM 583 CE LYSA 885 6.068 44.055 5.241 1.00 31.87 A C ATOM 584 NZ LYS A 885 4.75043.980 5.915 1.00 34.16 A N ATOM 585 C LYS A 885 10.100 46.150 2.1621.00 26.24 A C ATOM 586 O LYS A 885 10.219 47.179 2.825 1.00 25.99 A OATOM 587 N TYR A 886 10.409 46.081 0.870 1.00 25.58 A N ATOM 588 CA TYRA 886 10.808 47.264 0.125 1.00 24.39 A C ATOM 589 CB TYR A 886 11.46446.875 −1.209 1.00 22.20 A C ATOM 590 CG TYR A 886 12.945 46.541 −1.1261.00 21.86 A C ATOM 591 CD1 TYR A 886 13.885 47.509 −0.768 1.00 20.74 AC ATOM 592 CE1 TYR A 886 15.236 47.200 −0.681 1.00 19.63 A C ATOM 593CD2 TYR A 886 13.399 45.264 −1.397 1.00 20.05 A C ATOM 594 CE2 TYR A 88614.742 44.949 −1.313 1.00 19.69 A C ATOM 595 CZ TYR A 886 15.655 45.917−0.953 1.00 20.05 A C ATOM 596 OH TYR A 886 16.992 45.596 −0.860 1.0017.58 A O ATOM 597 C TYR A 886 9.461 47.948 −0.130 1.00 24.24 A C ATOM598 O TYR A 886 8.430 47.273 −0.267 1.00 24.22 A O ATOM 599 N ARG A 8879.452 49.272 −0.189 1.00 22.95 A N ATOM 600 CA ARG A 887 8.201 49.982−0.406 1.00 23.16 A C ATOM 601 CB ARG A 887 7.854 50.811 0.828 1.0023.19 A C ATOM 602 CG ARG A 887 7.348 49.964 1.972 1.00 27.32 A C ATOM603 CD ARG A 887 6.714 50.824 3.034 1.00 31.16 A C ATOM 604 NE ARG A 8875.672 51.681 2.476 1.00 32.24 A N ATOM 605 CZ ARG A 887 4.932 52.5233.192 1.00 33.92 A C ATOM 606 NH1 ARG A 887 5.124 52.618 4.502 1.0033.39 A N ATOM 607 NH2 ARG A 887 3.998 53.263 2.597 1.00 33.24 A N ATOM608 C ARG A 887 8.138 50.861 −1.644 1.00 23.65 A C ATOM 609 O ARG A 8877.051 51.144 −2.140 1.00 24.45 A O ATOM 610 N GLY A 888 9.291 51.285−2.150 1.00 24.72 A N ATOM 611 CA GLY A 888 9.299 52.139 −3.323 1.0024.04 A C ATOM 612 C GLY A 888 10.585 52.927 −3.492 1.00 23.39 A C ATOM613 O GLY A 888 11.577 52.673 −2.805 1.00 23.48 A O ATOM 614 N VAL A 88910.562 53.877 −4.420 1.00 20.54 A N ATOM 615 CA VAL A 889 11.709 54.719−4.722 1.00 20.10 A C ATOM 616 CB VAL A 889 12.123 54.570 −6.200 1.0021.03 A C ATOM 617 CG1 VAL A 889 13.115 55.656 −6.584 1.00 21.45 A CATOM 618 CG2 VAL A 889 12.719 53.200 −6.435 1.00 19.77 A C ATOM 619 CVAL A 889 11.317 56.167 −4.485 1.00 21.40 A C ATOM 620 O VAL A 88910.159 56.527 −4.684 1.00 22.69 A O ATOM 621 N SER A 890 12.262 57.001−4.057 1.00 20.80 A N ATOM 622 CA SER A 890 11.952 58.406 −3.830 1.0022.34 A C ATOM 623 CB SER A 890 12.629 58.920 −2.556 1.00 21.30 A C ATOM624 OG SER A 890 13.977 59.280 −2.804 1.00 24.15 A O ATOM 625 C SER A890 12.410 59.250 −5.012 1.00 24.18 A C ATOM 626 O SER A 890 13.35958.896 −5.717 1.00 24.15 A O ATOM 627 N TYR A 891 11.718 60.365 −5.2291.00 25.30 A N ATOM 628 CA TYR A 891 12.060 61.284 −6.309 1.00 27.29 A CATOM 629 CB TYR A 891 11.002 61.224 −7.411 1.00 27.04 A C ATOM 630 CGTYR A 891 11.081 59.936 −8.178 1.00 28.70 A C ATOM 631 CD1 TYR A 89112.162 59.667 −9.000 1.00 29.90 A C ATOM 632 CE1 TYR A 891 12.291 58.455−9.626 1.00 28.35 A C ATOM 633 CD2 TYR A 891 10.128 58.955 −8.014 1.0026.81 A C ATOM 634 CE2 TYR A 891 10.248 57.743 −8.632 1.00 27.95 A CATOM 635 CZ TYR A 891 11.333 57.491 −9.437 1.00 27.15 A C ATOM 636 OHTYR A 891 11.482 56.253 −10.028 1.00 25.99 A O ATOM 637 C TYR A 89112.236 62.715 −5.803 1.00 27.89 A C ATOM 638 O TYR A 891 11.358 63.256−5.136 1.00 28.25 A O ATOM 639 N GLY A 892 13.384 63.295 −6.149 1.0029.35 A N ATOM 640 CA GLY A 892 13.791 64.640 −5.767 1.00 34.56 A C ATOM641 C GLY A 892 12.859 65.827 −5.824 1.00 37.08 A C ATOM 642 O GLY A 89211.709 65.745 −5.397 1.00 41.32 A O ATOM 643 N PRO A 893 13.343 66.975−6.314 1.00 37.48 A N ATOM 644 CD PRO A 893 12.587 68.245 −6.303 1.0037.32 A C ATOM 645 CA PRO A 893 14.706 67.183 −6.804 1.00 37.32 A C ATOM646 CB PRO A 893 14.587 68.489 −7.576 1.00 36.43 A C ATOM 647 CG PRO A893 13.638 69.267 −6.701 1.00 37.84 A C ATOM 648 C PRO A 893 15.71067.298 −5.663 1.00 37.83 A C ATOM 649 O PRO A 893 15.576 66.660 −4.6061.00 38.11 A O ATOM 650 N GLY A 894 16.714 68.134 −5.884 1.00 35.65 A NATOM 651 CA GLY A 894 17.725 68.332 −4.865 1.00 33.37 A C ATOM 652 C GLYA 894 18.628 67.132 −4.686 1.00 30.83 A C ATOM 653 O GLY A 894 18.40166.080 −5.272 1.00 29.44 A O ATOM 654 N ARG A 895 19.654 67.308 −3.8611.00 31.54 A N ATOM 655 CA ARG A 895 20.645 66.280 −3.566 1.00 29.64 A CATOM 656 CB ARG A 895 21.477 66.703 −2.359 1.00 30.82 A C ATOM 657 CGARG A 895 21.949 68.136 −2.436 1.00 36.81 A C ATOM 658 CD ARG A 89522.739 68.556 −1.201 1.00 37.21 A C ATOM 659 NE ARG A 895 23.919 67.725−1.002 1.00 39.51 A N ATOM 660 CZ ARG A 895 23.966 66.658 −0.215 1.0042.26 A C ATOM 661 NH1 ARG A 895 22.885 66.279 0.471 1.00 41.34 A N ATOM662 NH2 ARG A 895 25.100 65.971 −0.125 1.00 41.86 A N ATOM 663 C ARG A895 20.044 64.919 −3.283 1.00 27.07 A C ATOM 664 O ARG A 895 20.51663.913 −3.784 1.00 26.22 A O ATOM 665 N GLN A 896 19.000 64.881 −2.4741.00 25.66 A N ATOM 666 CA GLN A 896 18.418 63.605 −2.141 1.00 26.88 A CATOM 667 CB GLN A 896 17.974 63.605 −0.674 1.00 27.75 A C ATOM 668 CGGLN A 896 19.095 63.703 0.367 1.00 23.25 A C ATOM 669 CD GLN A 89618.560 63.532 1.786 1.00 25.71 A C ATOM 670 OE1 GLN A 896 17.686 64.2792.219 1.00 25.96 A O ATOM 671 NE2 GLN A 896 19.077 62.538 2.511 1.0024.24 A N ATOM 672 C GLN A 896 17.253 63.187 −3.041 1.00 28.96 A C ATOM673 O GLN A 896 16.220 63.870 −3.113 1.00 32.60 A O ATOM 674 N SER A 89717.436 62.056 −3.717 1.00 26.09 A N ATOM 675 CA SER A 897 16.436 61.488−4.605 1.00 25.53 A C ATOM 676 CB SER A 897 16.200 62.418 −5.790 1.0026.04 A C ATOM 677 OG SER A 897 15.213 61.887 −6.648 1.00 23.93 A O ATOM678 C SER A 897 16.828 60.086 −5.101 1.00 25.24 A C ATOM 679 O SER A 89717.987 59.674 −4.993 1.00 22.93 A O ATOM 680 N LEU A 898 15.856 59.365−5.656 1.00 24.91 A N ATOM 681 CA LEU A 898 16.097 58.010 −6.125 1.0024.03 A C ATOM 682 CB LEU A 898 17.112 57.998 −7.268 1.00 24.88 A C ATOM683 CG LEU A 898 16.549 58.464 −8.609 1.00 23.32 A C ATOM 684 CD1 LEU A898 17.616 58.439 −9.659 1.00 24.28 A C ATOM 685 CD2 LEU A 898 15.41957.550 −9.015 1.00 26.25 A C ATOM 686 C LEU A 898 16.630 57.180 −4.9621.00 24.34 A C ATOM 687 O LEU A 898 17.584 56.433 −5.117 1.00 24.06 A OATOM 688 N ARG A 899 16.021 57.336 −3.791 1.00 24.15 A N ATOM 689 CA ARGA 899 16.433 56.589 −2.614 1.00 23.36 A C ATOM 690 CB ARG A 899 16.39657.491 −1.376 1.00 22.23 A C ATOM 691 CG ARG A 899 17.290 58.737 −1.4841.00 22.55 A C ATOM 692 CD ARG A 899 17.531 59.430 −0.121 1.00 23.29 A CATOM 693 NE ARG A 899 16.342 60.077 0.435 1.00 22.79 A N ATOM 694 CZ ARGA 899 16.231 60.489 1.698 1.00 23.20 A C ATOM 695 NH1 ARG A 899 15.11561.066 2.109 1.00 21.75 A N ATOM 696 NH2 ARG A 899 17.226 60.320 2.5571.00 21.19 A N ATOM 697 C ARG A 899 15.522 55.370 −2.427 1.00 24.79 A CATOM 698 O ARG A 899 14.410 55.313 −2.972 1.00 23.87 A O ATOM 699 N LEUA 900 16.005 54.395 −1.664 1.00 23.94 A N ATOM 700 CA LEU A 900 15.25853.175 −1.425 1.00 23.43 A C ATOM 701 CB LEU A 900 16.234 51.992 −1.3341.00 25.73 A C ATOM 702 CG LEU A 900 17.254 51.879 −2.479 1.00 22.68 A CATOM 703 CD1 LEU A 900 18.236 50.767 −2.198 1.00 21.83 A C ATOM 704 CD2LEU A 900 16.513 51.625 −3.782 1.00 23.99 A C ATOM 705 C LEU A 90014.467 53.306 −0.134 1.00 23.36 A C ATOM 706 O LEU A 900 15.055 53.4950.924 1.00 25.79 A O ATOM 707 N VAL A 901 13.140 53.215 −0.224 1.0023.16 A N ATOM 708 CA VAL A 901 12.247 53.327 0.943 1.00 21.00 A C ATOM709 CB VAL A 901 10.967 54.161 0.598 1.00 19.18 A C ATOM 710 CG1 VAL A901 10.220 54.541 1.872 1.00 16.79 A C ATOM 711 CG2 VAL A 901 11.34655.412 −0.179 1.00 16.04 A C ATOM 712 C VAL A 901 11.816 51.921 1.3671.00 21.72 A C ATOM 713 O VAL A 901 11.301 51.163 0.550 1.00 20.89 A OATOM 714 N MET A 902 12.018 51.573 2.635 1.00 22.44 A N ATOM 715 CA META 902 11.654 50.244 3.133 1.00 22.31 A C ATOM 716 CB MET A 902 12.91449.415 3.418 1.00 23.41 A C ATOM 717 CG MET A 902 14.029 49.527 2.4021.00 24.33 A C ATOM 718 SD MET A 902 15.610 48.975 3.107 1.00 28.16 A SATOM 719 CE MET A 902 16.470 50.599 3.415 1.00 18.42 A C ATOM 720 C META 902 10.879 50.342 4.445 1.00 22.84 A C ATOM 721 O MET A 902 10.78051.417 5.036 1.00 22.65 A O ATOM 722 N GLU A 903 10.341 49.212 4.9011.00 23.07 A N ATOM 723 CA GLU A 903 9.637 49.174 6.175 1.00 24.06 A CATOM 724 CB GLU A 903 8.908 47.835 6.369 1.00 21.47 A C ATOM 725 CG GLUA 903 9.829 46.644 6.571 1.00 25.28 A C ATOM 726 CD GLU A 903 9.09445.325 6.793 1.00 25.14 A C ATOM 727 OE1 GLU A 903 8.169 45.267 7.6341.00 23.48 A O ATOM 728 OE2 GLU A 903 9.458 44.333 6.129 1.00 27.12 A OATOM 729 C GLU A 903 10.769 49.342 7.204 1.00 26.12 A C ATOM 730 O GLU A903 11.907 48.919 6.962 1.00 25.33 A O ATOM 731 N TYR A 904 10.46549.956 8.342 1.00 25.19 A N ATOM 732 CA TYR A 904 11.480 50.213 9.3501.00 25.53 A C ATOM 733 CB TYR A 904 11.375 51.682 9.774 1.00 26.19 A CATOM 734 CG TYR A 904 12.144 52.041 11.014 1.00 24.20 A C ATOM 735 CD1TYR A 904 13.520 51.938 11.052 1.00 23.09 A C ATOM 736 CE1 TYR A 90414.216 52.277 12.180 1.00 23.97 A C ATOM 737 CD2 TYR A 904 11.489 52.49112.143 1.00 23.37 A C ATOM 738 CE2 TYR A 904 12.179 52.832 13.273 1.0023.70 A C ATOM 739 CZ TYR A 904 13.541 52.728 13.287 1.00 22.96 A C ATOM740 OH TYR A 904 14.225 53.123 14.408 1.00 26.04 A O ATOM 741 C TYR A904 11.437 49.303 10.576 1.00 25.47 A C ATOM 742 O TYR A 904 10.45149.286 11.309 1.00 25.58 A O ATOM 743 N LEU A 905 12.516 48.553 10.7951.00 24.91 A N ATOM 744 CA LEU A 905 12.610 47.649 11.942 1.00 24.94 A CATOM 745 CB LEU A 905 13.104 46.273 11.492 1.00 25.49 A C ATOM 746 CGLEU A 905 12.069 45.313 10.883 1.00 26.77 A C ATOM 747 CD1 LEU A 90511.533 45.849 9.540 1.00 22.44 A C ATOM 748 CD2 LEU A 905 12.739 43.93410.703 1.00 24.93 A C ATOM 749 C LEU A 905 13.567 48.243 12.977 1.0024.77 A C ATOM 750 O LEU A 905 14.774 48.153 12.835 1.00 23.75 A O ATOM751 N PRO A 906 13.021 48.844 14.043 1.00 25.08 A N ATOM 752 CD PRO A906 11.573 48.801 14.296 1.00 25.48 A C ATOM 753 CA PRO A 906 13.71749.499 15.157 1.00 26.75 A C ATOM 754 CB PRO A 906 12.564 50.077 15.9811.00 24.51 A C ATOM 755 CG PRO A 906 11.499 49.097 15.781 1.00 25.37 A CATOM 756 C PRO A 906 14.725 48.710 16.010 1.00 27.00 A C ATOM 757 O PROA 906 15.696 49.291 16.514 1.00 27.95 A O ATOM 758 N SER A 907 14.51147.408 16.171 1.00 26.18 A N ATOM 759 CA SER A 907 15.424 46.585 16.9631.00 24.34 A C ATOM 760 CB SER A 907 14.858 45.187 17.145 1.00 22.15 A CATOM 761 OG SER A 907 13.651 45.257 17.880 1.00 24.29 A O ATOM 762 C SERA 907 16.830 46.503 16.379 1.00 24.51 A C ATOM 763 O SER A 907 17.78146.200 17.093 1.00 24.00 A O ATOM 764 N GLY A 908 16.963 46.765 15.0851.00 23.26 A N ATOM 765 CA GLY A 908 18.277 46.751 14.485 1.00 22.85 A CATOM 766 C GLY A 908 18.759 45.418 13.965 1.00 23.80 A C ATOM 767 O GLYA 908 18.047 44.407 14.014 1.00 23.46 A O ATOM 768 N CYS A 909 19.99445.425 13.465 1.00 23.36 A N ATOM 769 CA CYS A 909 20.605 44.232 12.8991.00 23.89 A C ATOM 770 CB CYS A 909 21.937 44.568 12.253 1.00 21.36 A CATOM 771 SG CYS A 909 23.205 45.003 13.439 1.00 23.09 A S ATOM 772 C CYSA 909 20.822 43.143 13.931 1.00 24.75 A C ATOM 773 O CYS A 909 20.74243.383 15.133 1.00 24.37 A O ATOM 774 N LEU A 910 21.113 41.943 13.4381.00 24.76 A N ATOM 775 CA LEU A 910 21.331 40.788 14.285 1.00 25.40 A CATOM 776 CB LEU A 910 21.058 39.497 13.501 1.00 23.11 A C ATOM 777 CGLEU A 910 21.209 38.168 14.251 1.00 19.95 A C ATOM 778 CD1 LEU A 91020.317 38.176 15.486 1.00 19.52 A C ATOM 779 CD2 LEU A 910 20.833 37.00213.331 1.00 17.68 A C ATOM 780 C LEU A 910 22.761 40.796 14.793 1.0027.11 A C ATOM 781 O LEU A 910 23.032 40.324 15.892 1.00 27.00 A O ATOM782 N ARG A 911 23.669 41.331 13.983 1.00 28.24 A N ATOM 783 CA ARG A911 25.075 41.415 14.352 1.00 28.19 A C ATOM 784 CB ARG A 911 25.83942.249 13.316 1.00 28.23 A C ATOM 785 CG ARG A 911 27.309 42.450 13.6251.00 30.58 A C ATOM 786 CD ARG A 911 27.646 43.926 13.789 1.00 33.24 A CATOM 787 NE ARG A 911 27.952 44.595 12.524 1.00 36.27 A N ATOM 788 CZARG A 911 27.695 45.878 12.268 1.00 37.56 A C ATOM 789 NH1 ARG A 91127.115 46.636 13.194 1.00 34.55 A N ATOM 790 NH2 ARG A 911 28.029 46.40811.090 1.00 36.66 A N ATOM 791 C ARG A 911 25.205 42.050 15.735 1.0029.66 A C ATOM 792 O ARG A 911 25.791 41.461 16.633 1.00 28.96 A O ATOM793 N ASP A 912 24.645 43.245 15.911 1.00 30.49 A N ATOM 794 CA ASP A912 24.726 43.937 17.198 1.00 31.99 A C ATOM 795 CB ASP A 912 24.30045.396 17.041 1.00 31.19 A C ATOM 796 CG ASP A 912 25.211 46.166 16.1091.00 35.19 A C ATOM 797 OD1 ASP A 912 24.896 47.327 15.778 1.00 37.95 AO ATOM 798 OD2 ASP A 912 26.251 45.609 15.705 1.00 39.20 A O ATOM 799 CASP A 912 23.885 43.274 18.283 1.00 32.12 A C ATOM 800 O ASP A 91224.265 43.257 19.454 1.00 33.14 A O ATOM 801 N PHE A 913 22.744 42.72917.877 1.00 31.11 A N ATOM 802 CA PHE A 913 21.818 42.053 18.780 1.0029.01 A C ATOM 803 CB PHE A 913 20.610 41.561 17.984 1.00 27.73 A C ATOM804 CG PHE A 913 19.543 40.927 18.820 1.00 25.27 A C ATOM 805 CD1 PHE A913 18.543 41.699 19.380 1.00 25.20 A C ATOM 806 CD2 PHE A 913 19.52939.559 19.028 1.00 25.36 A C ATOM 807 CE1 PHE A 913 17.544 41.121 20.1321.00 26.53 A C ATOM 808 CE2 PHE A 913 18.533 38.966 19.783 1.00 27.33 AC ATOM 809 CZ PHE A 913 17.537 39.749 20.335 1.00 25.91 A C ATOM 810 CPHE A 913 22.476 40.857 19.472 1.00 29.07 A C ATOM 811 O PHE A 91322.295 40.636 20.664 1.00 29.72 A O ATOM 812 N LEU A 914 23.219 40.07418.707 1.00 28.66 A N ATOM 813 CA LEU A 914 23.883 38.910 19.242 1.0028.77 A C ATOM 814 CB LEU A 914 24.586 38.145 18.119 1.00 28.26 A C ATOM815 CG LEU A 914 23.745 37.401 17.074 1.00 29.50 A C ATOM 816 CD1 LEU A914 24.598 37.156 15.834 1.00 28.14 A C ATOM 817 CD2 LEU A 914 23.22036.097 17.634 1.00 25.43 A C ATOM 818 C LEU A 914 24.910 39.294 20.2941.00 30.60 A C ATOM 819 O LEU A 914 25.041 38.616 21.305 1.00 30.77 A OATOM 820 N GLN A 915 25.639 40.380 20.057 1.00 31.78 A N ATOM 821 CA GLNA 915 26.682 40.812 20.986 1.00 32.32 A C ATOM 822 CB GLN A 915 27.55041.897 20.346 1.00 29.51 A C ATOM 823 CG GLN A 915 28.275 41.430 19.1051.00 27.89 A C ATOM 824 CD GLN A 915 28.986 42.558 18.381 1.00 30.62 A CATOM 825 OE1 GLN A 915 29.960 43.110 18.879 1.00 34.44 A O ATOM 826 NE2GLN A 915 28.493 42.911 17.201 1.00 32.70 A N ATOM 827 C GLN A 91526.147 41.309 22.314 1.00 32.56 A C ATOM 828 O GLN A 915 26.696 40.99823.367 1.00 33.01 A O ATOM 829 N ARG A 916 25.072 42.080 22.259 1.0035.64 A N ATOM 830 CA ARG A 916 24.470 42.618 23.466 1.00 38.93 A C ATOM831 CB ARG A 916 23.378 43.623 23.111 1.00 40.92 A C ATOM 832 CG ARG A916 22.567 44.085 24.316 1.00 46.49 A C ATOM 833 CD ARG A 916 23.37645.002 25.246 1.00 51.88 A C ATOM 834 NE ARG A 916 23.508 46.365 24.7171.00 55.94 A N ATOM 835 CZ ARG A 916 22.523 47.263 24.672 1.00 56.13 A CATOM 836 NH1 ARG A 916 21.311 46.961 25.125 1.00 56.04 A N ATOM 837 NH2ARG A 916 22.755 48.470 24.171 1.00 56.78 A N ATOM 838 C ARG A 91623.880 41.530 24.350 1.00 39.54 A C ATOM 839 O ARG A 916 24.391 41.26925.432 1.00 41.77 A O ATOM 840 N HIS A 917 22.814 40.890 23.881 1.0040.60 A N ATOM 841 CA HIS A 917 22.128 39.861 24.657 1.00 40.90 A C ATOM842 CB HIS A 917 20.702 39.682 24.144 1.00 41.88 A C ATOM 843 CG HIS A917 20.000 40.970 23.863 1.00 43.18 A C ATOM 844 CD2 HIS A 917 19.19141.736 24.632 1.00 43.95 A C ATOM 845 ND1 HIS A 917 20.124 41.635 22.6601.00 43.84 A N ATOM 846 CE1 HIS A 917 19.421 42.750 22.702 1.00 45.33 AC ATOM 847 NE2 HIS A 917 18.844 42.838 23.889 1.00 45.00 A N ATOM 848 CHIS A 917 22.801 38.506 24.677 1.00 40.71 A C ATOM 849 O HIS A 91722.189 37.520 25.080 1.00 40.37 A O ATOM 850 N ARG A 918 24.054 38.45124.249 1.00 41.70 A N ATOM 851 CA ARG A 918 24.784 37.193 24.222 1.0043.37 A C ATOM 852 CB ARG A 918 26.288 37.459 24.141 1.00 44.88 A C ATOM853 CG ARG A 918 27.124 36.231 23.793 1.00 46.33 A C ATOM 854 CD ARG A918 28.607 36.535 23.906 1.00 48.49 A C ATOM 855 NE ARG A 918 29.44235.414 23.485 1.00 51.68 A N ATOM 856 CZ ARG A 918 29.319 34.174 23.9421.00 53.95 A C ATOM 857 NH1 ARG A 918 28.386 33.879 24.840 1.00 55.47 AN ATOM 858 NH2 ARG A 918 30.137 33.228 23.502 1.00 55.10 A N ATOM 859 CARG A 918 24.471 36.386 25.476 1.00 44.88 A C ATOM 860 O ARG A 91824.252 35.176 25.416 1.00 45.56 A O ATOM 861 N ALA A 919 24.436 37.07826.610 1.00 46.35 A N ATOM 862 CA ALA A 919 24.164 36.459 27.900 1.0046.62 A C ATOM 863 CB ALA A 919 23.801 37.532 28.904 1.00 46.80 A C ATOM864 C ALA A 919 23.082 35.375 27.886 1.00 46.74 A C ATOM 865 O ALA A 91923.342 34.226 28.242 1.00 45.80 A O ATOM 866 N ARG A 920 21.871 35.73727.477 1.00 46.25 A N ATOM 867 CA ARG A 920 20.774 34.780 27.457 1.0046.08 A C ATOM 868 CB ARG A 920 19.622 35.308 28.316 1.00 47.54 A C ATOM869 CG ARG A 920 19.363 36.807 28.203 1.00 47.40 A C ATOM 870 CD ARG A920 18.610 37.168 26.940 1.00 49.45 A C ATOM 871 NE ARG A 920 18.19438.569 26.925 1.00 49.65 A N ATOM 872 CZ ARG A 920 17.400 39.098 26.0011.00 49.78 A C ATOM 873 NH1 ARG A 920 16.933 38.342 25.013 1.00 49.39 AN ATOM 874 NH2 ARG A 920 17.069 40.379 26.067 1.00 49.52 A N ATOM 875 CARG A 920 20.261 34.405 26.074 1.00 46.13 A C ATOM 876 O ARG A 92019.134 34.750 25.705 1.00 44.96 A O ATOM 877 N LEU A 921 21.085 33.67825.322 1.00 45.06 A N ATOM 878 CA LEU A 921 20.727 33.241 23.973 1.0044.84 A C ATOM 879 CB LEU A 921 21.149 34.290 22.942 1.00 44.96 A C ATOM880 CG LEU A 921 20.422 35.635 22.925 1.00 45.84 A C ATOM 881 CD1 LEU A921 21.093 36.550 21.892 1.00 45.14 A C ATOM 882 CD2 LEU A 921 18.94035.427 22.594 1.00 45.08 A C ATOM 883 C LEU A 921 21.401 31.922 23.6391.00 44.13 A C ATOM 884 O LEU A 921 22.491 31.906 23.071 1.00 44.16 A OATOM 885 N ASP A 922 20.749 30.816 23.980 1.00 43.31 A N ATOM 886 CA ASPA 922 21.317 29.496 23.720 1.00 42.52 A C ATOM 887 CB ASP A 922 20.50528.420 24.443 1.00 42.97 A C ATOM 888 CG ASP A 922 19.069 28.384 23.9951.00 42.64 A C ATOM 889 OD1 ASP A 922 18.842 28.390 22.772 1.00 43.81 AO ATOM 890 OD2 ASP A 922 18.169 28.341 24.857 1.00 43.17 A O ATOM 891 CASP A 922 21.418 29.150 22.235 1.00 40.48 A C ATOM 892 O ASP A 92221.060 29.945 21.377 1.00 41.42 A O ATOM 893 N ALA A 923 21.896 27.94721.942 1.00 38.52 A N ATOM 894 CA ALA A 923 22.068 27.495 20.565 1.0036.73 A C ATOM 895 CB ALA A 923 22.890 26.215 20.546 1.00 36.05 A C ATOM896 C ALA A 923 20.743 27.273 19.839 1.00 36.44 A C ATOM 897 O ALA A 92320.691 27.246 18.610 1.00 35.30 A O ATOM 898 N SER A 924 19.675 27.10320.604 1.00 35.48 A N ATOM 899 CA SER A 924 18.371 26.892 20.010 1.0035.00 A C ATOM 900 CB SER A 924 17.343 26.562 21.095 1.00 34.87 A C ATOM901 OG SER A 924 17.551 25.248 21.574 1.00 36.69 A O ATOM 902 C SER A924 17.954 28.144 19.256 1.00 33.85 A C ATOM 903 O SER A 924 17.54728.087 18.095 1.00 33.17 A O ATOM 904 N ARG A 925 18.067 29.276 19.9311.00 32.59 A N ATOM 905 CA ARG A 925 17.707 30.548 19.348 1.00 32.54 A CATOM 906 CB ARG A 925 17.974 31.663 20.364 1.00 33.17 A C ATOM 907 CGARG A 925 17.325 32.978 20.013 1.00 36.60 A C ATOM 908 CD ARG A 92516.015 33.157 20.747 1.00 39.24 A C ATOM 909 NE ARG A 925 15.178 31.96420.685 1.00 42.43 A N ATOM 910 CZ ARG A 925 13.937 31.905 21.157 1.0042.81 A C ATOM 911 NH1 ARG A 925 13.237 30.779 21.073 1.00 43.91 A NATOM 912 NH2 ARG A 925 13.391 32.983 21.699 1.00 41.57 A N ATOM 913 CARG A 925 18.522 30.776 18.066 1.00 31.35 A C ATOM 914 O ARG A 92517.989 31.220 17.045 1.00 30.98 A O ATOM 915 N LEU A 926 19.812 30.46118.123 1.00 29.39 A N ATOM 916 CA LEU A 926 20.684 30.645 16.968 1.0026.98 A C ATOM 917 CB LEU A 926 22.137 30.278 17.321 1.00 25.24 A C ATOM918 CG LEU A 926 22.729 30.922 18.586 1.00 26.47 A C ATOM 919 CD1 LEU A926 24.164 30.453 18.762 1.00 22.76 A C ATOM 920 CD2 LEU A 926 22.66032.470 18.498 1.00 23.66 A C ATOM 921 C LEU A 926 20.177 29.759 15.8351.00 25.57 A C ATOM 922 O LEU A 926 20.222 30.144 14.674 1.00 25.52 A OATOM 923 N LEU A 927 19.695 28.573 16.185 1.00 24.45 A N ATOM 924 CA LEUA 927 19.166 27.636 15.203 1.00 25.10 A C ATOM 925 CB LEU A 927 18.91326.276 15.860 1.00 23.29 A C ATOM 926 CG LEU A 927 20.192 25.452 16.0791.00 23.60 A C ATOM 927 CD1 LEU A 927 19.914 24.230 16.951 1.00 21.29 AC ATOM 928 CD2 LEU A 927 20.741 25.045 14.713 1.00 21.28 A C ATOM 929 CLEU A 927 17.881 28.176 14.579 1.00 25.54 A C ATOM 930 O LEU A 92717.653 28.021 13.387 1.00 27.60 A O ATOM 931 N LEU A 928 17.043 28.81315.382 1.00 26.21 A N ATOM 932 CA LEU A 928 15.817 29.377 14.860 1.0028.46 A C ATOM 933 CB LEU A 928 14.986 29.994 15.990 1.00 29.01 A C ATOM934 CG LEU A 928 13.640 30.609 15.580 1.00 30.63 A C ATOM 935 CD1 LEU A928 12.726 29.543 14.983 1.00 28.56 A C ATOM 936 CD2 LEU A 928 12.98431.247 16.798 1.00 30.31 A C ATOM 937 C LEU A 928 16.172 30.452 13.8291.00 28.78 A C ATOM 938 O LEU A 928 15.627 30.467 12.727 1.00 31.05 A OATOM 939 N TYR A 929 17.092 31.345 14.188 1.00 28.81 A N ATOM 940 CA TYRA 929 17.499 32.404 13.278 1.00 26.06 A C ATOM 941 CB TYR A 929 18.55433.313 13.917 1.00 24.85 A C ATOM 942 CG TYR A 929 18.091 34.038 15.1711.00 24.20 A C ATOM 943 CD1 TYR A 929 16.739 34.249 15.420 1.00 22.44 AC ATOM 944 CE1 TYR A 929 16.319 34.898 16.562 1.00 23.86 A C ATOM 945CD2 TYR A 929 19.014 34.512 16.108 1.00 24.65 A C ATOM 946 CE2 TYR A 92918.600 35.165 17.251 1.00 23.64 A C ATOM 947 CZ TYR A 929 17.255 35.35217.476 1.00 23.72 A C ATOM 948 OH TYR A 929 16.836 35.970 18.627 1.0026.16 A O ATOM 949 C TYR A 929 18.068 31.765 12.032 1.00 25.81 A C ATOM950 O TYR A 929 17.813 32.217 10.924 1.00 26.45 A O ATOM 951 N SER A 93018.843 30.707 12.208 1.00 25.98 A N ATOM 952 CA SER A 930 19.426 30.03511.059 1.00 27.82 A C ATOM 953 CB SER A 930 20.325 28.885 11.513 1.0028.75 A C ATOM 954 OG SER A 930 21.528 29.393 12.064 1.00 30.14 A O ATOM955 C SER A 930 18.360 29.507 10.111 1.00 28.13 A C ATOM 956 O SER A 93018.482 29.628 8.886 1.00 27.24 A O ATOM 957 N SER A 931 17.313 28.93210.694 1.00 27.11 A N ATOM 958 CA SER A 931 16.211 28.360 9.934 1.0025.57 A C ATOM 959 CB SER A 931 15.262 27.618 10.887 1.00 25.40 A C ATOM960 OG SER A 931 14.196 26.996 10.183 1.00 26.62 A O ATOM 961 C SER A931 15.446 29.432 9.148 1.00 23.59 A C ATOM 962 O SER A 931 15.19329.284 7.957 1.00 21.65 A O ATOM 963 N GLN A 932 15.089 30.515 9.8211.00 21.56 A N ATOM 964 CA GLN A 932 14.340 31.578 9.173 1.00 20.32 A CATOM 965 CB GLN A 932 13.915 32.619 10.197 1.00 19.20 A C ATOM 966 CGGLN A 932 13.032 32.067 11.272 1.00 13.20 A C ATOM 967 CD GLN A 93212.775 33.085 12.345 1.00 17.11 A C ATOM 968 OE1 GLN A 932 13.518 34.06112.478 1.00 19.07 A O ATOM 969 NE2 GLN A 932 11.730 32.864 13.136 1.0018.46 A N ATOM 970 C GLN A 932 15.146 32.228 8.066 1.00 19.98 A C ATOM971 O GLN A 932 14.611 32.482 7.004 1.00 20.76 A O ATOM 972 N ILE A 93316.430 32.487 8.304 1.00 19.95 A N ATOM 973 CA ILE A 933 17.294 33.0887.287 1.00 19.59 A C ATOM 974 CB ILE A 933 18.744 33.298 7.834 1.0016.81 A C ATOM 975 CG2 ILE A 933 19.716 33.611 6.700 1.00 13.19 A C ATOM976 CG1 ILE A 933 18.747 34.420 8.876 1.00 14.44 A C ATOM 977 CD1 ILE A933 19.937 34.392 9.822 1.00 10.84 A C ATOM 978 C ILE A 933 17.33632.167 6.067 1.00 21.91 A C ATOM 979 O ILE A 933 17.282 32.635 4.9311.00 24.84 A O ATOM 980 N CYS A 934 17.422 30.858 6.302 1.00 22.23 A NATOM 981 CA CYS A 934 17.471 29.894 5.201 1.00 23.32 A C ATOM 982 CB CYSA 934 17.708 28.471 5.715 1.00 21.69 A C ATOM 983 SG CYS A 934 18.29227.313 4.412 1.00 30.12 A S ATOM 984 C CYS A 934 16.174 29.912 4.4011.00 23.55 A C ATOM 985 O CYS A 934 16.186 29.820 3.181 1.00 22.75 A OATOM 986 N LYS A 935 15.053 30.005 5.101 1.00 25.04 A N ATOM 987 CA LYSA 935 13.758 30.047 4.447 1.00 26.11 A C ATOM 988 CB LYS A 935 12.64130.114 5.487 1.00 28.76 A C ATOM 989 CG LYS A 935 12.201 28.770 5.9941.00 30.78 A C ATOM 990 CD LYS A 935 11.682 27.924 4.849 1.00 37.03 A CATOM 991 CE LYS A 935 10.571 28.633 4.079 1.00 38.59 A C ATOM 992 NZ LYSA 935 9.503 29.151 4.978 1.00 39.74 A N ATOM 993 C LYS A 935 13.68431.280 3.558 1.00 25.61 A C ATOM 994 O LYS A 935 13.192 31.218 2.4321.00 25.18 A O ATOM 995 N GLY A 936 14.184 32.401 4.063 1.00 23.46 A NATOM 996 CA GLY A 936 14.139 33.625 3.288 1.00 25.18 A C ATOM 997 C GLYA 936 14.925 33.529 1.997 1.00 25.97 A C ATOM 998 O GLY A 936 14.43833.854 0.910 1.00 25.47 A O ATOM 999 N MET A 937 16.160 33.068 2.1221.00 25.86 A N ATOM 1000 CA MET A 937 17.025 32.935 0.968 1.00 25.43 A CATOM 1001 CB MET A 937 18.398 32.465 1.415 1.00 21.83 A C ATOM 1002 CGMET A 937 19.145 33.521 2.195 1.00 22.95 A C ATOM 1003 SD MET A 93719.251 35.048 1.253 1.00 19.04 A S ATOM 1004 CE MET A 937 20.391 34.5390.040 1.00 19.63 A C ATOM 1005 C MET A 937 16.452 31.990 −0.070 1.0025.93 A C ATOM 1006 O MET A 937 16.563 32.247 −1.269 1.00 25.39 A O ATOM1007 N GLU A 938 15.844 30.898 0.396 1.00 25.81 A N ATOM 1008 CA GLU A938 15.249 29.907 −0.492 1.00 28.06 A C ATOM 1009 CB GLU A 938 14.69228.711 0.305 1.00 29.00 A C ATOM 1010 CG GLU A 938 13.949 27.709 −0.5731.00 34.20 A C ATOM 1011 CD GLU A 938 12.966 26.819 0.187 1.00 37.81 A CATOM 1012 OE1 GLU A 938 12.368 27.286 1.189 1.00 41.55 A O ATOM 1013 OE2GLU A 938 12.781 25.653 −0.234 1.00 37.20 A O ATOM 1014 C GLU A 93814.129 30.559 −1.309 1.00 28.74 A C ATOM 1015 O GLU A 938 14.013 30.344−2.513 1.00 27.91 A O ATOM 1016 N TYR A 939 13.304 31.358 −0.647 1.0028.43 A N ATOM 1017 CA TYR A 939 12.232 32.039 −1.341 1.00 27.01 A CATOM 1018 CB TYR A 939 11.367 32.814 −0.346 1.00 27.10 A C ATOM 1019 CGTYR A 939 10.389 33.739 −1.025 1.00 26.91 A C ATOM 1020 CD1 TYR A 9399.233 33.245 −1.631 1.00 25.87 A C ATOM 1021 CE1 TYR A 939 8.373 34.090−2.330 1.00 25.22 A C ATOM 1022 CD2 TYR A 939 10.654 35.101 −1.130 1.0026.73 A C ATOM 1023 CE2 TYR A 939 9.803 35.946 −1.825 1.00 26.34 A CATOM 1024 CZ TYR A 939 8.671 35.436 −2.424 1.00 25.07 A C ATOM 1025 OHTYR A 939 7.873 36.269 −3.156 1.00 24.42 A O ATOM 1026 C TYR A 93912.823 33.007 −2.377 1.00 27.57 A C ATOM 1027 O TYR A 939 12.354 33.085−3.515 1.00 27.74 A O ATOM 1028 N LEU A 940 13.865 33.739 −1.986 1.0027.06 A N ATOM 1029 CA LEU A 940 14.483 34.697 −2.892 1.00 25.89 A CATOM 1030 CB LEU A 940 15.561 35.505 −2.160 1.00 25.81 A C ATOM 1031 CGLEU A 940 15.134 36.223 −0.866 1.00 27.33 A C ATOM 1032 CD1 LEU A 94016.214 37.236 −0.463 1.00 25.01 A C ATOM 1033 CD2 LEU A 940 13.80736.937 −1.051 1.00 25.43 A C ATOM 1034 C LEU A 940 15.057 34.002 −4.1261.00 26.08 A C ATOM 1035 O LEU A 940 14.907 34.479 −5.252 1.00 26.56 A OATOM 1036 N GLY A 941 15.707 32.865 −3.924 1.00 26.30 A N ATOM 1037 CAGLY A 941 16.246 32.138 −5.062 1.00 25.14 A C ATOM 1038 C GLY A 94115.156 31.632 −6.004 1.00 23.69 A C ATOM 1039 O GLY A 941 15.274 31.741−7.223 1.00 21.15 A O ATOM 1040 N SER A 942 14.079 31.089 −5.452 1.0022.19 A N ATOM 1041 CA SER A 942 13.019 30.577 −6.306 1.00 24.17 A CATOM 1042 CB SER A 942 11.900 29.952 −5.468 1.00 21.56 A C ATOM 1043 OGSER A 942 11.195 30.924 −4.706 1.00 21.92 A O ATOM 1044 C SER A 94212.452 31.681 −7.199 1.00 26.30 A C ATOM 1045 O SER A 942 11.878 31.406−8.257 1.00 27.98 A O ATOM 1046 N ARG A 943 12.623 32.928 −6.776 1.0024.94 A N ATOM 1047 CA ARG A 943 12.117 34.059 −7.535 1.00 25.38 A CATOM 1048 CB ARG A 943 11.431 35.055 −6.597 1.00 26.85 A C ATOM 1049 CGARG A 943 10.155 34.526 −5.972 1.00 28.29 A C ATOM 1050 CD ARG A 9439.079 34.335 −7.038 1.00 34.65 A C ATOM 1051 NE ARG A 943 7.827 33.831−6.480 1.00 35.43 A N ATOM 1052 CZ ARG A 943 7.681 32.630 −5.926 1.0037.49 A C ATOM 1053 NH1 ARG A 943 6.501 32.258 −5.435 1.00 36.56 A NATOM 1054 NH2 ARG A 943 8.710 31.794 −5.871 1.00 36.84 A N ATOM 1055 CARG A 943 13.247 34.734 −8.300 1.00 25.91 A C ATOM 1056 O ARG A 94313.121 35.867 −8.767 1.00 25.66 A O ATOM 1057 N ARG A 944 14.356 34.015−8.425 1.00 27.92 A N ATOM 1058 CA ARG A 944 15.539 34.497 −9.140 1.0028.02 A C ATOM 1059 CB ARG A 944 15.225 34.609 −10.633 1.00 29.49 A CATOM 1060 CG ARG A 944 14.771 33.282 −11.235 1.00 33.87 A C ATOM 1061 CDARG A 944 14.640 33.361 −12.738 1.00 38.79 A C ATOM 1062 NE ARG A 94413.924 32.213 −13.289 1.00 41.68 A N ATOM 1063 CZ ARG A 944 14.40630.977 −13.353 1.00 42.92 A C ATOM 1064 NH1 ARG A 944 15.622 30.700−12.903 1.00 44.38 A N ATOM 1065 NH2 ARG A 944 13.660 30.010 −13.8651.00 43.95 A N ATOM 1066 C ARG A 944 16.134 35.806 −8.616 1.00 26.36 A CATOM 1067 O ARG A 944 16.580 36.652 −9.380 1.00 27.18 A O ATOM 1068 NCYS A 945 16.158 35.957 −7.300 1.00 25.76 A N ATOM 1069 CA CYS A 94516.715 37.152 −6.691 1.00 25.68 A C ATOM 1070 CB CYS A 945 15.708 37.756−5.711 1.00 26.82 A C ATOM 1071 SG CYS A 945 16.350 39.138 −4.735 1.0032.67 A S ATOM 1072 C CYS A 945 18.009 36.812 −5.951 1.00 23.68 A C ATOM1073 O CYS A 945 18.003 36.003 −5.029 1.00 21.55 A O ATOM 1074 N VAL A946 19.107 37.434 −6.369 1.00 22.39 A N ATOM 1075 CA VAL A 946 20.42137.242 −5.748 1.00 22.12 A C ATOM 1076 CB VAL A 946 21.531 37.211 −6.8201.00 20.56 A C ATOM 1077 CG1 VAL A 946 22.898 37.089 −6.167 1.00 19.82 AC ATOM 1078 CG2 VAL A 946 21.296 36.053 −7.757 1.00 18.31 A C ATOM 1079C VAL A 946 20.699 38.396 −4.777 1.00 22.09 A C ATOM 1080 O VAL A 94620.579 39.568 −5.152 1.00 25.08 A O ATOM 1081 N HIS A 947 21.070 38.058−3.544 1.00 21.72 A N ATOM 1082 CA HIS A 947 21.360 39.037 −2.485 1.0023.37 A C ATOM 1083 CB HIS A 947 21.438 38.345 −1.118 1.00 21.69 A CATOM 1084 CG HIS A 947 21.439 39.299 0.036 1.00 20.53 A C ATOM 1085 CD2HIS A 947 22.147 40.432 0.263 1.00 17.46 A C ATOM 1086 ND1 HIS A 94720.554 39.183 1.088 1.00 16.91 A N ATOM 1087 CE1 HIS A 947 20.710 40.2081.903 1.00 15.92 A C ATOM 1088 NE2 HIS A 947 21.669 40.982 1.427 1.0017.07 A N ATOM 1089 C HIS A 947 22.657 39.792 −2.706 1.00 24.97 A C ATOM1090 O HIS A 947 22.679 41.018 −2.693 1.00 27.85 A O ATOM 1091 N ARG A948 23.741 39.051 −2.887 1.00 28.00 A N ATOM 1092 CA ARG A 948 25.06539.629 −3.127 1.00 31.02 A C ATOM 1093 CB ARG A 948 25.015 40.688 −4.2431.00 32.92 A C ATOM 1094 CG ARG A 948 26.344 41.444 −4.373 1.00 38.57 AC ATOM 1095 CD ARG A 948 26.349 42.551 −5.425 1.00 41.31 A C ATOM 1096NE ARG A 948 27.434 43.507 −5.196 1.00 42.45 A N ATOM 1097 CZ ARG A 94827.956 44.285 −6.138 1.00 47.28 A C ATOM 1098 NH1 ARG A 948 28.93645.129 −5.838 1.00 48.64 A N ATOM 1099 NH2 ARG A 948 27.505 44.210−7.384 1.00 48.13 A N ATOM 1100 C ARG A 948 25.797 40.218 −1.912 1.0030.74 A C ATOM 1101 O ARG A 948 27.021 40.378 −1.951 1.00 32.58 A O ATOM1102 N ASP A 949 25.080 40.531 −0.836 1.00 28.19 A N ATOM 1103 CA ASP A949 25.741 41.085 0.347 1.00 25.95 A C ATOM 1104 CB ASP A 949 25.62842.611 0.325 1.00 28.52 A C ATOM 1105 CG ASP A 949 26.488 43.282 1.3731.00 29.95 A C ATOM 1106 OD1 ASP A 949 27.589 42.767 1.656 1.00 29.48 AO ATOM 1107 OD2 ASP A 949 26.069 44.339 1.899 1.00 29.30 A O ATOM 1108 CASP A 949 25.110 40.515 1.613 1.00 24.72 A C ATOM 1109 O ASP A 94924.730 41.245 2.522 1.00 21.62 A O ATOM 1110 N LEU A 950 25.006 39.1941.672 1.00 23.77 A N ATOM 1111 CA LEU A 950 24.383 38.558 2.822 1.0022.86 A C ATOM 1112 CB LEU A 950 23.932 37.141 2.451 1.00 19.95 A C ATOM1113 CG LEU A 950 23.108 36.364 3.482 1.00 20.83 A C ATOM 1114 CD1 LEU A950 21.733 37.032 3.667 1.00 15.52 A C ATOM 1115 CD2 LEU A 950 22.93834.917 3.005 1.00 17.15 A C ATOM 1116 C LEU A 950 25.370 38.529 3.9791.00 21.92 A C ATOM 1117 O LEU A 950 26.556 38.301 3.781 1.00 19.70 A OATOM 1118 N ALA A 951 24.876 38.762 5.189 1.00 21.14 A N ATOM 1119 CAALA A 951 25.740 38.768 6.358 1.00 19.64 A C ATOM 1120 CB ALA A 95126.860 39.772 6.165 1.00 16.06 A C ATOM 1121 C ALA A 951 24.917 39.1157.585 1.00 21.41 A C ATOM 1122 O ALA A 951 23.812 39.664 7.475 1.0023.99 A O ATOM 1123 N ALA A 952 25.447 38.796 8.760 1.00 21.05 A N ATOM1124 CA ALA A 952 24.729 39.063 10.002 1.00 19.39 A C ATOM 1125 CB ALA A952 25.569 38.616 11.205 1.00 18.53 A C ATOM 1126 C ALA A 952 24.32540.532 10.137 1.00 18.69 A C ATOM 1127 O ALA A 952 23.322 40.844 10.7721.00 21.48 A O ATOM 1128 N ARG A 953 25.114 41.440 9.570 1.00 17.77 A NATOM 1129 CA ARG A 953 24.757 42.854 9.618 1.00 19.31 A C ATOM 1130 CBARG A 953 25.922 43.735 9.171 1.00 17.94 A C ATOM 1131 CG ARG A 95326.277 43.580 7.723 1.00 16.54 A C ATOM 1132 CD ARG A 953 27.394 44.5387.370 1.00 18.36 A C ATOM 1133 NE ARG A 953 28.034 44.230 6.088 1.0020.26 A N ATOM 1134 CZ ARG A 953 28.894 43.232 5.895 1.00 18.10 A C ATOM1135 NH1 ARG A 953 29.222 42.432 6.902 1.00 22.15 A N ATOM 1136 NH2 ARGA 953 29.437 43.039 4.703 1.00 14.98 A N ATOM 1137 C ARG A 953 23.55143.142 8.704 1.00 20.52 A C ATOM 1138 O ARG A 953 22.786 44.069 8.9551.00 19.49 A O ATOM 1139 N ASN A 954 23.384 42.376 7.629 1.00 20.55 A NATOM 1140 CA ASN A 954 22.235 42.638 6.768 1.00 22.29 A C ATOM 1141 CBASN A 954 22.614 42.519 5.274 1.00 18.54 A C ATOM 1142 CG ASN A 95423.351 43.761 4.753 1.00 17.79 A C ATOM 1143 OD1 ASN A 954 23.022 44.8755.122 1.00 19.98 A O ATOM 1144 ND2 ASN A 954 24.335 43.566 3.889 1.0017.35 A N ATOM 1145 C ASN A 954 21.022 41.759 7.124 1.00 22.75 A C ATOM1146 O ASN A 954 20.183 41.472 6.279 1.00 23.62 A O ATOM 1147 N ILE A955 20.952 41.339 8.389 1.00 24.09 A N ATOM 1148 CA ILE A 955 19.83740.533 8.902 1.00 23.45 A C ATOM 1149 CB ILE A 955 20.306 39.205 9.5751.00 23.56 A C ATOM 1150 CG2 ILE A 955 19.135 38.562 10.335 1.00 22.40 AC ATOM 1151 CG1 ILE A 955 20.812 38.215 8.527 1.00 22.88 A C ATOM 1152CD1 ILE A 955 19.716 37.621 7.691 1.00 21.73 A C ATOM 1153 C ILE A 95519.211 41.390 9.988 1.00 24.33 A C ATOM 1154 O ILE A 955 19.818 41.58011.038 1.00 25.58 A O ATOM 1155 N LEU A 956 18.014 41.917 9.737 1.0025.10 A N ATOM 1156 CA LEU A 956 17.326 42.762 10.712 1.00 23.60 A CATOM 1157 CB LEU A 956 16.487 43.821 9.990 1.00 20.79 A C ATOM 1158 CGLEU A 956 17.271 44.953 9.322 1.00 19.09 A C ATOM 1159 CD1 LEU A 95616.344 45.759 8.426 1.00 15.72 A C ATOM 1160 CD2 LEU A 956 17.901 45.84310.386 1.00 16.65 A C ATOM 1161 C LEU A 956 16.446 41.944 11.655 1.0025.28 A C ATOM 1162 O LEU A 956 15.913 40.893 11.282 1.00 27.16 A O ATOM1163 N VAL A 957 16.301 42.441 12.880 1.00 24.88 A N ATOM 1164 CA VAL A957 15.505 41.773 13.902 1.00 24.09 A C ATOM 1165 CB VAL A 957 16.18841.866 15.313 1.00 23.67 A C ATOM 1166 CG1 VAL A 957 15.218 41.43916.419 1.00 18.34 A C ATOM 1167 CG2 VAL A 957 17.431 40.979 15.346 1.0022.54 A C ATOM 1168 C VAL A 957 14.093 42.329 14.006 1.00 24.66 A C ATOM1169 O VAL A 957 13.885 43.510 14.288 1.00 23.71 A O ATOM 1170 N GLU A958 13.125 41.456 13.761 1.00 25.24 A N ATOM 1171 CA GLU A 958 11.72941.821 13.842 1.00 27.40 A C ATOM 1172 CB GLU A 958 10.877 40.821 13.0611.00 27.40 A C ATOM 1173 CG GLU A 958 9.407 40.926 13.373 1.00 29.36 A CATOM 1174 CD GLU A 958 8.805 42.206 12.865 1.00 30.52 A C ATOM 1175 OE1GLU A 958 7.699 42.558 13.321 1.00 33.77 A O ATOM 1176 OE2 GLU A 9589.432 42.856 12.001 1.00 34.54 A O ATOM 1177 C GLU A 958 11.380 41.76915.324 1.00 27.35 A C ATOM 1178 O GLU A 958 10.733 42.669 15.855 1.0029.14 A O ATOM 1179 N SER A 959 11.822 40.704 15.982 1.00 28.13 A N ATOM1180 CA SER A 959 11.598 40.519 17.409 1.00 29.62 A C ATOM 1181 CB SER A959 10.139 40.162 17.700 1.00 27.47 A C ATOM 1182 OG SER A 959 9.89938.786 17.467 1.00 27.72 A O ATOM 1183 C SER A 959 12.514 39.388 17.8731.00 32.26 A C ATOM 1184 O SER A 959 13.239 38.808 17.071 1.00 31.08 A OATOM 1185 N GLU A 960 12.474 39.083 19.168 1.00 34.51 A N ATOM 1186 CAGLU A 960 13.304 38.041 19.755 1.00 35.90 A C ATOM 1187 CB GLU A 96012.896 37.807 21.208 1.00 39.24 A C ATOM 1188 CG GLU A 960 13.184 38.98022.141 1.00 46.55 A C ATOM 1189 CD GLU A 960 12.187 40.140 22.010 1.0048.81 A C ATOM 1190 OE1 GLU A 960 12.358 41.143 22.752 1.00 49.24 A OATOM 1191 OE2 GLU A 960 11.244 40.048 21.183 1.00 46.66 A O ATOM 1192 CGLU A 960 13.252 36.721 19.002 1.00 35.00 A C ATOM 1193 O GLU A 96014.272 36.044 18.834 1.00 34.68 A O ATOM 1194 N ALA A 961 12.060 36.36118.547 1.00 32.61 A N ATOM 1195 CA ALA A 961 11.884 35.114 17.825 1.0031.46 A C ATOM 1196 CB ALA A 961 10.787 34.309 18.475 1.00 33.09 A CATOM 1197 C ALA A 961 11.568 35.285 16.349 1.00 29.88 A C ATOM 1198 OALA A 961 10.867 34.457 15.787 1.00 30.47 A O ATOM 1199 N HIS A 96212.079 36.332 15.709 1.00 27.98 A N ATOM 1200 CA HIS A 962 11.781 36.55214.293 1.00 26.94 A C ATOM 1201 CB HIS A 962 10.367 37.137 14.150 1.0026.76 A C ATOM 1202 CG HIS A 962 9.845 37.164 12.746 1.00 29.25 A C ATOM1203 CD2 HIS A 962 10.482 37.125 11.548 1.00 30.41 A C ATOM 1204 ND1 HISA 962 8.499 37.259 12.461 1.00 29.15 A N ATOM 1205 CE1 HIS A 962 8.32837.277 11.149 1.00 29.36 A C ATOM 1206 NE2 HIS A 962 9.515 37.197 10.5731.00 29.28 A N ATOM 1207 C HIS A 962 12.785 37.483 13.635 1.00 25.52 A CATOM 1208 O HIS A 962 12.830 38.671 13.934 1.00 24.49 A O ATOM 1209 NVAL A 963 13.583 36.942 12.723 1.00 24.67 A N ATOM 1210 CA VAL A 96314.579 37.739 12.020 1.00 22.77 A C ATOM 1211 CB VAL A 963 15.997 37.13512.211 1.00 21.51 A C ATOM 1212 CG1 VAL A 963 16.385 37.214 13.677 1.0018.57 A C ATOM 1213 CG2 VAL A 963 16.043 35.690 11.716 1.00 15.30 A CATOM 1214 C VAL A 963 14.253 37.831 10.532 1.00 24.24 A C ATOM 1215 OVAL A 963 13.710 36.888 9.950 1.00 24.35 A O ATOM 1216 N LYS A 96414.577 38.968 9.920 1.00 24.66 A N ATOM 1217 CA LYS A 964 14.306 39.1598.493 1.00 26.34 A C ATOM 1218 CB LYS A 964 13.298 40.291 8.284 1.0029.10 A C ATOM 1219 CG LYS A 964 11.887 40.014 8.784 1.00 27.26 A C ATOM1220 CD LYS A 964 10.995 41.233 8.537 1.00 26.26 A C ATOM 1221 CE LYS A964 9.534 40.902 8.778 1.00 26.90 A C ATOM 1222 NZ LYS A 964 8.64742.060 8.526 1.00 30.62 A N ATOM 1223 C LYS A 964 15.546 39.468 7.6651.00 25.93 A C ATOM 1224 O LYS A 964 16.495 40.076 8.155 1.00 28.44 A OATOM 1225 N ILE A 965 15.535 39.040 6.408 1.00 24.00 A N ATOM 1226 CAILE A 965 16.654 39.305 5.510 1.00 23.02 A C ATOM 1227 CB ILE A 96516.684 38.296 4.332 1.00 23.20 A C ATOM 1228 CG2 ILE A 965 17.821 38.6253.385 1.00 21.71 A C ATOM 1229 CG1 ILE A 965 16.894 36.871 4.857 1.0022.96 A C ATOM 1230 CD1 ILE A 965 16.961 35.812 3.758 1.00 21.77 A CATOM 1231 C ILE A 965 16.506 40.735 4.972 1.00 23.73 A C ATOM 1232 O ILEA 965 15.398 41.173 4.614 1.00 22.06 A O ATOM 1233 N ALA A 966 17.62541.460 4.919 1.00 23.15 A N ATOM 1234 CA ALA A 966 17.627 42.852 4.4701.00 21.44 A C ATOM 1235 CB ALA A 966 17.822 43.780 5.676 1.00 19.27 A CATOM 1236 C ALA A 966 18.669 43.176 3.410 1.00 21.34 A C ATOM 1237 O ALAA 966 19.700 42.518 3.319 1.00 19.18 A O ATOM 1238 N ASP A 967 18.37344.197 2.605 1.00 20.95 A N ATOM 1239 CA ASP A 967 19.280 44.669 1.5651.00 21.84 A C ATOM 1240 CB ASP A 967 20.620 45.061 2.203 1.00 25.14 A CATOM 1241 CG ASP A 967 20.589 46.450 2.832 1.00 28.31 A C ATOM 1242 OD1ASP A 967 19.687 46.736 3.661 1.00 33.06 A O ATOM 1243 OD2 ASP A 96721.474 47.260 2.491 1.00 28.34 A O ATOM 1244 C ASP A 967 19.508 43.6810.431 1.00 20.89 A C ATOM 1245 O ASP A 967 20.583 43.615 −0.144 1.0019.01 A O ATOM 1246 N PHE A 968 18.472 42.936 0.087 1.00 23.31 A N ATOM1247 CA PHE A 968 18.578 41.948 −0.973 1.00 23.74 A C ATOM 1248 CB PHE A968 17.660 40.776 −0.643 1.00 22.73 A C ATOM 1249 CG PHE A 968 16.22041.174 −0.452 1.00 21.43 A C ATOM 1250 CD1 PHE A 968 15.337 41.180−1.518 1.00 21.04 A C ATOM 1251 CD2 PHE A 968 15.752 41.535 0.795 1.0021.28 A C ATOM 1252 CE1 PHE A 968 14.014 41.535 −1.340 1.00 21.80 A CATOM 1253 CE2 PHE A 968 14.427 41.893 0.977 1.00 21.96 A C ATOM 1254 CZPHE A 968 13.558 41.890 −0.094 1.00 21.99 A C ATOM 1255 C PHE A 96818.246 42.484 −2.364 1.00 25.69 A C ATOM 1256 O PHE A 968 17.488 43.454−2.513 1.00 24.40 A O ATOM 1257 N GLY A 969 18.841 41.835 −3.368 1.0027.11 A N ATOM 1258 CA GLY A 969 18.623 42.164 −4.770 1.00 28.84 A CATOM 1259 C GLY A 969 18.930 43.573 −5.239 1.00 28.12 A C ATOM 1260 OGLY A 969 18.100 44.195 −5.887 1.00 29.45 A O ATOM 1261 N LEU A 97020.128 44.066 −4.945 1.00 27.97 A N ATOM 1262 CA LEU A 970 20.522 45.415−5.345 1.00 27.04 A C ATOM 1263 CB LEU A 970 20.882 46.223 −4.098 1.0027.31 A C ATOM 1264 CG LEU A 970 19.885 47.280 −3.650 1.00 29.99 A CATOM 1265 CD1 LEU A 970 18.475 46.876 −4.035 1.00 29.45 A C ATOM 1266CD2 LEU A 970 20.017 47.474 −2.149 1.00 31.52 A C ATOM 1267 C LEU A 97021.705 45.418 −6.313 1.00 25.60 A C ATOM 1268 O LEU A 970 22.214 46.480−6.671 1.00 24.22 A O ATOM 1269 N ALA A 971 22.134 44.234 −6.736 1.0024.75 A N ATOM 1270 CA ALA A 971 23.278 44.103 −7.638 1.00 27.57 A CATOM 1271 CB ALA A 971 23.325 42.695 −8.231 1.00 26.59 A C ATOM 1272 CALA A 971 23.271 45.135 −8.753 1.00 29.20 A C ATOM 1273 O ALA A 97124.162 45.980 −8.820 1.00 31.64 A O ATOM 1274 N LYS A 972 22.259 45.065−9.615 1.00 29.46 A N ATOM 1275 CA LYS A 972 22.112 45.979 −10.744 1.0030.77 A C ATOM 1276 CB LYS A 972 20.697 45.850 −11.322 1.00 32.32 A CATOM 1277 CG LYS A 972 20.347 44.427 −11.749 1.00 34.37 A C ATOM 1278 CDLYS A 972 21.454 43.844 −12.607 1.00 36.13 A C ATOM 1279 CE LYS A 97221.197 42.389 −12.946 1.00 39.38 A C ATOM 1280 NZ LYS A 972 22.34641.812 −13.722 1.00 41.41 A N ATOM 1281 C LYS A 972 22.406 47.446−10.414 1.00 30.81 A C ATOM 1282 O LYS A 972 23.055 48.155 −11.182 1.0030.44 A O ATOM 1283 N LEU A 973 21.930 47.899 −9.265 1.00 30.52 A N ATOM1284 CA LEU A 973 22.141 49.276 −8.858 1.00 29.45 A C ATOM 1285 CB LEU A973 21.110 49.654 −7.792 1.00 27.35 A C ATOM 1286 CG LEU A 973 19.69050.011 −8.250 1.00 26.99 A C ATOM 1287 CD1 LEU A 973 19.474 49.507−9.674 1.00 27.84 A C ATOM 1288 CD2 LEU A 973 18.645 49.444 −7.269 1.0023.63 A C ATOM 1289 C LEU A 973 23.548 49.544 −8.322 1.00 30.66 A C ATOM1290 O LEU A 973 23.988 50.685 −8.308 1.00 30.62 A O ATOM 1291 N LEU A974 24.258 48.504 −7.888 1.00 32.78 A N ATOM 1292 CA LEU A 974 25.58948.690 −7.314 1.00 35.10 A C ATOM 1293 CB LEU A 974 26.035 47.429 −6.5601.00 34.09 A C ATOM 1294 CG LEU A 974 25.141 47.021 −5.372 1.00 31.33 AC ATOM 1295 CD1 LEU A 974 25.844 46.011 −4.476 1.00 31.22 A C ATOM 1296CD2 LEU A 974 24.786 48.258 −4.582 1.00 29.58 A C ATOM 1297 C LEU A 97426.644 49.095 −8.327 1.00 39.13 A C ATOM 1298 O LEU A 974 26.683 48.588−9.444 1.00 39.72 A O ATOM 1299 N PRO A 975 27.533 50.013 −7.931 1.0042.43 A N ATOM 1300 CD PRO A 975 27.809 50.379 −6.532 1.00 41.80 A CATOM 1301 CA PRO A 975 28.594 50.500 −8.811 1.00 43.55 A C ATOM 1302 CBPRO A 975 29.427 51.381 −7.883 1.00 43.38 A C ATOM 1303 CG PRO A 97529.288 50.685 −6.574 1.00 42.77 A C ATOM 1304 C PRO A 975 29.407 49.380−9.438 1.00 44.80 A C ATOM 1305 O PRO A 975 29.676 48.370 −8.799 1.0045.65 A O ATOM 1306 N LEU A 976 29.778 49.563 −10.700 1.00 46.34 A NATOM 1307 CA LEU A 976 30.580 48.578 −11.403 1.00 47.22 A C ATOM 1308 CBLEU A 976 30.980 49.108 −12.787 1.00 47.95 A C ATOM 1309 CG LEU A 97629.859 49.044 −13.840 1.00 48.59 A C ATOM 1310 CD1 LEU A 976 29.44147.571 −14.033 1.00 48.06 A C ATOM 1311 CD2 LEU A 976 28.666 49.890−13.389 1.00 47.77 A C ATOM 1312 C LEU A 976 31.815 48.314 −10.558 1.0048.24 A C ATOM 1313 O LEU A 976 31.776 47.482 −9.643 1.00 49.05 A O ATOM1314 N ASP A 977 32.898 49.039 −10.854 1.00 48.80 A N ATOM 1315 CA ASP A977 34.163 48.909 −10.119 1.00 48.49 A C ATOM 1316 CB ASP A 977 35.29449.712 −10.785 1.00 50.18 A C ATOM 1317 CG ASP A 977 36.480 49.982−9.818 1.00 52.34 A C ATOM 1318 OD1 ASP A 977 37.652 49.670 −10.196 1.0052.04 A O ATOM 1319 OD2 ASP A 977 36.233 50.509 −8.690 1.00 51.47 A OATOM 1320 C ASP A 977 34.033 49.427 −8.706 1.00 47.71 A C ATOM 1321 OASP A 977 33.806 50.620 −8.506 1.00 47.53 A O ATOM 1322 N LYS A 97834.207 48.547 −7.726 1.00 46.64 A N ATOM 1323 CA LYS A 978 34.139 48.946−6.315 1.00 46.31 A C ATOM 1324 CB LYS A 978 33.282 47.950 −5.522 1.0044.80 A C ATOM 1325 CG LYS A 978 33.214 48.272 −4.029 1.00 43.21 A CATOM 1326 CD LYS A 978 32.755 49.717 −3.804 1.00 41.49 A C ATOM 1327 CELYS A 978 32.597 50.038 −2.322 1.00 40.48 A C ATOM 1328 NZ LYS A 97831.726 49.077 −1.599 1.00 37.88 A N ATOM 1329 C LYS A 978 35.552 49.007−5.714 1.00 46.70 A C ATOM 1330 O LYS A 978 36.359 48.077 −5.894 1.0046.71 A O ATOM 1331 N ASP A 979 35.861 50.097 −5.016 1.00 47.20 A N ATOM1332 CA ASP A 979 37.182 50.241 −4.396 1.00 47.47 A C ATOM 1333 CB ASP A979 37.659 51.698 −4.492 1.00 49.44 A C ATOM 1334 CG ASP A 979 39.16551.840 −4.312 1.00 49.88 A C ATOM 1335 OD1 ASP A 979 39.708 52.886−4.737 1.00 50.87 A O ATOM 1336 OD2 ASP A 979 39.798 50.921 −3.742 1.0049.55 A O ATOM 1337 C ASP A 979 37.052 49.805 −2.942 1.00 45.95 A C ATOM1338 O ASP A 979 36.785 50.618 −2.052 1.00 44.33 A O ATOM 1339 N TYR A980 37.233 48.505 −2.727 1.00 45.35 A N ATOM 1340 CA TYR A 980 37.10747.891 −1.407 1.00 45.75 A C ATOM 1341 CB TYR A 980 37.086 46.367 −1.5571.00 42.56 A C ATOM 1342 CG TYR A 980 35.856 45.844 −2.267 1.00 40.45 AC ATOM 1343 CD1 TYR A 980 34.639 45.743 −1.613 1.00 37.80 A C ATOM 1344CE1 TYR A 980 33.512 45.271 −2.267 1.00 36.59 A C ATOM 1345 CD2 TYR A980 35.912 45.461 −3.597 1.00 39.77 A C ATOM 1346 CE2 TYR A 980 34.79344.993 −4.256 1.00 37.65 A C ATOM 1347 CZ TYR A 980 33.597 44.898 −3.5911.00 36.99 A C ATOM 1348 OH TYR A 980 32.489 44.433 −4.267 1.00 36.66 AO ATOM 1349 C TYR A 980 38.153 48.296 −0.367 1.00 47.00 A C ATOM 1350 OTYR A 980 38.011 47.982 0.814 1.00 47.86 A O ATOM 1351 N TYR A 98139.196 48.994 −0.800 1.00 48.44 A N ATOM 1352 CA TYR A 981 40.239 49.4330.117 1.00 49.65 A C ATOM 1353 CB TYR A 981 41.552 49.597 −0.641 1.0051.45 A C ATOM 1354 CG TYR A 981 42.026 48.307 −1.261 1.00 54.63 A CATOM 1355 CD1 TYR A 981 42.798 48.311 −2.416 1.00 55.85 A C ATOM 1356CE1 TYR A 981 43.214 47.127 −3.002 1.00 57.90 A C ATOM 1357 CD2 TYR A981 41.680 47.080 −0.703 1.00 56.41 A C ATOM 1358 CE2 TYR A 981 42.08945.888 −1.281 1.00 57.59 A C ATOM 1359 CZ TYR A 981 42.854 45.919 −2.4311.00 58.54 A C ATOM 1360 OH TYR A 981 43.256 44.741 −3.016 1.00 60.20 AO ATOM 1361 C TYR A 981 39.824 50.743 0.781 1.00 48.81 A C ATOM 1362 OTYR A 981 40.504 51.260 1.673 1.00 48.86 A O ATOM 1363 N VAL A 98238.688 51.266 0.339 1.00 48.42 A N ATOM 1364 CA VAL A 982 38.140 52.5010.880 1.00 46.99 A C ATOM 1365 CB VAL A 982 37.831 53.528 −0.243 1.0046.43 A C ATOM 1366 CG1 VAL A 982 37.265 54.802 0.359 1.00 45.87 A CATOM 1367 CG2 VAL A 982 39.090 53.827 −1.045 1.00 44.80 A C ATOM 1368 CVAL A 982 36.845 52.148 1.605 1.00 46.90 A C ATOM 1369 O VAL A 98235.773 52.122 1.004 1.00 45.78 A O ATOM 1370 N VAL A 983 36.965 51.8662.898 1.00 47.59 A N ATOM 1371 CA VAL A 983 35.824 51.510 3.729 1.0048.25 A C ATOM 1372 CB VAL A 983 35.733 49.970 3.898 1.00 48.58 A C ATOM1373 CG1 VAL A 983 37.076 49.417 4.360 1.00 49.17 A C ATOM 1374 CG2 VALA 983 34.631 49.608 4.884 1.00 47.78 A C ATOM 1375 C VAL A 983 35.92852.175 5.100 1.00 49.02 A C ATOM 1376 O VAL A 983 37.005 52.243 5.6911.00 49.70 A O ATOM 1377 N ARG A 984 34.803 52.671 5.601 1.00 49.82 A NATOM 1378 CA ARG A 984 34.778 53.333 6.895 1.00 49.53 A C ATOM 1379 CBARG A 984 33.426 54.011 7.127 1.00 52.18 A C ATOM 1380 CG ARG A 98433.463 55.085 8.205 1.00 55.52 A C ATOM 1381 CD ARG A 984 32.063 55.4668.673 1.00 59.59 A C ATOM 1382 NE ARG A 984 32.062 56.701 9.457 1.0062.13 A N ATOM 1383 CZ ARG A 984 32.749 56.885 10.581 1.00 63.45 A CATOM 1384 NH1 ARG A 984 32.678 58.052 11.210 1.00 64.01 A N ATOM 1385NH2 ARG A 984 33.499 55.908 11.079 1.00 61.84 A N ATOM 1386 C ARG A 98435.036 52.324 8.001 1.00 48.55 A C ATOM 1387 O ARG A 984 35.748 52.6198.962 1.00 49.22 A O ATOM 1388 N GLU A 985 34.449 51.137 7.871 1.0046.54 A N ATOM 1389 CA GLU A 985 34.631 50.081 8.864 1.00 44.17 A C ATOM1390 CB GLU A 985 33.338 49.854 9.653 1.00 45.48 A C ATOM 1391 CG GLU A985 33.574 49.373 11.092 1.00 50.99 A C ATOM 1392 CD GLU A 985 33.93750.504 12.068 1.00 53.46 A C ATOM 1393 OE1 GLU A 985 34.598 50.21613.094 1.00 54.69 A O ATOM 1394 OE2 GLU A 985 33.549 51.672 11.820 1.0054.79 A O ATOM 1395 C GLU A 985 35.050 48.793 8.159 1.00 41.59 A C ATOM1396 O GLU A 985 34.220 47.947 7.842 1.00 41.99 A O ATOM 1397 N PRO A986 36.363 48.626 7.928 1.00 39.68 A N ATOM 1398 CD PRO A 986 37.38449.483 8.550 1.00 37.11 A C ATOM 1399 CA PRO A 986 36.988 47.476 7.2611.00 37.84 A C ATOM 1400 CB PRO A 986 38.479 47.779 7.389 1.00 37.70 A CATOM 1401 CG PRO A 986 38.550 48.546 8.663 1.00 37.19 A C ATOM 1402 CPRO A 986 36.613 46.090 7.788 1.00 36.77 A C ATOM 1403 O PRO A 98636.536 45.131 7.026 1.00 37.02 A O ATOM 1404 N GLY A 987 36.380 45.9709.085 1.00 35.59 A N ATOM 1405 CA GLY A 987 36.010 44.671 9.607 1.0033.97 A C ATOM 1406 C GLY A 987 34.746 44.114 8.963 1.00 32.82 A C ATOM1407 O GLY A 987 34.510 42.912 9.012 1.00 32.56 A O ATOM 1408 N GLN A988 33.927 44.974 8.366 1.00 30.14 A N ATOM 1409 CA GLN A 988 32.70044.512 7.737 1.00 29.16 A C ATOM 1410 CB GLN A 988 31.493 45.292 8.2681.00 30.41 A C ATOM 1411 CG GLN A 988 31.206 45.078 9.756 1.00 29.44 A CATOM 1412 CD GLN A 988 30.776 43.654 10.082 1.00 31.42 A C ATOM 1413 OE1GLN A 988 29.653 43.244 9.684 1.00 26.26 A O ATOM 1414 NE2 GLN A 98831.576 42.947 10.735 1.00 32.03 A O ATOM 1415 C GLN A 988 32.765 44.6456.226 1.00 29.17 A C ATOM 1416 O GLN A 988 31.740 44.806 5.570 1.0027.90 A O ATOM 1417 N SER A 989 33.978 44.584 5.678 1.00 29.64 A N ATOM1418 CA SER A 989 34.172 44.687 4.236 1.00 27.96 A C ATOM 1419 CB SER A989 35.656 44.774 3.888 1.00 29.01 A C ATOM 1420 OG SER A 989 35.84344.762 2.483 1.00 28.27 A O ATOM 1421 C SER A 989 33.587 43.442 3.6041.00 28.16 A C ATOM 1422 O SER A 989 33.928 42.327 3.982 1.00 26.58 A OATOM 1423 N PRO A 990 32.714 43.624 2.608 1.00 28.39 A N ATOM 1424 CDPRO A 990 32.449 44.935 1.982 1.00 29.19 A C ATOM 1425 CA PRO A 99032.035 42.551 1.879 1.00 28.46 A C ATOM 1426 CB PRO A 990 31.472 43.2720.653 1.00 29.64 A C ATOM 1427 CG PRO A 990 31.205 44.662 1.169 1.0028.86 A C ATOM 1428 C PRO A 990 32.893 41.355 1.489 1.00 26.71 A C ATOM1429 O PRO A 990 32.386 40.242 1.408 1.00 27.68 A O ATOM 1430 N ILE A991 34.181 41.590 1.247 1.00 25.64 A N ATOM 1431 CA ILE A 991 35.10940.542 0.829 1.00 23.27 A C ATOM 1432 CB ILE A 991 36.508 41.121 0.5431.00 22.53 A C ATOM 1433 CG2 ILE A 991 36.390 42.242 −0.472 1.00 21.72 AC ATOM 1434 CG1 ILE A 991 37.162 41.592 1.851 1.00 21.38 A C ATOM 1435CD1 ILE A 991 38.659 41.885 1.740 1.00 17.35 A C ATOM 1436 C ILE A 99135.282 39.340 1.759 1.00 22.89 A C ATOM 1437 O ILE A 991 35.628 38.2671.292 1.00 22.75 A O ATOM 1438 N PHE A 992 35.061 39.504 3.060 1.0022.83 A N ATOM 1439 CA PHE A 992 35.218 38.367 3.972 1.00 24.27 A C ATOM1440 CB PHE A 992 35.468 38.832 5.423 1.00 21.98 A C ATOM 1441 CG PHE A992 36.692 39.675 5.575 1.00 18.63 A C ATOM 1442 CD1 PHE A 992 37.90539.225 5.092 1.00 19.36 A C ATOM 1443 CD2 PHE A 992 36.621 40.944 6.1291.00 18.42 A C ATOM 1444 CE1 PHE A 992 39.042 40.021 5.144 1.00 18.38 AC ATOM 1445 CE2 PHE A 992 37.747 41.751 6.188 1.00 20.39 A C ATOM 1446CZ PHE A 992 38.965 41.286 5.689 1.00 19.03 A C ATOM 1447 C PHE A 99234.010 37.434 3.945 1.00 24.41 A C ATOM 1448 O PHE A 992 33.986 36.4364.669 1.00 23.48 A O ATOM 1449 N TRP A 993 33.014 37.767 3.122 1.0024.17 A N ATOM 1450 CA TRP A 993 31.801 36.952 2.977 1.00 24.08 A C ATOM1451 CB TRP A 993 30.549 37.762 3.318 1.00 20.25 A C ATOM 1452 CG TRP A993 30.322 37.968 4.776 1.00 18.22 A C ATOM 1453 CD2 TRP A 993 30.93438.962 5.609 1.00 17.81 A C ATOM 1454 CE2 TRP A 993 30.465 38.750 6.9231.00 16.65 A C ATOM 1455 CE3 TRP A 993 31.836 40.012 5.371 1.00 17.27 AC ATOM 1456 CD1 TRP A 993 29.524 37.222 5.593 1.00 18.48 A C ATOM 1457NE1 TRP A 993 29.608 37.683 6.885 1.00 18.25 A N ATOM 1458 CZ2 TRP A 99330.867 39.544 7.998 1.00 16.84 A C ATOM 1459 CZ3 TRP A 993 32.235 40.8006.439 1.00 13.99 A C ATOM 1460 CH2 TRP A 993 31.752 40.562 7.738 1.0015.16 A C ATOM 1461 C TRP A 993 31.674 36.458 1.547 1.00 25.04 A C ATOM1462 O TRP A 993 30.772 35.691 1.224 1.00 27.65 A O ATOM 1463 N TYR A994 32.590 36.891 0.691 1.00 26.08 A N ATOM 1464 CA TYR A 994 32.53936.516 −0.713 1.00 26.22 A C ATOM 1465 CB TYR A 994 33.385 37.473 −1.5561.00 26.01 A C ATOM 1466 CG TYR A 994 32.752 38.812 −1.830 1.00 25.79 AC ATOM 1467 CD1 TYR A 994 31.565 39.180 −1.224 1.00 25.47 A C ATOM 1468CE1 TYR A 994 30.997 40.421 −1.472 1.00 29.26 A C ATOM 1469 CD2 TYR A994 33.358 39.719 −2.695 1.00 27.78 A C ATOM 1470 CE2 TYR A 994 32.79840.958 −2.949 1.00 27.26 A C ATOM 1471 CZ TYR A 994 31.620 41.304 −2.3371.00 28.81 A C ATOM 1472 OH TYR A 994 31.056 42.529 −2.598 1.00 31.86 AO ATOM 1473 C TYR A 994 33.018 35.111 −0.989 1.00 26.70 A C ATOM 1474 OTYR A 994 33.871 34.587 −0.281 1.00 26.37 A O ATOM 1475 N ALA A 99532.462 34.516 −2.040 1.00 27.56 A N ATOM 1476 CA ALA A 995 32.846 33.180−2.479 1.00 27.85 A C ATOM 1477 CB ALA A 995 31.653 32.478 −3.148 1.0026.19 A C ATOM 1478 C ALA A 995 33.980 33.383 −3.488 1.00 28.75 A C ATOM1479 O ALA A 995 34.156 34.486 −4.027 1.00 29.61 A O ATOM 1480 N PRO A996 34.762 32.329 −3.760 1.00 27.48 A N ATOM 1481 CD PRO A 996 34.69630.981 −3.181 1.00 26.63 A C ATOM 1482 CA PRO A 996 35.872 32.429 −4.7111.00 28.77 A C ATOM 1483 CB PRO A 996 36.309 30.978 −4.880 1.00 26.97 AC ATOM 1484 CG PRO A 996 36.050 30.418 −3.535 1.00 25.72 A C ATOM 1485 CPRO A 996 35.494 33.082 −6.041 1.00 29.95 A C ATOM 1486 O PRO A 99636.092 34.089 −6.423 1.00 32.04 A O ATOM 1487 N GLU A 997 34.507 32.517−6.736 1.00 30.01 A N ATOM 1488 CA GLU A 997 34.080 33.050 −8.026 1.0030.26 A C ATOM 1489 CB GLU A 997 32.822 32.323 −8.549 1.00 30.28 A CATOM 1490 CG GLU A 997 31.606 32.373 −7.648 1.00 30.56 A C ATOM 1491 CDGLU A 997 31.601 31.268 −6.606 1.00 32.94 A C ATOM 1492 OE1 GLU A 99732.683 30.961 −6.052 1.00 31.09 A O ATOM 1493 OE2 GLU A 997 30.50630.717 −6.338 1.00 33.32 A O ATOM 1494 C GLU A 997 33.829 34.550 −7.9481.00 30.85 A C ATOM 1495 O GLU A 997 34.057 35.281 −8.909 1.00 31.80 A OATOM 1496 N SER A 998 33.368 35.017 −6.797 1.00 32.03 A N ATOM 1497 CASER A 998 33.132 36.440 −6.626 1.00 32.09 A C ATOM 1498 CB SER A 99832.300 36.688 −5.379 1.00 31.27 A C ATOM 1499 OG SER A 998 30.955 36.327−5.607 1.00 32.96 A O ATOM 1500 C SER A 998 34.442 37.214 −6.522 1.0032.18 A C ATOM 1501 O SER A 998 34.644 38.198 −7.224 1.00 34.53 A O ATOM1502 N LEU A 999 35.329 36.770 −5.642 1.00 32.83 A N ATOM 1503 CA LEU A999 36.606 37.447 −5.448 1.00 33.92 A C ATOM 1504 CB LEU A 999 37.43536.730 −4.374 1.00 31.31 A C ATOM 1505 CG LEU A 999 37.076 36.949 −2.8971.00 29.60 A C ATOM 1506 CD1 LEU A 999 37.992 36.101 −2.035 1.00 28.05 AC ATOM 1507 CD2 LEU A 999 37.226 38.417 −2.515 1.00 28.42 A C ATOM 1508C LEU A 999 37.432 37.568 −6.724 1.00 35.90 A C ATOM 1509 O LEU A 99938.101 38.574 −6.936 1.00 36.64 A O ATOM 1510 N SER A 1000 37.374 36.556−7.581 1.00 36.91 A N ATOM 1511 CA SER A 1000 38.152 36.566 −8.808 1.0037.30 A C ATOM 1512 CB SER A 1000 38.755 35.192 −9.032 1.00 36.47 A CATOM 1513 OG SER A 1000 37.724 34.247 −9.246 1.00 34.60 A O ATOM 1514 CSER A 1000 37.425 36.977 −10.084 1.00 39.08 A C ATOM 1515 O SER A 100038.062 37.421 −11.033 1.00 40.17 A O ATOM 1516 N ASP A 1001 36.10936.831 −10.132 1.00 40.32 A N ATOM 1517 CA ASP A 1001 35.396 37.191−11.351 1.00 42.54 A C ATOM 1518 CB ASP A 1001 35.041 35.925 −12.1261.00 43.98 A C ATOM 1519 CG ASP A 1001 36.266 35.162 −12.574 1.00 45.00A C ATOM 1520 OD1 ASP A 1001 37.062 35.734 −13.349 1.00 44.52 A O ATOM1521 OD2 ASP A 1001 36.433 33.998 −12.147 1.00 45.98 A O ATOM 1522 C ASPA 1001 34.142 38.031 −11.171 1.00 42.36 A C ATOM 1523 O ASP A 100133.359 38.178 −12.104 1.00 42.53 A O ATOM 1524 N ASN A 1002 33.95738.589 −9.983 1.00 42.42 A N ATOM 1525 CA ASN A 1002 32.781 39.390−9.703 1.00 42.92 A C ATOM 1526 CB ASN A 1002 32.703 40.590 −10.641 1.0044.00 A C ATOM 1527 CG ASN A 1002 33.246 41.847 −10.015 1.00 45.61 A CATOM 1528 OD1 ASN A 1002 34.455 42.005 −9.846 1.00 49.08 A O ATOM 1529ND2 ASN A 1002 32.349 42.753 −9.653 1.00 45.40 A N ATOM 1530 C ASN A1002 31.514 38.570 −9.841 1.00 42.00 A C ATOM 1531 O ASN A 1002 30.42139.095 −9.676 1.00 43.55 A O ATOM 1532 N ILE A 1003 31.667 37.285−10.143 1.00 40.07 A N ATOM 1533 CA ILE A 1003 30.535 36.376 −10.3031.00 37.80 A C ATOM 1534 CB ILE A 1003 30.994 34.944 −10.651 1.00 38.03A C ATOM 1535 CG2 ILE A 1003 29.822 33.987 −10.536 1.00 35.71 A C ATOM1536 CG1 ILE A 1003 31.629 34.902 −12.037 1.00 35.29 A C ATOM 1537 CD1ILE A 1003 31.993 33.514 −12.454 1.00 33.06 A C ATOM 1538 C ILE A 100329.704 36.255 −9.037 1.00 37.43 A C ATOM 1539 O ILE A 1003 30.230 35.936−7.969 1.00 38.59 A O ATOM 1540 N PHE A 1004 28.404 36.488 −9.170 1.0036.18 A N ATOM 1541 CA PHE A 1004 27.474 36.390 −8.055 1.00 34.51 A CATOM 1542 CB PHE A 1004 27.055 37.787 −7.598 1.00 32.45 A C ATOM 1543 CGPHE A 1004 28.126 38.525 −6.828 1.00 34.32 A C ATOM 1544 CD1 PHE A 100428.492 38.110 −5.549 1.00 32.69 A C ATOM 1545 CD2 PHE A 1004 28.75739.637 −7.371 1.00 31.98 A C ATOM 1546 CE1 PHE A 1004 29.462 38.789−4.824 1.00 31.46 A C ATOM 1547 CE2 PHE A 1004 29.730 40.322 −6.651 1.0033.05 A C ATOM 1548 CZ PHE A 1004 30.081 39.895 −5.373 1.00 32.10 A CATOM 1549 C PHE A 1004 26.256 35.591 −8.511 1.00 35.47 A C ATOM 1550 OPHE A 1004 25.696 35.854 −9.575 1.00 37.28 A O ATOM 1551 N SER A 100525.853 34.610 −7.709 1.00 34.92 A N ATOM 1552 CA SER A 1005 24.71333.774 −8.045 1.00 32.73 A C ATOM 1553 CB SER A 1005 25.158 32.584−8.888 1.00 33.36 A C ATOM 1554 OG SER A 1005 25.959 31.704 −8.114 1.0036.71 A O ATOM 1555 C SER A 1005 24.051 33.245 −6.794 1.00 31.68 A CATOM 1556 O SER A 1005 24.536 33.449 −5.681 1.00 31.32 A O ATOM 1557 NARG A 1006 22.937 32.553 −6.996 1.00 29.32 A N ATOM 1558 CA ARG A 100622.197 31.961 −5.900 1.00 28.94 A C ATOM 1559 CB ARG A 1006 21.04031.130 −6.452 1.00 29.85 A C ATOM 1560 CG ARG A 1006 20.005 31.949−7.202 1.00 35.55 A C ATOM 1561 CD ARG A 1006 18.924 31.062 −7.843 1.0038.40 A C ATOM 1562 NE ARG A 1006 18.345 30.128 −6.876 1.00 43.57 A NATOM 1563 CZ ARG A 1006 17.471 29.168 −7.174 1.00 44.56 A C ATOM 1564NH1 ARG A 1006 17.009 28.367 −6.220 1.00 41.70 A N ATOM 1565 NH2 ARG A1006 17.053 29.012 −8.420 1.00 44.91 A N ATOM 1566 C ARG A 1006 23.12531.068 −5.081 1.00 27.76 A C ATOM 1567 O ARG A 1006 22.995 30.967 −3.8611.00 25.65 A O ATOM 1568 N GLN A 1007 24.077 30.433 −5.755 1.00 27.21 AN ATOM 1569 CA GLN A 1007 24.979 29.524 −5.067 1.00 27.69 A C ATOM 1570CB GLN A 1007 25.552 28.492 −6.041 1.00 27.27 A C ATOM 1571 CG GLN A1007 24.566 27.386 −6.456 1.00 30.11 A C ATOM 1572 CD GLN A 1007 24.00826.541 −5.273 1.00 32.03 A C ATOM 1573 OE1 GLN A 1007 22.897 26.788−4.771 1.00 28.18 A O ATOM 1574 NE2 GLN A 1007 24.785 25.542 −4.836 1.0029.04 A N ATOM 1575 C GLN A 1007 26.093 30.236 −4.313 1.00 27.70 A CATOM 1576 O GLN A 1007 26.567 29.750 −3.276 1.00 26.19 A O ATOM 1577 NSER A 1008 26.506 31.390 −4.822 1.00 26.86 A N ATOM 1578 CA SER A 100827.542 32.155 −4.150 1.00 26.66 A C ATOM 1579 CB SER A 1008 27.99733.331 −5.018 1.00 29.18 A C ATOM 1580 OG SER A 1008 26.903 34.144−5.400 1.00 31.80 A O ATOM 1581 C SER A 1008 26.950 32.654 −2.830 1.0026.32 A C ATOM 1582 O SER A 1008 27.659 32.816 −1.828 1.00 26.69 A OATOM 1583 N ASP A 1009 25.641 32.892 −2.830 1.00 25.13 A N ATOM 1584 CAASP A 1009 24.974 33.341 −1.620 1.00 24.62 A C ATOM 1585 CB ASP A 100923.493 33.663 −1.882 1.00 26.26 A C ATOM 1586 CG ASP A 1009 23.27535.087 −2.421 1.00 29.77 A C ATOM 1587 OD1 ASP A 1009 22.195 35.364−2.993 1.00 31.03 A O ATOM 1588 OD2 ASP A 1009 24.175 35.937 −2.268 1.0030.20 A O ATOM 1589 C ASP A 1009 25.097 32.221 −0.602 1.00 23.09 A CATOM 1590 O ASP A 1009 25.382 32.469 0.566 1.00 24.34 A O ATOM 1591 NVAL A 1010 24.904 30.987 −1.051 1.00 21.87 A N ATOM 1592 CA VAL A 101024.986 29.833 −0.155 1.00 21.43 A C ATOM 1593 CB VAL A 1010 24.90628.497 −0.933 1.00 18.75 A C ATOM 1594 CG1 VAL A 1010 25.308 27.344−0.033 1.00 18.01 A C ATOM 1595 CG2 VAL A 1010 23.499 28.277 −1.432 1.0017.23 A C ATOM 1596 C VAL A 1010 26.279 29.868 0.649 1.00 21.21 A C ATOM1597 O VAL A 1010 26.285 29.538 1.827 1.00 18.67 A O ATOM 1598 N TRP A1011 27.355 30.289 −0.012 1.00 22.19 A N ATOM 1599 CA TRP A 1011 28.67130.408 0.582 1.00 21.30 A C ATOM 1600 CB TRP A 1011 29.676 30.823 −0.4941.00 21.09 A C ATOM 1601 CG TRP A 1011 31.004 31.272 0.051 1.00 22.20 AC ATOM 1602 CD2 TRP A 1011 32.242 30.555 −0.013 1.00 23.32 A C ATOM 1603CE2 TRP A 1011 33.216 31.343 0.643 1.00 23.77 A C ATOM 1604 CE3 TRP A1011 32.622 29.326 −0.558 1.00 23.63 A C ATOM 1605 CD1 TRP A 1011 31.27132.436 0.726 1.00 22.11 A C ATOM 1606 NE1 TRP A 1011 32.596 32.484 1.0841.00 22.41 A N ATOM 1607 CZ2 TRP A 1011 34.546 30.940 0.769 1.00 23.00 AC ATOM 1608 CZ3 TRP A 1011 33.949 28.926 −0.433 1.00 25.04 A C ATOM 1609CH2 TRP A 1011 34.893 29.734 0.226 1.00 24.41 A C ATOM 1610 C TRP A 101128.642 31.456 1.690 1.00 21.41 A C ATOM 1611 O TRP A 1011 29.159 31.2312.780 1.00 20.92 A O ATOM 1612 N SER A 1012 28.035 32.602 1.401 1.0022.30 A N ATOM 1613 CA SER A 1012 27.940 33.684 2.373 1.00 21.76 A CATOM 1614 CB SER A 1012 27.286 34.926 1.742 1.00 24.85 A C ATOM 1615 OGSER A 1012 27.933 35.297 0.534 1.00 28.52 A O ATOM 1616 C SER A 101227.107 33.232 3.565 1.00 19.93 A C ATOM 1617 O SER A 1012 27.303 33.7134.677 1.00 20.35 A O ATOM 1618 N PHE A 1013 26.167 32.322 3.332 1.0018.72 A N ATOM 1619 CA PHE A 1013 25.324 31.823 4.409 1.00 19.74 A CATOM 1620 CB PHE A 1013 24.197 30.958 3.850 1.00 21.64 A C ATOM 1621 CGPHE A 1013 23.267 30.431 4.902 1.00 21.29 A C ATOM 1622 CD1 PHE A 101322.582 31.307 5.738 1.00 21.35 A C ATOM 1623 CD2 PHE A 1013 23.04829.069 5.033 1.00 20.51 A C ATOM 1624 CE1 PHE A 1013 21.689 30.832 6.6841.00 20.93 A C ATOM 1625 CE2 PHE A 1013 22.156 28.579 5.973 1.00 21.44 AC ATOM 1626 CZ PHE A 1013 21.470 29.462 6.804 1.00 21.79 A C ATOM 1627 CPHE A 1013 26.191 31.002 5.355 1.00 18.87 A C ATOM 1628 O PHE A 101325.924 30.912 6.549 1.00 18.16 A O ATOM 1629 N GLY A 1014 27.236 30.3994.806 1.00 19.32 A N ATOM 1630 CA GLY A 1014 28.143 29.634 5.639 1.0023.18 A C ATOM 1631 C GLY A 1014 28.825 30.545 6.654 1.00 24.21 A C ATOM1632 O GLY A 1014 28.994 30.177 7.815 1.00 23.51 A O ATOM 1633 N VAL A1015 29.206 31.745 6.216 1.00 25.95 A N ATOM 1634 CA VAL A 1015 29.87432.705 7.093 1.00 26.43 A C ATOM 1635 CB VAL A 1015 30.547 33.841 6.2821.00 25.36 A C ATOM 1636 CG1 VAL A 1015 31.399 34.710 7.195 1.00 26.40 AC ATOM 1637 CG2 VAL A 1015 31.404 33.253 5.185 1.00 24.13 A C ATOM 1638C VAL A 1015 28.873 33.305 8.070 1.00 27.70 A C ATOM 1639 O VAL A 101529.229 33.721 9.174 1.00 29.33 A O ATOM 1640 N VAL A 1016 27.610 33.3457.674 1.00 26.63 A N ATOM 1641 CA VAL A 1016 26.600 33.897 8.559 1.0026.58 A C ATOM 1642 CB VAL A 1016 25.275 34.134 7.813 1.00 27.70 A CATOM 1643 CG1 VAL A 1016 24.194 34.545 8.804 1.00 25.02 A C ATOM 1644CG2 VAL A 1016 25.469 35.196 6.738 1.00 24.95 A C ATOM 1645 C VAL A 101626.363 32.924 9.709 1.00 26.56 A C ATOM 1646 O VAL A 1016 26.105 33.33410.843 1.00 25.68 A O ATOM 1647 N LEU A 1017 26.445 31.630 9.406 1.0025.79 A N ATOM 1648 CA LEU A 1017 26.259 30.595 10.420 1.00 25.37 A CATOM 1649 CB LEU A 1017 26.231 29.204 9.768 1.00 24.57 A C ATOM 1650 CGLEU A 1017 24.935 28.765 9.069 1.00 23.17 A C ATOM 1651 CD1 LEU A 101725.212 27.540 8.190 1.00 22.94 A C ATOM 1652 CD2 LEU A 1017 23.85628.468 10.107 1.00 19.40 A C ATOM 1653 C LEU A 1017 27.417 30.702 11.4041.00 25.14 A C ATOM 1654 O LEU A 1017 27.242 30.556 12.609 1.00 24.28 AO ATOM 1655 N TYR A 1018 28.603 30.964 10.871 1.00 26.09 A N ATOM 1656CA TYR A 1018 29.788 31.130 11.687 1.00 27.05 A C ATOM 1657 CB TYR A1018 31.003 31.388 10.801 1.00 28.96 A C ATOM 1658 CG TYR A 1018 32.27631.654 11.584 1.00 32.69 A C ATOM 1659 CD1 TYR A 1018 32.924 30.62712.263 1.00 31.98 A C ATOM 1660 CE1 TYR A 1018 34.082 30.865 12.978 1.0031.92 A C ATOM 1661 CD2 TYR A 1018 32.830 32.936 11.647 1.00 31.48 A CATOM 1662 CE2 TYR A 1018 33.993 33.180 12.364 1.00 31.23 A C ATOM 1663CZ TYR A 1018 34.610 32.139 13.023 1.00 32.76 A C ATOM 1664 OH TYR A1018 35.763 32.357 13.732 1.00 34.73 A O ATOM 1665 C TYR A 1018 29.59032.316 12.636 1.00 28.41 A C ATOM 1666 O TYR A 1018 29.937 32.228 13.8071.00 29.27 A O ATOM 1667 N GLU A 1019 29.024 33.416 12.130 1.00 28.77 AN ATOM 1668 CA GLU A 1019 28.786 34.623 12.931 1.00 28.13 A C ATOM 1669CB GLU A 1019 28.258 35.773 12.046 1.00 29.97 A C ATOM 1670 CG GLU A1019 29.188 36.251 10.919 1.00 29.60 A C ATOM 1671 CD GLU A 1019 28.73837.577 10.299 1.00 29.59 A C ATOM 1672 OE1 GLU A 1019 28.910 38.63810.937 1.00 31.77 A O ATOM 1673 OE2 GLU A 1019 28.208 37.564 9.171 1.0028.17 A O ATOM 1674 C GLU A 1019 27.796 34.396 14.086 1.00 27.33 A CATOM 1675 O GLU A 1019 27.988 34.897 15.195 1.00 25.68 A O ATOM 1676 NLEU A 1020 26.730 33.650 13.825 1.00 27.14 A N ATOM 1677 CA LEU A 102025.735 33.394 14.855 1.00 26.16 A C ATOM 1678 CB LEU A 1020 24.51332.683 14.255 1.00 25.72 A C ATOM 1679 CG LEU A 1020 23.673 33.44913.223 1.00 27.06 A C ATOM 1680 CD1 LEU A 1020 22.199 33.148 13.464 1.0026.70 A C ATOM 1681 CD2 LEU A 1020 23.917 34.949 13.329 1.00 26.86 A CATOM 1682 C LEU A 1020 26.318 32.560 15.988 1.00 25.00 A C ATOM 1683 OLEU A 1020 26.214 32.929 17.153 1.00 23.85 A O ATOM 1684 N PHE A 102126.935 31.438 15.637 1.00 25.96 A N ATOM 1685 CA PHE A 1021 27.54030.551 16.622 1.00 28.26 A C ATOM 1686 CB PHE A 1021 27.756 29.17315.998 1.00 28.65 A C ATOM 1687 CG PHE A 1021 26.514 28.328 15.974 1.0030.48 A C ATOM 1688 CD1 PHE A 1021 26.105 27.648 17.107 1.00 30.22 A CATOM 1689 CD2 PHE A 1021 25.721 28.270 14.846 1.00 31.61 A C ATOM 1690CE1 PHE A 1021 24.932 26.932 17.119 1.00 32.06 A C ATOM 1691 CE2 PHE A1021 24.537 27.552 14.853 1.00 33.64 A C ATOM 1692 CZ PHE A 1021 24.14526.882 15.994 1.00 33.78 A C ATOM 1693 C PHE A 1021 28.848 31.115 17.1841.00 29.12 A C ATOM 1694 O PHE A 1021 29.517 30.477 17.992 1.00 30.42 AO ATOM 1695 N THR A 1022 29.190 32.325 16.751 1.00 29.23 A N ATOM 1696CA THR A 1022 30.386 33.014 17.201 1.00 28.15 A C ATOM 1697 CB THR A1022 31.291 33.380 15.994 1.00 28.82 A C ATOM 1698 OG1 THR A 1022 32.64332.998 16.273 1.00 30.39 A O ATOM 1699 CG2 THR A 1022 31.237 34.85915.693 1.00 28.63 A C ATOM 1700 C THR A 1022 29.899 34.276 17.905 1.0028.32 A C ATOM 1701 O THR A 1022 30.692 35.071 18.422 1.00 27.51 A OATOM 1702 N TYR A 1023 28.573 34.427 17.931 1.00 28.68 A N ATOM 1703 CATYR A 1023 27.897 35.573 18.545 1.00 27.59 A C ATOM 1704 CB TYR A 102328.003 35.531 20.067 1.00 27.08 A C ATOM 1705 CG TYR A 1023 27.15134.471 20.710 1.00 27.19 A C ATOM 1706 CD1 TYR A 1023 27.691 33.25221.089 1.00 27.11 A C ATOM 1707 CE1 TYR A 1023 26.900 32.281 21.682 1.0026.29 A C ATOM 1708 CD2 TYR A 1023 25.799 34.690 20.937 1.00 26.09 A CATOM 1709 CE2 TYR A 1023 25.006 33.730 21.524 1.00 25.32 A C ATOM 1710CZ TYR A 1023 25.559 32.528 21.896 1.00 26.71 A C ATOM 1711 OH TYR A1023 24.766 31.569 22.484 1.00 27.13 A O ATOM 1712 C TYR A 1023 28.47136.886 18.062 1.00 26.01 A C ATOM 1713 O TYR A 1023 28.307 37.913 18.7121.00 26.91 A O ATOM 1714 N CYS A 1024 29.150 36.849 16.924 1.00 24.48 AN ATOM 1715 CA CYS A 1024 29.760 38.042 16.359 1.00 27.84 A C ATOM 1716CB CYS A 1024 28.698 39.077 15.971 1.00 27.22 A C ATOM 1717 SG CYS A1024 27.882 38.643 14.441 1.00 31.28 A S ATOM 1718 C CYS A 1024 30.78738.681 17.266 1.00 28.38 A C ATOM 1719 O CYS A 1024 30.903 39.905 17.3461.00 28.99 A O ATOM 1720 N ASP A 1025 31.543 37.845 17.950 1.00 28.57 AN ATOM 1721 CA ASP A 1025 32.582 38.353 18.807 1.00 30.59 A C ATOM 1722CB ASP A 1025 33.163 37.211 19.630 1.00 35.06 A C ATOM 1723 CG ASP A1025 34.099 37.697 20.698 1.00 39.47 A C ATOM 1724 OD1 ASP A 1025 33.65838.530 21.525 1.00 42.23 A O ATOM 1725 OD2 ASP A 1025 35.269 37.24920.704 1.00 42.12 A O ATOM 1726 C ASP A 1025 33.647 38.945 17.874 1.0030.39 A C ATOM 1727 O ASP A 1025 34.007 38.326 16.870 1.00 29.56 A OATOM 1728 N LYS A 1026 34.139 40.136 18.201 1.00 31.27 A N ATOM 1729 CALYS A 1026 35.143 40.817 17.381 1.00 33.10 A C ATOM 1730 CB LYS A 102635.401 42.228 17.914 1.00 35.51 A C ATOM 1731 CG LYS A 1026 34.15343.016 18.261 1.00 39.16 A C ATOM 1732 CD LYS A 1026 33.229 43.16917.082 1.00 42.21 A C ATOM 1733 CE LYS A 1026 33.853 43.995 15.984 1.0043.30 A C ATOM 1734 NZ LYS A 1026 32.833 44.288 14.939 1.00 46.56 A NATOM 1735 C LYS A 1026 36.468 40.065 17.327 1.00 33.00 A C ATOM 1736 OLYS A 1026 37.176 40.116 16.323 1.00 32.10 A O ATOM 1737 N SER A 102736.797 39.368 18.410 1.00 34.41 A N ATOM 1738 CA SER A 1027 38.04238.605 18.491 1.00 34.79 A C ATOM 1739 CB SER A 1027 38.153 37.90919.856 1.00 33.89 A C ATOM 1740 OG SER A 1027 37.889 38.809 20.914 1.0038.74 A O ATOM 1741 C SER A 1027 38.156 37.545 17.391 1.00 34.36 A CATOM 1742 O SER A 1027 39.198 37.413 16.750 1.00 33.83 A O ATOM 1743 NCYS A 1028 37.080 36.790 17.178 1.00 33.80 A N ATOM 1744 CA CYS A 102837.075 35.716 16.182 1.00 32.68 A C ATOM 1745 CB CYS A 1028 36.65034.408 16.850 1.00 32.82 A C ATOM 1746 SG CYS A 1028 35.060 34.53317.704 1.00 33.09 A S ATOM 1747 C CYS A 1028 36.164 35.973 14.982 1.0030.73 A C ATOM 1748 O CYS A 1028 35.772 35.043 14.282 1.00 30.74 A OATOM 1749 N SER A 1029 35.827 37.230 14.741 1.00 29.90 A N ATOM 1750 CASER A 1029 34.959 37.558 13.626 1.00 29.19 A C ATOM 1751 CB SER A 102934.726 39.067 13.567 1.00 28.86 A C ATOM 1752 OG SER A 1029 35.88439.732 13.096 1.00 31.25 A O ATOM 1753 C SER A 1029 35.598 37.086 12.3271.00 28.26 A C ATOM 1754 O SER A 1029 36.762 36.669 12.303 1.00 30.05 AO ATOM 1755 N PRO A 1030 34.834 37.121 11.229 1.00 25.74 A N ATOM 1756CD PRO A 1030 33.369 37.260 11.198 1.00 22.85 A C ATOM 1757 CA PRO A1030 35.350 36.694 9.928 1.00 24.51 A C ATOM 1758 CB PRO A 1030 34.14936.904 9.017 1.00 23.05 A C ATOM 1759 CG PRO A 1030 33.010 36.539 9.9291.00 24.45 A C ATOM 1760 C PRO A 1030 36.605 37.469 9.475 1.00 24.86 A CATOM 1761 O PRO A 1030 37.535 36.898 8.872 1.00 23.18 A O ATOM 1762 NSER A 1031 36.632 38.766 9.768 1.00 24.48 A N ATOM 1763 CA SER A 103137.772 39.609 9.406 1.00 24.82 A C ATOM 1764 CB SER A 1031 37.422 41.0849.609 1.00 21.99 A C ATOM 1765 OG SER A 1031 36.210 41.207 10.327 1.0027.23 A O ATOM 1766 C SER A 1031 39.013 39.245 10.231 1.00 25.14 A CATOM 1767 O SER A 1031 40.072 38.938 9.685 1.00 25.36 A O ATOM 1768 NALA A 1032 38.875 39.279 11.548 1.00 27.52 A N ATOM 1769 CA ALA A 103239.979 38.950 12.435 1.00 28.18 A C ATOM 1770 CB ALA A 1032 39.47438.857 13.876 1.00 27.52 A C ATOM 1771 C ALA A 1032 40.668 37.648 12.0311.00 29.01 A C ATOM 1772 O ALA A 1032 41.877 37.637 11.783 1.00 30.30 AO ATOM 1773 N GLU A 1033 39.905 36.556 11.966 1.00 29.03 A N ATOM 1774CA GLU A 1033 40.458 35.247 11.593 1.00 28.45 A C ATOM 1775 CB GLU A1033 39.354 34.183 11.531 1.00 31.07 A C ATOM 1776 CG GLU A 1033 38.74533.851 12.870 1.00 33.50 A C ATOM 1777 CD GLU A 1033 39.798 33.68513.925 1.00 35.91 A C ATOM 1778 OE1 GLU A 1033 40.810 33.015 13.637 1.0037.80 A O ATOM 1779 OE2 GLU A 1033 39.615 34.220 15.036 1.00 36.97 A OATOM 1780 C GLU A 1033 41.190 35.262 10.260 1.00 26.35 A C ATOM 1781 OGLU A 1033 42.372 34.948 10.186 1.00 25.54 A O ATOM 1782 N PHE A 103440.479 35.610 9.199 1.00 27.44 A N ATOM 1783 CA PHE A 1034 41.083 35.6497.879 1.00 27.26 A C ATOM 1784 CB PHE A 1034 40.080 36.198 6.872 1.0026.93 A C ATOM 1785 CG PHE A 1034 39.129 35.165 6.337 1.00 29.70 A CATOM 1786 CD1 PHE A 1034 37.809 35.493 6.063 1.00 29.12 A C ATOM 1787CD2 PHE A 1034 39.566 33.882 6.055 1.00 28.02 A C ATOM 1788 CE1 PHE A1034 36.947 34.559 5.517 1.00 29.46 A C ATOM 1789 CE2 PHE A 1034 38.70732.950 5.508 1.00 29.09 A C ATOM 1790 CZ PHE A 1034 37.396 33.289 5.2381.00 29.30 A C ATOM 1791 C PHE A 1034 42.323 36.512 7.899 1.00 27.70 A CATOM 1792 O PHE A 1034 43.342 36.168 7.298 1.00 28.43 A O ATOM 1793 NLEU A 1035 42.242 37.635 8.600 1.00 28.83 A N ATOM 1794 CA LEU A 103543.371 38.550 8.668 1.00 31.32 A C ATOM 1795 CB LEU A 1035 42.936 39.8639.326 1.00 30.92 A C ATOM 1796 CG LEU A 1035 43.110 41.158 8.527 1.0029.53 A C ATOM 1797 CD1 LEU A 1035 42.484 41.056 7.144 1.00 27.99 A CATOM 1798 CD2 LEU A 1035 42.468 42.274 9.318 1.00 29.65 A C ATOM 1799 CLEU A 1035 44.560 37.936 9.408 1.00 33.17 A C ATOM 1800 O LEU A 103545.703 38.007 8.938 1.00 31.72 A O ATOM 1801 N ARG A 1036 44.300 37.32210.560 1.00 31.84 A N ATOM 1802 CA ARG A 1036 45.395 36.717 11.292 1.0034.63 A C ATOM 1803 CB ARG A 1036 45.012 36.432 12.746 1.00 34.04 A CATOM 1804 CG ARG A 1036 43.831 35.531 12.933 1.00 36.91 A C ATOM 1805 CDARG A 1036 43.730 35.091 14.385 1.00 36.17 A C ATOM 1806 NE ARG A 103644.811 34.176 14.715 1.00 34.71 A N ATOM 1807 CZ ARG A 1036 44.72132.855 14.611 1.00 33.73 A C ATOM 1808 NH1 ARG A 1036 43.590 32.29814.203 1.00 32.21 A N ATOM 1809 NH2 ARG A 1036 45.775 32.093 14.879 1.0033.32 A N ATOM 1810 C ARG A 1036 45.890 35.441 10.621 1.00 36.65 A CATOM 1811 O ARG A 1036 47.060 35.084 10.752 1.00 38.90 A O ATOM 1812 NMET A 1037 45.014 34.764 9.886 1.00 38.66 A N ATOM 1813 CA MET A 103745.404 33.539 9.207 1.00 40.19 A C ATOM 1814 CB MET A 1037 44.189 32.8948.525 1.00 41.26 A C ATOM 1815 CG MET A 1037 43.389 31.971 9.443 1.0041.69 A C ATOM 1816 SD MET A 1037 41.858 31.301 8.730 1.00 42.48 A SATOM 1817 CE MET A 1037 42.498 30.138 7.523 1.00 42.39 A C ATOM 1818 CMET A 1037 46.516 33.791 8.192 1.00 41.59 A C ATOM 1819 O MET A 103747.477 33.023 8.108 1.00 42.63 A O ATOM 1820 N MET A 1038 46.398 34.8717.428 1.00 43.48 A N ATOM 1821 CA MET A 1038 47.418 35.187 6.433 1.0043.88 A C ATOM 1822 CB MET A 1038 46.753 35.624 5.120 1.00 44.08 A CATOM 1823 CG MET A 1038 45.450 36.379 5.283 1.00 44.10 A C ATOM 1824 SDMET A 1038 44.666 36.794 3.686 1.00 42.80 A S ATOM 1825 CE MET A 103843.115 37.477 4.272 1.00 43.10 A C ATOM 1826 C MET A 1038 48.457 36.2186.897 1.00 44.50 A C ATOM 1827 O MET A 1038 49.252 36.722 6.096 1.0044.74 A O ATOM 1828 N GLY A 1039 48.443 36.508 8.196 1.00 44.49 A N ATOM1829 CA GLY A 1039 49.394 37.434 8.791 1.00 45.60 A C ATOM 1830 C GLY A1039 49.386 38.877 8.331 1.00 46.45 A C ATOM 1831 O GLY A 1039 50.38339.579 8.503 1.00 46.86 A O ATOM 1832 N CYS A 1040 48.265 39.324 7.7681.00 47.04 A N ATOM 1833 CA CYS A 1040 48.124 40.690 7.270 1.00 45.91 AC ATOM 1834 CB CYS A 1040 46.874 40.805 6.406 1.00 44.80 A C ATOM 1835SG CYS A 1040 46.619 42.464 5.760 1.00 44.01 A S ATOM 1836 C CYS A 104048.033 41.715 8.392 1.00 46.80 A C ATOM 1837 O CYS A 1040 47.246 41.5529.321 1.00 45.47 A O ATOM 1838 N GLU A 1041 48.834 42.774 8.299 1.0047.51 A N ATOM 1839 CA GLU A 1041 48.823 43.823 9.314 1.00 49.46 A CATOM 1840 CB GLU A 1041 50.229 44.395 9.504 1.00 49.04 A C ATOM 1841 CGGLU A 1041 51.136 44.225 8.317 1.00 49.42 A C ATOM 1842 CD GLU A 104152.547 44.678 8.612 1.00 50.81 A C ATOM 1843 OE1 GLU A 1041 53.43844.401 7.784 1.00 50.66 A O ATOM 1844 OE2 GLU A 1041 52.765 45.315 9.6701.00 50.52 A O ATOM 1845 C GLU A 1041 47.834 44.929 8.957 1.00 50.58 A CATOM 1846 O GLU A 1041 47.369 45.680 9.822 1.00 50.40 A O ATOM 1847 NARG A 1042 47.522 45.017 7.668 1.00 50.93 A N ATOM 1848 CA ARG A 104246.558 45.985 7.164 1.00 51.11 A C ATOM 1849 CB ARG A 1042 46.623 46.0475.638 1.00 52.02 A C ATOM 1850 CG ARG A 1042 47.953 46.510 5.094 1.0054.33 A C ATOM 1851 CD ARG A 1042 47.964 46.457 3.580 1.00 56.72 A CATOM 1852 NE ARG A 1042 48.896 47.432 3.029 1.00 58.81 A N ATOM 1853 CZARG A 1042 48.728 48.746 3.124 1.00 59.85 A C ATOM 1854 NH1 ARG A 104247.661 49.232 3.746 1.00 59.79 A N ATOM 1855 NH2 ARG A 1042 49.62949.572 2.609 1.00 60.58 A N ATOM 1856 C ARG A 1042 45.177 45.499 7.5831.00 50.01 A C ATOM 1857 O ARG A 1042 44.984 44.308 7.843 1.00 49.66 A OATOM 1858 N ASP A 1043 44.210 46.406 7.644 1.00 48.38 A N ATOM 1859 CAASP A 1043 42.866 46.002 8.031 1.00 46.88 A C ATOM 1860 CB ASP A 104342.072 47.208 8.536 1.00 48.76 A C ATOM 1861 CG ASP A 1043 42.676 47.8159.780 1.00 50.44 A C ATOM 1862 OD1 ASP A 1043 43.032 47.040 10.692 1.0049.73 A O ATOM 1863 OD2 ASP A 1043 42.793 49.061 9.848 1.00 53.87 A OATOM 1864 C ASP A 1043 42.131 45.344 6.869 1.00 44.75 A C ATOM 1865 OASP A 1043 41.085 44.720 7.058 1.00 44.07 A O ATOM 1866 N VAL A 104442.686 45.487 5.669 1.00 43.28 A N ATOM 1867 CA VAL A 1044 42.088 44.9184.461 1.00 42.27 A C ATOM 1868 CB VAL A 1044 41.217 45.960 3.700 1.0039.69 A C ATOM 1869 CG1 VAL A 1044 40.503 45.297 2.552 1.00 38.77 A CATOM 1870 CG2 VAL A 1044 40.219 46.602 4.631 1.00 39.30 A C ATOM 1871 CVAL A 1044 43.219 44.479 3.543 1.00 41.86 A C ATOM 1872 O VAL A 104443.960 45.303 3.018 1.00 42.88 A O ATOM 1873 N PRO A 1045 43.353 43.1703.328 1.00 41.70 A N ATOM 1874 CD PRO A 1045 42.500 42.111 3.901 1.0042.62 A C ATOM 1875 CA PRO A 1045 44.394 42.596 2.477 1.00 41.48 A CATOM 1876 CB PRO A 1045 44.510 41.181 3.013 1.00 42.55 A C ATOM 1877 CGPRO A 1045 43.055 40.839 3.243 1.00 42.55 A C ATOM 1878 C PRO A 104544.017 42.597 1.007 1.00 41.10 A C ATOM 1879 O PRO A 1045 42.840 42.6540.672 1.00 41.90 A O ATOM 1880 N ALA A 1046 45.018 42.532 0.133 1.0040.68 A N ATOM 1881 CA ALA A 1046 44.763 42.478 −1.300 1.00 40.27 A CATOM 1882 CB ALA A 1046 46.063 42.224 −2.060 1.00 38.59 A C ATOM 1883 CALA A 1046 43.797 41.313 −1.500 1.00 40.14 A C ATOM 1884 O ALA A 104643.802 40.359 −0.718 1.00 39.01 A O ATOM 1885 N LEU A 1047 42.973 41.387−2.540 1.00 39.96 A N ATOM 1886 CA LEU A 1047 42.002 40.330 −2.801 1.0039.57 A C ATOM 1887 CB LEU A 1047 40.917 40.840 −3.754 1.00 40.40 A CATOM 1888 CG LEU A 1047 39.964 41.889 −3.172 1.00 41.57 A C ATOM 1889CD1 LEU A 1047 40.729 42.949 −2.374 1.00 41.75 A C ATOM 1890 CD2 LEU A1047 39.193 42.524 −4.306 1.00 41.77 A C ATOM 1891 C LEU A 1047 42.65139.070 −3.364 1.00 39.02 A C ATOM 1892 O LEU A 1047 42.210 37.954 −3.0841.00 37.37 A O ATOM 1893 N CYS A 1048 43.700 39.247 −4.156 1.00 37.99 AN ATOM 1894 CA CYS A 1048 44.390 38.105 −4.735 1.00 39.05 A C ATOM 1895CB CYS A 1048 45.504 38.576 −5.687 1.00 40.67 A C ATOM 1896 SG CYS A1048 46.817 39.620 −4.933 1.00 44.56 A S ATOM 1897 C CYS A 1048 44.97437.254 −3.609 1.00 38.04 A C ATOM 1898 O CYS A 1048 45.072 36.038 −3.7261.00 37.74 A O ATOM 1899 N ARG A 1049 45.337 37.912 −2.512 1.00 37.48 AN ATOM 1900 CA ARG A 1049 45.903 37.260 −1.334 1.00 38.07 A C ATOM 1901CB ARG A 1049 46.426 38.334 −0.385 1.00 41.00 A C ATOM 1902 CG ARG A1049 47.138 37.822 0.848 1.00 44.03 A C ATOM 1903 CD ARG A 1049 47.47238.995 1.746 1.00 49.13 A C ATOM 1904 NE ARG A 1049 48.367 38.655 2.8491.00 52.70 A N ATOM 1905 CZ ARG A 1049 48.742 39.529 3.777 1.00 54.00 AC ATOM 1906 NH1 ARG A 1049 49.559 39.168 4.756 1.00 54.29 A N ATOM 1907NH2 ARG A 1049 48.288 40.775 3.722 1.00 55.55 A N ATOM 1908 C ARG A 104944.845 36.408 −0.616 1.00 36.85 A C ATOM 1909 O ARG A 1049 45.070 35.237−0.297 1.00 35.82 A O ATOM 1910 N LEU A 1050 43.695 37.022 −0.359 1.0033.99 A N ATOM 1911 CA LEU A 1050 42.583 36.357 0.296 1.00 33.03 A CATOM 1912 CB LEU A 1050 41.436 37.352 0.511 1.00 31.26 A C ATOM 1913 CGLEU A 1050 40.191 36.791 1.203 1.00 31.23 A C ATOM 1914 CD1 LEU A 105040.584 36.118 2.516 1.00 31.70 A C ATOM 1915 CD2 LEU A 1050 39.19637.891 1.447 1.00 27.72 A C ATOM 1916 C LEU A 1050 42.110 35.184 −0.5641.00 32.10 A C ATOM 1917 O LEU A 1050 41.851 34.098 −0.050 1.00 29.58 AO ATOM 1918 N LEU A 1051 42.001 35.413 −1.870 1.00 32.63 A N ATOM 1919CA LEU A 1051 41.587 34.376 −2.813 1.00 34.32 A C ATOM 1920 CB LEU A1051 41.476 34.957 −4.226 1.00 33.80 A C ATOM 1921 CG LEU A 1051 41.25533.929 −5.342 1.00 34.32 A C ATOM 1922 CD1 LEU A 1051 39.849 33.357−5.237 1.00 31.96 A C ATOM 1923 CD2 LEU A 1051 41.469 34.582 −6.716 1.0033.65 A C ATOM 1924 C LEU A 1051 42.603 33.233 −2.817 1.00 34.75 A CATOM 1925 O LEU A 1051 42.243 32.065 −2.967 1.00 34.98 A O ATOM 1926 NGLU A 1052 43.875 33.586 −2.663 1.00 35.72 A N ATOM 1927 CA GLU A 105244.958 32.609 −2.631 1.00 36.23 A C ATOM 1928 CB GLU A 1052 46.30433.326 −2.548 1.00 39.64 A C ATOM 1929 CG GLU A 1052 47.475 32.427−2.167 1.00 43.74 A C ATOM 1930 CD GLU A 1052 48.809 33.137 −2.295 1.0046.95 A C ATOM 1931 OE1 GLU A 1052 49.015 34.155 −1.591 1.00 48.67 A OATOM 1932 OE2 GLU A 1052 49.644 32.678 −3.106 1.00 47.66 A O ATOM 1933 CGLU A 1052 44.811 31.692 −1.429 1.00 35.08 A C ATOM 1934 O GLU A 105245.019 30.487 −1.522 1.00 33.30 A O ATOM 1935 N LEU A 1053 44.469 32.281−0.292 1.00 35.01 A N ATOM 1936 CA LEU A 1053 44.285 31.518 0.930 1.0032.96 A C ATOM 1937 CB LEU A 1053 43.964 32.459 2.096 1.00 30.50 A CATOM 1938 CG LEU A 1053 43.745 31.774 3.443 1.00 30.65 A C ATOM 1939 CD1LEU A 1053 45.030 31.079 3.864 1.00 32.92 A C ATOM 1940 CD2 LEU A 105343.321 32.784 4.487 1.00 32.45 A C ATOM 1941 C LEU A 1053 43.144 30.5210.743 1.00 32.04 A C ATOM 1942 O LEU A 1053 43.240 29.378 1.182 1.0032.79 A O ATOM 1943 N LEU A 1054 42.072 30.958 0.085 1.00 31.62 A N ATOM1944 CA LEU A 1054 40.907 30.105 −0.145 1.00 31.95 A C ATOM 1945 CB LEUA 1054 39.682 30.957 −0.527 1.00 30.46 A C ATOM 1946 CG LEU A 105439.007 31.743 0.619 1.00 28.90 A C ATOM 1947 CD1 LEU A 1054 37.99032.716 0.083 1.00 27.05 A C ATOM 1948 CD2 LEU A 1054 38.336 30.776 1.5711.00 28.35 A C ATOM 1949 C LEU A 1054 41.176 29.056 −1.212 1.00 32.04 AC ATOM 1950 O LEU A 1054 40.636 27.951 −1.152 1.00 30.77 A O ATOM 1951 NGLU A 1055 42.022 29.406 −2.178 1.00 34.23 A N ATOM 1952 CA GLU A 105542.391 28.499 −3.261 1.00 35.51 A C ATOM 1953 CB GLU A 1055 43.15729.265 −4.344 1.00 35.87 A C ATOM 1954 CG GLU A 1055 42.246 30.077−5.257 1.00 39.71 A C ATOM 1955 CD GLU A 1055 42.980 30.842 −6.353 1.0039.88 A C ATOM 1956 OE1 GLU A 1055 42.318 31.202 −7.349 1.00 39.86 A OATOM 1957 OE2 GLU A 1055 44.199 31.095 −6.223 1.00 40.73 A O ATOM 1958 CGLU A 1055 43.228 27.321 −2.764 1.00 36.34 A C ATOM 1959 O GLU A 105543.353 26.306 −3.445 1.00 35.49 A O ATOM 1960 N GLU A 1056 43.799 27.456−1.575 1.00 37.58 A N ATOM 1961 CA GLU A 1056 44.615 26.396 −1.014 1.0038.62 A C ATOM 1962 CB GLU A 1056 45.799 26.980 −0.239 1.00 40.75 A CATOM 1963 CG GLU A 1056 46.638 27.967 −1.050 1.00 46.03 A C ATOM 1964 CDGLU A 1056 47.817 28.551 −0.266 1.00 49.39 A C ATOM 1965 OE1 GLU A 105647.625 29.026 0.879 1.00 50.27 A O ATOM 1966 OE2 GLU A 1056 48.94428.544 −0.812 1.00 51.90 A O ATOM 1967 C GLU A 1056 43.776 25.541 −0.0901.00 38.57 A C ATOM 1968 O GLU A 1056 44.303 24.669 0.596 1.00 39.87 A OATOM 1969 N GLY A 1057 42.473 25.803 −0.061 1.00 37.04 A N ATOM 1970 CAGLY A 1057 41.579 25.030 0.784 1.00 36.00 A C ATOM 1971 C GLY A 105741.388 25.534 2.203 1.00 36.34 A C ATOM 1972 O GLY A 1057 40.717 24.8843.007 1.00 37.96 A O ATOM 1973 N GLN A 1058 41.959 26.691 2.520 1.0034.56 A N ATOM 1974 CA GLN A 1058 41.837 27.261 3.855 1.00 33.27 A CATOM 1975 CB GLN A 1058 42.883 28.358 4.032 1.00 34.13 A C ATOM 1976 CGGLN A 1058 44.307 27.852 3.907 1.00 35.03 A C ATOM 1977 CD GLN A 105844.927 27.530 5.250 1.00 36.09 A C ATOM 1978 OE1 GLN A 1058 44.31026.873 6.087 1.00 37.42 A O ATOM 1979 NE2 GLN A 1058 46.159 27.989 5.4611.00 35.08 A N ATOM 1980 C GLN A 1058 40.435 27.820 4.122 1.00 33.23 A CATOM 1981 O GLN A 1058 39.807 28.399 3.236 1.00 33.08 A O ATOM 1982 NARG A 1059 39.951 27.646 5.349 1.00 31.87 A N ATOM 1983 CA ARG A 105938.626 28.123 5.724 1.00 31.24 A C ATOM 1984 CB ARG A 1059 37.595 26.9955.609 1.00 28.73 A C ATOM 1985 CG ARG A 1059 37.471 26.382 4.211 1.0030.52 A C ATOM 1986 CD ARG A 1059 36.676 27.284 3.264 1.00 31.00 A CATOM 1987 NE ARG A 1059 36.415 26.677 1.960 1.00 27.97 A N ATOM 1988 CZARG A 1059 37.266 26.682 0.936 1.00 27.94 A C ATOM 1989 NH1 ARG A 105938.448 27.265 1.046 1.00 24.82 A N ATOM 1990 NH2 ARG A 1059 36.93426.100 −0.210 1.00 28.85 A N ATOM 1991 C ARG A 1059 38.664 28.618 7.1581.00 31.11 A C ATOM 1992 O ARG A 1059 39.686 28.523 7.817 1.00 31.41 A OATOM 1993 N LEU A 1060 37.548 29.162 7.627 1.00 33.19 A N ATOM 1994 CALEU A 1060 37.441 29.660 8.987 1.00 34.25 A C ATOM 1995 CB LEU A 106036.165 30.477 9.142 1.00 32.03 A C ATOM 1996 CG LEU A 1060 36.057 31.8228.416 1.00 34.02 A C ATOM 1997 CD1 LEU A 1060 34.688 32.454 8.726 1.0032.53 A C ATOM 1998 CD2 LEU A 1060 37.182 32.749 8.854 1.00 30.27 A CATOM 1999 C LEU A 1060 37.413 28.517 9.998 1.00 36.03 A C ATOM 2000 OLEU A 1060 36.772 27.495 9.769 1.00 36.83 A O ATOM 2001 N PRO A 106138.112 28.678 11.132 1.00 37.96 A N ATOM 2002 CD PRO A 1061 38.96629.821 11.495 1.00 37.87 A C ATOM 2003 CA PRO A 1061 38.153 27.65212.180 1.00 39.04 A C ATOM 2004 CB PRO A 1061 39.247 28.154 13.110 1.0038.27 A C ATOM 2005 CG PRO A 1061 39.108 29.640 12.998 1.00 38.72 A CATOM 2006 C PRO A 1061 36.821 27.544 12.907 1.00 41.03 A C ATOM 2007 OPRO A 1061 36.318 28.537 13.428 1.00 44.44 A O ATOM 2008 N ALA A 106236.264 26.337 12.943 1.00 41.14 A N ATOM 2009 CA ALA A 1062 34.99726.075 13.615 1.00 41.14 A C ATOM 2010 CB ALA A 1062 34.888 24.59613.941 1.00 40.50 A C ATOM 2011 C ALA A 1062 34.867 26.890 14.894 1.0041.04 A C ATOM 2012 O ALA A 1062 35.752 26.870 15.744 1.00 42.44 A OATOM 2013 N PRO A 1063 33.759 27.627 15.044 1.00 40.13 A N ATOM 2014 CDPRO A 1063 32.615 27.790 14.130 1.00 37.87 A C ATOM 2015 CA PRO A 106333.586 28.426 16.257 1.00 41.05 A C ATOM 2016 CB PRO A 1063 32.26229.153 16.003 1.00 38.84 A C ATOM 2017 CG PRO A 1063 31.540 28.24215.057 1.00 38.22 A C ATOM 2018 C PRO A 1063 33.584 27.547 17.518 1.0042.11 A C ATOM 2019 O PRO A 1063 33.066 26.431 17.513 1.00 41.67 A OATOM 2020 N PRO A 1064 34.190 28.045 18.607 1.00 43.41 A N ATOM 2021 CDPRO A 1064 34.900 29.335 18.645 1.00 42.90 A C ATOM 2022 CA PRO A 106434.301 27.363 19.902 1.00 43.90 A C ATOM 2023 CB PRO A 1064 34.94228.425 20.794 1.00 42.85 A C ATOM 2024 CG PRO A 1064 35.826 29.15219.838 1.00 42.18 A C ATOM 2025 C PRO A 1064 32.986 26.853 20.475 1.0044.26 A C ATOM 2026 O PRO A 1064 32.100 27.641 20.809 1.00 45.70 A OATOM 2027 N ALA A 1065 32.879 25.530 20.589 1.00 43.97 A N ATOM 2028 CAALA A 1065 31.699 24.866 21.141 1.00 44.07 A C ATOM 2029 CB ALA A 106531.305 25.523 22.459 1.00 42.97 A C ATOM 2030 C ALA A 1065 30.508 24.85420.187 1.00 44.37 A C ATOM 2031 O ALA A 1065 29.356 24.964 20.611 1.0045.07 A O ATOM 2032 N CYS A 1066 30.784 24.706 18.900 1.00 43.46 A NATOM 2033 CA CYS A 1066 29.723 24.696 17.909 1.00 43.03 A C ATOM 2034 CBCYS A 1066 30.255 25.251 16.582 1.00 43.32 A C ATOM 2035 SG CYS A 106628.994 25.547 15.320 1.00 45.07 A S ATOM 2036 C CYS A 1066 29.188 23.28417.714 1.00 42.43 A C ATOM 2037 O CYS A 1066 29.952 22.318 17.665 1.0042.66 A O ATOM 2038 N PRO A 1067 27.860 23.144 17.616 1.00 40.86 A NATOM 2039 CD PRO A 1067 26.841 24.185 17.802 1.00 40.79 A C ATOM 2040 CAPRO A 1067 27.236 21.834 17.423 1.00 40.84 A C ATOM 2041 CB PRO A 106725.766 22.185 17.246 1.00 41.20 A C ATOM 2042 CG PRO A 1067 25.61723.370 18.152 1.00 40.13 A C ATOM 2043 C PRO A 1067 27.831 21.147 16.2001.00 40.94 A C ATOM 2044 O PRO A 1067 27.826 21.700 15.096 1.00 42.30 AO ATOM 2045 N ALA A 1068 28.351 19.943 16.409 1.00 39.79 A N ATOM 2046CA ALA A 1068 28.977 19.168 15.344 1.00 39.39 A C ATOM 2047 CB ALA A1068 29.105 17.706 15.779 1.00 37.82 A C ATOM 2048 C ALA A 1068 28.26119.254 13.993 1.00 38.42 A C ATOM 2049 O ALA A 1068 28.881 19.558 12.9701.00 36.38 A O ATOM 2050 N GLU A 1069 26.959 18.985 13.992 1.00 38.56 AN ATOM 2051 CA GLU A 1069 26.185 19.013 12.761 1.00 40.94 A C ATOM 2052CB GLU A 1069 24.825 18.344 12.980 1.00 43.16 A C ATOM 2053 CG GLU A1069 24.115 18.787 14.246 1.00 48.31 A C ATOM 2054 CD GLU A 1069 24.60618.064 15.490 1.00 48.90 A C ATOM 2055 OE1 GLU A 1069 24.303 16.86015.636 1.00 48.25 A O ATOM 2056 OE2 GLU A 1069 25.291 18.704 16.318 1.0050.20 A O ATOM 2057 C GLU A 1069 26.004 20.416 12.170 1.00 40.52 A CATOM 2058 O GLU A 1069 25.711 20.561 10.984 1.00 40.07 A O ATOM 2059 NVAL A 1070 26.182 21.447 12.990 1.00 39.74 A N ATOM 2060 CA VAL A 107026.056 22.822 12.511 1.00 39.24 A C ATOM 2061 CB VAL A 1070 25.89723.811 13.679 1.00 39.84 A C ATOM 2062 CG1 VAL A 1070 26.045 25.22913.167 1.00 41.40 A C ATOM 2063 CG2 VAL A 1070 24.542 23.633 14.337 1.0040.18 A C ATOM 2064 C VAL A 1070 27.307 23.207 11.715 1.00 38.46 A CATOM 2065 O VAL A 1070 27.232 23.876 10.683 1.00 35.39 A O ATOM 2066 NHIS A 1071 28.461 22.774 12.211 1.00 39.05 A N ATOM 2067 CA HIS A 107129.731 23.049 11.561 1.00 38.75 A C ATOM 2068 CB HIS A 1071 30.88022.686 12.506 1.00 39.65 A C ATOM 2069 CG HIS A 1071 32.235 22.96211.939 1.00 40.75 A C ATOM 2070 CD2 HIS A 1071 33.282 22.138 11.693 1.0041.51 A C ATOM 2071 ND1 HIS A 1071 32.618 24.212 11.508 1.00 42.40 A NATOM 2072 CE1 HIS A 1071 33.843 24.147 11.014 1.00 42.63 A C ATOM 2073NE2 HIS A 1071 34.267 22.900 11.115 1.00 43.15 A N ATOM 2074 C HIS A1071 29.847 22.265 10.248 1.00 38.96 A C ATOM 2075 O HIS A 1071 30.52122.696 9.308 1.00 38.24 A O ATOM 2076 N GLU A 1072 29.176 21.119 10.1721.00 38.32 A N ATOM 2077 CA GLU A 1072 29.233 20.318 8.955 1.00 39.59 AC ATOM 2078 CB GLU A 1072 28.687 18.914 9.213 1.00 44.08 A C ATOM 2079CG GLU A 1072 29.130 17.901 8.180 1.00 49.99 A C ATOM 2080 CD GLU A 107229.125 16.493 8.735 1.00 55.49 A C ATOM 2081 OE1 GLU A 1072 28.02015.960 8.998 1.00 57.05 A O ATOM 2082 OE2 GLU A 1072 30.231 15.930 8.9191.00 57.75 A O ATOM 2083 C GLU A 1072 28.458 20.975 7.814 1.00 37.22 A CATOM 2084 O GLU A 1072 28.882 20.927 6.657 1.00 36.12 A O ATOM 2085 NLEU A 1073 27.324 21.586 8.146 1.00 34.76 A N ATOM 2086 CA LEU A 107326.502 22.270 7.156 1.00 34.30 A C ATOM 2087 CB LEU A 1073 25.197 22.7837.793 1.00 33.32 A C ATOM 2088 CG LEU A 1073 24.188 21.723 8.263 1.0032.92 A C ATOM 2089 CD1 LEU A 1073 22.954 22.376 8.870 1.00 32.52 A CATOM 2090 CD2 LEU A 1073 23.802 20.851 7.070 1.00 32.45 A C ATOM 2091 CLEU A 1073 27.281 23.444 6.567 1.00 34.69 A C ATOM 2092 O LEU A 107327.421 23.569 5.347 1.00 34.74 A O ATOM 2093 N MET A 1074 27.806 24.2987.437 1.00 34.59 A N ATOM 2094 CA MET A 1074 28.549 25.441 6.961 1.0033.88 A C ATOM 2095 CB MET A 1074 28.911 26.381 8.113 1.00 33.70 A CATOM 2096 CG MET A 1074 30.006 25.915 9.028 1.00 32.46 A C ATOM 2097 SDMET A 1074 30.443 27.221 10.202 1.00 30.20 A S ATOM 2098 CE MET A 107428.953 27.318 11.178 1.00 24.80 A C ATOM 2099 C MET A 1074 29.790 24.9606.245 1.00 34.28 A C ATOM 2100 O MET A 1074 30.260 25.598 5.309 1.0036.55 A O ATOM 2101 N LYS A 1075 30.313 23.818 6.672 1.00 33.90 A N ATOM2102 CA LYS A 1075 31.498 23.258 6.034 1.00 33.51 A C ATOM 2103 CB LYS A1075 31.914 21.970 6.742 1.00 35.85 A C ATOM 2104 CG LYS A 1075 33.38521.659 6.671 1.00 35.71 A C ATOM 2105 CD LYS A 1075 34.094 22.141 7.9291.00 37.92 A C ATOM 2106 CE LYS A 1075 35.611 22.142 7.732 1.00 39.92 AC ATOM 2107 NZ LYS A 1075 36.041 23.064 6.618 1.00 37.97 A N ATOM 2108 CLYS A 1075 31.150 22.954 4.572 1.00 32.67 A C ATOM 2109 O LYS A 107531.969 23.147 3.688 1.00 34.17 A O ATOM 2110 N LEU A 1076 29.926 22.4764.340 1.00 30.61 A N ATOM 2111 CA LEU A 1076 29.419 22.154 3.004 1.0028.22 A C ATOM 2112 CB LEU A 1076 28.101 21.389 3.127 1.00 27.15 A CATOM 2113 CG LEU A 1076 28.083 20.006 3.787 1.00 27.60 A C ATOM 2114 CD1LEU A 1076 26.637 19.545 3.999 1.00 25.25 A C ATOM 2115 CD2 LEU A 107628.831 19.031 2.911 1.00 24.89 A C ATOM 2116 C LEU A 1076 29.175 23.4092.147 1.00 28.61 A C ATOM 2117 O LEU A 1076 29.316 23.383 0.923 1.0027.41 A O ATOM 2118 N CYS A 1077 28.785 24.502 2.796 1.00 26.68 A N ATOM2119 CA CYS A 1077 28.529 25.746 2.088 1.00 24.29 A C ATOM 2120 CB CYS A1077 27.953 26.794 3.032 1.00 21.98 A C ATOM 2121 SG CYS A 1077 26.29726.455 3.616 1.00 19.81 A S ATOM 2122 C CYS A 1077 29.798 26.301 1.4761.00 24.04 A C ATOM 2123 O CYS A 1077 29.738 27.048 0.500 1.00 23.84 A OATOM 2124 N TRP A 1078 30.951 25.940 2.042 1.00 24.55 A N ATOM 2125 CATRP A 1078 32.224 26.450 1.529 1.00 23.47 A C ATOM 2126 CB TRP A 107833.164 26.849 2.670 1.00 24.02 A C ATOM 2127 CG TRP A 1078 32.570 27.8123.646 1.00 23.46 A C ATOM 2128 CD2 TRP A 1078 32.859 27.895 5.042 1.0023.76 A C ATOM 2129 CE2 TRP A 1078 32.073 28.943 5.571 1.00 23.34 A CATOM 2130 CE3 TRP A 1078 33.705 27.183 5.901 1.00 21.71 A C ATOM 2131CD1 TRP A 1078 31.651 28.789 3.386 1.00 24.07 A C ATOM 2132 NE1 TRP A1078 31.344 29.472 4.537 1.00 24.54 A N ATOM 2133 CZ2 TRP A 1078 32.10729.300 6.916 1.00 21.87 A C ATOM 2134 CZ3 TRP A 1078 33.737 27.538 7.2351.00 22.31 A C ATOM 2135 CH2 TRP A 1078 32.942 28.587 7.730 1.00 22.33 AC ATOM 2136 C TRP A 1078 32.962 25.514 0.594 1.00 23.07 A C ATOM 2137 OTRP A 1078 34.191 25.455 0.609 1.00 21.26 A O ATOM 2138 N ALA A 107932.216 24.790 −0.229 1.00 24.72 A N ATOM 2139 CA ALA A 1079 32.83723.889 −1.190 1.00 26.31 A C ATOM 2140 CB ALA A 1079 31.791 22.931−1.788 1.00 25.35 A C ATOM 2141 C ALA A 1079 33.421 24.768 −2.281 1.0026.85 A C ATOM 2142 O ALA A 1079 32.825 25.766 −2.669 1.00 25.36 A OATOM 2143 N PRO A 1080 34.602 24.410 −2.791 1.00 28.40 A N ATOM 2144 CDPRO A 1080 35.464 23.286 −2.388 1.00 27.17 A C ATOM 2145 CA PRO A 108035.228 25.207 −3.848 1.00 29.11 A C ATOM 2146 CB PRO A 1080 36.37124.318 −4.318 1.00 27.39 A C ATOM 2147 CG PRO A 1080 36.780 23.622−3.072 1.00 27.10 A C ATOM 2148 C PRO A 1080 34.263 25.547 −4.979 1.0030.79 A C ATOM 2149 O PRO A 1080 33.973 26.716 −5.219 1.00 32.38 A OATOM 2150 N SER A 1081 33.767 24.521 −5.667 1.00 31.66 A N ATOM 2151 CASER A 1081 32.851 24.716 −6.791 1.00 31.24 A C ATOM 2152 CB SER A 108132.873 23.504 −7.724 1.00 35.04 A C ATOM 2153 OG SER A 1081 32.00323.698 −8.829 1.00 39.04 A O ATOM 2154 C SER A 1081 31.427 24.958 −6.3451.00 28.44 A C ATOM 2155 O SER A 1081 30.903 24.244 −5.494 1.00 28.65 AO ATOM 2156 N PRO A 1082 30.775 25.968 −6.939 1.00 26.44 A N ATOM 2157CD PRO A 1082 31.403 26.880 −7.908 1.00 25.21 A C ATOM 2158 CA PRO A1082 29.397 26.383 −6.667 1.00 26.31 A C ATOM 2159 CB PRO A 1082 29.18827.519 −7.655 1.00 23.89 A C ATOM 2160 CG PRO A 1082 30.552 28.100−7.783 1.00 24.30 A C ATOM 2161 C PRO A 1082 28.376 25.264 −6.852 1.0028.12 A C ATOM 2162 O PRO A 1082 27.398 25.178 −6.113 1.00 28.72 A OATOM 2163 N GLN A 1083 28.604 24.409 −7.839 1.00 28.62 A N ATOM 2164 CAGLN A 1083 27.691 23.315 −8.095 1.00 31.77 A C ATOM 2165 CB GLN A 108327.953 22.722 −9.477 1.00 36.51 A C ATOM 2166 CG GLN A 1083 29.42522.603 −9.827 1.00 43.60 A C ATOM 2167 CD GLN A 1083 29.670 21.625−10.960 1.00 48.06 A C ATOM 2168 OE1 GLN A 1083 29.004 21.683 −11.9971.00 50.45 A O ATOM 2169 NE2 GLN A 1083 30.633 20.721 −10.771 1.00 50.35A N ATOM 2170 C GLN A 1083 27.805 22.227 −7.040 1.00 31.92 A C ATOM 2171O GLN A 1083 27.016 21.289 −7.031 1.00 30.95 A O ATOM 2172 N ASP A 108428.775 22.350 −6.141 1.00 33.65 A N ATOM 2173 CA ASP A 1084 28.94421.336 −5.101 1.00 35.56 A C ATOM 2174 CB ASP A 1084 30.420 20.927−4.989 1.00 37.26 A C ATOM 2175 CG ASP A 1084 30.863 19.995 −6.113 1.0037.96 A C ATOM 2176 OD1 ASP A 1084 32.049 20.052 −6.502 1.00 39.77 A OATOM 2177 OD2 ASP A 1084 30.037 19.196 −6.598 1.00 38.93 A O ATOM 2178 CASP A 1084 28.406 21.769 −3.733 1.00 34.87 A C ATOM 2179 O ASP A 108428.311 20.954 −2.813 1.00 33.98 A O ATOM 2180 N ARG A 1085 28.057 23.049−3.600 1.00 32.96 A N ATOM 2181 CA ARG A 1085 27.509 23.557 −2.343 1.0029.33 A C ATOM 2182 CB ARG A 1085 27.624 25.072 −2.275 1.00 25.99 A CATOM 2183 CG ARG A 1085 29.028 25.556 −2.474 1.00 25.88 A C ATOM 2184 CDARG A 1085 29.052 27.026 −2.784 1.00 25.19 A C ATOM 2185 NE ARG A 108530.372 27.424 −3.241 1.00 22.90 A N ATOM 2186 CZ ARG A 1085 30.61728.516 −3.949 1.00 23.32 A C ATOM 2187 NH1 ARG A 1085 29.616 29.330−4.282 1.00 20.28 A N ATOM 2188 NH2 ARG A 1085 31.862 28.770 −4.341 1.0022.67 A N ATOM 2189 C ARG A 1085 26.051 23.183 −2.325 1.00 29.39 A CATOM 2190 O ARG A 1085 25.404 23.136 −3.369 1.00 30.36 A O ATOM 2191 NPRO A 1086 25.508 22.908 −1.139 1.00 29.52 A N ATOM 2192 CD PRO A 108626.123 22.945 0.198 1.00 27.74 A C ATOM 2193 CA PRO A 1086 24.097 22.541−1.064 1.00 29.00 A C ATOM 2194 CB PRO A 1086 23.946 22.070 0.375 1.0029.16 A C ATOM 2195 CG PRO A 1086 24.918 22.947 1.101 1.00 29.76 A CATOM 2196 C PRO A 1086 23.218 23.742 −1.373 1.00 29.28 A C ATOM 2197 OPRO A 1086 23.659 24.884 −1.287 1.00 30.82 A O ATOM 2198 N SER A 108721.976 23.475 −1.744 1.00 28.64 A N ATOM 2199 CA SER A 1087 21.04024.538 −2.048 1.00 29.08 A C ATOM 2200 CB SER A 1087 19.990 24.048−3.055 1.00 26.07 A C ATOM 2201 OG SER A 1087 18.954 23.323 −2.414 1.0028.14 A O ATOM 2202 C SER A 1087 20.371 24.936 −0.723 1.00 29.13 A CATOM 2203 O SER A 1087 20.535 24.255 0.292 1.00 30.28 A O ATOM 2204 NPHE A 1088 19.631 26.039 −0.727 1.00 27.78 A N ATOM 2205 CA PHE A 108818.958 26.480 0.476 1.00 27.90 A C ATOM 2206 CB PHE A 1088 18.426 27.9060.289 1.00 27.36 A C ATOM 2207 CG PHE A 1088 19.481 28.974 0.431 1.0028.07 A C ATOM 2208 CD1 PHE A 1088 19.957 29.337 1.690 1.00 25.93 A CATOM 2209 CD2 PHE A 1088 20.032 29.586 −0.696 1.00 25.71 A C ATOM 2210CE1 PHE A 1088 20.960 30.285 1.816 1.00 25.98 A C ATOM 2211 CE2 PHE A1088 21.035 30.532 −0.580 1.00 24.01 A C ATOM 2212 CZ PHE A 1088 21.50430.884 0.675 1.00 24.15 A C ATOM 2213 C PHE A 1088 17.813 25.527 0.8091.00 29.45 A C ATOM 2214 O PHE A 1088 17.482 25.321 1.976 1.00 30.46 A OATOM 2215 N SER A 1089 17.217 24.930 −0.216 1.00 29.59 A N ATOM 2216 CASER A 1089 16.099 24.025 0.007 1.00 30.75 A C ATOM 2217 CB SER A 108915.436 23.665 −1.315 1.00 30.39 A C ATOM 2218 OG SER A 1089 16.27222.786 −2.037 1.00 34.77 A O ATOM 2219 C SER A 1089 16.581 22.758 0.6981.00 31.30 A C ATOM 2220 O SER A 1089 15.834 22.117 1.439 1.00 30.83 A OATOM 2221 N ALA A 1090 17.837 22.405 0.445 1.00 31.74 A N ATOM 2222 CAALA A 1090 18.444 21.227 1.056 1.00 33.23 A C ATOM 2223 CB ALA A 109019.648 20.771 0.228 1.00 32.69 A C ATOM 2224 C ALA A 1090 18.874 21.5072.505 1.00 33.07 A C ATOM 2225 O ALA A 1090 18.610 20.710 3.399 1.0033.17 A O ATOM 2226 N LEU A 1091 19.524 22.644 2.740 1.00 33.22 A N ATOM2227 CA LEU A 1091 19.979 22.993 4.089 1.00 33.26 A C ATOM 2228 CB LEU A1091 20.848 24.252 4.044 1.00 31.95 A C ATOM 2229 CG LEU A 1091 22.17624.091 3.305 1.00 31.49 A C ATOM 2230 CD1 LEU A 1091 22.732 25.436 2.8931.00 29.88 A C ATOM 2231 CD2 LEU A 1091 23.146 23.352 4.208 1.00 32.95 AC ATOM 2232 C LEU A 1091 18.819 23.219 5.047 1.00 33.65 A C ATOM 2233 OLEU A 1091 18.876 22.810 6.210 1.00 33.75 A O ATOM 2234 N GLY A 109217.771 23.869 4.545 1.00 33.60 A N ATOM 2235 CA GLY A 1092 16.597 24.1725.350 1.00 33.92 A C ATOM 2236 C GLY A 1092 16.140 23.084 6.307 1.0035.32 A C ATOM 2237 O GLY A 1092 16.383 23.174 7.514 1.00 33.70 A O ATOM2238 N PRO A 1093 15.463 22.042 5.798 1.00 35.60 A N ATOM 2239 CD PRO A1093 15.256 21.731 4.376 1.00 36.28 A C ATOM 2240 CA PRO A 1093 14.98520.949 6.646 1.00 37.04 A C ATOM 2241 CB PRO A 1093 14.523 19.899 5.6331.00 37.68 A C ATOM 2242 CG PRO A 1093 15.311 20.234 4.383 1.00 37.09 AC ATOM 2243 C PRO A 1093 16.056 20.441 7.610 1.00 38.12 A C ATOM 2244 OPRO A 1093 15.751 20.082 8.750 1.00 38.30 A O ATOM 2245 N GLN A 109417.309 20.417 7.155 1.00 38.45 A N ATOM 2246 CA GLN A 1094 18.422 19.9928.004 1.00 38.71 A C ATOM 2247 CB GLN A 1094 19.751 20.139 7.264 1.0039.86 A C ATOM 2248 CG GLN A 1094 20.135 18.928 6.425 1.00 43.63 A CATOM 2249 CD GLN A 1094 20.575 17.740 7.275 1.00 46.77 A C ATOM 2250 OE1GLN A 1094 19.800 17.213 8.083 1.00 45.34 A O ATOM 2251 NE2 GLN A 109421.831 17.317 7.100 1.00 46.94 A N ATOM 2252 C GLN A 1094 18.442 20.8509.268 1.00 39.49 A C ATOM 2253 O GLN A 1094 18.443 20.331 10.385 1.0039.14 A O ATOM 2254 N LEU A 1095 18.446 22.168 9.087 1.00 40.38 A N ATOM2255 CA LEU A 1095 18.448 23.089 10.220 1.00 40.12 A C ATOM 2256 CB LEUA 1095 18.596 24.533 9.727 1.00 37.84 A C ATOM 2257 CG LEU A 1095 19.98324.906 9.179 1.00 38.91 A C ATOM 2258 CD1 LEU A 1095 19.930 26.219 8.4181.00 37.27 A C ATOM 2259 CD2 LEU A 1095 20.973 24.992 10.324 1.00 37.75A C ATOM 2260 C LEU A 1095 17.180 22.946 11.066 1.00 40.39 A C ATOM 2261O LEU A 1095 17.237 22.991 12.296 1.00 38.60 A O ATOM 2262 N ASP A 109616.036 22.773 10.414 1.00 41.84 A N ATOM 2263 CA ASP A 1096 14.78922.622 11.153 1.00 44.60 A C ATOM 2264 CB ASP A 1096 13.633 22.34710.200 1.00 46.86 A C ATOM 2265 CG ASP A 1096 12.893 23.603 9.813 1.0049.73 A C ATOM 2266 OD1 ASP A 1096 12.144 23.554 8.812 1.00 51.70 A OATOM 2267 OD2 ASP A 1096 13.058 24.635 10.507 1.00 50.84 A O ATOM 2268 CASP A 1096 14.883 21.496 12.172 1.00 44.97 A C ATOM 2269 O ASP A 109614.418 21.637 13.302 1.00 43.90 A O ATOM 2270 N MET A 1097 15.484 20.38111.761 1.00 46.10 A N ATOM 2271 CA MET A 1097 15.649 19.227 12.636 1.0046.72 A C ATOM 2272 CB MET A 1097 16.219 18.041 11.863 1.00 49.78 A CATOM 2273 CG MET A 1097 15.238 17.360 10.932 1.00 51.99 A C ATOM 2274 SDMET A 1097 16.001 15.928 10.169 1.00 55.68 A S ATOM 2275 CE MET A 109716.746 16.676 8.742 1.00 54.91 A C ATOM 2276 C MET A 1097 16.580 19.54813.788 1.00 46.48 A C ATOM 2277 O MET A 1097 16.275 19.246 14.938 1.0047.57 A O ATOM 2278 N LEU A 1098 17.722 20.149 13.478 1.00 45.27 A NATOM 2279 CA LEU A 1098 18.686 20.504 14.508 1.00 45.26 A C ATOM 2280 CBLEU A 1098 19.872 21.240 13.890 1.00 44.97 A C ATOM 2281 CG LEU A 109820.593 20.490 12.767 1.00 44.21 A C ATOM 2282 CD1 LEU A 1098 21.75621.322 12.245 1.00 45.02 A C ATOM 2283 CD2 LEU A 1098 21.084 19.15013.294 1.00 44.66 A C ATOM 2284 C LEU A 1098 18.031 21.383 15.566 1.0046.70 A C ATOM 2285 O LEU A 1098 18.218 21.170 16.768 1.00 46.72 A OATOM 2286 N TRP A 1099 17.261 22.367 15.108 1.00 47.34 A N ATOM 2287 CATRP A 1099 16.568 23.288 16.003 1.00 47.89 A C ATOM 2288 CB TRP A 109915.587 24.157 15.210 1.00 46.51 A C ATOM 2289 CG TRP A 1099 14.76125.053 16.073 1.00 46.41 A C ATOM 2290 CD2 TRP A 1099 13.347 24.97416.274 1.00 46.89 A C ATOM 2291 CE2 TRP A 1099 12.999 25.985 17.190 1.0046.27 A C ATOM 2292 CE3 TRP A 1099 12.341 24.144 15.770 1.00 46.19 A CATOM 2293 CD1 TRP A 1099 15.202 26.085 16.852 1.00 46.39 A C ATOM 2294NE1 TRP A 1099 14.148 26.649 17.528 1.00 44.71 A N ATOM 2295 CZ2 TRP A1099 11.691 26.189 17.610 1.00 46.50 A C ATOM 2296 CZ3 TRP A 1099 11.04324.347 16.189 1.00 45.66 A C ATOM 2297 CH2 TRP A 1099 10.729 25.35917.100 1.00 46.54 A C ATOM 2298 C TRP A 1099 15.824 22.527 17.098 1.0048.58 A C ATOM 2299 O TRP A 1099 15.812 22.943 18.258 1.00 48.53 A OATOM 2300 N SER A 1100 15.210 21.408 16.723 1.00 49.93 A N ATOM 2301 CASER A 1100 14.475 20.578 17.673 1.00 51.25 A C ATOM 2302 CB SER A 110013.238 19.965 16.997 1.00 51.15 A C ATOM 2303 OG SER A 1100 13.58619.037 15.982 1.00 49.25 A O ATOM 2304 C SER A 1100 15.375 19.471 18.2401.00 52.03 A C ATOM 2305 O SER A 1100 15.541 19.416 19.478 1.00 53.12 AO ATOM 2306 OXT SER A 1100 15.915 18.674 17.445 1.00 51.89 A O TER 1 SERA 1100 A ATOM 2307 CB ASP B 813 2.825 23.672 6.637 1.00 41.77 B C ATOM2308 CG ASP B 813 1.930 24.126 7.778 1.00 43.25 B C ATOM 2309 OD1 ASP B813 1.989 23.509 8.863 1.00 45.61 B O ATOM 2310 OD2 ASP B 813 1.16925.103 7.587 1.00 43.25 B O ATOM 2311 C ASP B 813 1.324 21.690 6.5661.00 39.86 B C ATOM 2312 O ASP B 813 0.396 22.265 5.997 1.00 40.64 B OATOM 2313 N ASP B 813 3.241 21.818 5.032 1.00 40.52 B N ATOM 2314 CA ASPB 813 2.754 22.160 6.398 1.00 40.76 B C ATOM 2315 N PRO B 814 1.13320.629 7.357 1.00 38.57 B N ATOM 2316 CD PRO B 814 2.240 19.827 7.9101.00 37.96 B C ATOM 2317 CA PRO B 814 −0.157 20.006 7.657 1.00 36.41 B CATOM 2318 CB PRO B 814 0.233 18.772 8.474 1.00 37.07 B C ATOM 2319 CGPRO B 814 1.617 18.459 8.004 1.00 36.97 B C ATOM 2320 C PRO B 814 −1.12620.888 8.433 1.00 35.03 B C ATOM 2321 O PRO B 814 −0.726 21.746 9.2241.00 34.82 B O ATOM 2322 N THR B 815 −2.408 20.645 8.194 1.00 33.52 B NATOM 2323 CA THR B 815 −3.495 21.344 8.859 1.00 32.14 B C ATOM 2324 CBTHR B 815 −4.327 22.158 7.862 1.00 31.18 B C ATOM 2325 OG1 THR B 815−3.534 23.238 7.352 1.00 30.84 B O ATOM 2326 CG2 THR B 815 −5.563 22.7118.533 1.00 28.45 B C ATOM 2327 C THR B 815 −4.364 20.247 9.461 1.0032.63 B C ATOM 2328 O THR B 815 −5.159 20.484 10.372 1.00 31.96 B O ATOM2329 N ILE B 816 −4.178 19.040 8.932 1.00 33.41 B N ATOM 2330 CA ILE B816 −4.896 17.842 9.352 1.00 33.58 B C ATOM 2331 CB ILE B 816 −5.66017.235 8.164 1.00 35.25 B C ATOM 2332 CG2 ILE B 816 −6.418 15.992 8.5951.00 37.17 B C ATOM 2333 CG1 ILE B 816 −6.647 18.268 7.622 1.00 37.48 BC ATOM 2334 CD1 ILE B 816 −7.728 18.638 8.595 1.00 34.45 B C ATOM 2335 CILE B 816 −3.858 16.846 9.850 1.00 32.05 B C ATOM 2336 O ILE B 816−3.011 16.390 9.087 1.00 34.53 B O ATOM 2337 N PHE B 817 −3.933 16.50511.128 1.00 29.25 B N ATOM 2338 CA PHE B 817 −2.967 15.600 11.729 1.0028.03 B C ATOM 2339 CB PHE B 817 −2.381 16.230 13.002 1.00 26.53 B CATOM 2340 CG PHE B 817 −1.354 17.315 12.743 1.00 22.84 B C ATOM 2341 CD1PHE B 817 0.001 17.017 12.719 1.00 22.76 B C ATOM 2342 CD2 PHE B 817−1.744 18.627 12.537 1.00 20.42 B C ATOM 2343 CE1 PHE B 817 0.949 18.01312.496 1.00 21.47 B C ATOM 2344 CE2 PHE B 817 −0.801 19.628 12.311 1.0021.52 B C ATOM 2345 CZ PHE B 817 0.546 19.319 12.292 1.00 19.38 B C ATOM2346 C PHE B 817 −3.543 14.243 12.069 1.00 28.62 B C ATOM 2347 O PHE B817 −4.620 14.125 12.661 1.00 28.42 B O ATOM 2348 N GLU B 818 −2.80113.212 11.706 1.00 28.25 B N ATOM 2349 CA GLU B 818 −3.231 11.859 11.9761.00 30.35 B C ATOM 2350 CB GLU B 818 −2.673 10.932 10.901 1.00 31.20 BC ATOM 2351 CG GLU B 818 −3.408 9.624 10.807 1.00 33.27 B C ATOM 2352 CDGLU B 818 −2.963 8.817 9.632 1.00 34.34 B C ATOM 2353 OE1 GLU B 818−3.443 7.671 9.498 1.00 35.01 B O ATOM 2354 OE2 GLU B 818 −2.136 9.3348.849 1.00 33.80 B O ATOM 2355 C GLU B 818 −2.740 11.430 13.358 1.0030.11 B C ATOM 2356 O GLU B 818 −1.557 11.591 13.670 1.00 29.23 B O ATOM2357 N GLU B 819 −3.651 10.898 14.178 1.00 28.41 B N ATOM 2358 CA GLU B819 −3.326 10.444 15.536 1.00 29.21 B C ATOM 2359 CB GLU B 819 −4.5609.853 16.228 1.00 27.11 B C ATOM 2360 CG GLU B 819 −5.454 10.856 16.9631.00 26.82 B C ATOM 2361 CD GLU B 819 −4.707 11.618 18.056 1.00 26.05 BC ATOM 2362 OE1 GLU B 819 −3.821 11.016 18.694 1.00 25.30 B O ATOM 2363OE2 GLU B 819 −5.010 12.809 18.282 1.00 22.67 B O ATOM 2364 C GLU B 819−2.186 9.428 15.630 1.00 31.75 B C ATOM 2365 O GLU B 819 −1.368 9.49916.551 1.00 33.63 B O ATOM 2366 N ARG B 820 −2.120 8.485 14.694 1.0032.89 B N ATOM 2367 CA ARG B 820 −1.057 7.488 14.741 1.00 34.85 B C ATOM2368 CB ARG B 820 −1.301 6.394 13.685 1.00 37.02 B C ATOM 2369 CG ARG B820 −0.780 6.690 12.289 1.00 41.86 B C ATOM 2370 CD ARG B 820 0.3335.717 11.892 1.00 46.24 B C ATOM 2371 NE ARG B 820 1.482 5.810 12.7951.00 50.85 B N ATOM 2372 CZ ARG B 820 2.666 5.237 12.587 1.00 51.37 B CATOM 2373 NH1 ARG B 820 2.884 4.516 11.494 1.00 53.33 B N ATOM 2374 NH2ARG B 820 3.637 5.387 13.478 1.00 51.30 B N ATOM 2375 C ARG B 820 0.3498.107 14.571 1.00 35.30 B C ATOM 2376 O ARG B 820 1.371 7.455 14.8191.00 35.40 B O ATOM 2377 N HIS B 821 0.411 9.368 14.165 1.00 32.42 B NATOM 2378 CA HIS B 821 1.706 9.996 13.997 1.00 31.18 B C ATOM 2379 CBHIS B 821 1.756 10.803 12.695 1.00 32.60 B C ATOM 2380 CG HIS B 8211.583 9.969 11.460 1.00 35.70 B C ATOM 2381 CD2 HIS B 821 1.094 10.28210.235 1.00 35.90 B C ATOM 2382 ND1 HIS B 821 1.964 8.645 11.391 1.0037.49 B N ATOM 2383 CE1 HIS B 821 1.715 8.177 10.180 1.00 36.47 B C ATOM2384 NE2 HIS B 821 1.187 9.150 9.461 1.00 37.66 B N ATOM 2385 C HIS B821 2.050 10.887 15.184 1.00 30.63 B C ATOM 2386 O HIS B 821 3.11511.508 15.215 1.00 30.21 B O ATOM 2387 N LEU B 822 1.157 10.955 16.1661.00 28.80 B N ATOM 2388 CA LEU B 822 1.428 11.776 17.339 1.00 29.94 B CATOM 2389 CB LEU B 822 0.172 12.579 17.739 1.00 28.15 B C ATOM 2390 CGLEU B 822 −0.372 13.555 16.676 1.00 28.24 B C ATOM 2391 CD1 LEU B 822−1.490 14.423 17.249 1.00 27.85 B C ATOM 2392 CD2 LEU B 822 0.753 14.44916.184 1.00 27.24 B C ATOM 2393 C LEU B 822 1.935 10.911 18.508 1.0030.54 B C ATOM 2394 O LEU B 822 1.157 10.351 19.269 1.00 29.84 B O ATOM2395 N LYS B 823 3.252 10.794 18.638 1.00 31.98 B N ATOM 2396 CA LYS B823 3.811 9.987 19.715 1.00 32.61 B C ATOM 2397 CB LYS B 823 5.234 9.54619.368 1.00 33.58 B C ATOM 2398 CG LYS B 823 5.295 8.359 18.418 1.0036.00 B C ATOM 2399 CD LYS B 823 4.736 8.690 17.048 1.00 37.37 B C ATOM2400 CE LYS B 823 4.240 7.436 16.336 1.00 37.83 B C ATOM 2401 NZ LYS B823 5.262 6.364 16.216 1.00 40.50 B N ATOM 2402 C LYS B 823 3.809 10.69821.065 1.00 31.17 B C ATOM 2403 O LYS B 823 4.499 11.696 21.255 1.0031.27 B O ATOM 2404 N TYR B 824 3.014 10.178 21.992 1.00 30.97 B N ATOM2405 CA TYR B 824 2.922 10.726 23.335 1.00 33.67 B C ATOM 2406 CB TYR B824 1.984 9.868 24.184 1.00 34.02 B C ATOM 2407 CG TYR B 824 2.06610.155 25.670 1.00 34.31 B C ATOM 2408 CD1 TYR B 824 1.183 11.035 26.2761.00 34.19 B C ATOM 2409 CE1 TYR B 824 1.253 11.302 27.626 1.00 34.94 BC ATOM 2410 CD2 TYR B 824 3.030 9.549 26.463 1.00 36.32 B C ATOM 2411CE2 TYR B 824 3.110 9.814 27.821 1.00 37.02 B C ATOM 2412 CZ TYR B 8242.216 10.692 28.394 1.00 37.15 B C ATOM 2413 OH TYR B 824 2.275 10.96229.746 1.00 39.76 B O ATOM 2414 C TYR B 824 4.299 10.757 24.010 1.0034.77 B C ATOM 2415 O TYR B 824 5.037 9.769 23.988 1.00 31.82 B O ATOM2416 N ILE B 825 4.632 11.885 24.626 1.00 35.64 B N ATOM 2417 CA ILE B825 5.910 12.004 25.305 1.00 36.01 B C ATOM 2418 CB ILE B 825 6.75113.173 24.749 1.00 34.52 B C ATOM 2419 CG2 ILE B 825 8.031 13.325 25.5711.00 34.43 B C ATOM 2420 CG1 ILE B 825 7.083 12.926 23.275 1.00 33.06 BC ATOM 2421 CD1 ILE B 825 8.072 13.922 22.688 1.00 31.39 B C ATOM 2422 CILE B 825 5.711 12.208 26.799 1.00 35.95 B C ATOM 2423 O ILE B 825 6.53711.783 27.605 1.00 35.84 B O ATOM 2424 N SER B 826 4.610 12.853 27.1651.00 36.03 B N ATOM 2425 CA SER B 826 4.303 13.115 28.573 1.00 36.98 B CATOM 2426 CB SER B 826 5.507 13.725 29.300 1.00 36.75 B C ATOM 2427 OGSER B 826 5.831 15.003 28.779 1.00 37.67 B O ATOM 2428 C SER B 826 3.14414.082 28.668 1.00 35.86 B C ATOM 2429 O SER B 826 2.789 14.734 27.6881.00 37.04 B O ATOM 2430 N GLN B 827 2.565 14.179 29.857 1.00 36.30 B NATOM 2431 CA GLN B 827 1.439 15.073 30.087 1.00 36.00 B C ATOM 2432 CBGLN B 827 0.463 14.425 31.073 1.00 37.07 B C ATOM 2433 CG GLN B 827−0.743 13.784 30.402 1.00 42.24 B C ATOM 2434 CD GLN B 827 −1.219 12.53231.120 1.00 46.18 B C ATOM 2435 OE1 GLN B 827 −0.546 11.491 31.104 1.0047.45 B O ATOM 2436 NE2 GLN B 827 −2.382 12.625 31.759 1.00 47.48 B NATOM 2437 C GLN B 827 1.893 16.433 30.609 1.00 34.37 B C ATOM 2438 O GLNB 827 2.720 16.510 31.521 1.00 33.94 B O ATOM 2439 N LEU B 828 1.35017.501 30.023 1.00 32.18 B N ATOM 2440 CA LEU B 828 1.694 18.862 30.4351.00 30.39 B C ATOM 2441 CB LEU B 828 1.616 19.814 29.239 1.00 29.07 B CATOM 2442 CG LEU B 828 2.633 19.544 28.133 1.00 27.77 B C ATOM 2443 CD1LEU B 828 2.337 20.429 26.957 1.00 25.72 B C ATOM 2444 CD2 LEU B 8284.051 19.780 28.654 1.00 25.98 B C ATOM 2445 C LEU B 828 0.829 19.40131.574 1.00 29.13 B C ATOM 2446 O LEU B 828 1.286 20.229 32.356 1.0030.42 B O ATOM 2447 N GLY B 829 −0.412 18.930 31.675 1.00 29.64 B N ATOM2448 CA GLY B 829 −1.303 19.384 32.733 1.00 27.62 B C ATOM 2449 C GLY B829 −2.758 19.513 32.304 1.00 29.05 B C ATOM 2450 O GLY B 829 −3.08319.433 31.115 1.00 29.17 B O ATOM 2451 N LYS B 830 −3.642 19.706 33.2771.00 29.83 B N ATOM 2452 CA LYS B 830 −5.072 19.859 33.018 1.00 29.11 BC ATOM 2453 CB LYS B 830 −5.867 18.796 33.775 1.00 31.52 B C ATOM 2454CG LYS B 830 −7.294 19.234 34.070 1.00 38.23 B C ATOM 2455 CD LYS B 830−8.018 18.309 35.034 1.00 41.99 B C ATOM 2456 CE LYS B 830 −9.305 18.96235.542 1.00 43.97 B C ATOM 2457 NZ LYS B 830 −10.060 18.082 36.480 1.0045.94 B N ATOM 2458 C LYS B 830 −5.516 21.246 33.489 1.00 27.73 B C ATOM2459 O LYS B 830 −5.007 21.744 34.487 1.00 26.97 B O ATOM 2460 N GLY B831 −6.457 21.865 32.774 1.00 25.89 B N ATOM 2461 CA GLY B 831 −6.93723.182 33.153 1.00 23.83 B C ATOM 2462 C GLY B 831 −8.447 23.217 33.3101.00 24.22 B C ATOM 2463 O GLY B 831 −9.044 22.225 33.717 1.00 24.73 B OATOM 2464 N ASN B 832 −9.055 24.353 32.961 1.00 23.96 B N ATOM 2465 CAASN B 832 −10.502 24.580 33.046 1.00 21.93 B C ATOM 2466 CB ASN B 832−10.804 26.075 33.033 1.00 21.24 B C ATOM 2467 CG ASN B 832 −10.37626.770 34.290 1.00 19.88 B C ATOM 2468 OD1 ASN B 832 −10.895 26.47535.363 1.00 18.71 B O ATOM 2469 ND2 ASN B 832 −9.429 27.710 34.171 1.0015.25 B N ATOM 2470 C ASN B 832 −11.351 23.970 31.940 1.00 23.37 B CATOM 2471 O ASN B 832 −12.535 23.717 32.151 1.00 22.56 B O ATOM 2472 NPHE B 833 −10.779 23.772 30.753 1.00 23.17 B N ATOM 2473 CA PHE B 833−11.567 23.228 29.647 1.00 24.16 B C ATOM 2474 CB PHE B 833 −11.79024.303 28.573 1.00 23.51 B C ATOM 2475 CG PHE B 833 −12.414 25.56729.094 1.00 23.24 B C ATOM 2476 CD1 PHE B 833 −11.627 26.641 29.455 1.0023.38 B C ATOM 2477 CD2 PHE B 833 −13.791 25.675 29.242 1.00 22.46 B CATOM 2478 CE1 PHE B 833 −12.198 27.808 29.958 1.00 23.81 B C ATOM 2479CE2 PHE B 833 −14.369 26.842 29.747 1.00 23.47 B C ATOM 2480 CZ PHE B833 −13.572 27.905 30.104 1.00 23.00 B C ATOM 2481 C PHE B 833 −11.00521.973 28.974 1.00 25.60 B C ATOM 2482 O PHE B 833 −11.657 21.397 28.1061.00 25.79 B O ATOM 2483 N GLY B 834 −9.805 21.548 29.360 1.00 24.96 B NATOM 2484 CA GLY B 834 −9.242 20.369 28.746 1.00 24.52 B C ATOM 2485 CGLY B 834 −7.951 19.924 29.390 1.00 27.71 B C ATOM 2486 O GLY B 834−7.689 20.223 30.557 1.00 29.31 B O ATOM 2487 N SER B 835 −7.149 19.18928.626 1.00 27.33 B N ATOM 2488 CA SER B 835 −5.872 18.688 29.096 1.0028.87 B C ATOM 2489 CB SER B 835 −6.027 17.258 29.604 1.00 28.44 B CATOM 2490 OG SER B 835 −6.763 16.488 28.673 1.00 32.42 B O ATOM 2491 CSER B 835 −4.888 18.746 27.939 1.00 29.32 B C ATOM 2492 O SER B 835−5.280 18.656 26.775 1.00 30.81 B O ATOM 2493 N VAL B 836 −3.610 18.89228.263 1.00 28.87 B N ATOM 2494 CA VAL B 836 −2.573 19.005 27.250 1.0027.94 B C ATOM 2495 CB VAL B 836 −1.864 20.358 27.379 1.00 27.26 B CATOM 2496 CG1 VAL B 836 −0.904 20.560 26.221 1.00 27.80 B C ATOM 2497CG2 VAL B 836 −2.902 21.478 27.442 1.00 28.52 B C ATOM 2498 C VAL B 836−1.525 17.915 27.352 1.00 29.07 B C ATOM 2499 O VAL B 836 −1.244 17.41228.437 1.00 30.56 B O ATOM 2500 N GLU B 837 −0.941 17.556 26.213 1.0030.14 B N ATOM 2501 CA GLU B 837 0.101 16.540 26.172 1.00 29.01 B C ATOM2502 CB GLU B 837 −0.432 15.215 25.635 1.00 29.10 B C ATOM 2503 CG GLU B837 −1.601 14.646 26.378 1.00 28.69 B C ATOM 2504 CD GLU B 837 −1.75713.170 26.110 1.00 26.28 B C ATOM 2505 OE1 GLU B 837 −1.559 12.75924.949 1.00 26.70 B O ATOM 2506 OE2 GLU B 837 −2.081 12.427 27.054 1.0025.64 B O ATOM 2507 C GLU B 837 1.213 16.997 25.252 1.00 29.17 B C ATOM2508 O GLU B 837 0.973 17.733 24.293 1.00 27.85 B O ATOM 2509 N LEU B838 2.430 16.552 25.564 1.00 30.14 B N ATOM 2510 CA LEU B 838 3.62016.858 24.769 1.00 30.84 B C ATOM 2511 CB LEU B 838 4.837 17.118 25.6711.00 30.33 B C ATOM 2512 CG LEU B 838 6.222 17.126 24.999 1.00 31.49 B CATOM 2513 CD1 LEU B 838 6.315 18.235 23.951 1.00 31.48 B C ATOM 2514 CD2LEU B 838 7.303 17.315 26.059 1.00 30.64 B C ATOM 2515 C LEU B 838 3.87615.628 23.917 1.00 30.49 B C ATOM 2516 O LEU B 838 4.277 14.587 24.4331.00 32.32 B O ATOM 2517 N CYS B 839 3.624 15.742 22.619 1.00 29.82 B NATOM 2518 CA CYS B 839 3.819 14.627 21.700 1.00 29.62 B C ATOM 2519 CBCYS B 839 2.521 14.304 20.960 1.00 26.21 B C ATOM 2520 SG CYS B 8391.103 14.029 21.990 1.00 25.86 B S ATOM 2521 C CYS B 839 4.867 14.97220.655 1.00 30.35 B C ATOM 2522 O CYS B 839 5.418 16.069 20.646 1.0029.37 B O ATOM 2523 N ARG B 840 5.138 14.023 19.769 1.00 32.26 B N ATOM2524 CA ARG B 840 6.083 14.272 18.692 1.00 35.32 B C ATOM 2525 CB ARG B840 7.361 13.442 18.879 1.00 36.76 B C ATOM 2526 CG ARG B 840 8.40113.640 17.780 1.00 39.60 B C ATOM 2527 CD ARG B 840 9.699 12.899 18.0831.00 42.80 B C ATOM 2528 NE ARG B 840 10.542 13.641 19.019 1.00 44.90 BN ATOM 2529 CZ ARG B 840 11.121 13.129 20.104 1.00 45.26 B C ATOM 2530NH1 ARG B 840 10.964 11.845 20.421 1.00 44.02 B N ATOM 2531 NH2 ARG B840 11.847 13.921 20.883 1.00 44.63 B N ATOM 2532 C ARG B 840 5.39313.908 17.384 1.00 34.75 B C ATOM 2533 O ARG B 840 4.787 12.841 17.2731.00 33.34 B O ATOM 2534 N TYR B 841 5.446 14.817 16.413 1.00 36.29 B NATOM 2535 CA TYR B 841 4.832 14.566 15.116 1.00 39.08 B C ATOM 2536 CBTYR B 841 4.463 15.877 14.407 1.00 38.47 B C ATOM 2537 CG TYR B 8413.756 15.674 13.079 1.00 39.29 B C ATOM 2538 CD1 TYR B 841 2.737 14.73612.950 1.00 38.25 B C ATOM 2539 CE1 TYR B 841 2.092 14.538 11.743 1.0037.76 B C ATOM 2540 CD2 TYR B 841 4.109 16.416 11.956 1.00 39.45 B CATOM 2541 CE2 TYR B 841 3.467 16.228 10.741 1.00 38.84 B C ATOM 2542 CZTYR B 841 2.458 15.285 10.642 1.00 39.62 B C ATOM 2543 OH TYR B 8411.809 15.084 9.441 1.00 40.43 B O ATOM 2544 C TYR B 841 5.890 13.82014.345 1.00 41.24 B C ATOM 2545 O TYR B 841 6.773 14.420 13.753 1.0042.10 B O ATOM 2546 N ASP B 842 5.793 12.497 14.362 1.00 44.63 B N ATOM2547 CA ASP B 842 6.781 11.662 13.711 1.00 46.51 B C ATOM 2548 CB ASP B842 7.449 10.796 14.779 1.00 45.68 B C ATOM 2549 CG ASP B 842 8.81910.324 14.369 1.00 45.45 B C ATOM 2550 OD1 ASP B 842 9.593 11.153 13.8491.00 44.25 B O ATOM 2551 OD2 ASP B 842 9.124 9.130 14.579 1.00 44.55 B OATOM 2552 C ASP B 842 6.237 10.787 12.586 1.00 48.84 B C ATOM 2553 O ASPB 842 6.237 9.558 12.688 1.00 49.65 B O ATOM 2554 N PRO B 843 5.77311.412 11.491 1.00 51.03 B N ATOM 2555 CD PRO B 843 5.703 12.871 11.2951.00 51.92 B C ATOM 2556 CA PRO B 843 5.228 10.700 10.330 1.00 52.68 B CATOM 2557 CB PRO B 843 5.019 11.814 9.310 1.00 52.46 B C ATOM 2558 CGPRO B 843 4.709 12.999 10.165 1.00 52.25 B C ATOM 2559 C PRO B 843 6.1979.628 9.819 1.00 54.74 B C ATOM 2560 O PRO B 843 5.793 8.688 9.141 1.0055.91 B O ATOM 2561 N LEU B 844 7.478 9.780 10.145 1.00 56.20 B N ATOM2562 CA LEU B 844 8.497 8.820 9.730 1.00 58.07 B C ATOM 2563 CB LEU B844 9.699 9.555 9.133 1.00 58.51 B C ATOM 2564 CG LEU B 844 9.416 10.5187.974 1.00 59.43 B C ATOM 2565 CD1 LEU B 844 8.650 9.777 6.893 1.0058.93 B C ATOM 2566 CD2 LEU B 844 8.610 11.715 8.455 1.00 59.39 B C ATOM2567 C LEU B 844 8.941 8.003 10.945 1.00 59.20 B C ATOM 2568 O LEU B 8448.979 8.516 12.060 1.00 60.38 B O ATOM 2569 N GLY B 845 9.274 6.73510.728 1.00 60.38 B N ATOM 2570 CA GLY B 845 9.694 5.882 11.826 1.0060.46 B C ATOM 2571 C GLY B 845 10.727 6.510 12.740 1.00 61.81 B C ATOM2572 O GLY B 845 10.627 6.417 13.966 1.00 62.35 B O ATOM 2573 N ASP B846 11.725 7.149 12.138 1.00 61.41 B N ATOM 2574 CA ASP B 846 12.7967.801 12.880 1.00 61.12 B C ATOM 2575 CB ASP B 846 13.815 8.393 11.9021.00 63.52 B C ATOM 2576 CG ASP B 846 13.163 9.224 10.804 1.00 64.79 B CATOM 2577 OD1 ASP B 846 13.865 9.584 9.833 1.00 65.93 B O ATOM 2578 OD2ASP B 846 11.953 9.520 10.910 1.00 66.12 B O ATOM 2579 C ASP B 84612.252 8.893 13.788 1.00 60.47 B C ATOM 2580 O ASP B 846 11.215 9.47613.501 1.00 61.57 B O ATOM 2581 N ASN B 847 12.958 9.174 14.877 1.0059.01 B N ATOM 2582 CA ASN B 847 12.530 10.199 15.827 1.00 56.87 B CATOM 2583 CB ASN B 847 13.062 9.863 17.214 1.00 58.01 B C ATOM 2584 CGASN B 847 12.536 8.551 17.722 1.00 58.36 B C ATOM 2585 OD1 ASN B 84711.474 8.494 18.341 1.00 58.73 B O ATOM 2586 ND2 ASN B 847 13.265 7.47517.441 1.00 58.76 B N ATOM 2587 C ASN B 847 13.005 11.588 15.442 1.0054.91 B C ATOM 2588 O ASN B 847 13.483 12.343 16.289 1.00 54.35 B O ATOM2589 N THR B 848 12.870 11.924 14.167 1.00 52.24 B N ATOM 2590 CA THR B848 13.299 13.226 13.684 1.00 51.03 B C ATOM 2591 CB THR B 848 13.70413.157 12.214 1.00 50.95 B C ATOM 2592 OG1 THR B 848 12.547 12.87111.419 1.00 50.21 B O ATOM 2593 CG2 THR B 848 14.738 12.069 12.004 1.0050.33 B C ATOM 2594 C THR B 848 12.199 14.272 13.817 1.00 49.92 B C ATOM2595 O THR B 848 12.481 15.465 13.911 1.00 49.66 B O ATOM 2596 N GLY B849 10.950 13.817 13.820 1.00 47.29 B N ATOM 2597 CA GLY B 849 9.81714.722 13.923 1.00 44.59 B C ATOM 2598 C GLY B 849 9.944 15.813 14.9691.00 41.66 B C ATOM 2599 O GLY B 849 10.759 15.708 15.881 1.00 41.89 B OATOM 2600 N ALA B 850 9.125 16.855 14.835 1.00 40.04 B N ATOM 2601 CAALA B 850 9.124 17.993 15.755 1.00 37.64 B C ATOM 2602 CB ALA B 8508.782 19.269 14.993 1.00 37.63 B C ATOM 2603 C ALA B 850 8.163 17.83116.931 1.00 36.65 B C ATOM 2604 O ALA B 850 7.197 17.067 16.869 1.0035.41 B O ATOM 2605 N LEU B 851 8.432 18.566 18.005 1.00 35.80 B N ATOM2606 CA LEU B 851 7.581 18.515 19.189 1.00 35.03 B C ATOM 2607 CB LEU B851 8.384 18.865 20.440 1.00 36.07 B C ATOM 2608 CG LEU B 851 9.62018.013 20.740 1.00 38.49 B C ATOM 2609 CD1 LEU B 851 10.456 18.72121.792 1.00 38.97 B C ATOM 2610 CD2 LEU B 851 9.214 16.630 21.219 1.0038.23 B C ATOM 2611 C LEU B 851 6.429 19.501 19.045 1.00 32.82 B C ATOM2612 O LEU B 851 6.566 20.529 18.386 1.00 32.71 B O ATOM 2613 N VAL B852 5.293 19.179 19.658 1.00 30.52 B N ATOM 2614 CA VAL B 852 4.12420.054 19.619 1.00 28.26 B C ATOM 2615 CB VAL B 852 3.228 19.804 18.3601.00 28.68 B C ATOM 2616 CG1 VAL B 852 3.906 20.344 17.105 1.00 28.83 BC ATOM 2617 CG2 VAL B 852 2.923 18.315 18.212 1.00 26.07 B C ATOM 2618 CVAL B 852 3.251 19.850 20.852 1.00 27.93 B C ATOM 2619 O VAL B 852 3.34418.832 21.537 1.00 27.53 B O ATOM 2620 N ALA B 853 2.407 20.826 21.1471.00 26.02 B N ATOM 2621 CA ALA B 853 1.504 20.680 22.269 1.00 25.71 B CATOM 2622 CB ALA B 853 1.305 21.998 22.946 1.00 25.74 B C ATOM 2623 CALA B 853 0.178 20.181 21.694 1.00 27.28 B C ATOM 2624 O ALA B 853−0.270 20.650 20.642 1.00 26.81 B O ATOM 2625 N VAL B 854 −0.446 19.22322.371 1.00 26.44 B N ATOM 2626 CA VAL B 854 −1.719 18.704 21.897 1.0026.10 B C ATOM 2627 CB VAL B 854 −1.603 17.240 21.464 1.00 24.99 B CATOM 2628 CG1 VAL B 854 −2.890 16.797 20.801 1.00 26.57 B C ATOM 2629CG2 VAL B 854 −0.433 17.074 20.509 1.00 25.76 B C ATOM 2630 C VAL B 854−2.793 18.817 22.971 1.00 26.92 B C ATOM 2631 O VAL B 854 −2.791 18.06823.945 1.00 27.18 B O ATOM 2632 N LYS B 855 −3.709 19.766 22.798 1.0026.33 B N ATOM 2633 CA LYS B 855 −4.775 19.934 23.768 1.00 25.94 B CATOM 2634 CB LYS B 855 −5.015 21.409 24.084 1.00 22.34 B C ATOM 2635 CGLYS B 855 −6.335 21.613 24.811 1.00 23.65 B C ATOM 2636 CD LYS B 855−6.706 23.063 25.021 1.00 19.73 B C ATOM 2637 CE LYS B 855 −5.997 23.68226.197 1.00 17.77 B C ATOM 2638 NZ LYS B 855 −6.896 24.693 26.805 1.0015.49 B N ATOM 2639 C LYS B 855 −6.089 19.321 23.300 1.00 26.94 B C ATOM2640 O LYS B 855 −6.501 19.506 22.159 1.00 26.18 B O ATOM 2641 N GLN B856 −6.732 18.577 24.196 1.00 29.24 B N ATOM 2642 CA GLN B 856 −8.02117.964 23.919 1.00 29.00 B C ATOM 2643 CB GLN B 856 −7.965 16.456 24.1521.00 29.02 B C ATOM 2644 CG GLN B 856 −9.299 15.739 23.913 1.00 31.97 BC ATOM 2645 CD GLN B 856 −9.154 14.220 23.867 1.00 33.49 B C ATOM 2646OE1 GLN B 856 −8.570 13.613 24.764 1.00 37.69 B O ATOM 2647 NE2 GLN B856 −9.682 13.603 22.818 1.00 31.47 B N ATOM 2648 C GLN B 856 −9.02618.598 24.875 1.00 30.25 B C ATOM 2649 O GLN B 856 −8.826 18.596 26.0891.00 30.29 B O ATOM 2650 N LEU B 857 −10.096 19.152 24.320 1.00 32.05 BN ATOM 2651 CA LEU B 857 −11.135 19.793 25.116 1.00 34.93 B C ATOM 2652CB LEU B 857 −11.879 20.828 24.259 1.00 32.54 B C ATOM 2653 CG LEU B 857−11.173 22.161 23.971 1.00 32.83 B C ATOM 2654 CD1 LEU B 857 −9.69921.937 23.781 1.00 34.65 B C ATOM 2655 CD2 LEU B 857 −11.765 22.81722.733 1.00 32.44 B C ATOM 2656 C LEU B 857 −12.133 18.779 25.670 1.0037.68 B C ATOM 2657 O LEU B 857 −12.298 17.689 25.125 1.00 35.98 B OATOM 2658 N GLN B 858 −12.771 19.135 26.778 1.00 41.97 B N ATOM 2659 CAGLN B 858 −13.785 18.285 27.377 1.00 48.02 B C ATOM 2660 CB GLN B 858−14.058 18.705 28.820 1.00 49.27 B C ATOM 2661 CG GLN B 858 −15.10717.856 29.506 1.00 53.78 B C ATOM 2662 CD GLN B 858 −15.374 18.27730.942 1.00 56.64 B C ATOM 2663 OE1 GLN B 858 −14.453 18.366 31.764 1.0057.31 B O ATOM 2664 NE2 GLN B 858 −16.643 18.533 31.254 1.00 56.69 B NATOM 2665 C GLN B 858 −15.009 18.565 26.518 1.00 51.34 B C ATOM 2666 OGLN B 858 −15.540 19.678 26.516 1.00 51.97 B O ATOM 2667 N HIS B 859−15.451 17.564 25.774 1.00 55.49 B N ATOM 2668 CA HIS B 859 −16.58517.750 24.888 1.00 59.37 B C ATOM 2669 CB HIS B 859 −16.117 17.62223.434 1.00 60.01 B C ATOM 2670 CG HIS B 859 −17.057 18.227 22.438 1.0061.60 B C ATOM 2671 CD2 HIS B 859 −16.825 19.001 21.352 1.00 61.93 B CATOM 2672 ND1 HIS B 859 −18.419 18.026 22.482 1.00 62.55 B N ATOM 2673CE1 HIS B 859 −18.987 18.650 21.465 1.00 62.95 B C ATOM 2674 NE2 HIS B859 −18.042 19.248 20.764 1.00 63.01 B N ATOM 2675 C HIS B 859 −17.67016.728 25.172 1.00 61.41 B C ATOM 2676 O HIS B 859 −17.551 15.563 24.7911.00 62.79 B O ATOM 2677 N SER B 860 −18.725 17.160 25.850 1.00 63.19 BN ATOM 2678 CA SER B 860 −19.830 16.262 26.158 1.00 64.59 B C ATOM 2679CB SER B 860 −20.137 16.266 27.658 1.00 65.49 B C ATOM 2680 OG SER B 860−19.100 15.632 28.388 1.00 65.65 B O ATOM 2681 C SER B 860 −21.06116.671 25.369 1.00 65.19 B C ATOM 2682 O SER B 860 −21.907 17.428 25.8471.00 65.42 B O ATOM 2683 N GLY B 861 −21.133 16.161 24.145 1.00 65.17 BN ATOM 2684 CA GLY B 861 −22.241 16.438 23.252 1.00 64.91 B C ATOM 2685C GLY B 861 −21.825 15.917 21.892 1.00 64.88 B C ATOM 2686 O GLY B 861−20.727 15.374 21.771 1.00 65.32 B O ATOM 2687 N PRO B 862 −22.66416.039 20.854 1.00 64.29 B N ATOM 2688 CD PRO B 862 −23.978 16.69620.759 1.00 64.63 B C ATOM 2689 CA PRO B 862 −22.231 15.533 19.547 1.0063.09 B C ATOM 2690 CB PRO B 862 −23.435 15.824 18.649 1.00 63.47 B CATOM 2691 CG PRO B 862 −24.050 17.029 19.291 1.00 63.98 B C ATOM 2692 CPRO B 862 −20.954 16.244 19.082 1.00 61.34 B C ATOM 2693 O PRO B 862−20.909 17.471 18.994 1.00 60.26 B O ATOM 2694 N ASP B 863 −19.91315.464 18.815 1.00 59.65 B N ATOM 2695 CA ASP B 863 −18.641 16.01318.361 1.00 57.84 B C ATOM 2696 CB ASP B 863 −17.621 14.898 18.145 1.0059.72 B C ATOM 2697 CG ASP B 863 −17.906 14.092 16.885 1.00 59.59 B CATOM 2698 OD1 ASP B 863 −19.027 13.543 16.778 1.00 60.44 B O ATOM 2699OD2 ASP B 863 −17.017 14.015 16.007 1.00 58.51 B O ATOM 2700 C ASP B 863−18.911 16.660 17.023 1.00 55.52 B C ATOM 2701 O ASP B 863 −19.63016.097 16.202 1.00 56.67 B O ATOM 2702 N GLN B 864 −18.340 17.833 16.7901.00 50.93 B N ATOM 2703 CA GLN B 864 −18.553 18.496 15.518 1.00 45.49 BC ATOM 2704 CB GLN B 864 −19.307 19.798 15.720 1.00 48.68 B C ATOM 2705CG GLN B 864 −20.798 19.572 15.845 1.00 51.79 B C ATOM 2706 CD GLN B 864−21.292 18.598 14.792 1.00 53.83 B C ATOM 2707 OE1 GLN B 864 −21.02318.775 13.597 1.00 55.56 B O ATOM 2708 NE2 GLN B 864 −22.013 17.56115.224 1.00 52.86 B N ATOM 2709 C GLN B 864 −17.254 18.738 14.782 1.0040.84 B C ATOM 2710 O GLN B 864 −16.640 19.798 14.890 1.00 40.71 B OATOM 2711 N GLN B 865 −16.852 17.725 14.029 1.00 34.97 B N ATOM 2712 CAGLN B 865 −15.629 17.754 13.266 1.00 31.61 B C ATOM 2713 CB GLN B 865−15.589 16.516 12.378 1.00 28.65 B C ATOM 2714 CG GLN B 865 −14.43716.458 11.410 1.00 27.56 B C ATOM 2715 CD GLN B 865 −14.698 17.26510.155 1.00 26.59 B C ATOM 2716 OE1 GLN B 865 −15.741 17.111 9.508 1.0024.08 B O ATOM 2717 NE2 GLN B 865 −13.747 18.126 9.797 1.00 25.55 B NATOM 2718 C GLN B 865 −15.479 19.035 12.445 1.00 30.61 B C ATOM 2719 OGLN B 865 −14.467 19.735 12.552 1.00 28.62 B O ATOM 2720 N ARG B 866−16.490 19.339 11.638 1.00 29.87 B N ATOM 2721 CA ARG B 866 −16.47620.532 10.800 1.00 28.92 B C ATOM 2722 CB ARG B 866 −17.797 20.66810.040 1.00 29.98 B C ATOM 2723 CG ARG B 866 −17.936 19.702 8.876 1.0032.46 B C ATOM 2724 CD ARG B 866 −19.170 20.020 8.056 1.00 31.87 B CATOM 2725 NE ARG B 866 −20.035 18.859 7.879 1.00 34.46 B N ATOM 2726 CZARG B 866 −19.936 17.987 6.881 1.00 33.51 B C ATOM 2727 NH1 ARG B 866−19.005 18.129 5.948 1.00 33.94 B N ATOM 2728 NH2 ARG B 866 −20.78316.974 6.806 1.00 30.60 B N ATOM 2729 C ARG B 866 −16.196 21.805 11.5961.00 27.94 B C ATOM 2730 O ARG B 866 −15.380 22.623 11.182 1.00 25.73 BO ATOM 2731 N ASP B 867 −16.869 21.978 12.730 1.00 29.03 B N ATOM 2732CA ASP B 867 −16.635 23.151 13.566 1.00 30.85 B C ATOM 2733 CB ASP B 867−17.448 23.070 14.859 1.00 32.87 B C ATOM 2734 CG ASP B 867 −18.94223.283 14.630 1.00 36.23 B C ATOM 2735 OD1 ASP B 867 −19.339 24.35214.103 1.00 36.54 B O ATOM 2736 OD2 ASP B 867 −19.726 22.376 14.985 1.0038.32 B O ATOM 2737 C ASP B 867 −15.157 23.296 13.904 1.00 30.96 B CATOM 2738 O ASP B 867 −14.558 24.329 13.599 1.00 31.28 B O ATOM 2739 NPHE B 868 −14.571 22.267 14.526 1.00 32.13 B N ATOM 2740 CA PHE B 868−13.148 22.297 14.894 1.00 31.94 B C ATOM 2741 CB PHE B 868 −12.67520.940 15.446 1.00 29.88 B C ATOM 2742 CG PHE B 868 −13.005 20.70716.896 1.00 27.56 B C ATOM 2743 CD1 PHE B 868 −14.312 20.517 17.306 1.0026.67 B C ATOM 2744 CD2 PHE B 868 −11.999 20.675 17.852 1.00 28.33 B CATOM 2745 CE1 PHE B 868 −14.612 20.301 18.648 1.00 27.39 B C ATOM 2746CE2 PHE B 868 −12.289 20.461 19.196 1.00 27.40 B C ATOM 2747 CZ PHE B868 −13.596 20.275 19.595 1.00 25.66 B C ATOM 2748 C PHE B 868 −12.31222.627 13.662 1.00 32.28 B C ATOM 2749 O PHE B 868 −11.351 23.389 13.7221.00 33.97 B O ATOM 2750 N GLN B 869 −12.688 22.038 12.540 1.00 32.23 BN ATOM 2751 CA GLN B 869 −11.974 22.249 11.291 1.00 32.63 B C ATOM 2752CB GLN B 869 −12.571 21.327 10.223 1.00 33.42 B C ATOM 2753 CG GLN B 869−11.852 21.318 8.896 1.00 38.59 B C ATOM 2754 CD GLN B 869 −10.45420.729 8.970 1.00 42.27 B C ATOM 2755 OE1 GLN B 869 −9.720 20.742 7.9821.00 45.09 B O ATOM 2756 NE2 GLN B 869 −10.078 20.209 10.135 1.00 42.53B N ATOM 2757 C GLN B 869 −12.056 23.713 10.850 1.00 31.04 B C ATOM 2758O GLN B 869 −11.073 24.300 10.398 1.00 31.14 B O ATOM 2759 N ARG B 870−13.232 24.303 11.002 1.00 29.80 B N ATOM 2760 CA ARG B 870 −13.45325.684 10.600 1.00 28.79 B C ATOM 2761 CB ARG B 870 −14.947 26.01610.751 1.00 28.73 B C ATOM 2762 CG ARG B 870 −15.346 27.449 10.417 1.0029.41 B C ATOM 2763 CD ARG B 870 −16.761 27.746 10.889 1.00 26.01 B CATOM 2764 NE ARG B 870 −16.875 27.628 12.338 1.00 24.89 B N ATOM 2765 CZARG B 870 −17.761 26.859 12.960 1.00 26.54 B C ATOM 2766 NH1 ARG B 870−18.624 26.129 12.258 1.00 23.91 B N ATOM 2767 NH2 ARG B 870 −17.78026.815 14.288 1.00 23.42 B N ATOM 2768 C ARG B 870 −12.602 26.657 11.4151.00 28.20 B C ATOM 2769 O ARG B 870 −11.893 27.492 10.857 1.00 27.89 BO ATOM 2770 N GLU B 871 −12.670 26.535 12.735 1.00 28.44 B N ATOM 2771CA GLU B 871 −11.932 27.416 13.629 1.00 29.10 B C ATOM 2772 CB GLU B 871−12.327 27.110 15.073 1.00 28.98 B C ATOM 2773 CG GLU B 871 −13.82127.293 15.330 1.00 27.67 B C ATOM 2774 CD GLU B 871 −14.295 28.70915.029 1.00 30.59 B C ATOM 2775 OE1 GLU B 871 −15.422 28.862 14.501 1.0028.93 B O ATOM 2776 OE2 GLU B 871 −13.542 29.668 15.326 1.00 29.15 B OATOM 2777 C GLU B 871 −10.414 27.353 13.454 1.00 30.42 B C ATOM 2778 OGLU B 871 −9.746 28.386 13.315 1.00 29.98 B O ATOM 2779 N ILE B 872−9.864 26.147 13.448 1.00 30.79 B N ATOM 2780 CA ILE B 872 −8.426 26.00113.283 1.00 32.19 B C ATOM 2781 CB ILE B 872 −8.012 24.524 13.279 1.0033.29 B C ATOM 2782 CG2 ILE B 872 −6.888 24.301 12.305 1.00 34.00 B CATOM 2783 CG1 ILE B 872 −7.572 24.114 14.678 1.00 33.72 B C ATOM 2784CD1 ILE B 872 −6.373 24.849 15.148 1.00 29.33 B C ATOM 2785 C ILE B 872−7.916 26.662 12.012 1.00 32.54 B C ATOM 2786 O ILE B 872 −6.819 27.21511.997 1.00 34.61 B O ATOM 2787 N GLN B 873 −8.696 26.609 10.936 1.0032.00 B N ATOM 2788 CA GLN B 873 −8.253 27.234 9.697 1.00 29.37 B C ATOM2789 CB GLN B 873 −9.112 26.785 8.516 1.00 30.42 B C ATOM 2790 CG GLN B873 −9.011 25.305 8.255 1.00 33.60 B C ATOM 2791 CD GLN B 873 −9.61324.874 6.935 1.00 36.54 B C ATOM 2792 OE1 GLN B 873 −9.545 23.695 6.5841.00 40.58 B O ATOM 2793 NE2 GLN B 873 −10.202 25.820 6.193 1.00 36.08 BN ATOM 2794 C GLN B 873 −8.316 28.741 9.845 1.00 28.83 B C ATOM 2795 OGLN B 873 −7.571 29.471 9.189 1.00 27.50 B O ATOM 2796 N ILE B 874−9.213 29.201 10.714 1.00 26.87 B N ATOM 2797 CA ILE B 874 −9.365 30.62710.971 1.00 26.03 B C ATOM 2798 CB ILE B 874 −10.718 30.939 11.681 1.0025.77 B C ATOM 2799 CG2 ILE B 874 −10.687 32.326 12.277 1.00 25.42 B CATOM 2800 CG1 ILE B 874 −11.874 30.854 10.690 1.00 24.44 B C ATOM 2801CD1 ILE B 874 −13.199 31.183 11.296 1.00 25.79 B C ATOM 2802 C ILE B 874−8.216 31.066 11.875 1.00 27.22 B C ATOM 2803 O ILE B 874 −7.586 32.10611.648 1.00 26.87 B O ATOM 2804 N LEU B 875 −7.947 30.251 12.898 1.0027.62 B N ATOM 2805 CA LEU B 875 −6.886 30.535 13.859 1.00 25.96 B CATOM 2806 CB LEU B 875 −7.024 29.638 15.099 1.00 24.59 B C ATOM 2807 CGLEU B 875 −8.270 29.838 15.983 1.00 24.64 B C ATOM 2808 CD1 LEU B 875−8.328 28.786 17.075 1.00 22.44 B C ATOM 2809 CD2 LEU B 875 −8.24831.208 16.601 1.00 24.13 B C ATOM 2810 C LEU B 875 −5.510 30.377 13.2281.00 26.34 B C ATOM 2811 O LEU B 875 −4.621 31.206 13.439 1.00 27.82 B OATOM 2812 N LYS B 876 −5.328 29.335 12.430 1.00 25.15 B N ATOM 2813 CALYS B 876 −4.034 29.145 11.796 1.00 25.86 B C ATOM 2814 CB LYS B 876−4.012 27.832 11.022 1.00 24.63 B C ATOM 2815 CG LYS B 876 −2.646 27.47710.473 1.00 24.05 B C ATOM 2816 CD LYS B 876 −2.659 26.077 9.898 1.0023.72 B C ATOM 2817 CE LYS B 876 −1.280 25.687 9.445 1.00 23.59 B C ATOM2818 NZ LYS B 876 −1.240 24.405 8.706 1.00 24.88 B N ATOM 2819 C LYS B876 −3.648 30.307 10.866 1.00 26.99 B C ATOM 2820 O LYS B 876 −2.46130.594 10.689 1.00 29.84 B O ATOM 2821 N ALA B 877 −4.634 30.973 10.2691.00 26.24 B N ATOM 2822 CA ALA B 877 −4.350 32.100 9.377 1.00 27.52 B CATOM 2823 CB ALA B 877 −5.592 32.435 8.548 1.00 26.74 B C ATOM 2824 CALA B 877 −3.858 33.352 10.144 1.00 28.24 B C ATOM 2825 O ALA B 877−3.229 34.229 9.569 1.00 27.71 B O ATOM 2826 N LEU B 878 −4.140 33.42811.442 1.00 30.40 B N ATOM 2827 CA LEU B 878 −3.702 34.561 12.266 1.0029.17 B C ATOM 2828 CB LEU B 878 −4.304 34.452 13.656 1.00 27.14 B CATOM 2829 CG LEU B 878 −5.822 34.321 13.719 1.00 27.92 B C ATOM 2830 CD1LEU B 878 −6.218 33.768 15.073 1.00 27.76 B C ATOM 2831 CD2 LEU B 878−6.465 35.663 13.458 1.00 26.98 B C ATOM 2832 C LEU B 878 −2.186 34.52112.383 1.00 29.28 B C ATOM 2833 O LEU B 878 −1.619 33.457 12.610 1.0028.90 B O ATOM 2834 N HIS B 879 −1.536 35.672 12.237 1.00 30.42 B N ATOM2835 CA HIS B 879 −0.081 35.741 12.321 1.00 31.74 B C ATOM 2836 CB HIS B879 0.514 35.780 10.925 1.00 32.65 B C ATOM 2837 CG HIS B 879 0.38634.489 10.186 1.00 37.56 B C ATOM 2838 CD2 HIS B 879 0.520 33.208 10.6021.00 39.16 B C ATOM 2839 ND1 HIS B 879 0.112 34.426 8.837 1.00 39.12 B NATOM 2840 CE1 HIS B 879 0.083 33.163 8.453 1.00 39.56 B C ATOM 2841 NE2HIS B 879 0.328 32.405 9.506 1.00 41.59 B N ATOM 2842 C HIS B 879 0.45936.918 13.125 1.00 32.27 B C ATOM 2843 O HIS B 879 0.257 38.076 12.7621.00 32.06 B O ATOM 2844 N SER B 880 1.165 36.597 14.207 1.00 30.30 B NATOM 2845 CA SER B 880 1.767 37.590 15.091 1.00 30.83 B C ATOM 2846 CBSER B 880 0.720 38.147 16.062 1.00 29.12 B C ATOM 2847 OG SER B 8801.336 38.938 17.063 1.00 25.06 B O ATOM 2848 C SER B 880 2.923 36.96415.882 1.00 31.96 B C ATOM 2849 O SER B 880 2.840 35.818 16.334 1.0032.79 B O ATOM 2850 N ASP B 881 4.003 37.711 16.053 1.00 31.67 B N ATOM2851 CA ASP B 881 5.131 37.172 16.786 1.00 31.34 B C ATOM 2852 CB ASP B881 6.346 38.069 16.642 1.00 34.15 B C ATOM 2853 CG ASP B 881 6.97637.961 15.283 1.00 38.28 B C ATOM 2854 OD1 ASP B 881 8.035 38.584 15.0811.00 41.45 B O ATOM 2855 OD2 ASP B 881 6.414 37.258 14.416 1.00 40.35 BO ATOM 2856 C ASP B 881 4.806 37.010 18.249 1.00 28.71 B C ATOM 2857 OASP B 881 5.532 36.346 18.977 1.00 26.63 B O ATOM 2858 N PHE B 882 3.70937.618 18.681 1.00 26.82 B N ATOM 2859 CA PHE B 882 3.319 37.526 20.0811.00 25.00 B C ATOM 2860 CB PHE B 882 3.045 38.923 20.628 1.00 25.06 B CATOM 2861 CG PHE B 882 4.170 39.886 20.397 1.00 25.00 B C ATOM 2862 CD1PHE B 882 5.431 39.631 20.899 1.00 26.44 B C ATOM 2863 CD2 PHE B 8823.979 41.021 19.631 1.00 27.51 B C ATOM 2864 CE1 PHE B 882 6.491 40.49220.636 1.00 27.79 B C ATOM 2865 CE2 PHE B 882 5.030 41.884 19.365 1.0027.41 B C ATOM 2866 CZ PHE B 882 6.287 41.620 19.866 1.00 25.41 B C ATOM2867 C PHE B 882 2.093 36.630 20.254 1.00 23.95 B C ATOM 2868 O PHE B882 1.238 36.892 21.092 1.00 24.37 B O ATOM 2869 N ILE B 883 2.03335.561 19.463 1.00 23.06 B N ATOM 2870 CA ILE B 883 0.921 34.616 19.4921.00 23.35 B C ATOM 2871 CB ILE B 883 −0.083 34.904 18.339 1.00 25.35 BC ATOM 2872 CG2 ILE B 883 −0.362 33.652 17.546 1.00 25.61 B C ATOM 2873CG1 ILE B 883 −1.378 35.470 18.907 1.00 24.93 B C ATOM 2874 CD1 ILE B883 −1.239 36.865 19.365 1.00 23.61 B C ATOM 2875 C ILE B 883 1.43033.190 19.351 1.00 22.62 B C ATOM 2876 O ILE B 883 2.351 32.917 18.5871.00 19.13 B O ATOM 2877 N VAL B 884 0.842 32.276 20.105 1.00 24.11 B NATOM 2878 CA VAL B 884 1.257 30.881 20.025 1.00 24.99 B C ATOM 2879 CBVAL B 884 0.836 30.129 21.289 1.00 25.13 B C ATOM 2880 CG1 VAL B 8841.339 28.699 21.232 1.00 24.82 B C ATOM 2881 CG2 VAL B 884 1.361 30.85922.520 1.00 27.61 B C ATOM 2882 C VAL B 884 0.595 30.252 18.792 1.0024.61 B C ATOM 2883 O VAL B 884 −0.627 30.199 18.698 1.00 23.23 B O ATOM2884 N LYS B 885 1.415 29.783 17.857 1.00 25.26 B N ATOM 2885 CA LYS B885 0.929 29.198 16.612 1.00 25.39 B C ATOM 2886 CB LYS B 885 2.10028.837 15.702 1.00 25.63 B C ATOM 2887 CG LYS B 885 3.023 29.989 15.3511.00 28.38 B C ATOM 2888 CD LYS B 885 4.276 29.480 14.643 1.00 30.17 B CATOM 2889 CE LYS B 885 5.217 30.615 14.293 1.00 32.49 B C ATOM 2890 NZLYS B 885 4.547 31.591 13.381 1.00 35.37 B N ATOM 2891 C LYS B 885 0.05827.968 16.751 1.00 25.44 B C ATOM 2892 O LYS B 885 0.393 27.036 17.4691.00 26.56 B O ATOM 2893 N TYR B 886 −1.073 27.982 16.063 1.00 25.34 B NATOM 2894 CA TYR B 886 −1.954 26.833 16.045 1.00 25.02 B C ATOM 2895 CBTYR B 886 −3.417 27.277 15.944 1.00 25.04 B C ATOM 2896 CG TYR B 886−4.100 27.564 17.274 1.00 21.78 B C ATOM 2897 CD1 TYR B 886 −4.29126.560 18.220 1.00 20.76 B C ATOM 2898 CE1 TYR B 886 −4.962 26.80919.403 1.00 18.65 B C ATOM 2899 CD2 TYR B 886 −4.597 28.820 17.556 1.0020.53 B C ATOM 2900 CE2 TYR B 886 −5.266 29.075 18.728 1.00 20.17 B CATOM 2901 CZ TYR B 886 −5.447 28.074 19.648 1.00 19.43 B C ATOM 2902 OHTYR B 886 −6.118 28.366 20.815 1.00 17.53 B O ATOM 2903 C TYR B 886−1.508 26.123 14.768 1.00 24.51 B C ATOM 2904 O TYR B 886 −1.266 26.77213.743 1.00 22.88 B O ATOM 2905 N ARG B 887 −1.378 24.803 14.818 1.0024.90 B N ATOM 2906 CA ARG B 887 −0.916 24.070 13.645 1.00 24.72 B CATOM 2907 CB ARG B 887 0.283 23.199 14.016 1.00 25.16 B C ATOM 2908 CGARG B 887 1.551 23.983 14.248 1.00 27.60 B C ATOM 2909 CD ARG B 8872.733 23.042 14.379 1.00 30.25 B C ATOM 2910 NE ARG B 887 2.962 22.28713.154 1.00 31.62 B N ATOM 2911 CZ ARG B 887 3.892 21.349 13.023 1.0032.40 B C ATOM 2912 NH1 ARG B 887 4.674 21.054 14.046 1.00 34.33 B NATOM 2913 NH2 ARG B 887 4.049 20.710 11.869 1.00 33.94 B N ATOM 2914 CARG B 887 −1.946 23.220 12.919 1.00 23.82 B C ATOM 2915 O ARG B 887−1.855 23.047 11.706 1.00 24.22 B O ATOM 2916 N GLY B 888 −2.916 22.68113.649 1.00 23.86 B N ATOM 2917 CA GLY B 888 −3.923 21.852 13.011 1.0022.84 B C ATOM 2918 C GLY B 888 −4.841 21.140 13.984 1.00 23.38 B C ATOM2919 O GLY B 888 −4.868 21.450 15.182 1.00 23.89 B O ATOM 2920 N VAL B889 −5.594 20.181 13.448 1.00 21.47 B N ATOM 2921 CA VAL B 889 −6.54319.373 14.210 1.00 21.70 B C ATOM 2922 CB VAL B 889 −7.998 19.607 13.7251.00 20.93 B C ATOM 2923 CG1 VAL B 889 −8.921 18.534 14.281 1.00 19.14 BC ATOM 2924 CG2 VAL B 889 −8.471 20.966 14.169 1.00 23.06 B C ATOM 2925C VAL B 889 −6.221 17.898 14.012 1.00 21.52 B C ATOM 2926 O VAL B 889−5.950 17.462 12.900 1.00 22.29 B O ATOM 2927 N SER B 890 −6.276 17.11715.080 1.00 22.47 B N ATOM 2928 CA SER B 890 −5.966 15.705 14.945 1.0024.44 B C ATOM 2929 CB SER B 890 −5.233 15.195 16.183 1.00 21.47 B CATOM 2930 OG SER B 890 −6.168 14.893 17.203 1.00 23.05 B O ATOM 2931 CSER B 890 −7.228 14.875 14.745 1.00 26.17 B C ATOM 2932 O SER B 890−8.289 15.185 15.291 1.00 27.00 B O ATOM 2933 N TYR B 891 −7.105 13.82013.948 1.00 27.10 B N ATOM 2934 CA TYR B 891 −8.223 12.926 13.708 1.0027.93 B C ATOM 2935 CB TYR B 891 −8.644 12.987 12.243 1.00 27.86 B CATOM 2936 CG TYR B 891 −9.260 14.312 11.916 1.00 30.15 B C ATOM 2937 CD1TYR B 891 −10.480 14.672 12.447 1.00 31.47 B C ATOM 2938 CE1 TYR B 891−11.015 15.912 12.216 1.00 30.53 B C ATOM 2939 CD2 TYR B 891 −8.59415.231 11.140 1.00 27.69 B C ATOM 2940 CE2 TYR B 891 −9.118 16.46810.905 1.00 28.64 B C ATOM 2941 CZ TYR B 891 −10.329 16.809 11.447 1.0029.64 B C ATOM 2942 OH TYR B 891 −10.851 18.069 11.246 1.00 30.89 B OATOM 2943 C TYR B 891 −7.863 11.506 14.116 1.00 28.23 B C ATOM 2944 OTYR B 891 −6.875 10.943 13.648 1.00 25.30 B O ATOM 2945 N GLY B 892−8.698 10.956 14.992 1.00 30.66 B N ATOM 2946 CA GLY B 892 −8.548 9.61915.539 1.00 35.15 B C ATOM 2947 C GLY B 892 −8.159 8.464 14.652 1.0036.94 B C ATOM 2948 O GLY B 892 −7.194 8.567 13.900 1.00 40.72 B O ATOM2949 N PRO B 893 −8.865 7.326 14.752 1.00 37.28 B N ATOM 2950 CD PRO B893 −8.482 6.075 14.068 1.00 37.20 B C ATOM 2951 CA PRO B 893 −9.9977.096 15.655 1.00 37.62 B C ATOM 2952 CB PRO B 893 −10.583 5.791 15.1351.00 37.35 B C ATOM 2953 CG PRO B 893 −9.338 5.035 14.768 1.00 38.08 B CATOM 2954 C PRO B 893 −9.597 6.973 17.124 1.00 37.60 B C ATOM 2955 O PROB 893 −8.594 7.546 17.585 1.00 37.03 B O ATOM 2956 N GLY B 894 −10.3926.201 17.851 1.00 35.38 B N ATOM 2957 CA GLY B 894 −10.121 6.004 19.2621.00 33.52 B C ATOM 2958 C GLY B 894 −10.552 7.189 20.100 1.00 31.99 B CATOM 2959 O GLY B 894 −11.030 8.188 19.565 1.00 29.77 B O ATOM 2960 NARG B 895 −10.383 7.070 21.417 1.00 32.32 B N ATOM 2961 CA ARG B 895−10.753 8.122 22.365 1.00 30.91 B C ATOM 2962 CB ARG B 895 −10.360 7.72223.797 1.00 32.42 B C ATOM 2963 CG ARG B 895 −11.237 6.645 24.398 1.0035.42 B C ATOM 2964 CD ARG B 895 −10.720 6.093 25.744 1.00 37.59 B CATOM 2965 NE ARG B 895 −10.850 7.020 26.866 1.00 38.06 B N ATOM 2966 CZARG B 895 −9.883 7.830 27.285 1.00 41.12 B C ATOM 2967 NH1 ARG B 895−8.699 7.829 26.676 1.00 40.31 B N ATOM 2968 NH2 ARG B 895 −10.105 8.64128.313 1.00 40.07 B N ATOM 2969 C ARG B 895 −10.109 9.460 22.032 1.0028.48 B C ATOM 2970 O ARG B 895 −10.770 10.496 22.077 1.00 27.31 B OATOM 2971 N GLN B 896 −8.826 9.452 21.695 1.00 26.23 B N ATOM 2972 CAGLN B 896 −8.167 10.711 21.397 1.00 27.50 B C ATOM 2973 CB GLN B 896−6.704 10.671 21.852 1.00 26.61 B C ATOM 2974 CG GLN B 896 −6.539 10.50923.361 1.00 21.98 B C ATOM 2975 CD GLN B 896 −5.128 10.816 23.834 1.0023.58 B C ATOM 2976 OE1 GLN B 896 −4.150 10.290 23.298 1.00 26.22 B OATOM 2977 NE2 GLN B 896 −5.015 11.667 24.845 1.00 21.74 B N ATOM 2978 CGLN B 896 −8.248 11.133 19.941 1.00 28.56 B C ATOM 2979 O GLN B 896−7.594 10.558 19.074 1.00 31.99 B O ATOM 2980 N SER B 897 −9.051 12.15819.679 1.00 28.29 B N ATOM 2981 CA SER B 897 −9.218 12.678 18.327 1.0026.97 B C ATOM 2982 CB SER B 897 −10.161 11.770 17.532 1.00 26.11 B CATOM 2983 OG SER B 897 −10.161 12.129 16.162 1.00 24.03 B O ATOM 2984 CSER B 897 −9.767 14.113 18.357 1.00 26.27 B C ATOM 2985 O SER B 897−10.235 14.587 19.392 1.00 24.86 B O ATOM 2986 N LEU B 898 −9.722 14.79817.219 1.00 25.36 B N ATOM 2987 CA LEU B 898 −10.204 16.170 17.160 1.0026.00 B C ATOM 2988 CB LEU B 898 −11.723 16.216 17.341 1.00 26.02 B CATOM 2989 CG LEU B 898 −12.565 15.882 16.108 1.00 24.07 B C ATOM 2990CD1 LEU B 898 −14.011 15.662 16.510 1.00 23.90 B C ATOM 2991 CD2 LEU B898 −12.459 17.016 15.113 1.00 24.33 B C ATOM 2992 C LEU B 898 −9.53017.007 18.242 1.00 26.30 B C ATOM 2993 O LEU B 898 −10.170 17.830 18.8881.00 28.60 B O ATOM 2994 N ARG B 899 −8.234 16.779 18.437 1.00 25.95 B NATOM 2995 CA ARG B 899 −7.457 17.516 19.425 1.00 24.40 B C ATOM 2996 CBARG B 899 −6.443 16.595 20.114 1.00 22.59 B C ATOM 2997 CG ARG B 899−7.058 15.350 20.727 1.00 22.64 B C ATOM 2998 CD ARG B 899 −6.076 14.63721.641 1.00 23.58 B C ATOM 2999 NE ARG B 899 −4.855 14.240 20.951 1.0023.78 B N ATOM 3000 CZ ARG B 899 −3.763 13.805 21.570 1.00 24.40 B CATOM 3001 NH1 ARG B 899 −2.696 13.461 20.868 1.00 26.08 B N ATOM 3002NH2 ARG B 899 −3.727 13.730 22.890 1.00 23.65 B N ATOM 3003 C ARG B 899−6.731 18.659 18.711 1.00 24.37 B C ATOM 3004 O ARG B 899 −6.476 18.60117.509 1.00 25.32 B O ATOM 3005 N LEU B 900 −6.394 19.693 19.461 1.0022.83 B N ATOM 3006 CA LEU B 900 −5.736 20.848 18.901 1.00 22.29 B CATOM 3007 CB LEU B 900 −6.203 22.095 19.673 1.00 23.06 B C ATOM 3008 CGLEU B 900 −7.727 22.284 19.877 1.00 18.99 B C ATOM 3009 CD1 LEU B 900−8.021 23.367 20.901 1.00 20.49 B C ATOM 3010 CD2 LEU B 900 −8.36922.632 18.564 1.00 20.01 B C ATOM 3011 C LEU B 900 −4.218 20.681 18.9801.00 23.70 B C ATOM 3012 O LEU B 900 −3.663 20.403 20.047 1.00 24.33 B OATOM 3013 N VAL B 901 −3.552 20.839 17.841 1.00 24.29 B N ATOM 3014 CAVAL B 901 −2.102 20.713 17.765 1.00 23.11 B C ATOM 3015 CB VAL B 901−1.679 19.896 16.508 1.00 23.04 B C ATOM 3016 CG1 VAL B 901 −0.17019.702 16.485 1.00 16.20 B C ATOM 3017 CG2 VAL B 901 −2.396 18.53816.500 1.00 21.11 B C ATOM 3018 C VAL B 901 −1.499 22.113 17.677 1.0024.80 B C ATOM 3019 O VAL B 901 −1.844 22.890 16.790 1.00 25.60 B O ATOM3020 N MET B 902 −0.587 22.433 18.587 1.00 26.09 B N ATOM 3021 CA MET B902 0.026 23.752 18.591 1.00 25.58 B C ATOM 3022 CB MET B 902 −0.41224.530 19.822 1.00 26.88 B C ATOM 3023 CG MET B 902 −1.878 24.456 20.1271.00 27.85 B C ATOM 3024 SD MET B 902 −2.092 24.944 21.814 1.00 28.15 BS ATOM 3025 CE MET B 902 −2.056 23.354 22.644 1.00 23.45 B C ATOM 3026 CMET B 902 1.533 23.636 18.650 1.00 25.59 B C ATOM 3027 O MET B 902 2.07222.556 18.912 1.00 24.38 B O ATOM 3028 N GLU B 903 2.205 24.762 18.4201.00 24.65 B N ATOM 3029 CA GLU B 903 3.650 24.798 18.509 1.00 26.30 B CATOM 3030 CB GLU B 903 4.199 26.136 17.987 1.00 25.66 B C ATOM 3031 CGGLU B 903 3.970 27.328 18.910 1.00 27.57 B C ATOM 3032 CD GLU B 9034.572 28.629 18.381 1.00 26.55 B C ATOM 3033 OE1 GLU B 903 5.638 28.58117.728 1.00 25.12 B O ATOM 3034 OE2 GLU B 903 3.980 29.699 18.638 1.0025.41 B O ATOM 3035 C GLU B 903 3.910 24.651 20.010 1.00 26.13 B C ATOM3036 O GLU B 903 3.087 25.068 20.830 1.00 28.56 B O ATOM 3037 N TYR B904 5.039 24.058 20.369 1.00 24.40 B N ATOM 3038 CA TYR B 904 5.38423.840 21.769 1.00 24.74 B C ATOM 3039 CB TYR B 904 5.891 22.409 21.9211.00 23.92 B C ATOM 3040 CG TYR B 904 6.433 22.085 23.289 1.00 24.77 B CATOM 3041 CD1 TYR B 904 5.590 21.959 24.379 1.00 24.64 B C ATOM 3042 CE1TYR B 904 6.084 21.600 25.613 1.00 24.42 B C ATOM 3043 CD2 TYR B 9047.791 21.852 23.480 1.00 24.71 B C ATOM 3044 CE2 TYR B 904 8.291 21.49224.706 1.00 22.58 B C ATOM 3045 CZ TYR B 904 7.435 21.363 25.766 1.0023.33 B C ATOM 3046 OH TYR B 904 7.932 20.953 26.978 1.00 25.34 B O ATOM3047 C TYR B 904 6.433 24.809 22.340 1.00 24.37 B C ATOM 3048 O TYR B904 7.525 24.950 21.780 1.00 23.11 B O ATOM 3049 N LEU B 905 6.09725.470 23.448 1.00 23.71 B N ATOM 3050 CA LEU B 905 7.025 26.394 24.1131.00 23.78 B C ATOM 3051 CB LEU B 905 6.398 27.770 24.306 1.00 23.71 B CATOM 3052 CG LEU B 905 6.535 28.734 23.124 1.00 24.68 B C ATOM 3053 CD1LEU B 905 5.750 28.211 21.936 1.00 22.49 B C ATOM 3054 CD2 LEU B 9056.026 30.119 23.541 1.00 23.69 B C ATOM 3055 C LEU B 905 7.372 25.82325.470 1.00 23.58 B C ATOM 3056 O LEU B 905 6.633 26.026 26.429 1.0024.54 B O ATOM 3057 N PRO B 906 8.513 25.114 25.568 1.00 24.82 B N ATOM3058 CD PRO B 906 9.481 25.084 24.457 1.00 26.24 B C ATOM 3059 CA PRO B906 9.080 24.443 26.743 1.00 26.73 B C ATOM 3060 CB PRO B 906 10.36623.822 26.191 1.00 26.64 B C ATOM 3061 CG PRO B 906 10.787 24.789 25.1681.00 25.89 B C ATOM 3062 C PRO B 906 9.316 25.248 28.024 1.00 28.44 B CATOM 3063 O PRO B 906 9.476 24.663 29.098 1.00 31.05 B O ATOM 3064 N SERB 907 9.338 26.571 27.938 1.00 27.81 B N ATOM 3065 CA SER B 907 9.55227.360 29.143 1.00 25.91 B C ATOM 3066 CB SER B 907 10.091 28.739 28.7931.00 25.32 B C ATOM 3067 OG SER B 907 11.451 28.635 28.422 1.00 25.14 BO ATOM 3068 C SER B 907 8.319 27.486 30.024 1.00 24.89 B C ATOM 3069 OSER B 907 8.420 27.921 31.164 1.00 25.08 B O ATOM 3070 N GLY B 908 7.15327.115 29.504 1.00 24.02 B N ATOM 3071 CA GLY B 908 5.949 27.173 30.3181.00 23.21 B C ATOM 3072 C GLY B 908 5.254 28.513 30.404 1.00 23.91 B CATOM 3073 O GLY B 908 5.668 29.485 29.762 1.00 23.15 B O ATOM 3074 N CYSB 909 4.199 28.565 31.220 1.00 23.69 B N ATOM 3075 CA CYS B 909 3.40529.783 31.391 1.00 24.23 B C ATOM 3076 CB CYS B 909 2.080 29.468 32.0971.00 23.91 B C ATOM 3077 SG CYS B 909 2.192 28.992 33.844 1.00 26.62 B SATOM 3078 C CYS B 909 4.116 30.922 32.116 1.00 25.56 B C ATOM 3079 O CYSB 909 5.124 30.722 32.781 1.00 28.14 B O ATOM 3080 N LEU B 910 3.57532.126 31.994 1.00 25.80 B N ATOM 3081 CA LEU B 910 4.187 33.280 32.6121.00 25.97 B C ATOM 3082 CB LEU B 910 3.703 34.555 31.928 1.00 25.51 B CATOM 3083 CG LEU B 910 4.255 35.889 32.424 1.00 21.94 B C ATOM 3084 CD1LEU B 910 5.764 35.900 32.325 1.00 19.02 B C ATOM 3085 CD2 LEU B 9103.651 37.004 31.588 1.00 21.42 B C ATOM 3086 C LEU B 910 3.841 33.31934.075 1.00 27.73 B C ATOM 3087 O LEU B 910 4.581 33.882 34.872 1.0029.03 B O ATOM 3088 N ARG B 911 2.710 32.718 34.423 1.00 29.17 B N ATOM3089 CA ARG B 911 2.261 32.677 35.804 1.00 30.07 B C ATOM 3090 CB ARG B911 0.955 31.886 35.907 1.00 30.79 B C ATOM 3091 CG ARG B 911 0.36031.832 37.299 1.00 31.95 B C ATOM 3092 CD ARG B 911 0.525 30.472 37.9651.00 35.46 B C ATOM 3093 NE ARG B 911 −0.638 29.607 37.749 1.00 37.85 BN ATOM 3094 CZ ARG B 911 −0.706 28.645 36.831 1.00 37.82 B C ATOM 3095NH1 ARG B 911 0.336 28.414 36.039 1.00 37.46 B N ATOM 3096 NH2 ARG B 911−1.819 27.924 36.696 1.00 34.64 B N ATOM 3097 C ARG B 911 3.329 32.05136.692 1.00 31.19 B C ATOM 3098 O ARG B 911 3.693 32.627 37.711 1.0031.62 B O ATOM 3099 N ASP B 912 3.842 30.886 36.298 1.00 31.73 B N ATOM3100 CA ASP B 912 4.870 30.195 37.081 1.00 32.01 B C ATOM 3101 CB ASP B912 4.969 28.732 36.654 1.00 31.15 B C ATOM 3102 CG ASP B 912 3.68627.962 36.903 1.00 33.95 B C ATOM 3103 OD1 ASP B 912 3.597 26.796 36.4611.00 37.34 B O ATOM 3104 OD2 ASP B 912 2.768 28.515 37.542 1.00 35.80 BO ATOM 3105 C ASP B 912 6.244 30.846 36.946 1.00 32.72 B C ATOM 3106 OASP B 912 7.044 30.842 37.886 1.00 35.14 B O ATOM 3107 N PHE B 913 6.51231.396 35.768 1.00 30.42 B N ATOM 3108 CA PHE B 913 7.781 32.047 35.4931.00 27.92 B C ATOM 3109 CB PHE B 913 7.789 32.552 34.057 1.00 27.63 B CATOM 3110 CG PHE B 913 9.131 32.976 33.575 1.00 24.31 B C ATOM 3111 CD1PHE B 913 10.023 32.041 33.077 1.00 25.48 B C ATOM 3112 CD2 PHE B 9139.498 34.313 33.601 1.00 25.91 B C ATOM 3113 CE1 PHE B 913 11.270 32.42732.604 1.00 25.71 B C ATOM 3114 CE2 PHE B 913 10.741 34.717 33.133 1.0026.67 B C ATOM 3115 CZ PHE B 913 11.632 33.769 32.630 1.00 26.64 B CATOM 3116 C PHE B 913 7.969 33.228 36.439 1.00 28.84 B C ATOM 3117 O PHEB 913 9.021 33.396 37.061 1.00 28.01 B O ATOM 3118 N LEU B 914 6.94134.059 36.525 1.00 28.32 B N ATOM 3119 CA LEU B 914 6.989 35.217 37.3891.00 28.91 B C ATOM 3120 CB LEU B 914 5.641 35.944 37.369 1.00 26.17 B CATOM 3121 CG LEU B 914 5.350 36.893 36.203 1.00 25.31 B C ATOM 3122 CD1LEU B 914 3.852 37.120 36.120 1.00 23.40 B C ATOM 3123 CD2 LEU B 9146.086 38.217 36.391 1.00 21.60 B C ATOM 3124 C LEU B 914 7.351 34.83938.823 1.00 30.29 B C ATOM 3125 O LEU B 914 8.151 35.518 39.461 1.0031.24 B O ATOM 3126 N GLN B 915 6.778 33.750 39.322 1.00 30.78 B N ATOM3127 CA GLN B 915 7.036 33.326 40.695 1.00 31.85 B C ATOM 3128 CB GLN B915 6.017 32.263 41.107 1.00 28.47 B C ATOM 3129 CG GLN B 915 4.59932.792 41.121 1.00 26.27 B C ATOM 3130 CD GLN B 915 3.551 31.705 41.2161.00 27.48 B C ATOM 3131 OE1 GLN B 915 2.756 31.690 42.143 1.00 28.95 BO ATOM 3132 NE2 GLN B 915 3.545 30.791 40.253 1.00 29.42 B N ATOM 3133 CGLN B 915 8.453 32.817 40.943 1.00 32.63 B C ATOM 3134 O GLN B 915 9.05933.123 41.962 1.00 31.97 B O ATOM 3135 N ARG B 916 8.980 32.049 40.0081.00 35.56 B N ATOM 3136 CA ARG B 916 10.318 31.510 40.144 1.00 39.61 BC ATOM 3137 CB ARG B 916 10.593 30.538 39.001 1.00 41.84 B C ATOM 3138CG ARG B 916 12.058 30.148 38.868 1.00 46.16 B C ATOM 3139 CD ARG B 91612.473 29.106 39.908 1.00 51.32 B C ATOM 3140 NE ARG B 916 12.152 27.73839.487 1.00 55.40 B N ATOM 3141 CZ ARG B 916 12.816 27.058 38.554 1.0055.68 B C ATOM 3142 NH1 ARG B 916 13.853 27.607 37.931 1.00 55.82 B NATOM 3143 NH2 ARG B 916 12.441 25.824 38.243 1.00 56.52 B N ATOM 3144 CARG B 916 11.420 32.568 40.162 1.00 41.25 B C ATOM 3145 O ARG B 91612.159 32.697 41.136 1.00 43.76 B O ATOM 3146 N HIS B 917 11.532 33.32339.076 1.00 41.99 B N ATOM 3147 CA HIS B 917 12.578 34.324 38.954 1.0041.77 B C ATOM 3148 CB HIS B 917 13.046 34.404 37.504 1.00 42.37 B CATOM 3149 CG HIS B 917 13.113 33.077 36.817 1.00 43.07 B C ATOM 3150 CD2HIS B 917 14.170 32.340 36.402 1.00 43.65 B C ATOM 3151 ND1 HIS B 91711.987 32.376 36.443 1.00 44.34 B N ATOM 3152 CE1 HIS B 917 12.34731.267 35.822 1.00 44.79 B C ATOM 3153 NE2 HIS B 917 13.666 31.22235.783 1.00 44.29 B N ATOM 3154 C HIS B 917 12.179 35.707 39.419 1.0041.88 B C ATOM 3155 O HIS B 917 12.767 36.696 38.989 1.00 41.51 B O ATOM3156 N ARG B 918 11.184 35.778 40.294 1.00 42.86 B N ATOM 3157 CA ARG B918 10.718 37.060 40.813 1.00 44.49 B C ATOM 3158 CB ARG B 918 9.80236.849 42.017 1.00 45.42 B C ATOM 3159 CG ARG B 918 9.269 38.145 42.6131.00 47.61 B C ATOM 3160 CD ARG B 918 8.412 37.874 43.839 1.00 49.68 B CATOM 3161 NE ARG B 918 7.700 39.061 44.301 1.00 52.10 B N ATOM 3162 CZARG B 918 8.266 40.249 44.470 1.00 55.07 B C ATOM 3163 NH1 ARG B 9189.557 40.410 44.208 1.00 56.53 B N ATOM 3164 NH2 ARG B 918 7.547 41.27444.919 1.00 55.39 B N ATOM 3165 C ARG B 918 11.901 37.900 41.254 1.0045.45 B C ATOM 3166 O ARG B 918 11.879 39.126 41.168 1.00 45.70 B O ATOM3167 N ALA B 919 12.934 37.217 41.730 1.00 46.64 B N ATOM 3168 CA ALA B919 14.135 37.868 42.219 1.00 46.70 B C ATOM 3169 CB ALA B 919 15.13936.816 42.670 1.00 46.55 B C ATOM 3170 C ALA B 919 14.789 38.813 41.2221.00 46.47 B C ATOM 3171 O ALA B 919 15.070 39.959 41.555 1.00 46.26 B OATOM 3172 N ARG B 920 15.020 38.345 40.000 1.00 45.92 B N ATOM 3173 CAARG B 920 15.680 39.180 39.011 1.00 46.71 B C ATOM 3174 CB ARG B 92016.943 38.464 38.500 1.00 48.83 B C ATOM 3175 CG ARG B 920 16.764 36.99238.107 1.00 50.57 B C ATOM 3176 CD ARG B 920 16.469 36.813 36.607 1.0053.25 B C ATOM 3177 NE ARG B 920 16.442 35.401 36.206 1.00 54.08 B NATOM 3178 CZ ARG B 920 16.323 34.966 34.952 1.00 52.53 B C ATOM 3179 NH1ARG B 920 16.216 35.828 33.945 1.00 51.03 B N ATOM 3180 NH2 ARG B 92016.317 33.664 34.707 1.00 50.11 B N ATOM 3181 C ARG B 920 14.833 39.65737.839 1.00 45.45 B C ATOM 3182 O ARG B 920 15.245 39.558 36.688 1.0044.69 B O ATOM 3183 N LEU B 921 13.659 40.204 38.138 1.00 45.01 B N ATOM3184 CA LEU B 921 12.759 40.714 37.102 1.00 44.34 B C ATOM 3185 CB LEU B921 11.623 39.720 36.840 1.00 44.36 B C ATOM 3186 CG LEU B 921 11.90038.396 36.128 1.00 44.22 B C ATOM 3187 CD1 LEU B 921 10.599 37.62035.958 1.00 44.74 B C ATOM 3188 CD2 LEU B 921 12.511 38.669 34.775 1.0045.69 B C ATOM 3189 C LEU B 921 12.167 42.055 37.539 1.00 43.53 B C ATOM3190 O LEU B 921 11.150 42.097 38.237 1.00 44.06 B O ATOM 3191 N ASP B922 12.799 43.147 37.120 1.00 42.34 B N ATOM 3192 CA ASP B 922 12.33544.477 37.499 1.00 41.85 B C ATOM 3193 CB ASP B 922 13.462 45.511 37.3391.00 41.06 B C ATOM 3194 CG ASP B 922 13.976 45.614 35.909 1.00 42.29 BC ATOM 3195 OD1 ASP B 922 13.142 45.659 34.975 1.00 39.58 B O ATOM 3196OD2 ASP B 922 15.219 45.666 35.730 1.00 43.31 B O ATOM 3197 C ASP B 92211.106 44.943 36.731 1.00 39.87 B C ATOM 3198 O ASP B 922 10.672 44.30635.781 1.00 41.23 B O ATOM 3199 N ALA B 923 10.552 46.068 37.158 1.0037.59 B N ATOM 3200 CA ALA B 923 9.376 46.629 36.523 1.00 36.35 B C ATOM3201 CB ALA B 923 9.017 47.950 37.187 1.00 35.54 B C ATOM 3202 C ALA B923 9.553 46.824 35.017 1.00 35.68 B C ATOM 3203 O ALA B 923 8.58846.730 34.260 1.00 35.30 B O ATOM 3204 N SER B 924 10.775 47.097 34.5741.00 33.91 B N ATOM 3205 CA SER B 924 10.991 47.290 33.151 1.00 33.74 BC ATOM 3206 CB SER B 924 12.465 47.551 32.859 1.00 34.61 B C ATOM 3207OG SER B 924 12.840 48.836 33.318 1.00 40.21 B O ATOM 3208 C SER B 92410.523 46.061 32.390 1.00 33.14 B C ATOM 3209 O SER B 924 9.803 46.16331.395 1.00 32.57 B O ATOM 3210 N ARG B 925 10.931 44.899 32.876 1.0030.83 B N ATOM 3211 CA ARG B 925 10.552 43.653 32.259 1.00 31.63 B CATOM 3212 CB ARG B 925 11.199 42.489 33.003 1.00 33.57 B C ATOM 3213 CGARG B 925 10.900 41.147 32.394 1.00 35.20 B C ATOM 3214 CD ARG B 92512.156 40.548 31.836 1.00 39.12 B C ATOM 3215 NE ARG B 925 12.823 41.46130.920 1.00 41.44 B N ATOM 3216 CZ ARG B 925 14.029 41.240 30.416 1.0042.69 B C ATOM 3217 NH1 ARG B 925 14.576 42.117 29.585 1.00 43.07 B NATOM 3218 NH2 ARG B 925 14.685 40.138 30.753 1.00 41.67 B N ATOM 3219 CARG B 925 9.035 43.493 32.286 1.00 31.85 B C ATOM 3220 O ARG B 925 8.41543.165 31.270 1.00 30.05 B O ATOM 3221 N LEU B 926 8.442 43.723 33.4571.00 30.42 B N ATOM 3222 CA LEU B 926 6.998 43.589 33.614 1.00 28.04 B CATOM 3223 CB LEU B 926 6.570 44.056 35.002 1.00 27.26 B C ATOM 3224 CGLEU B 926 7.230 43.348 36.185 1.00 28.68 B C ATOM 3225 CD1 LEU B 9266.539 43.811 37.487 1.00 26.24 B C ATOM 3226 CD2 LEU B 926 7.119 41.81936.004 1.00 24.28 B C ATOM 3227 C LEU B 926 6.285 44.412 32.551 1.0027.32 B C ATOM 3228 O LEU B 926 5.294 43.971 31.969 1.00 27.38 B O ATOM3229 N LEU B 927 6.806 45.610 32.302 1.00 25.79 B N ATOM 3230 CA LEU B927 6.239 46.509 31.305 1.00 25.06 B C ATOM 3231 CB LEU B 927 6.82947.921 31.474 1.00 22.03 B C ATOM 3232 CG LEU B 927 6.221 48.706 32.6501.00 20.16 B C ATOM 3233 CD1 LEU B 927 6.929 50.021 32.861 1.00 19.40 BC ATOM 3234 CD2 LEU B 927 4.742 48.949 32.363 1.00 21.09 B C ATOM 3235 CLEU B 927 6.488 45.959 29.897 1.00 25.65 B C ATOM 3236 O LEU B 927 5.66046.115 28.996 1.00 25.31 B O ATOM 3237 N LEU B 928 7.622 45.298 29.7141.00 26.41 B N ATOM 3238 CA LEU B 928 7.922 44.693 28.429 1.00 27.69 B CATOM 3239 CB LEU B 928 9.310 44.038 28.452 1.00 27.36 B C ATOM 3240 CGLEU B 928 9.829 43.541 27.093 1.00 29.18 B C ATOM 3241 CD1 LEU B 9289.870 44.697 26.100 1.00 26.86 B C ATOM 3242 CD2 LEU B 928 11.220 42.93027.259 1.00 28.41 B C ATOM 3243 C LEU B 928 6.840 43.635 28.141 1.0027.69 B C ATOM 3244 O LEU B 928 6.178 43.695 27.109 1.00 29.81 B O ATOM3245 N TYR B 929 6.649 42.685 29.059 1.00 26.62 B N ATOM 3246 CA TYR B929 5.646 41.634 28.873 1.00 25.73 B C ATOM 3247 CB TYR B 929 5.57040.676 30.078 1.00 24.73 B C ATOM 3248 CG TYR B 929 6.863 39.964 30.4231.00 25.65 B C ATOM 3249 CD1 TYR B 929 7.710 39.488 29.428 1.00 26.25 BC ATOM 3250 CE1 TYR B 929 8.900 38.847 29.749 1.00 26.35 B C ATOM 3251CD2 TYR B 929 7.241 39.771 31.750 1.00 25.40 B C ATOM 3252 CE2 TYR B 9298.421 39.131 32.077 1.00 23.77 B C ATOM 3253 CZ TYR B 929 9.245 38.67531.077 1.00 26.10 B C ATOM 3254 OH TYR B 929 10.427 38.057 31.394 1.0026.76 B O ATOM 3255 C TYR B 929 4.270 42.236 28.676 1.00 24.74 B C ATOM3256 O TYR B 929 3.439 41.656 27.995 1.00 23.60 B O ATOM 3257 N SER B930 4.029 43.391 29.289 1.00 25.64 B N ATOM 3258 CA SER B 930 2.73044.052 29.183 1.00 26.06 B C ATOM 3259 CB SER B 930 2.622 45.176 30.2131.00 26.82 B C ATOM 3260 OG SER B 930 2.832 44.674 31.525 1.00 28.96 B OATOM 3261 C SER B 930 2.512 44.600 27.782 1.00 25.97 B C ATOM 3262 O SERB 930 1.434 44.454 27.210 1.00 26.37 B O ATOM 3263 N SER B 931 3.55045.208 27.221 1.00 26.24 B N ATOM 3264 CA SER B 931 3.472 45.768 25.8771.00 24.72 B C ATOM 3265 CB SER B 931 4.746 46.562 25.559 1.00 25.41 B CATOM 3266 OG SER B 931 4.663 47.190 24.288 1.00 25.63 B O ATOM 3267 CSER B 931 3.272 44.671 24.829 1.00 22.71 B C ATOM 3268 O SER B 931 2.44044.804 23.937 1.00 22.21 B O ATOM 3269 N GLN B 932 4.043 43.594 24.9261.00 21.13 B N ATOM 3270 CA GLN B 932 3.922 42.501 23.967 1.00 20.19 B CATOM 3271 CB GLN B 932 5.018 41.469 24.195 1.00 18.59 B C ATOM 3272 CGGLN B 932 6.417 42.034 24.201 1.00 16.41 B C ATOM 3273 CD GLN B 9327.450 40.960 24.447 1.00 18.92 B C ATOM 3274 OE1 GLN B 932 7.173 39.96325.111 1.00 19.34 B O ATOM 3275 NE2 GLN B 932 8.659 41.161 23.928 1.0020.97 B N ATOM 3276 C GLN B 932 2.552 41.830 24.062 1.00 20.13 B C ATOM3277 O GLN B 932 1.987 41.438 23.052 1.00 20.51 B O ATOM 3278 N ILE B933 2.014 41.708 25.272 1.00 19.68 B N ATOM 3279 CA ILE B 933 0.71441.087 25.452 1.00 20.83 B C ATOM 3280 CB ILE B 933 0.396 40.865 26.9571.00 20.65 B C ATOM 3281 CG2 ILE B 933 −1.099 40.537 27.156 1.00 18.30 BC ATOM 3282 CG1 ILE B 933 1.274 39.731 27.506 1.00 17.48 B C ATOM 3283CD1 ILE B 933 1.297 39.640 29.005 1.00 14.75 B C ATOM 3284 C ILE B 933−0.330 41.997 24.825 1.00 23.98 B C ATOM 3285 O ILE B 933 −1.262 41.53024.165 1.00 27.92 B O ATOM 3286 N CYS B 934 −0.162 43.302 25.009 1.0024.95 B N ATOM 3287 CA CYS B 934 −1.096 44.271 24.450 1.00 23.96 B CATOM 3288 CB CYS B 934 −0.771 45.675 24.962 1.00 22.48 B C ATOM 3289 SGCYS B 934 −2.047 46.909 24.612 1.00 26.90 B S ATOM 3290 C CYS B 934−1.027 44.258 22.927 1.00 23.61 B C ATOM 3291 O CYS B 934 −2.050 44.29122.236 1.00 21.24 B O ATOM 3292 N LYS B 935 0.189 44.212 22.401 1.0025.11 B N ATOM 3293 CA LYS B 935 0.378 44.212 20.957 1.00 25.85 B C ATOM3294 CB LYS B 935 1.878 44.169 20.629 1.00 28.60 B C ATOM 3295 CG LYS B935 2.217 44.378 19.162 1.00 31.12 B C ATOM 3296 CD LYS B 935 1.62845.673 18.661 1.00 36.08 B C ATOM 3297 CE LYS B 935 1.778 45.817 17.1591.00 37.38 B C ATOM 3298 NZ LYS B 935 0.958 46.965 16.669 1.00 39.57 B NATOM 3299 C LYS B 935 −0.356 43.008 20.370 1.00 25.95 B C ATOM 3300 OLYS B 935 −1.099 43.147 19.403 1.00 26.64 B O ATOM 3301 N GLY B 936−0.176 41.840 20.981 1.00 24.87 B N ATOM 3302 CA GLY B 936 −0.846 40.64520.503 1.00 25.53 B C ATOM 3303 C GLY B 936 −2.367 40.737 20.520 1.0025.87 B C ATOM 3304 O GLY B 936 −3.046 40.382 19.541 1.00 22.39 B O ATOM3305 N MET B 937 −2.903 41.218 21.637 1.00 24.22 B N ATOM 3306 CA MET B937 −4.344 41.354 21.784 1.00 25.26 B C ATOM 3307 CB MET B 937 −4.68041.810 23.208 1.00 22.36 B C ATOM 3308 CG MET B 937 −4.476 40.693 24.2131.00 23.06 B C ATOM 3309 SD MET B 937 −5.425 39.200 23.698 1.00 20.48 BS ATOM 3310 CE MET B 937 −7.049 39.901 23.661 1.00 15.72 B C ATOM 3311 CMET B 937 −4.908 42.319 20.746 1.00 25.24 B C ATOM 3312 O MET B 937−6.030 42.155 20.276 1.00 25.83 B O ATOM 3313 N GLU B 938 −4.115 43.31420.372 1.00 27.10 B N ATOM 3314 CA GLU B 938 −4.553 44.279 19.373 1.0029.62 B C ATOM 3315 CB GLU B 938 −3.575 45.458 19.307 1.00 30.48 B CATOM 3316 CG GLU B 938 −3.911 46.454 18.221 1.00 35.52 B C ATOM 3317 CDGLU B 938 −2.834 47.506 18.000 1.00 38.79 B C ATOM 3318 OE1 GLU B 938−1.636 47.140 17.896 1.00 40.52 B O ATOM 3319 OE2 GLU B 938 −3.19848.698 17.915 1.00 38.59 B O ATOM 3320 C GLU B 938 −4.675 43.609 17.9931.00 28.94 B C ATOM 3321 O GLU B 938 −5.659 43.803 17.282 1.00 27.75 B OATOM 3322 N TYR B 939 −3.677 42.819 17.623 1.00 27.57 B N ATOM 3323 CATYR B 939 −3.720 42.139 16.345 1.00 27.18 B C ATOM 3324 CB TYR B 939−2.428 41.354 16.133 1.00 26.82 B C ATOM 3325 CG TYR B 939 −2.512 40.41014.969 1.00 28.23 B C ATOM 3326 CD1 TYR B 939 −2.672 40.879 13.676 1.0027.67 B C ATOM 3327 CE1 TYR B 939 −2.818 39.995 12.613 1.00 27.50 B CATOM 3328 CD2 TYR B 939 −2.495 39.034 15.170 1.00 30.11 B C ATOM 3329CE2 TYR B 939 −2.641 38.143 14.113 1.00 27.69 B C ATOM 3330 CZ TYR B 939−2.803 38.630 12.844 1.00 25.76 B C ATOM 3331 OH TYR B 939 −2.969 37.74611.809 1.00 28.05 B O ATOM 3332 C TYR B 939 −4.936 41.196 16.283 1.0027.22 B C ATOM 3333 O TYR B 939 −5.730 41.229 15.333 1.00 25.58 B O ATOM3334 N LEU B 940 −5.084 40.365 17.312 1.00 27.83 B N ATOM 3335 CA LEU B940 −6.194 39.422 17.370 1.00 27.45 B C ATOM 3336 CB LEU B 940 −6.15938.621 18.678 1.00 25.08 B C ATOM 3337 CG LEU B 940 −4.922 37.722 18.8641.00 27.64 B C ATOM 3338 CD1 LEU B 940 −5.154 36.762 20.017 1.00 24.40 BC ATOM 3339 CD2 LEU B 940 −4.625 36.931 17.591 1.00 27.99 B C ATOM 3340C LEU B 940 −7.533 40.138 17.216 1.00 26.86 B C ATOM 3341 O LEU B 940−8.439 39.627 16.562 1.00 28.15 B O ATOM 3342 N GLY B 941 −7.643 41.32917.796 1.00 26.05 B N ATOM 3343 CA GLY B 941 −8.879 42.092 17.707 1.0023.74 B C ATOM 3344 C GLY B 941 −9.205 42.585 16.312 1.00 21.83 B C ATOM3345 O GLY B 941 −10.338 42.461 15.841 1.00 19.35 B O ATOM 3346 N SER B942 −8.206 43.153 15.651 1.00 21.40 B N ATOM 3347 CA SER B 942 −8.38443.660 14.307 1.00 23.07 B C ATOM 3348 CB SER B 942 −7.086 44.309 13.8151.00 20.62 B C ATOM 3349 OG SER B 942 −6.006 43.388 13.817 1.00 16.12 BO ATOM 3350 C SER B 942 −8.801 42.536 13.359 1.00 26.33 B C ATOM 3351 OSER B 942 −9.307 42.793 12.260 1.00 29.50 B O ATOM 3352 N ARG B 943−8.593 41.293 13.782 1.00 24.35 B N ATOM 3353 CA ARG B 943 −8.954 40.16112.963 1.00 23.61 B C ATOM 3354 CB ARG B 943 −7.827 39.141 12.956 1.0026.33 B C ATOM 3355 CG ARG B 943 −6.624 39.601 12.198 1.00 29.12 B CATOM 3356 CD ARG B 943 −6.909 39.625 10.718 1.00 34.41 B C ATOM 3357 NEARG B 943 −5.854 40.306 9.975 1.00 37.63 B N ATOM 3358 CZ ARG B 943−5.479 41.557 10.216 1.00 38.64 B C ATOM 3359 NH1 ARG B 943 −4.51242.127 9.502 1.00 38.73 B N ATOM 3360 NH2 ARG B 943 −6.075 42.233 11.1881.00 40.59 B N ATOM 3361 C ARG B 943 −10.221 39.535 13.494 1.00 24.10 BC ATOM 3362 O ARG B 943 −10.549 38.392 13.171 1.00 23.79 B O ATOM 3363 NARG B 944 −10.929 40.288 14.327 1.00 25.80 B N ATOM 3364 CA ARG B 944−12.190 39.832 14.902 1.00 27.06 B C ATOM 3365 CB ARG B 944 −13.22239.690 13.786 1.00 29.29 B C ATOM 3366 CG ARG B 944 −13.328 40.94412.931 1.00 33.03 B C ATOM 3367 CD ARG B 944 −14.432 40.833 11.901 1.0037.88 B C ATOM 3368 NE ARG B 944 −14.475 42.000 11.018 1.00 41.34 B NATOM 3369 CZ ARG B 944 −14.967 43.192 11.345 1.00 42.38 B C ATOM 3370NH1 ARG B 944 −15.482 43.410 12.550 1.00 43.09 B N ATOM 3371 NH2 ARG B944 −14.928 44.179 10.460 1.00 43.07 B N ATOM 3372 C ARG B 944 −12.13738.538 15.722 1.00 27.11 B C ATOM 3373 O ARG B 944 −13.102 37.777 15.7391.00 27.61 B O ATOM 3374 N CYS B 945 −11.020 38.298 16.404 1.00 24.94 BN ATOM 3375 CA CYS B 945 −10.863 37.112 17.239 1.00 24.53 B C ATOM 3376CB CYS B 945 −9.489 36.485 17.004 1.00 25.33 B C ATOM 3377 SG CYS B 945−9.124 35.025 18.022 1.00 30.16 B S ATOM 3378 C CYS B 945 −11.014 37.46618.728 1.00 23.62 B C ATOM 3379 O CYS B 945 −10.477 38.472 19.188 1.0023.54 B O ATOM 3380 N VAL B 946 −11.745 36.635 19.468 1.00 22.35 B NATOM 3381 CA VAL B 946 −11.959 36.844 20.900 1.00 21.99 B C ATOM 3382 CBVAL B 946 −13.468 36.922 21.219 1.00 19.57 B C ATOM 3383 CG1 VAL B 946−13.699 37.058 22.729 1.00 17.37 B C ATOM 3384 CG2 VAL B 946 −14.06438.114 20.500 1.00 17.89 B C ATOM 3385 C VAL B 946 −11.300 35.725 21.7281.00 23.03 B C ATOM 3386 O VAL B 946 −11.554 34.537 21.510 1.00 26.36 BO ATOM 3387 N HIS B 947 −10.454 36.120 22.671 1.00 20.78 B N ATOM 3388CA HIS B 947 −9.731 35.172 23.510 1.00 22.55 B C ATOM 3389 CB HIS B 947−8.707 35.896 24.395 1.00 20.18 B C ATOM 3390 CG HIS B 947 −7.680 34.98024.980 1.00 17.97 B C ATOM 3391 CD2 HIS B 947 −7.802 33.946 25.842 1.0016.23 B C ATOM 3392 ND1 HIS B 947 −6.363 34.987 24.573 1.00 16.76 B NATOM 3393 CE1 HIS B 947 −5.719 33.990 25.152 1.00 14.12 B C ATOM 3394NE2 HIS B 947 −6.569 33.341 25.925 1.00 16.69 B N ATOM 3395 C HIS B 947−10.636 34.354 24.404 1.00 22.03 B C ATOM 3396 O HIS B 947 −10.64433.138 24.324 1.00 24.74 B O ATOM 3397 N ARG B 948 −11.378 35.030 25.2681.00 24.81 B N ATOM 3398 CA ARG B 948 −12.302 34.386 26.204 1.00 29.26 BC ATOM 3399 CB ARG B 948 −13.059 33.233 25.530 1.00 32.27 B C ATOM 3400CG ARG B 948 −14.516 33.556 25.207 1.00 37.63 B C ATOM 3401 CD ARG B 948−15.406 32.314 25.302 1.00 43.26 B C ATOM 3402 NE ARG B 948 −15.33031.674 26.617 1.00 46.10 B N ATOM 3403 CZ ARG B 948 −16.182 30.75327.057 1.00 48.54 B C ATOM 3404 NH1 ARG B 948 −16.021 30.238 28.268 1.0049.33 B N ATOM 3405 NH2 ARG B 948 −17.195 30.352 26.294 1.00 49.77 B NATOM 3406 C ARG B 948 −11.697 33.889 27.522 1.00 28.75 B C ATOM 3407 OARG B 948 −12.397 33.831 28.532 1.00 30.89 B O ATOM 3408 N ASP B 949−10.415 33.542 27.536 1.00 28.05 B N ATOM 3409 CA ASP B 949 −9.80133.070 28.773 1.00 26.91 B C ATOM 3410 CB ASP B 949 −9.766 31.535 28.7791.00 28.13 B C ATOM 3411 CG ASP B 949 −9.324 30.955 30.116 1.00 30.51 BC ATOM 3412 OD1 ASP B 949 −9.744 31.469 31.166 1.00 32.59 B O ATOM 3413OD2 ASP B 949 −8.565 29.969 30.124 1.00 31.18 B O ATOM 3414 C ASP B 949−8.393 33.653 28.937 1.00 25.45 B C ATOM 3415 O ASP B 949 −7.426 32.92729.151 1.00 25.26 B O ATOM 3416 N LEU B 950 −8.279 34.971 28.829 1.0023.58 B N ATOM 3417 CA LEU B 950 −6.976 35.608 28.958 1.00 22.80 B CATOM 3418 CB LEU B 950 −7.000 37.024 28.392 1.00 20.62 B C ATOM 3419 CGLEU B 950 −5.676 37.798 28.285 1.00 18.98 B C ATOM 3420 CD1 LEU B 950−4.751 37.141 27.253 1.00 13.37 B C ATOM 3421 CD2 LEU B 950 −5.97039.246 27.867 1.00 12.59 B C ATOM 3422 C LEU B 950 −6.618 35.644 30.4251.00 22.41 B C ATOM 3423 O LEU B 950 −7.473 35.910 31.264 1.00 20.85 B OATOM 3424 N ALA B 951 −5.352 35.362 30.717 1.00 20.76 B N ATOM 3425 CAALA B 951 −4.852 35.331 32.078 1.00 17.81 B C ATOM 3426 CB ALA B 951−5.594 34.306 32.859 1.00 12.31 B C ATOM 3427 C ALA B 951 −3.368 34.99732.041 1.00 19.23 B C ATOM 3428 O ALA B 951 −2.879 34.395 31.084 1.0022.05 B O ATOM 3429 N ALA B 952 −2.647 35.393 33.083 1.00 19.76 B N ATOM3430 CA ALA B 952 −1.209 35.154 33.157 1.00 18.16 B C ATOM 3431 CB ALA B952 −0.671 35.622 34.518 1.00 18.36 B C ATOM 3432 C ALA B 952 −0.83133.696 32.911 1.00 17.28 B C ATOM 3433 O ALA B 952 0.298 33.403 32.5031.00 18.38 B O ATOM 3434 N ARG B 953 −1.761 32.783 33.174 1.00 17.20 B NATOM 3435 CA ARG B 953 −1.501 31.359 32.958 1.00 19.59 B C ATOM 3436 CBARG B 953 −2.502 30.490 33.734 1.00 18.77 B C ATOM 3437 CG ARG B 953−3.902 30.571 33.184 1.00 18.10 B C ATOM 3438 CD ARG B 953 −4.843 29.69233.962 1.00 19.26 B C ATOM 3439 NE ARG B 953 −6.241 30.056 33.733 1.0019.94 B N ATOM 3440 CZ ARG B 953 −6.897 30.984 34.421 1.00 20.48 B CATOM 3441 NH1 ARG B 953 −6.292 31.652 35.395 1.00 22.23 B N ATOM 3442NH2 ARG B 953 −8.161 31.246 34.137 1.00 19.77 B N ATOM 3443 C ARG B 953−1.606 31.044 31.462 1.00 21.37 B C ATOM 3444 O ARG B 953 −0.991 30.09030.967 1.00 20.33 B O ATOM 3445 N ASN B 954 −2.389 31.837 30.734 1.0021.32 B N ATOM 3446 CA ASN B 954 −2.507 31.594 29.301 1.00 22.57 B CATOM 3447 CB ASN B 954 −3.966 31.740 28.836 1.00 19.78 B C ATOM 3448 CGASN B 954 −4.824 30.542 29.243 1.00 18.80 B C ATOM 3449 OD1 ASN B 954−4.347 29.404 29.258 1.00 16.51 B O ATOM 3450 ND2 ASN B 954 −6.08830.791 29.568 1.00 18.61 B N ATOM 3451 C ASN B 954 −1.563 32.460 28.4671.00 23.15 B C ATOM 3452 O ASN B 954 −1.837 32.764 27.305 1.00 24.11 B OATOM 3453 N ILE B 955 −0.447 32.840 29.085 1.00 22.78 B N ATOM 3454 CAILE B 955 0.600 33.636 28.446 1.00 23.25 B C ATOM 3455 CB ILE B 9550.911 34.930 29.252 1.00 22.42 B C ATOM 3456 CG2 ILE B 955 2.137 35.62728.660 1.00 21.63 B C ATOM 3457 CG1 ILE B 955 −0.317 35.851 29.285 1.0020.99 B C ATOM 3458 CD1 ILE B 955 −0.663 36.492 27.966 1.00 19.44 B CATOM 3459 C ILE B 955 1.846 32.761 28.489 1.00 24.65 B C ATOM 3460 O ILEB 955 2.390 32.527 29.570 1.00 27.02 B O ATOM 3461 N LEU B 956 2.30232.274 27.339 1.00 24.24 B N ATOM 3462 CA LEU B 956 3.480 31.405 27.3151.00 24.52 B C ATOM 3463 CB LEU B 956 3.298 30.311 26.244 1.00 23.14 B CATOM 3464 CG LEU B 956 2.291 29.206 26.637 1.00 21.34 B C ATOM 3465 CD1LEU B 956 1.936 28.336 25.446 1.00 20.11 B C ATOM 3466 CD2 LEU B 9562.875 28.338 27.737 1.00 19.45 B C ATOM 3467 C LEU B 956 4.793 32.16927.113 1.00 26.13 B C ATOM 3468 O LEU B 956 4.827 33.196 26.437 1.0027.09 B O ATOM 3469 N VAL B 957 5.869 31.664 27.716 1.00 26.24 B N ATOM3470 CA VAL B 957 7.187 32.296 27.631 1.00 25.04 B C ATOM 3471 CB VAL B957 8.000 32.098 28.950 1.00 25.69 B C ATOM 3472 CG1 VAL B 957 9.43132.628 28.780 1.00 21.14 B C ATOM 3473 CG2 VAL B 957 7.297 32.805 30.1131.00 24.99 B C ATOM 3474 C VAL B 957 8.045 31.787 26.477 1.00 25.81 B CATOM 3475 O VAL B 957 8.475 30.630 26.469 1.00 27.02 B O ATOM 3476 N GLUB 958 8.288 32.649 25.498 1.00 26.44 B N ATOM 3477 CA GLU B 958 9.12632.274 24.368 1.00 28.76 B C ATOM 3478 CB GLU B 958 8.912 33.237 23.1961.00 28.56 B C ATOM 3479 CG GLU B 958 9.876 33.025 22.035 1.00 30.73 B CATOM 3480 CD GLU B 958 9.599 31.765 21.224 1.00 32.95 B C ATOM 3481 OE1GLU B 958 10.401 31.465 20.315 1.00 35.94 B O ATOM 3482 OE2 GLU B 9588.592 31.075 21.474 1.00 33.94 B O ATOM 3483 C GLU B 958 10.567 32.36424.868 1.00 29.72 B C ATOM 3484 O GLU B 958 11.401 31.514 24.571 1.0030.94 B O ATOM 3485 N SER B 959 10.842 33.404 25.645 1.00 31.11 B N ATOM3486 CA SER B 959 12.164 33.609 26.210 1.00 32.58 B C ATOM 3487 CB SER B959 13.152 34.054 25.137 1.00 30.97 B C ATOM 3488 OG SER B 959 13.23535.465 25.113 1.00 33.82 B O ATOM 3489 C SER B 959 12.039 34.688 27.2861.00 34.54 B C ATOM 3490 O SER B 959 10.961 35.246 27.482 1.00 33.70 B OATOM 3491 N GLU B 960 13.147 34.978 27.962 1.00 35.55 B N ATOM 3492 CAGLU B 960 13.189 35.961 29.038 1.00 36.85 B C ATOM 3493 CB GLU B 96014.615 36.058 29.594 1.00 39.46 B C ATOM 3494 CG GLU B 960 15.207 34.70429.961 1.00 46.26 B C ATOM 3495 CD GLU B 960 15.453 33.813 28.738 1.0050.12 B C ATOM 3496 OE1 GLU B 960 15.423 32.565 28.888 1.00 51.89 B OATOM 3497 OE2 GLU B 960 15.684 34.358 27.629 1.00 51.11 B O ATOM 3498 CGLU B 960 12.703 37.344 28.622 1.00 35.60 B C ATOM 3499 O GLU B 96012.252 38.134 29.455 1.00 35.96 B O ATOM 3500 N ALA B 961 12.788 37.64427.336 1.00 32.86 B N ATOM 3501 CA ALA B 961 12.347 38.945 26.869 1.0031.54 B C ATOM 3502 CB ALA B 961 13.542 39.737 26.370 1.00 32.46 B CATOM 3503 C ALA B 961 11.282 38.857 25.776 1.00 30.73 B C ATOM 3504 OALA B 961 11.186 39.740 24.928 1.00 30.46 B O ATOM 3505 N HIS B 96210.474 37.801 25.802 1.00 29.79 B N ATOM 3506 CA HIS B 962 9.433 37.62724.791 1.00 28.25 B C ATOM 3507 CB HIS B 962 10.070 37.195 23.468 1.0027.95 B C ATOM 3508 CG HIS B 962 9.109 37.137 22.322 1.00 28.31 B C ATOM3509 CD2 HIS B 962 7.810 36.764 22.263 1.00 28.79 B C ATOM 3510 ND1 HISB 962 9.461 37.504 21.041 1.00 31.00 B N ATOM 3511 CE1 HIS B 962 8.41837.365 20.243 1.00 29.74 B C ATOM 3512 NE2 HIS B 962 7.404 36.918 20.9591.00 30.22 B N ATOM 3513 C HIS B 962 8.354 36.623 25.191 1.00 28.20 B CATOM 3514 O HIS B 962 8.611 35.419 25.293 1.00 28.83 B O ATOM 3515 N VALB 963 7.139 37.123 25.393 1.00 25.95 B N ATOM 3516 CA VAL B 963 6.01336.279 25.768 1.00 24.74 B C ATOM 3517 CB VAL B 963 5.334 36.815 27.0551.00 23.78 B C ATOM 3518 CG1 VAL B 963 6.308 36.684 28.219 1.00 21.06 BC ATOM 3519 CG2 VAL B 963 4.897 38.280 26.876 1.00 17.99 B C ATOM 3520 CVAL B 963 4.980 36.159 24.644 1.00 25.21 B C ATOM 3521 O VAL B 963 4.91837.004 23.754 1.00 26.73 B O ATOM 3522 N LYS B 964 4.176 35.102 24.6831.00 24.96 B N ATOM 3523 CA LYS B 964 3.155 34.877 23.655 1.00 25.16 B CATOM 3524 CB LYS B 964 3.553 33.727 22.729 1.00 25.01 B C ATOM 3525 CGLYS B 964 4.701 34.011 21.783 1.00 24.77 B C ATOM 3526 CD LYS B 9645.061 32.737 21.023 1.00 26.76 B C ATOM 3527 CE LYS B 964 6.084 32.98219.931 1.00 28.31 B C ATOM 3528 NZ LYS B 964 6.299 31.771 19.085 1.0028.80 B N ATOM 3529 C LYS B 964 1.794 34.547 24.243 1.00 25.01 B C ATOM3530 O LYS B 964 1.702 33.913 25.296 1.00 25.35 B O ATOM 3531 N ILE B965 0.743 34.982 23.549 1.00 24.07 B N ATOM 3532 CA ILE B 965 −0.62934.721 23.971 1.00 23.22 B C ATOM 3533 CB ILE B 965 −1.615 35.726 23.3261.00 24.06 B C ATOM 3534 CG2 ILE B 965 −3.035 35.382 23.708 1.00 22.79 BC ATOM 3535 CG1 ILE B 965 −1.303 37.145 23.800 1.00 24.57 B C ATOM 3536CD1 ILE B 965 −2.055 38.217 23.050 1.00 24.62 B C ATOM 3537 C ILE B 965−1.010 33.305 23.539 1.00 23.90 B C ATOM 3538 O ILE B 965 −0.729 32.88322.406 1.00 23.98 B O ATOM 3539 N ALA B 966 −1.653 32.577 24.445 1.0023.77 B N ATOM 3540 CA ALA B 966 −2.062 31.199 24.181 1.00 22.79 B CATOM 3541 CB ALA B 966 −1.185 30.222 24.992 1.00 20.10 B C ATOM 3542 CALA B 966 −3.529 30.935 24.494 1.00 21.11 B C ATOM 3543 O ALA B 966−4.151 31.653 25.272 1.00 19.04 B O ATOM 3544 N ASP B 967 −4.065 29.88723.875 1.00 20.78 B N ATOM 3545 CA ASP B 967 −5.440 29.482 24.089 1.0022.00 B C ATOM 3546 CB ASP B 967 −5.625 29.127 25.555 1.00 24.96 B CATOM 3547 CG ASP B 967 −5.199 27.729 25.851 1.00 28.88 B C ATOM 3548 OD1ASP B 967 −4.008 27.409 25.637 1.00 35.17 B O ATOM 3549 OD2 ASP B 967−6.058 26.943 26.279 1.00 30.71 B O ATOM 3550 C ASP B 967 −6.489 30.49823.677 1.00 21.34 B C ATOM 3551 O ASP B 967 −7.487 30.687 24.374 1.0019.28 B O ATOM 3552 N PHE B 968 −6.256 31.147 22.546 1.00 21.34 B N ATOM3553 CA PHE B 968 −7.172 32.154 22.042 1.00 23.12 B C ATOM 3554 CB PHE B968 −6.373 33.312 21.440 1.00 19.95 B C ATOM 3555 CG PHE B 968 −5.42832.897 20.346 1.00 20.95 B C ATOM 3556 CD1 PHE B 968 −5.844 32.85019.021 1.00 19.89 B C ATOM 3557 CD2 PHE B 968 −4.107 32.586 20.637 1.0020.34 B C ATOM 3558 CE1 PHE B 968 −4.955 32.507 18.000 1.00 19.70 B CATOM 3559 CE2 PHE B 968 −3.210 32.240 19.623 1.00 20.58 B C ATOM 3560 CZPHE B 968 −3.633 32.202 18.304 1.00 20.85 B C ATOM 3561 C PHE B 968−8.156 31.609 21.005 1.00 24.50 B C ATOM 3562 O PHE B 968 −7.913 30.57120.384 1.00 24.19 B O ATOM 3563 N GLY B 969 −9.273 32.316 20.855 1.0025.76 B N ATOM 3564 CA GLY B 969 −10.296 31.964 19.888 1.00 28.10 B CATOM 3565 C GLY B 969 −10.837 30.551 19.900 1.00 28.39 B C ATOM 3566 OGLY B 969 −10.864 29.902 18.863 1.00 29.91 B O ATOM 3567 N LEU B 970−11.287 30.083 21.060 1.00 29.33 B N ATOM 3568 CA LEU B 970 −11.83228.733 21.198 1.00 27.90 B C ATOM 3569 CB LEU B 970 −11.023 27.93822.221 1.00 25.43 B C ATOM 3570 CG LEU B 970 −10.135 26.800 21.722 1.0027.12 B C ATOM 3571 CD1 LEU B 970 −9.196 27.267 20.639 1.00 25.92 B CATOM 3572 CD2 LEU B 970 −9.351 26.256 22.897 1.00 30.60 B C ATOM 3573 CLEU B 970 −13.285 28.765 21.631 1.00 27.45 B C ATOM 3574 O LEU B 970−13.894 27.714 21.823 1.00 28.00 B O ATOM 3575 N ALA B 971 −13.83029.974 21.774 1.00 27.93 B N ATOM 3576 CA ALA B 971 −15.222 30.18922.193 1.00 29.28 B C ATOM 3577 CB ALA B 971 −15.618 31.631 21.926 1.0028.90 B C ATOM 3578 C ALA B 971 −16.220 29.252 21.519 1.00 30.92 B CATOM 3579 O ALA B 971 −17.003 28.584 22.193 1.00 33.05 B O ATOM 3580 NLYS B 972 −16.189 29.209 20.188 1.00 30.45 B N ATOM 3581 CA LYS B 972−17.083 28.348 19.419 1.00 30.30 B C ATOM 3582 CB LYS B 972 −16.81128.512 17.915 1.00 32.31 B C ATOM 3583 CG LYS B 972 −17.115 29.90017.374 1.00 33.11 B C ATOM 3584 CD LYS B 972 −18.541 30.263 17.675 1.0035.45 B C ATOM 3585 CE LYS B 972 −18.803 31.733 17.461 1.00 38.07 B CATOM 3586 NZ LYS B 972 −20.202 32.046 17.893 1.00 40.65 B N ATOM 3587 CLYS B 972 −16.968 26.868 19.795 1.00 29.76 B C ATOM 3588 O LYS B 972−17.890 26.094 19.553 1.00 29.15 B O ATOM 3589 N LEU B 973 −15.83726.473 20.375 1.00 29.72 B N ATOM 3590 CA LEU B 973 −15.630 25.07820.766 1.00 29.44 B C ATOM 3591 CB LEU B 973 −14.195 24.643 20.436 1.0028.00 B C ATOM 3592 CG LEU B 973 −13.825 24.196 19.010 1.00 28.81 B CATOM 3593 CD1 LEU B 973 −14.845 24.746 18.014 1.00 30.28 B C ATOM 3594CD2 LEU B 973 −12.403 24.649 18.659 1.00 24.48 B C ATOM 3595 C LEU B 973−15.900 24.803 22.246 1.00 31.37 B C ATOM 3596 O LEU B 973 −15.98923.647 22.649 1.00 30.12 B O ATOM 3597 N LEU B 974 −16.027 25.854 23.0571.00 32.64 B N ATOM 3598 CA LEU B 974 −16.243 25.666 24.487 1.00 34.63 BC ATOM 3599 CB LEU B 974 −15.721 26.865 25.283 1.00 33.19 B C ATOM 3600CG LEU B 974 −14.238 27.196 25.105 1.00 30.52 B C ATOM 3601 CD1 LEU B974 −13.887 28.402 25.940 1.00 30.49 B C ATOM 3602 CD2 LEU B 974 −13.39225.993 25.471 1.00 28.88 B C ATOM 3603 C LEU B 974 −17.681 25.399 24.8701.00 38.43 B C ATOM 3604 O LEU B 974 −18.615 26.000 24.340 1.00 38.84 BO ATOM 3605 N PRO B 975 −17.873 24.500 25.836 1.00 42.06 B N ATOM 3606CD PRO B 975 −16.847 23.998 26.771 1.00 40.92 B C ATOM 3607 CA PRO B 975−19.211 24.148 26.295 1.00 42.75 B C ATOM 3608 CB PRO B 975 −18.92523.212 27.466 1.00 43.15 B C ATOM 3609 CG PRO B 975 −17.649 23.76828.024 1.00 41.14 B C ATOM 3610 C PRO B 975 −20.055 25.354 26.694 1.0044.41 B C ATOM 3611 O PRO B 975 −19.644 26.179 27.501 1.00 45.61 B OATOM 3612 N LEU B 976 −21.238 25.453 26.103 1.00 46.22 B N ATOM 3613 CALEU B 976 −22.163 26.529 26.412 1.00 47.83 B C ATOM 3614 CB LEU B 976−23.509 26.249 25.723 1.00 48.67 B C ATOM 3615 CG LEU B 976 −23.55526.755 24.275 1.00 49.00 B C ATOM 3616 CD1 LEU B 976 −23.755 28.27024.297 1.00 48.21 B C ATOM 3617 CD2 LEU B 976 −22.231 26.379 23.542 1.0048.02 B C ATOM 3618 C LEU B 976 −22.340 26.661 27.929 1.00 48.28 B CATOM 3619 O LEU B 976 −21.939 27.668 28.520 1.00 48.72 B O ATOM 3620 NASP B 977 −22.925 25.646 28.560 1.00 48.12 B N ATOM 3621 CA ASP B 977−23.113 25.678 30.007 1.00 48.62 B C ATOM 3622 CB ASP B 977 −24.53625.268 30.380 1.00 50.40 B C ATOM 3623 CG ASP B 977 −24.668 24.89831.863 1.00 53.25 B C ATOM 3624 OD1 ASP B 977 −25.490 25.542 32.578 1.0053.02 B O ATOM 3625 OD2 ASP B 977 −23.943 23.959 32.302 1.00 53.55 B OATOM 3626 C ASP B 977 −22.145 24.730 30.704 1.00 48.29 B C ATOM 3627 OASP B 977 −22.227 23.513 30.525 1.00 48.69 B O ATOM 3628 N LYS B 978−21.232 25.273 31.502 1.00 47.40 B N ATOM 3629 CA LYS B 978 −20.27224.430 32.223 1.00 47.27 B C ATOM 3630 CB LYS B 978 −18.848 24.66331.710 1.00 46.05 B C ATOM 3631 CG LYS B 978 −18.223 25.970 32.220 1.0044.25 B C ATOM 3632 CD LYS B 978 −16.986 25.663 33.059 1.00 42.04 B CATOM 3633 CE LYS B 978 −15.979 24.889 32.225 1.00 40.46 B C ATOM 3634 NZLYS B 978 −14.751 24.538 32.986 1.00 39.42 B N ATOM 3635 C LYS B 978−20.297 24.745 33.717 1.00 46.58 B C ATOM 3636 O LYS B 978 −20.16325.903 34.116 1.00 46.31 B O ATOM 3637 N ASP B 979 −20.458 23.716 34.5391.00 47.40 B N ATOM 3638 CA ASP B 979 −20.485 23.904 35.984 1.00 47.45 BC ATOM 3639 CB ASP B 979 −20.788 22.577 36.677 1.00 49.65 B C ATOM 3640CG ASP B 979 −21.116 22.747 38.138 1.00 50.70 B C ATOM 3641 OD1 ASP B979 −21.512 21.737 38.765 1.00 51.90 B O ATOM 3642 OD2 ASP B 979 −20.97723.883 38.651 1.00 50.64 B O ATOM 3643 C ASP B 979 −19.140 24.437 36.4531.00 46.35 B C ATOM 3644 O ASP B 979 −18.150 23.702 36.515 1.00 44.91 BO ATOM 3645 N TYR B 980 −19.115 25.724 36.781 1.00 45.52 B N ATOM 3646CA TYR B 980 −17.897 26.383 37.230 1.00 45.44 B C ATOM 3647 CB TYR B 980−18.069 27.899 37.131 1.00 43.35 B C ATOM 3648 CG TYR B 980 −17.83328.436 35.739 1.00 41.95 B C ATOM 3649 CD1 TYR B 980 −16.548 28.50235.207 1.00 39.92 B C ATOM 3650 CE1 TYR B 980 −16.326 28.968 33.918 1.0037.64 B C ATOM 3651 CD2 TYR B 980 −18.893 28.851 34.944 1.00 39.33 B CATOM 3652 CE2 TYR B 980 −18.683 29.317 33.654 1.00 37.16 B C ATOM 3653CZ TYR B 980 −17.401 29.374 33.144 1.00 36.17 B C ATOM 3654 OH TYR B 980−17.205 29.827 31.859 1.00 32.46 B O ATOM 3655 C TYR B 980 −17.43126.006 38.635 1.00 46.34 B C ATOM 3656 O TYR B 980 −16.342 26.403 39.0611.00 47.06 B O ATOM 3657 N TYR B 981 −18.235 25.229 39.351 1.00 46.87 BN ATOM 3658 CA TYR B 981 −17.856 24.830 40.696 1.00 48.41 B C ATOM 3659CB TYR B 981 −19.096 24.676 41.570 1.00 50.55 B C ATOM 3660 CG TYR B 981−19.918 25.940 41.626 1.00 54.49 B C ATOM 3661 CD1 TYR B 981 −20.88226.207 40.655 1.00 56.05 B C ATOM 3662 CE1 TYR B 981 −21.594 27.39840.656 1.00 57.69 B C ATOM 3663 CD2 TYR B 981 −19.689 26.902 42.610 1.0055.62 B C ATOM 3664 CE2 TYR B 981 −20.397 28.101 42.620 1.00 57.77 B CATOM 3665 CZ TYR B 981 −21.347 28.340 41.638 1.00 58.18 B C ATOM 3666 OHTYR B 981 −22.043 29.525 41.629 1.00 59.14 B O ATOM 3667 C TYR B 981−17.037 23.551 40.688 1.00 47.81 B C ATOM 3668 O TYR B 981 −16.37623.211 41.674 1.00 47.25 B O ATOM 3669 N VAL B 982 −17.076 22.850 39.5631.00 47.13 B N ATOM 3670 CA VAL B 982 −16.317 21.621 39.411 1.00 46.15 BC ATOM 3671 CB VAL B 982 −17.082 20.599 38.547 1.00 45.79 B C ATOM 3672CG1 VAL B 982 −16.290 19.319 38.426 1.00 44.97 B C ATOM 3673 CG2 VAL B982 −18.435 20.316 39.161 1.00 45.38 B C ATOM 3674 C VAL B 982 −14.99321.971 38.735 1.00 46.37 B C ATOM 3675 O VAL B 982 −14.864 21.867 37.5151.00 46.84 B O ATOM 3676 N VAL B 983 −14.021 22.401 39.537 1.00 46.67 BN ATOM 3677 CA VAL B 983 −12.703 22.774 39.031 1.00 47.04 B C ATOM 3678CB VAL B 983 −12.512 24.313 39.075 1.00 47.43 B C ATOM 3679 CG1 VAL B983 −12.785 24.836 40.482 1.00 45.36 B C ATOM 3680 CG2 VAL B 983 −11.10924.681 38.614 1.00 44.47 B C ATOM 3681 C VAL B 983 −11.594 22.095 39.8371.00 47.73 B C ATOM 3682 O VAL B 983 −11.692 21.968 41.054 1.00 48.13 BO ATOM 3683 N ARG B 984 −10.545 21.652 39.148 1.00 48.65 B N ATOM 3684CA ARG B 984 −9.426 20.974 39.795 1.00 49.00 B C ATOM 3685 CB ARG B 984−8.537 20.288 38.746 1.00 51.15 B C ATOM 3686 CG ARG B 984 −8.174 18.83839.065 1.00 54.57 B C ATOM 3687 CD ARG B 984 −7.740 18.701 40.513 1.0059.55 B C ATOM 3688 NE ARG B 984 −7.279 17.355 40.849 1.00 62.55 B NATOM 3689 CZ ARG B 984 −6.104 16.851 40.487 1.00 64.30 B C ATOM 3690 NH1ARG B 984 −5.780 15.614 40.843 1.00 65.05 B N ATOM 3691 NH2 ARG B 984−5.252 17.582 39.776 1.00 63.24 B N ATOM 3692 C ARG B 984 −8.594 21.96640.598 1.00 48.48 B C ATOM 3693 O ARG B 984 −7.965 21.602 41.593 1.0049.43 B O ATOM 3694 N GLU B 985 −8.581 23.219 40.161 1.00 46.65 B N ATOM3695 CA GLU B 985 −7.828 24.248 40.861 1.00 43.97 B C ATOM 3696 CB GLU B985 −6.458 24.443 40.208 1.00 45.70 B C ATOM 3697 CG GLU B 985 −5.40825.041 41.147 1.00 51.85 B C ATOM 3698 CD GLU B 985 −4.850 24.038 42.1611.00 53.27 B C ATOM 3699 OE1 GLU B 985 −4.300 24.479 43.195 1.00 54.45 BO ATOM 3700 OE2 GLU B 985 −4.944 22.814 41.921 1.00 55.23 B O ATOM 3701C GLU B 985 −8.625 25.542 40.811 1.00 41.24 B C ATOM 3702 O GLU B 985−8.401 26.387 39.947 1.00 40.60 B O ATOM 3703 N PRO B 986 −9.564 25.71241.756 1.00 38.73 B N ATOM 3704 CD PRO B 986 −9.658 24.841 42.939 1.0037.63 B C ATOM 3705 CA PRO B 986 −10.456 26.869 41.903 1.00 37.13 B CATOM 3706 CB PRO B 986 −11.165 26.589 43.231 1.00 35.86 B C ATOM 3707 CGPRO B 986 −10.161 25.801 43.991 1.00 36.53 B C ATOM 3708 C PRO B 986−9.799 28.258 41.853 1.00 36.29 B C ATOM 3709 O PRO B 986 −10.418 29.22041.405 1.00 36.29 B O ATOM 3710 N GLY B 987 −8.557 28.372 42.310 1.0034.80 B N ATOM 3711 CA GLY B 987 −7.900 29.665 42.266 1.00 32.48 B CATOM 3712 C GLY B 987 −7.729 30.195 40.848 1.00 30.71 B C ATOM 3713 OGLY B 987 −7.573 31.397 40.654 1.00 28.46 B O ATOM 3714 N GLN B 988−7.750 29.298 39.862 1.00 28.88 B N ATOM 3715 CA GLN B 988 −7.593 29.67438.461 1.00 27.63 B C ATOM 3716 CB GLN B 988 −6.546 28.788 37.791 1.0028.47 B C ATOM 3717 CG GLN B 988 −5.165 28.913 38.413 1.00 29.70 B CATOM 3718 CD GLN B 988 −4.569 30.293 38.220 1.00 29.60 B C ATOM 3719 OE1GLN B 988 −4.197 30.621 37.078 1.00 25.73 B O ATOM 3720 NE2 GLN B 988−4.484 31.049 39.212 1.00 31.49 B O ATOM 3721 C GLN B 988 −8.904 29.58837.688 1.00 28.49 B C ATOM 3722 O GLN B 988 −8.904 29.479 36.460 1.0026.59 B O ATOM 3723 N SER B 989 −10.017 29.625 38.421 1.00 29.21 B NATOM 3724 CA SER B 989 −11.344 29.581 37.824 1.00 29.21 B C ATOM 3725 CBSER B 989 −12.427 29.566 38.896 1.00 28.70 B C ATOM 3726 OG SER B 989−13.694 29.771 38.300 1.00 29.29 B O ATOM 3727 C SER B 989 −11.50530.833 36.982 1.00 29.58 B C ATOM 3728 O SER B 989 −11.334 31.945 37.4741.00 30.64 B O ATOM 3729 N PRO B 990 −11.860 30.666 35.703 1.00 29.48 BN ATOM 3730 CD PRO B 990 −12.224 29.381 35.078 1.00 29.21 B C ATOM 3731CA PRO B 990 −12.044 31.775 34.762 1.00 29.66 B C ATOM 3732 CB PRO B 990−12.692 31.095 33.555 1.00 30.57 B C ATOM 3733 CG PRO B 990 −12.09729.698 33.609 1.00 30.85 B C ATOM 3734 C PRO B 990 −12.865 32.951 35.2781.00 27.44 B C ATOM 3735 O PRO B 990 −12.640 34.081 34.856 1.00 28.69 BO ATOM 3736 N ILE B 991 −13.807 32.689 36.180 1.00 25.37 B N ATOM 3737CA ILE B 991 −14.656 33.751 36.717 1.00 24.21 B C ATOM 3738 CB ILE B 991−15.636 33.216 37.789 1.00 22.18 B C ATOM 3739 CG2 ILE B 991 −16.40832.041 37.252 1.00 21.00 B C ATOM 3740 CG1 ILE B 991 −14.872 32.79739.037 1.00 22.49 B C ATOM 3741 CD1 ILE B 991 −15.770 32.280 40.129 1.0020.47 B C ATOM 3742 C ILE B 991 −13.915 34.956 37.318 1.00 22.89 B CATOM 3743 O ILE B 991 −14.380 36.084 37.184 1.00 22.11 B O ATOM 3744 NPHE B 992 −12.771 34.738 37.961 1.00 20.98 B N ATOM 3745 CA PHE B 992−12.052 35.867 38.555 1.00 21.73 B C ATOM 3746 CB PHE B 992 −10.97235.365 39.528 1.00 19.62 B C ATOM 3747 CG PHE B 992 −11.520 34.51240.634 1.00 18.15 B C ATOM 3748 CD1 PHE B 992 −12.614 34.947 41.378 1.0017.59 B C ATOM 3749 CD2 PHE B 992 −10.968 33.272 40.912 1.00 16.48 B CATOM 3750 CE1 PHE B 992 −13.154 34.162 42.379 1.00 17.22 B C ATOM 3751CE2 PHE B 992 −11.495 32.476 41.909 1.00 18.83 B C ATOM 3752 CZ PHE B992 −12.596 32.921 42.650 1.00 18.84 B C ATOM 3753 C PHE B 992 −11.43936.841 37.544 1.00 21.99 B C ATOM 3754 O PHE B 992 −10.912 37.884 37.9331.00 21.24 B O ATOM 3755 N TRP B 993 −11.520 36.494 36.257 1.00 21.93 BN ATOM 3756 CA TRP B 993 −11.004 37.325 35.159 1.00 23.05 B C ATOM 3757CB TRP B 993 −10.049 36.515 34.275 1.00 19.09 B C ATOM 3758 CG TRP B 993−8.689 36.325 34.848 1.00 20.94 B C ATOM 3759 CD2 TRP B 993 −8.29635.374 35.852 1.00 20.70 B C ATOM 3760 CE2 TRP B 993 −6.932 35.60836.129 1.00 20.32 B C ATOM 3761 CE3 TRP B 993 −8.965 34.348 36.541 1.0020.74 B C ATOM 3762 CD1 TRP B 993 −7.579 37.065 34.568 1.00 21.22 B CATOM 3763 NE1 TRP B 993 −6.523 36.644 35.336 1.00 22.28 B N ATOM 3764CZ2 TRP B 993 −6.222 34.857 37.073 1.00 18.70 B C ATOM 3765 CZ3 TRP B993 −8.257 33.602 37.479 1.00 16.48 B C ATOM 3766 CH2 TRP B 993 −6.89733.864 37.734 1.00 17.27 B C ATOM 3767 C TRP B 993 −12.153 37.841 34.2881.00 24.85 B C ATOM 3768 O TRP B 993 −11.966 38.714 33.436 1.00 26.79 BO ATOM 3769 N TYR B 994 −13.347 37.307 34.506 1.00 25.07 B N ATOM 3770CA TYR B 994 −14.492 37.685 33.689 1.00 25.56 B C ATOM 3771 CB TYR B 994−15.661 36.721 33.929 1.00 26.05 B C ATOM 3772 CG TYR B 994 −15.48735.343 33.314 1.00 26.17 B C ATOM 3773 CD1 TYR B 994 −14.323 35.00532.624 1.00 25.80 B C ATOM 3774 CE1 TYR B 994 −14.189 33.761 32.008 1.0026.46 B C ATOM 3775 CD2 TYR B 994 −16.510 34.397 33.376 1.00 26.01 B CATOM 3776 CE2 TYR B 994 −16.384 33.153 32.763 1.00 25.93 B C ATOM 3777CZ TYR B 994 −15.223 32.840 32.079 1.00 26.41 B C ATOM 3778 OH TYR B 994−15.090 31.616 31.458 1.00 27.87 B O ATOM 3779 C TYR B 994 −14.98139.095 33.902 1.00 25.85 B C ATOM 3780 O TYR B 994 −15.005 39.587 35.0201.00 27.26 B O ATOM 3781 N ALA B 995 −15.369 39.752 32.816 1.00 26.65 BN ATOM 3782 CA ALA B 995 −15.911 41.094 32.925 1.00 25.40 B C ATOM 3783CB ALA B 995 −15.883 41.789 31.578 1.00 23.16 B C ATOM 3784 C ALA B 995−17.352 40.907 33.389 1.00 25.46 B C ATOM 3785 O ALA B 995 −17.91639.813 33.284 1.00 23.51 B O ATOM 3786 N PRO B 996 −17.963 41.970 33.9171.00 25.58 B N ATOM 3787 CD PRO B 996 −17.400 43.304 34.173 1.00 25.53 BC ATOM 3788 CA PRO B 996 −19.344 41.893 34.389 1.00 27.00 B C ATOM 3789CB PRO B 996 −19.683 43.349 34.682 1.00 24.54 B C ATOM 3790 CG PRO B 996−18.395 43.888 35.131 1.00 24.67 B C ATOM 3791 C PRO B 996 −20.30341.263 33.374 1.00 28.59 B C ATOM 3792 O PRO B 996 −20.943 40.252 33.6741.00 28.72 B O ATOM 3793 N GLU B 997 −20.391 41.850 32.179 1.00 29.28 BN ATOM 3794 CA GLU B 997 −21.301 41.342 31.153 1.00 30.88 B C ATOM 3795CB GLU B 997 −21.101 42.057 29.798 1.00 31.68 B C ATOM 3796 CG GLU B 997−19.734 41.900 29.169 1.00 30.63 B C ATOM 3797 CD GLU B 997 −18.77942.982 29.608 1.00 32.64 B C ATOM 3798 OE1 GLU B 997 −18.945 43.48330.745 1.00 31.73 B O ATOM 3799 OE2 GLU B 997 −17.864 43.322 28.822 1.0031.67 B O ATOM 3800 C GLU B 997 −21.134 39.847 30.963 1.00 31.40 B CATOM 3801 O GLU B 997 −22.082 39.151 30.611 1.00 31.19 B O ATOM 3802 NSER B 998 −19.926 39.348 31.202 1.00 31.66 B N ATOM 3803 CA SER B 998−19.676 37.923 31.053 1.00 30.81 B C ATOM 3804 CB SER B 998 −18.17837.633 31.053 1.00 29.42 B C ATOM 3805 OG SER B 998 −17.611 37.93329.793 1.00 30.14 B O ATOM 3806 C SER B 998 −20.343 37.131 32.159 1.0030.19 B C ATOM 3807 O SER B 998 −20.926 36.081 31.911 1.00 32.24 B OATOM 3808 N LEU B 999 −20.261 37.631 33.381 1.00 31.65 B N ATOM 3809 CALEU B 999 −20.854 36.931 34.508 1.00 33.55 B C ATOM 3810 CB LEU B 999−20.399 37.560 35.828 1.00 30.58 B C ATOM 3811 CG LEU B 999 −18.94937.373 36.287 1.00 30.41 B C ATOM 3812 CD1 LEU B 999 −18.792 37.99237.667 1.00 29.34 B C ATOM 3813 CD2 LEU B 999 −18.595 35.904 36.351 1.0028.97 B C ATOM 3814 C LEU B 999 −22.378 36.909 34.458 1.00 35.12 B CATOM 3815 O LEU B 999 −22.999 35.902 34.788 1.00 35.62 B O ATOM 3816 NSER B 1000 −22.982 38.014 34.039 1.00 36.04 B N ATOM 3817 CA SER B 1000−24.433 38.094 33.986 1.00 37.54 B C ATOM 3818 CB SER B 1000 −24.88939.515 34.319 1.00 38.20 B C ATOM 3819 OG SER B 1000 −24.368 40.45333.391 1.00 39.11 B O ATOM 3820 C SER B 1000 −25.076 37.677 32.671 1.0038.49 B C ATOM 3821 O SER B 1000 −26.296 37.563 32.603 1.00 38.27 B OATOM 3822 N ASP B 1001 −24.279 37.445 31.633 1.00 38.91 B N ATOM 3823 CAASP B 1001 −24.847 37.075 30.339 1.00 41.24 B C ATOM 3824 CB ASP B 1001−25.201 38.350 29.573 1.00 42.19 B C ATOM 3825 CG ASP B 1001 −26.33039.118 30.220 1.00 44.29 B C ATOM 3826 OD1 ASP B 1001 −27.446 38.56130.286 1.00 43.63 B O ATOM 3827 OD2 ASP B 1001 −26.103 40.271 30.6601.00 45.40 B O ATOM 3828 C ASP B 1001 −24.001 36.167 29.434 1.00 41.18 BC ATOM 3829 O ASP B 1001 −24.409 35.859 28.313 1.00 39.87 B O ATOM 3830N ASN B 1002 −22.839 35.735 29.914 1.00 40.49 B N ATOM 3831 CA ASN B1002 −21.952 34.892 29.118 1.00 41.92 B C ATOM 3832 CB ASN B 1002−22.680 33.636 28.625 1.00 43.88 B C ATOM 3833 CG ASN B 1002 −23.03932.696 29.748 1.00 47.49 B C ATOM 3834 OD1 ASN B 1002 −22.165 32.21630.465 1.00 50.58 B O ATOM 3835 ND2 ASN B 1002 −24.331 32.425 29.9111.00 48.38 B N ATOM 3836 C ASN B 1002 −21.415 35.668 27.916 1.00 42.17 BC ATOM 3837 O ASN B 1002 −20.720 35.109 27.072 1.00 42.74 B O ATOM 3838N ILE B 1003 −21.737 36.958 27.850 1.00 40.60 B N ATOM 3839 CA ILE B1003 −21.293 37.822 26.760 1.00 37.90 B C ATOM 3840 CB ILE B 1003−21.949 39.218 26.855 1.00 38.42 B C ATOM 3841 CG2 ILE B 1003 −21.37540.150 25.821 1.00 35.41 B C ATOM 3842 CG1 ILE B 1003 −23.456 39.09926.667 1.00 38.11 B C ATOM 3843 CD1 ILE B 1003 −24.163 40.422 26.7941.00 36.73 B C ATOM 3844 C ILE B 1003 −19.781 38.007 26.777 1.00 37.25 BC ATOM 3845 O ILE B 1003 −19.209 38.409 27.791 1.00 38.16 B O ATOM 3846N PHE B 1004 −19.143 37.710 25.649 1.00 34.80 B N ATOM 3847 CA PHE B1004 −17.701 37.846 25.505 1.00 33.02 B C ATOM 3848 CB PHE B 1004−17.053 36.468 25.379 1.00 31.30 B C ATOM 3849 CG PHE B 1004 −17.01035.695 26.672 1.00 33.33 B C ATOM 3850 CD1 PHE B 1004 −16.122 36.05327.681 1.00 31.07 B C ATOM 3851 CD2 PHE B 1004 −17.871 34.619 26.8891.00 33.88 B C ATOM 3852 CE1 PHE B 1004 −16.088 35.360 28.882 1.00 31.19B C ATOM 3853 CE2 PHE B 1004 −17.848 33.913 28.094 1.00 33.73 B C ATOM3854 CZ PHE B 1004 −16.953 34.284 29.094 1.00 31.84 B C ATOM 3855 C PHEB 1004 −17.416 38.672 24.261 1.00 33.61 B C ATOM 3856 O PHE B 1004−18.005 38.426 23.214 1.00 36.40 B O ATOM 3857 N SER B 1005 −16.52139.651 24.373 1.00 32.85 B N ATOM 3858 CA SER B 1005 −16.181 40.50723.243 1.00 31.81 B C ATOM 3859 CB SER B 1005 −17.128 41.697 23.178 1.0032.82 B C ATOM 3860 OG SER B 1005 −16.862 42.582 24.254 1.00 35.29 B OATOM 3861 C SER B 1005 −14.764 41.038 23.368 1.00 31.55 B C ATOM 3862 OSER B 1005 −14.071 40.758 24.346 1.00 30.74 B O ATOM 3863 N ARG B 1006−14.342 41.811 22.371 1.00 30.35 B N ATOM 3864 CA ARG B 1006 −13.01042.399 22.375 1.00 31.73 B C ATOM 3865 CB ARG B 1006 −12.791 43.23321.103 1.00 32.08 B C ATOM 3866 CG ARG B 1006 −12.340 42.401 19.909 1.0035.73 B C ATOM 3867 CD ARG B 1006 −12.529 43.117 18.571 1.00 38.23 B CATOM 3868 NE ARG B 1006 −11.797 44.376 18.500 1.00 42.85 B N ATOM 3869CZ ARG B 1006 −11.646 45.100 17.393 1.00 43.99 B C ATOM 3870 NH1 ARG B1006 −10.968 46.238 17.433 1.00 42.77 B N ATOM 3871 NH2 ARG B 1006−12.159 44.681 16.244 1.00 45.31 B N ATOM 3872 C ARG B 1006 −12.83643.273 23.612 1.00 31.29 B C ATOM 3873 O ARG B 1006 −11.750 43.35224.191 1.00 30.22 B O ATOM 3874 N GLN B 1007 −13.924 43.910 24.029 1.0030.47 B N ATOM 3875 CA GLN B 1007 −13.881 44.788 25.184 1.00 28.48 B CATOM 3876 CB GLN B 1007 −15.064 45.757 25.139 1.00 29.31 B C ATOM 3877CG GLN B 1007 −14.935 46.827 24.039 1.00 30.12 B C ATOM 3878 CD GLN B1007 −13.647 47.677 24.155 1.00 31.23 B C ATOM 3879 OE1 GLN B 1007−12.602 47.362 23.559 1.00 24.82 B O ATOM 3880 NE2 GLN B 1007 −13.72948.756 24.936 1.00 29.95 B N ATOM 3881 C GLN B 1007 −13.838 44.03326.509 1.00 26.99 B C ATOM 3882 O GLN B 1007 −13.243 44.505 27.478 1.0025.04 B O ATOM 3883 N SER B 1008 −14.468 42.865 26.559 1.00 25.68 B NATOM 3884 CA SER B 1008 −14.434 42.057 27.772 1.00 26.10 B C ATOM 3885CB SER B 1008 −15.421 40.891 27.665 1.00 27.87 B C ATOM 3886 OG SER B1008 −15.080 40.026 26.598 1.00 31.41 B O ATOM 3887 C SER B 1008 −12.99541.538 27.944 1.00 26.67 B C ATOM 3888 O SER B 1008 −12.501 41.38429.065 1.00 26.79 B O ATOM 3889 N ASP B 1009 −12.324 41.265 26.825 1.0025.33 B N ATOM 3890 CA ASP B 1009 −10.943 40.806 26.872 1.00 25.36 B CATOM 3891 CB ASP B 1009 −10.409 40.469 25.468 1.00 26.35 B C ATOM 3892CG ASP B 1009 −10.917 39.121 24.942 1.00 29.84 B C ATOM 3893 OD1 ASP B1009 −10.675 38.823 23.742 1.00 30.40 B O ATOM 3894 OD2 ASP B 1009−11.543 38.365 25.723 1.00 28.13 B O ATOM 3895 C ASP B 1009 −10.10541.926 27.472 1.00 24.93 B C ATOM 3896 O ASP B 1009 −9.102 41.680 28.1431.00 24.99 B O ATOM 3897 N VAL B 1010 −10.524 43.162 27.228 1.00 22.69 BN ATOM 3898 CA VAL B 1010 −9.797 44.307 27.751 1.00 23.10 B C ATOM 3899CB VAL B 1010 −10.400 45.641 27.246 1.00 21.13 B C ATOM 3900 CG1 VAL B1010 −9.916 46.783 28.110 1.00 21.03 B C ATOM 3901 CG2 VAL B 1010 −9.99245.886 25.803 1.00 18.23 B C ATOM 3902 C VAL B 1010 −9.823 44.278 29.2771.00 23.05 B C ATOM 3903 O VAL B 1010 −8.823 44.568 29.927 1.00 22.50 BO ATOM 3904 N TRP B 1011 −10.977 43.924 29.833 1.00 23.37 B N ATOM 3905CA TRP B 1011 −11.156 43.834 31.274 1.00 22.16 B C ATOM 3906 CB TRP B1011 −12.605 43.436 31.582 1.00 21.39 B C ATOM 3907 CG TRP B 1011−12.856 43.017 33.021 1.00 22.17 B C ATOM 3908 CD2 TRP B 1011 −13.63343.722 33.994 1.00 21.79 B C ATOM 3909 CE2 TRP B 1011 −13.611 42.95635.187 1.00 22.59 B C ATOM 3910 CE3 TRP B 1011 −14.346 44.924 33.9771.00 20.63 B C ATOM 3911 CD1 TRP B 1011 −12.400 41.885 33.647 1.00 21.99B C ATOM 3912 NE1 TRP B 1011 −12.851 41.840 34.946 1.00 20.90 B N ATOM3913 CZ2 TRP B 1011 −14.276 43.353 36.350 1.00 22.92 B C ATOM 3914 CZ3TRP B 1011 −15.006 45.318 35.130 1.00 22.87 B C ATOM 3915 CH2 TRP B 1011−14.966 44.532 36.302 1.00 24.34 B C ATOM 3916 C TRP B 1011 −10.19942.783 31.832 1.00 22.62 B C ATOM 3917 O TRP B 1011 −9.496 43.006 32.8181.00 22.51 B O ATOM 3918 N SER B 1012 −10.184 41.628 31.185 1.00 23.22 BN ATOM 3919 CA SER B 1012 −9.329 40.540 31.614 1.00 21.86 B C ATOM 3920CB SER B 1012 −9.583 39.315 30.745 1.00 23.31 B C ATOM 3921 OG SER B1012 −10.969 39.024 30.712 1.00 26.28 B O ATOM 3922 C SER B 1012 −7.86940.952 31.547 1.00 20.42 B C ATOM 3923 O SER B 1012 −7.054 40.446 32.3121.00 19.32 B O ATOM 3924 N PHE B 1013 −7.544 41.864 30.630 1.00 19.51 BN ATOM 3925 CA PHE B 1013 −6.178 42.369 30.480 1.00 20.32 B C ATOM 3926CB PHE B 1013 −6.060 43.253 29.241 1.00 22.41 B C ATOM 3927 CG PHE B1013 −4.738 43.954 29.127 1.00 24.71 B C ATOM 3928 CD1 PHE B 1013 −3.56643.233 28.933 1.00 25.77 B C ATOM 3929 CD2 PHE B 1013 −4.660 45.33529.215 1.00 24.66 B C ATOM 3930 CE1 PHE B 1013 −2.340 43.881 28.825 1.0025.47 B C ATOM 3931 CE2 PHE B 1013 −3.441 45.992 29.109 1.00 24.49 B CATOM 3932 CZ PHE B 1013 −2.278 45.263 28.912 1.00 24.92 B C ATOM 3933 CPHE B 1013 −5.823 43.189 31.722 1.00 20.57 B C ATOM 3934 O PHE B 1013−4.671 43.203 32.178 1.00 18.68 B O ATOM 3935 N GLY B 1014 −6.829 43.86832.261 1.00 18.88 B N ATOM 3936 CA GLY B 1014 −6.621 44.653 33.460 1.0023.16 B C ATOM 3937 C GLY B 1014 −6.124 43.788 34.616 1.00 25.05 B CATOM 3938 O GLY B 1014 −5.211 44.166 35.357 1.00 24.37 B O ATOM 3939 NVAL B 1015 −6.729 42.614 34.762 1.00 26.14 B N ATOM 3940 CA VAL B 1015−6.365 41.681 35.819 1.00 25.90 B C ATOM 3941 CB VAL B 1015 −7.41440.524 35.941 1.00 25.19 B C ATOM 3942 CG1 VAL B 1015 −7.097 39.64937.130 1.00 26.98 B C ATOM 3943 CG2 VAL B 1015 −8.811 41.089 36.094 1.0024.45 B C ATOM 3944 C VAL B 1015 −4.990 41.096 35.514 1.00 26.88 B CATOM 3945 O VAL B 1015 −4.188 40.881 36.419 1.00 29.42 B O ATOM 3946 NVAL B 1016 −4.707 40.835 34.242 1.00 26.06 B N ATOM 3947 CA VAL B 1016−3.401 40.296 33.874 1.00 25.47 B C ATOM 3948 CB VAL B 1016 −3.29540.064 32.363 1.00 26.29 B C ATOM 3949 CG1 VAL B 1016 −1.829 40.01731.953 1.00 24.37 B C ATOM 3950 CG2 VAL B 1016 −4.007 38.774 31.988 1.0025.27 B C ATOM 3951 C VAL B 1016 −2.301 41.270 34.290 1.00 24.52 B CATOM 3952 O VAL B 1016 −1.230 40.859 34.711 1.00 24.76 B O ATOM 3953 NLEU B 1017 −2.565 42.565 34.148 1.00 24.65 B N ATOM 3954 CA LEU B 1017−1.594 43.582 34.543 1.00 24.58 B C ATOM 3955 CB LEU B 1017 −2.11344.983 34.216 1.00 23.12 B C ATOM 3956 CG LEU B 1017 −2.027 45.46032.761 1.00 24.37 B C ATOM 3957 CD1 LEU B 1017 −2.982 46.629 32.545 1.0023.70 B C ATOM 3958 CD2 LEU B 1017 −0.601 45.846 32.420 1.00 21.72 B CATOM 3959 C LEU B 1017 −1.373 43.457 36.042 1.00 25.27 B C ATOM 3960 OLEU B 1017 −0.257 43.645 36.540 1.00 24.20 B O ATOM 3961 N TYR B 1018−2.452 43.132 36.752 1.00 25.30 B N ATOM 3962 CA TYR B 1018 −2.40242.960 38.195 1.00 26.88 B C ATOM 3963 CB TYR B 1018 −3.794 42.65738.729 1.00 26.68 B C ATOM 3964 CG TYR B 1018 −3.862 42.524 40.231 1.0030.83 B C ATOM 3965 CD1 TYR B 1018 −3.656 43.624 41.057 1.00 32.09 B CATOM 3966 CE1 TYR B 1018 −3.736 43.509 42.430 1.00 30.76 B C ATOM 3967CD2 TYR B 1018 −4.147 41.301 40.826 1.00 31.00 B C ATOM 3968 CE2 TYR B1018 −4.228 41.178 42.198 1.00 31.86 B C ATOM 3969 CZ TYR B 1018 −4.02242.284 42.990 1.00 31.82 B C ATOM 3970 OH TYR B 1018 −4.101 42.15944.350 1.00 33.07 B O ATOM 3971 C TYR B 1018 −1.449 41.816 38.549 1.0028.71 B C ATOM 3972 O TYR B 1018 −0.540 41.979 39.372 1.00 29.73 B OATOM 3973 N GLU B 1019 −1.652 40.669 37.902 1.00 29.08 B N ATOM 3974 CAGLU B 1019 −0.838 39.475 38.138 1.00 28.73 B C ATOM 3975 CB GLU B 1019−1.273 38.322 37.212 1.00 28.24 B C ATOM 3976 CG GLU B 1019 −2.73737.877 37.359 1.00 28.46 B C ATOM 3977 CD GLU B 1019 −3.029 36.55436.653 1.00 29.77 B C ATOM 3978 OE1 GLU B 1019 −2.463 35.518 37.057 1.0033.63 B O ATOM 3979 OE2 GLU B 1019 −3.824 36.538 35.691 1.00 30.03 B OATOM 3980 C GLU B 1019 0.654 39.737 37.950 1.00 28.13 B C ATOM 3981 OGLU B 1019 1.475 39.295 38.759 1.00 27.79 B O ATOM 3982 N LEU B 10201.002 40.452 36.885 1.00 27.07 B N ATOM 3983 CA LEU B 1020 2.400 40.76236.598 1.00 28.46 B C ATOM 3984 CB LEU B 1020 2.518 41.508 35.256 1.0028.04 B C ATOM 3985 CG LEU B 1020 2.371 40.718 33.948 1.00 31.18 B CATOM 3986 CD1 LEU B 1020 3.729 40.598 33.271 1.00 30.88 B C ATOM 3987CD2 LEU B 1020 1.763 39.333 34.221 1.00 30.43 B C ATOM 3988 C LEU B 10203.054 41.592 37.709 1.00 27.19 B C ATOM 3989 O LEU B 1020 4.108 41.22938.225 1.00 27.55 B O ATOM 3990 N PHE B 1021 2.428 42.704 38.070 1.0027.54 B N ATOM 3991 CA PHE B 1021 2.962 43.573 39.108 1.00 30.47 B CATOM 3992 CB PHE B 1021 2.370 44.977 38.954 1.00 29.66 B C ATOM 3993 CGPHE B 1021 2.887 45.705 37.750 1.00 32.67 B C ATOM 3994 CD1 PHE B 10214.129 46.331 37.781 1.00 32.20 B C ATOM 3995 CD2 PHE B 1021 2.190 45.67336.556 1.00 32.11 B C ATOM 3996 CE1 PHE B 1021 4.667 46.902 36.648 1.0032.96 B C ATOM 3997 CE2 PHE B 1021 2.726 46.243 35.416 1.00 34.86 B CATOM 3998 CZ PHE B 1021 3.970 46.858 35.464 1.00 34.05 B C ATOM 3999 CPHE B 1021 2.687 43.005 40.498 1.00 31.35 B C ATOM 4000 O PHE B 10212.954 43.640 41.513 1.00 33.73 B O ATOM 4001 N THR B 1022 2.157 41.79340.531 1.00 29.56 B N ATOM 4002 CA THR B 1022 1.855 41.122 41.782 1.0027.88 B C ATOM 4003 CB THR B 1022 0.337 40.771 41.815 1.00 27.78 B CATOM 4004 OG1 THR B 1022 −0.276 41.380 42.959 1.00 29.16 B O ATOM 4005CG2 THR B 1022 0.105 39.265 41.830 1.00 27.02 B C ATOM 4006 C THR B 10222.725 39.857 41.774 1.00 27.55 B C ATOM 4007 O THR B 1022 2.716 39.06042.711 1.00 25.85 B O ATOM 4008 N TYR B 1023 3.482 39.708 40.686 1.0028.38 B N ATOM 4009 CA TYR B 1023 4.349 38.554 40.446 1.00 27.73 B CATOM 4010 CB TYR B 1023 5.563 38.595 41.375 1.00 28.82 B C ATOM 4011 CGTYR B 1023 6.554 39.677 41.004 1.00 29.97 B C ATOM 4012 CD1 TYR B 10236.475 40.948 41.562 1.00 30.60 B C ATOM 4013 CE1 TYR B 1023 7.373 41.94141.213 1.00 28.91 B C ATOM 4014 CD2 TYR B 1023 7.558 39.432 40.083 1.0029.49 B C ATOM 4015 CE2 TYR B 1023 8.455 40.419 39.732 1.00 29.77 B CATOM 4016 CZ TYR B 1023 8.356 41.667 40.301 1.00 29.39 B C ATOM 4017 OHTYR B 1023 9.258 42.637 39.961 1.00 29.99 B O ATOM 4018 C TYR B 10233.600 37.222 40.610 1.00 26.68 B C ATOM 4019 O TYR B 1023 4.210 36.15440.690 1.00 23.68 B O ATOM 4020 N CYS B 1024 2.275 37.305 40.633 1.0025.16 B N ATOM 4021 CA CYS B 1024 1.411 36.141 40.801 1.00 30.36 B CATOM 4022 CB CYS B 1024 1.695 35.062 39.745 1.00 29.66 B C ATOM 4023 SGCYS B 1024 0.991 35.464 38.132 1.00 31.45 B S ATOM 4024 C CYS B 10241.539 35.542 42.180 1.00 31.11 B C ATOM 4025 O CYS B 1024 1.458 34.32642.353 1.00 33.32 B O ATOM 4026 N ASP B 1025 1.736 36.394 43.172 1.0030.88 B N ATOM 4027 CA ASP B 1025 1.843 35.888 44.523 1.00 32.73 B CATOM 4028 CB ASP B 1025 2.062 37.031 45.501 1.00 35.93 B C ATOM 4029 CGASP B 1025 2.440 36.541 46.869 1.00 39.06 B C ATOM 4030 OD1 ASP B 10253.542 35.963 46.993 1.00 41.51 B O ATOM 4031 OD2 ASP B 1025 1.637 36.72347.809 1.00 41.43 B O ATOM 4032 C ASP B 1025 0.539 35.165 44.859 1.0031.75 B C ATOM 4033 O ASP B 1025 −0.536 35.619 44.482 1.00 28.94 B OATOM 4034 N LYS B 1026 0.637 34.046 45.567 1.00 33.64 B N ATOM 4035 CALYS B 1026 −0.545 33.267 45.934 1.00 34.91 B C ATOM 4036 CB LYS B 1026−0.140 31.856 46.378 1.00 37.07 B C ATOM 4037 CG LYS B 1026 0.308 30.94445.244 1.00 39.64 B C ATOM 4038 CD LYS B 1026 −0.822 30.721 44.235 1.0043.37 B C ATOM 4039 CE LYS B 1026 −0.378 29.791 43.097 1.00 45.58 B CATOM 4040 NZ LYS B 1026 −1.366 29.696 41.972 1.00 46.97 B N ATOM 4041 CLYS B 1026 −1.358 33.928 47.035 1.00 34.73 B C ATOM 4042 O LYS B 1026−2.544 33.653 47.184 1.00 34.89 B O ATOM 4043 N SER B 1027 −0.712 34.80347.798 1.00 35.10 B N ATOM 4044 CA SER B 1027 −1.366 35.507 48.891 1.0034.69 B C ATOM 4045 CB SER B 1027 −0.314 36.141 49.788 1.00 35.42 B CATOM 4046 OG SER B 1027 0.677 35.191 50.131 1.00 39.15 B O ATOM 4047 CSER B 1027 −2.329 36.586 48.410 1.00 34.71 B C ATOM 4048 O SER B 1027−3.418 36.741 48.960 1.00 35.34 B O ATOM 4049 N CYS B 1028 −1.935 37.33547.386 1.00 34.72 B N ATOM 4050 CA CYS B 1028 −2.795 38.405 46.879 1.0034.48 B C ATOM 4051 CB CYS B 1028 −2.073 39.741 47.008 1.00 34.38 B CATOM 4052 SG CYS B 1028 −0.504 39.739 46.191 1.00 37.79 B S ATOM 4053 CCYS B 1028 −3.262 38.220 45.434 1.00 31.11 B C ATOM 4054 O CYS B 1028−3.480 39.187 44.713 1.00 31.03 B O ATOM 4055 N SER B 1029 −3.417 36.97445.020 1.00 30.32 B N ATOM 4056 CA SER B 1029 −3.867 36.665 43.670 1.0029.14 B C ATOM 4057 CB SER B 1029 −3.800 35.163 43.449 1.00 29.51 B CATOM 4058 OG SER B 1029 −4.812 34.543 44.225 1.00 32.23 B O ATOM 4059 CSER B 1029 −5.317 37.115 43.517 1.00 26.52 B C ATOM 4060 O SER B 1029−5.968 37.498 44.489 1.00 27.24 B O ATOM 4061 N PRO B 1030 −5.839 37.06242.287 1.00 24.08 B N ATOM 4062 CD PRO B 1030 −5.086 36.857 41.039 1.0022.45 B C ATOM 4063 CA PRO B 1030 −7.210 37.457 41.987 1.00 23.13 B CATOM 4064 CB PRO B 1030 −7.299 37.196 40.496 1.00 22.81 B C ATOM 4065 CGPRO B 1030 −5.934 37.581 40.043 1.00 20.71 B C ATOM 4066 C PRO B 1030−8.262 36.702 42.796 1.00 24.05 B C ATOM 4067 O PRO B 1030 −9.180 37.30943.374 1.00 23.62 B O ATOM 4068 N SER B 1031 −8.136 35.380 42.834 1.0024.60 B N ATOM 4069 CA SER B 1031 −9.066 34.567 43.600 1.00 25.29 B CATOM 4070 CB SER B 1031 −8.741 33.081 43.411 1.00 24.41 B C ATOM 4071 OGSER B 1031 −7.367 32.829 43.619 1.00 29.84 B O ATOM 4072 C SER B 1031−9.035 34.936 45.098 1.00 26.53 B C ATOM 4073 O SER B 1031 −10.08235.168 45.707 1.00 26.40 B O ATOM 4074 N ALA B 1032 −7.836 35.000 45.6801.00 27.33 B N ATOM 4075 CA ALA B 1032 −7.675 35.332 47.094 1.00 27.47 BC ATOM 4076 CB ALA B 1032 −6.189 35.394 47.447 1.00 28.40 B C ATOM 4077C ALA B 1032 −8.364 36.646 47.479 1.00 28.39 B C ATOM 4078 O ALA B 1032−9.314 36.645 48.266 1.00 27.17 B O ATOM 4079 N GLU B 1033 −7.887 37.76046.925 1.00 28.39 B N ATOM 4080 CA GLU B 1033 −8.474 39.073 47.208 1.0028.46 B C ATOM 4081 CB GLU B 1033 −7.907 40.142 46.270 1.00 30.40 B CATOM 4082 CG GLU B 1033 −6.432 40.445 46.464 1.00 34.55 B C ATOM 4083 CDGLU B 1033 −6.063 40.634 47.920 1.00 36.21 B C ATOM 4084 OE1 GLU B 1033−6.955 40.978 48.723 1.00 35.21 B O ATOM 4085 OE2 GLU B 1033 −4.87440.448 48.257 1.00 37.70 B O ATOM 4086 C GLU B 1033 −9.984 39.074 47.0681.00 27.91 B C ATOM 4087 O GLU B 1033 −10.691 39.580 47.931 1.00 28.02 BO ATOM 4088 N PHE B 1034 −10.480 38.523 45.965 1.00 28.93 B N ATOM 4089CA PHE B 1034 −11.917 38.466 45.728 1.00 27.01 B C ATOM 4090 CB PHE B1034 −12.195 37.895 44.335 1.00 25.79 B C ATOM 4091 CG PHE B 1034−12.171 38.935 43.234 1.00 28.49 B C ATOM 4092 CD1 PHE B 1034 −11.56938.664 42.009 1.00 25.37 B C ATOM 4093 CD2 PHE B 1034 −12.770 40.17843.423 1.00 26.16 B C ATOM 4094 CE1 PHE B 1034 −11.564 39.612 40.9961.00 25.58 B C ATOM 4095 CE2 PHE B 1034 −12.764 41.129 42.407 1.00 26.17B C ATOM 4096 CZ PHE B 1034 −12.160 40.842 41.194 1.00 25.18 B C ATOM4097 C PHE B 1034 −12.594 37.620 46.785 1.00 26.89 B C ATOM 4098 O PHE B1034 −13.633 37.991 47.324 1.00 26.48 B O ATOM 4099 N LEU B 1035 −11.98636.483 47.091 1.00 29.42 B N ATOM 4100 CA LEU B 1035 −12.533 35.56848.080 1.00 30.90 B C ATOM 4101 CB LEU B 1035 −11.767 34.243 48.025 1.0030.10 B C ATOM 4102 CG LEU B 1035 −12.523 33.012 47.518 1.00 28.66 B CATOM 4103 CD1 LEU B 1035 −13.344 33.332 46.304 1.00 27.57 B C ATOM 4104CD2 LEU B 1035 −11.527 31.926 47.229 1.00 29.37 B C ATOM 4105 C LEU B1035 −12.517 36.148 49.494 1.00 32.42 B C ATOM 4106 O LEU B 1035 −13.47035.959 50.251 1.00 33.93 B O ATOM 4107 N ARG B 1036 −11.446 36.85249.857 1.00 32.89 B N ATOM 4108 CA ARG B 1036 −11.380 37.443 51.189 1.0034.45 B C ATOM 4109 CB ARG B 1036 −9.941 37.700 51.627 1.00 33.31 B CATOM 4110 CG ARG B 1036 −9.195 38.666 50.758 1.00 35.78 B C ATOM 4111 CDARG B 1036 −7.951 39.174 51.461 1.00 36.21 B C ATOM 4112 NE ARG B 1036−8.294 40.190 52.447 1.00 34.88 B N ATOM 4113 CZ ARG B 1036 −8.24041.498 52.220 1.00 33.46 B C ATOM 4114 NH1 ARG B 1036 −7.850 41.95551.040 1.00 33.99 B N ATOM 4115 NH2 ARG B 1036 −8.589 42.352 53.169 1.0034.43 B N ATOM 4116 C ARG B 1036 −12.163 38.743 51.250 1.00 35.70 B CATOM 4117 O ARG B 1036 −12.517 39.196 52.333 1.00 37.83 B O ATOM 4118 NMET B 1037 −12.441 39.342 50.094 1.00 37.15 B N ATOM 4119 CA MET B 1037−13.209 40.583 50.055 1.00 38.00 B C ATOM 4120 CB MET B 1037 −13.09041.258 48.678 1.00 37.73 B C ATOM 4121 CG MET B 1037 −11.842 42.13448.519 1.00 40.65 B C ATOM 4122 SD MET B 1037 −11.573 42.840 46.867 1.0038.90 B S ATOM 4123 CE MET B 1037 −12.983 43.932 46.734 1.00 40.28 B CATOM 4124 C MET B 1037 −14.680 40.331 50.389 1.00 39.11 B C ATOM 4125 OMET B 1037 −15.257 41.003 51.245 1.00 39.07 B O ATOM 4126 N MET B 1038−15.292 39.357 49.728 1.00 41.37 B N ATOM 4127 CA MET B 1038 −16.69739.072 49.991 1.00 43.13 B C ATOM 4128 CB MET B 1038 −17.395 38.66048.692 1.00 43.22 B C ATOM 4129 CG MET B 1038 −16.556 37.788 47.794 1.0043.58 B C ATOM 4130 SD MET B 1038 −17.231 37.655 46.142 1.00 41.45 B SATOM 4131 CE MET B 1038 −18.295 36.342 46.357 1.00 41.55 B C ATOM 4132 CMET B 1038 −16.910 38.037 51.097 1.00 44.01 B C ATOM 4133 O MET B 1038−18.017 37.543 51.301 1.00 44.45 B O ATOM 4134 N GLY B 1039 −15.83437.739 51.820 1.00 46.15 B N ATOM 4135 CA GLY B 1039 −15.889 36.79552.923 1.00 47.55 B C ATOM 4136 C GLY B 1039 −16.353 35.393 52.593 1.0049.20 B C ATOM 4137 O GLY B 1039 −17.181 34.831 53.309 1.00 50.66 B OATOM 4138 N CYS B 1040 −15.810 34.814 51.526 1.00 48.90 B N ATOM 4139 CACYS B 1040 −16.198 33.471 51.119 1.00 47.27 B C ATOM 4140 CB CYS B 1040−16.251 33.391 49.597 1.00 46.11 B C ATOM 4141 SG CYS B 1040 −16.88531.828 48.977 1.00 45.49 B S ATOM 4142 C CYS B 1040 −15.242 32.41151.655 1.00 47.59 B C ATOM 4143 O CYS B 1040 −14.040 32.468 51.405 1.0046.95 B O ATOM 4144 N GLU B 1041 −15.780 31.445 52.395 1.00 48.51 B NATOM 4145 CA GLU B 1041 −14.968 30.369 52.951 1.00 49.20 B C ATOM 4146CB GLU B 1041 −15.517 29.926 54.317 1.00 48.69 B C ATOM 4147 CG GLU B1041 −17.032 29.972 54.468 1.00 48.21 B C ATOM 4148 CD GLU B 1041−17.513 29.317 55.764 1.00 48.81 B C ATOM 4149 OE1 GLU B 1041 −18.71529.444 56.080 1.00 47.24 B O ATOM 4150 OE2 GLU B 1041 −16.691 28.67056.461 1.00 48.13 B O ATOM 4151 C GLU B 1041 −14.894 29.186 51.986 1.0049.69 B C ATOM 4152 O GLU B 1041 −14.219 28.186 52.243 1.00 49.89 B OATOM 4153 N ARG B 1042 −15.598 29.315 50.868 1.00 50.29 B N ATOM 4154 CAARG B 1042 −15.597 28.293 49.830 1.00 50.96 B C ATOM 4155 CB ARG B 1042−16.953 28.251 49.123 1.00 52.40 B C ATOM 4156 CG ARG B 1042 −18.07627.691 49.965 1.00 54.46 B C ATOM 4157 CD ARG B 1042 −19.371 27.65449.179 1.00 56.84 B C ATOM 4158 NE ARG B 1042 −20.129 26.438 49.455 1.0059.33 B N ATOM 4159 CZ ARG B 1042 −19.777 25.222 49.041 1.00 60.78 B CATOM 4160 NH1 ARG B 1042 −18.675 25.047 48.321 1.00 60.88 B N ATOM 4161NH2 ARG B 1042 −20.529 24.177 49.355 1.00 61.43 B N ATOM 4162 C ARG B1042 −14.506 28.647 48.818 1.00 50.04 B C ATOM 4163 O ARG B 1042 −14.29629.822 48.511 1.00 49.09 B O ATOM 4164 N ASP B 1043 −13.808 27.63348.313 1.00 49.24 B N ATOM 4165 CA ASP B 1043 −12.747 27.846 47.336 1.0046.56 B C ATOM 4166 CB ASP B 1043 −12.223 26.510 46.820 1.00 49.16 B CATOM 4167 CG ASP B 1043 −11.444 25.747 47.864 1.00 52.26 B C ATOM 4168OD1 ASP B 1043 −10.478 26.327 48.401 1.00 52.24 B O ATOM 4169 OD2 ASP B1043 −11.793 24.571 48.135 1.00 53.66 B O ATOM 4170 C ASP B 1043 −13.24728.673 46.160 1.00 43.96 B C ATOM 4171 O ASP B 1043 −12.509 29.48345.609 1.00 43.39 B O ATOM 4172 N VAL B 1044 −14.496 28.448 45.768 1.0042.85 B N ATOM 4173 CA VAL B 1044 −15.104 29.173 44.653 1.00 41.15 B CATOM 4174 CB VAL B 1044 −15.403 28.255 43.436 1.00 38.53 B C ATOM 4175CG1 VAL B 1044 −16.208 29.008 42.390 1.00 37.89 B C ATOM 4176 CG2 VAL B1044 −14.120 27.781 42.821 1.00 38.24 B C ATOM 4177 C VAL B 1044 −16.41629.743 45.143 1.00 40.47 B C ATOM 4178 O VAL B 1044 −17.240 29.03445.701 1.00 40.60 B O ATOM 4179 N PRO B 1045 −16.621 31.042 44.938 1.0040.56 B N ATOM 4180 CD PRO B 1045 −15.641 32.000 44.385 1.00 40.52 B CATOM 4181 CA PRO B 1045 −17.843 31.719 45.362 1.00 40.24 B C ATOM 4182CB PRO B 1045 −17.381 33.160 45.519 1.00 41.27 B C ATOM 4183 CG PRO B1045 −16.426 33.307 44.352 1.00 40.98 B C ATOM 4184 C PRO B 1045 −18.93531.597 44.318 1.00 39.56 B C ATOM 4185 O PRO B 1045 −18.665 31.26043.173 1.00 39.45 B O ATOM 4186 N ALA B 1046 −20.170 31.868 44.725 1.0040.46 B N ATOM 4187 CA ALA B 1046 −21.300 31.839 43.809 1.00 40.51 B CATOM 4188 CB ALA B 1046 −22.600 32.073 44.568 1.00 40.27 B C ATOM 4189 CALA B 1046 −21.038 32.989 42.838 1.00 40.45 B C ATOM 4190 O ALA B 1046−20.504 34.029 43.235 1.00 39.83 B O ATOM 4191 N LEU B 1047 −21.40332.807 41.574 1.00 39.65 B N ATOM 4192 CA LEU B 1047 −21.169 33.84640.583 1.00 40.13 B C ATOM 4193 CB LEU B 1047 −21.357 33.289 39.162 1.0040.46 B C ATOM 4194 CG LEU B 1047 −20.193 32.428 38.639 1.00 41.20 B CATOM 4195 CD1 LEU B 1047 −20.117 31.114 39.423 1.00 41.20 B C ATOM 4196CD2 LEU B 1047 −20.380 32.145 37.162 1.00 40.74 B C ATOM 4197 C LEU B1047 −22.024 35.095 40.781 1.00 39.34 B C ATOM 4198 O LEU B 1047 −21.53736.212 40.610 1.00 38.91 B O ATOM 4199 N CYS B 1048 −23.287 34.92041.151 1.00 39.20 B N ATOM 4200 CA CYS B 1048 −24.162 36.068 41.363 1.0039.30 B C ATOM 4201 CB CYS B 1048 −25.573 35.603 41.723 1.00 39.50 B CATOM 4202 SG CYS B 1048 −25.664 34.837 43.349 1.00 42.73 B S ATOM 4203 CCYS B 1048 −23.600 36.928 42.495 1.00 39.35 B C ATOM 4204 O CYS B 1048−23.779 38.145 42.519 1.00 39.73 B O ATOM 4205 N ARG B 1049 −22.91636.282 43.432 1.00 38.09 B N ATOM 4206 CA ARG B 1049 −22.316 36.97444.568 1.00 38.17 B C ATOM 4207 CB ARG B 1049 −21.897 35.931 45.600 1.0040.51 B C ATOM 4208 CG ARG B 1049 −21.512 36.458 46.959 1.00 44.21 B CATOM 4209 CD ARG B 1049 −21.091 35.286 47.845 1.00 48.40 B C ATOM 4210NE ARG B 1049 −20.499 35.709 49.111 1.00 51.54 B N ATOM 4211 CZ ARG B1049 −19.797 34.906 49.903 1.00 52.10 B C ATOM 4212 NH1 ARG B 1049−19.293 35.360 51.039 1.00 52.46 B N ATOM 4213 NH2 ARG B 1049 −19.59233.644 49.551 1.00 53.64 B N ATOM 4214 C ARG B 1049 −21.098 37.79044.092 1.00 36.74 B C ATOM 4215 O ARG B 1049 −20.865 38.922 44.526 1.0034.35 B O ATOM 4216 N LEU B 1050 −20.335 37.198 43.183 1.00 34.32 B NATOM 4217 CA LEU B 1050 −19.152 37.840 42.630 1.00 33.57 B C ATOM 4218CB LEU B 1050 −18.341 36.816 41.815 1.00 30.44 B C ATOM 4219 CG LEU B1050 −17.161 37.394 41.031 1.00 29.65 B C ATOM 4220 CD1 LEU B 1050−16.365 38.366 41.921 1.00 26.93 B C ATOM 4221 CD2 LEU B 1050 −16.30636.283 40.494 1.00 22.80 B C ATOM 4222 C LEU B 1050 −19.563 39.02841.753 1.00 33.51 B C ATOM 4223 O LEU B 1050 −18.971 40.105 41.835 1.0032.04 B O ATOM 4224 N LEU B 1051 −20.581 38.817 40.920 1.00 34.24 B NATOM 4225 CA LEU B 1051 −21.113 39.857 40.041 1.00 34.48 B C ATOM 4226CB LEU B 1051 −22.277 39.287 39.216 1.00 34.57 B C ATOM 4227 CG LEU B1051 −23.108 40.276 38.394 1.00 33.44 B C ATOM 4228 CD1 LEU B 1051−22.273 40.836 37.250 1.00 31.21 B C ATOM 4229 CD2 LEU B 1051 −24.34139.583 37.871 1.00 30.70 B C ATOM 4230 C LEU B 1051 −21.604 41.04340.887 1.00 35.06 B C ATOM 4231 O LEU B 1051 −21.340 42.199 40.571 1.0035.49 B O ATOM 4232 N GLU B 1052 −22.329 40.746 41.957 1.00 35.65 B NATOM 4233 CA GLU B 1052 −22.837 41.781 42.848 1.00 37.17 B C ATOM 4234CB GLU B 1052 −23.554 41.124 44.025 1.00 39.94 B C ATOM 4235 CG GLU B1052 −24.094 42.072 45.076 1.00 42.75 B C ATOM 4236 CD GLU B 1052−24.868 41.331 46.152 1.00 46.05 B C ATOM 4237 OE1 GLU B 1052 −24.23740.571 46.921 1.00 49.05 B O ATOM 4238 OE2 GLU B 1052 −26.106 41.49546.225 1.00 46.95 B O ATOM 4239 C GLU B 1052 −21.701 42.667 43.369 1.0037.09 B C ATOM 4240 O GLU B 1052 −21.793 43.892 43.353 1.00 35.90 B OATOM 4241 N LEU B 1053 −20.633 42.028 43.839 1.00 37.03 B N ATOM 4242 CALEU B 1053 −19.476 42.735 44.371 1.00 34.66 B C ATOM 4243 CB LEU B 1053−18.366 41.736 44.720 1.00 33.52 B C ATOM 4244 CG LEU B 1053 −17.02042.336 45.133 1.00 33.63 B C ATOM 4245 CD1 LEU B 1053 −17.136 42.94046.515 1.00 32.45 B C ATOM 4246 CD2 LEU B 1053 −15.945 41.268 45.1001.00 34.11 B C ATOM 4247 C LEU B 1053 −18.970 43.734 43.340 1.00 34.06 BC ATOM 4248 O LEU B 1053 −18.637 44.868 43.678 1.00 33.84 B O ATOM 4249N LEU B 1054 −18.913 43.303 42.083 1.00 33.58 B N ATOM 4250 CA LEU B1054 −18.460 44.166 40.988 1.00 34.37 B C ATOM 4251 CB LEU B 1054−18.126 43.323 39.747 1.00 33.25 B C ATOM 4252 CG LEU B 1054 −16.86942.443 39.809 1.00 32.78 B C ATOM 4253 CD1 LEU B 1054 −16.779 41.55438.584 1.00 32.14 B C ATOM 4254 CD2 LEU B 1054 −15.649 43.321 39.8971.00 31.57 B C ATOM 4255 C LEU B 1054 −19.522 45.217 40.635 1.00 34.18 BC ATOM 4256 O LEU B 1054 −19.198 46.362 40.311 1.00 32.80 B O ATOM 4257N GLU B 1055 −20.790 44.826 40.704 1.00 36.25 B N ATOM 4258 CA GLU B1055 −21.877 45.748 40.396 1.00 38.15 B C ATOM 4259 CB GLU B 1055−23.212 44.996 40.321 1.00 37.35 B C ATOM 4260 CG GLU B 1055 −23.37944.222 39.022 1.00 40.80 B C ATOM 4261 CD GLU B 1055 −24.735 43.54238.884 1.00 41.88 B C ATOM 4262 OE1 GLU B 1055 −25.159 43.295 37.7351.00 41.74 B O ATOM 4263 OE2 GLU B 1055 −25.372 43.240 39.914 1.00 44.00B O ATOM 4264 C GLU B 1055 −21.957 46.873 41.421 1.00 38.20 B C ATOM4265 O GLU B 1055 −22.727 47.816 41.261 1.00 38.44 B O ATOM 4266 N GLU B1056 −21.155 46.777 42.473 1.00 38.46 B N ATOM 4267 CA GLU B 1056−21.156 47.811 43.490 1.00 39.89 B C ATOM 4268 CB GLU B 1056 −21.19547.207 44.890 1.00 42.00 B C ATOM 4269 CG GLU B 1056 −22.401 46.32645.151 1.00 47.57 B C ATOM 4270 CD GLU B 1056 −22.500 45.872 46.602 1.0049.21 B C ATOM 4271 OE1 GLU B 1056 −21.445 45.560 47.205 1.00 48.52 B OATOM 4272 OE2 GLU B 1056 −23.639 45.820 47.127 1.00 50.36 B O ATOM 4273C GLU B 1056 −19.935 48.701 43.368 1.00 40.12 B C ATOM 4274 O GLU B 1056−19.733 49.575 44.203 1.00 42.38 B O ATOM 4275 N GLY B 1057 −19.11448.474 42.347 1.00 38.76 B N ATOM 4276 CA GLY B 1057 −17.934 49.30242.155 1.00 36.47 B C ATOM 4277 C GLY B 1057 −16.638 48.773 42.739 1.0036.71 B C ATOM 4278 O GLY B 1057 −15.565 49.343 42.521 1.00 37.03 B OATOM 4279 N GLN B 1058 −16.728 47.677 43.481 1.00 35.24 B N ATOM 4280 CAGLN B 1058 −15.560 47.069 44.099 1.00 32.79 B C ATOM 4281 CB GLN B 1058−16.011 45.969 45.057 1.00 32.99 B C ATOM 4282 CG GLN B 1058 −16.91746.467 46.169 1.00 34.23 B C ATOM 4283 CD GLN B 1058 −16.242 46.45247.527 1.00 34.06 B C ATOM 4284 OE1 GLN B 1058 −15.024 46.622 47.6301.00 34.44 B O ATOM 4285 NE2 GLN B 1058 −17.035 46.262 48.581 1.00 31.51B N ATOM 4286 C GLN B 1058 −14.588 46.487 43.072 1.00 33.29 B C ATOM4287 O GLN B 1058 −14.984 45.704 42.209 1.00 34.91 B O ATOM 4288 N ARG B1059 −13.317 46.872 43.174 1.00 32.14 B N ATOM 4289 CA ARG B 1059−12.267 46.385 42.283 1.00 31.05 B C ATOM 4290 CB ARG B 1059 −11.72947.519 41.417 1.00 31.00 B C ATOM 4291 CG ARG B 1059 −12.191 47.49239.963 1.00 33.01 B C ATOM 4292 CD ARG B 1059 −13.652 47.142 39.862 1.0032.34 B C ATOM 4293 NE ARG B 1059 −14.329 47.791 38.746 1.00 30.92 B NATOM 4294 CZ ARG B 1059 −15.643 47.738 38.558 1.00 32.32 B C ATOM 4295NH1 ARG B 1059 −16.399 47.054 39.409 1.00 29.29 B N ATOM 4296 NH2 ARG B1059 −16.203 48.402 37.554 1.00 32.00 B N ATOM 4297 C ARG B 1059 −11.12245.814 43.112 1.00 30.78 B C ATOM 4298 O ARG B 1059 −11.116 45.93744.328 1.00 31.26 B O ATOM 4299 N LEU B 1060 −10.155 45.188 42.449 1.0031.98 B N ATOM 4300 CA LEU B 1060 −8.999 44.620 43.131 1.00 32.82 B CATOM 4301 CB LEU B 1060 −8.147 43.810 42.156 1.00 30.99 B C ATOM 4302 CGLEU B 1060 −8.791 42.576 41.510 1.00 33.63 B C ATOM 4303 CD1 LEU B 1060−7.897 42.047 40.385 1.00 32.89 B C ATOM 4304 CD2 LEU B 1060 −9.03541.513 42.570 1.00 30.44 B C ATOM 4305 C LEU B 1060 −8.137 45.719 43.7311.00 35.16 B C ATOM 4306 O LEU B 1060 −8.011 46.808 43.165 1.00 35.31 BO ATOM 4307 N PRO B 1061 −7.526 45.448 44.891 1.00 37.66 B N ATOM 4308CD PRO B 1061 −7.628 44.209 45.686 1.00 38.68 B C ATOM 4309 CA PRO B1061 −6.666 46.429 45.557 1.00 38.74 B C ATOM 4310 CB PRO B 1061 −6.47245.829 46.945 1.00 37.50 B C ATOM 4311 CG PRO B 1061 −6.461 44.35146.661 1.00 39.71 B C ATOM 4312 C PRO B 1061 −5.355 46.560 44.798 1.0040.11 B C ATOM 4313 O PRO B 1061 −4.671 45.566 44.570 1.00 42.72 B OATOM 4314 N ALA B 1062 −5.023 47.787 44.406 1.00 40.89 B N ATOM 4315 CAALA B 1062 −3.795 48.078 43.669 1.00 41.43 B C ATOM 4316 CB ALA B 1062−3.455 49.565 43.791 1.00 42.02 B C ATOM 4317 C ALA B 1062 −2.620 47.24244.162 1.00 40.81 B C ATOM 4318 O ALA B 1062 −2.380 47.136 45.365 1.0040.36 B O ATOM 4319 N PRO B 1063 −1.874 46.629 43.230 1.00 40.11 B NATOM 4320 CD PRO B 1063 −2.038 46.655 41.768 1.00 38.16 B C ATOM 4321 CAPRO B 1063 −0.727 45.810 43.619 1.00 40.35 B C ATOM 4322 CB PRO B 1063−0.190 45.305 42.279 1.00 38.03 B C ATOM 4323 CG PRO B 1063 −0.66746.318 41.298 1.00 36.80 B C ATOM 4324 C PRO B 1063 0.292 46.630 44.4151.00 41.69 B C ATOM 4325 O PRO B 1063 0.612 47.763 44.052 1.00 40.07 B OATOM 4326 N PRO B 1064 0.787 46.064 45.532 1.00 42.80 B N ATOM 4327 CDPRO B 1064 0.311 44.773 46.054 1.00 42.45 B C ATOM 4328 CA PRO B 10641.766 46.652 46.455 1.00 43.51 B C ATOM 4329 CB PRO B 1064 2.019 45.52247.442 1.00 43.04 B C ATOM 4330 CG PRO B 1064 0.685 44.873 47.521 1.0043.10 B C ATOM 4331 C PRO B 1064 3.051 47.123 45.798 1.00 43.88 B C ATOM4332 O PRO B 1064 3.897 46.309 45.439 1.00 44.89 B O ATOM 4333 N ALA B1065 3.182 48.437 45.639 1.00 43.57 B N ATOM 4334 CA ALA B 1065 4.36349.047 45.033 1.00 44.73 B C ATOM 4335 CB ALA B 1065 5.617 48.244 45.3841.00 44.54 B C ATOM 4336 C ALA B 1065 4.254 49.204 43.518 1.00 44.87 B CATOM 4337 O ALA B 1065 5.240 49.491 42.840 1.00 45.51 B O ATOM 4338 NCYS B 1066 3.051 49.017 42.991 1.00 44.57 B N ATOM 4339 CA CYS B 10662.813 49.148 41.560 1.00 42.80 B C ATOM 4340 CB CYS B 1066 1.385 48.70241.220 1.00 41.77 B C ATOM 4341 SG CYS B 1066 0.764 49.168 39.564 1.0042.74 B S ATOM 4342 C CYS B 1066 2.999 50.582 41.111 1.00 41.34 B C ATOM4343 O CYS B 1066 2.634 51.516 41.809 1.00 41.68 B O ATOM 4344 N PRO B1067 3.599 50.774 39.941 1.00 40.50 B N ATOM 4345 CD PRO B 1067 4.31849.776 39.135 1.00 40.21 B C ATOM 4346 CA PRO B 1067 3.803 52.123 39.4231.00 40.36 B C ATOM 4347 CB PRO B 1067 4.405 51.863 38.054 1.00 39.69 BC ATOM 4348 CG PRO B 1067 5.223 50.636 38.290 1.00 38.76 B C ATOM 4349 CPRO B 1067 2.434 52.803 39.326 1.00 41.40 B C ATOM 4350 O PRO B 10671.429 52.153 39.022 1.00 42.80 B O ATOM 4351 N ALA B 1068 2.402 54.10539.576 1.00 41.17 B N ATOM 4352 CA ALA B 1068 1.163 54.887 39.535 1.0041.52 B C ATOM 4353 CB ALA B 1068 1.473 56.353 39.907 1.00 41.43 B CATOM 4354 C ALA B 1068 0.383 54.829 38.203 1.00 40.64 B C ATOM 4355 OALA B 1068 −0.825 54.584 38.192 1.00 39.24 B O ATOM 4356 N GLU B 10691.065 55.072 37.089 1.00 40.27 B N ATOM 4357 CA GLU B 1069 0.414 55.04335.784 1.00 41.72 B C ATOM 4358 CB GLU B 1069 1.305 55.718 34.738 1.0044.54 B C ATOM 4359 CG GLU B 1069 2.792 55.431 34.901 1.00 47.65 B CATOM 4360 CD GLU B 1069 3.412 56.113 36.114 1.00 47.70 B C ATOM 4361 OE1GLU B 1069 3.262 57.343 36.252 1.00 47.97 B O ATOM 4362 OE2 GLU B 10694.060 55.419 36.925 1.00 48.18 B O ATOM 4363 C GLU B 1069 0.040 53.62735.332 1.00 41.70 B C ATOM 4364 O GLU B 1069 −0.907 53.441 34.562 1.0041.28 B O ATOM 4365 N VAL B 1070 0.780 52.631 35.810 1.00 40.03 B N ATOM4366 CA VAL B 1070 0.485 51.249 35.462 1.00 39.46 B C ATOM 4367 CB VAL B1070 1.559 50.276 36.014 1.00 41.14 B C ATOM 4368 CG1 VAL B 1070 0.92448.927 36.330 1.00 41.59 B C ATOM 4369 CG2 VAL B 1070 2.681 50.09134.987 1.00 40.03 B C ATOM 4370 C VAL B 1070 −0.872 50.875 36.053 1.0039.70 B C ATOM 4371 O VAL B 1070 −1.700 50.261 35.381 1.00 39.20 B OATOM 4372 N HIS B 1071 −1.088 51.264 37.312 1.00 40.03 B N ATOM 4373 CAHIS B 1071 −2.331 50.994 38.041 1.00 40.05 B C ATOM 4374 CB HIS B 1071−2.165 51.344 39.528 1.00 40.50 B C ATOM 4375 CG HIS B 1071 −3.39951.124 40.349 1.00 41.67 B C ATOM 4376 CD2 HIS B 1071 −4.059 51.94341.203 1.00 40.99 B C ATOM 4377 ND1 HIS B 1071 −4.090 49.932 40.358 1.0042.50 B N ATOM 4378 CE1 HIS B 1071 −5.123 50.025 41.177 1.00 38.81 B CATOM 4379 NE2 HIS B 1071 −5.125 51.235 41.701 1.00 39.78 B N ATOM 4380 CHIS B 1071 −3.488 51.794 37.462 1.00 40.65 B C ATOM 4381 O HIS B 1071−4.645 51.403 37.587 1.00 40.56 B O ATOM 4382 N GLU B 1072 −3.178 52.91936.829 1.00 40.18 B N ATOM 4383 CA GLU B 1072 −4.221 53.743 36.240 1.0040.50 B C ATOM 4384 CB GLU B 1072 −3.693 55.157 35.975 1.00 44.39 B CATOM 4385 CG GLU B 1072 −4.766 56.138 35.550 1.00 50.86 B C ATOM 4386 CDGLU B 1072 −4.385 57.579 35.834 1.00 55.90 B C ATOM 4387 OE1 GLU B 1072−3.348 58.034 35.303 1.00 57.49 B O ATOM 4388 OE2 GLU B 1072 −5.12258.253 36.593 1.00 58.81 B O ATOM 4389 C GLU B 1072 −4.735 53.102 34.9471.00 38.98 B C ATOM 4390 O GLU B 1072 −5.900 53.263 34.588 1.00 37.76 BO ATOM 4391 N LEU B 1073 −3.870 52.367 34.249 1.00 37.52 B N ATOM 4392CA LEU B 1073 −4.287 51.697 33.023 1.00 35.30 B C ATOM 4393 CB LEU B1073 −3.090 51.114 32.267 1.00 34.93 B C ATOM 4394 CG LEU B 1073 −2.10152.111 31.674 1.00 34.74 B C ATOM 4395 CD1 LEU B 1073 −1.079 51.38430.837 1.00 33.55 B C ATOM 4396 CD2 LEU B 1073 −2.857 53.111 30.823 1.0036.36 B C ATOM 4397 C LEU B 1073 −5.252 50.568 33.359 1.00 34.77 B CATOM 4398 O LEU B 1073 −6.318 50.467 32.765 1.00 34.13 B O ATOM 4399 NMET B 1074 −4.878 49.719 34.313 1.00 35.06 B N ATOM 4400 CA MET B 1074−5.742 48.608 34.690 1.00 33.81 B C ATOM 4401 CB MET B 1074 −5.02247.632 35.632 1.00 32.66 B C ATOM 4402 CG MET B 1074 −4.646 48.18336.999 1.00 30.09 B C ATOM 4403 SD MET B 1074 −3.884 46.950 38.130 1.0023.51 B S ATOM 4404 CE MET B 1074 −2.271 46.878 37.495 1.00 21.36 B CATOM 4405 C MET B 1074 −6.983 49.137 35.361 1.00 33.43 B C ATOM 4406 OMET B 1074 −7.960 48.422 35.516 1.00 35.76 B O ATOM 4407 N LYS B 1075−6.956 50.401 35.748 1.00 32.86 B N ATOM 4408 CA LYS B 1075 −8.10550.984 36.412 1.00 34.05 B C ATOM 4409 CB LYS B 1075 −7.717 52.30537.081 1.00 36.76 B C ATOM 4410 CG LYS B 1075 −8.596 52.684 38.266 1.0036.63 B C ATOM 4411 CD LYS B 1075 −8.189 51.893 39.498 1.00 36.73 B CATOM 4412 CE LYS B 1075 −9.300 51.859 40.545 1.00 38.31 B C ATOM 4413 NZLYS B 1075 −10.509 51.089 40.106 1.00 33.91 B N ATOM 4414 C LYS B 1075−9.193 51.241 35.380 1.00 32.72 B C ATOM 4415 O LYS B 1075 −10.36450.956 35.614 1.00 33.59 B O ATOM 4416 N LEU B 1076 −8.784 51.790 34.2401.00 30.33 B N ATOM 4417 CA LEU B 1076 −9.687 52.113 33.143 1.00 27.87 BC ATOM 4418 CB LEU B 1076 −8.935 52.919 32.080 1.00 27.60 B C ATOM 4419CG LEU B 1076 −8.395 54.307 32.467 1.00 25.81 B C ATOM 4420 CD1 LEU B1076 −7.729 54.956 31.266 1.00 23.58 B C ATOM 4421 CD2 LEU B 1076 −9.53955.179 32.947 1.00 23.87 B C ATOM 4422 C LEU B 1076 −10.263 50.85332.511 1.00 27.92 B C ATOM 4423 O LEU B 1076 −11.416 50.818 32.067 1.0027.92 B O ATOM 4424 N CYS B 1077 −9.437 49.818 32.466 1.00 25.91 B NATOM 4425 CA CYS B 1077 −9.838 48.550 31.899 1.00 23.62 B C ATOM 4426 CBCYS B 1077 −8.695 47.538 32.002 1.00 21.19 B C ATOM 4427 SG CYS B 1077−7.269 47.783 30.894 1.00 21.49 B S ATOM 4428 C CYS B 1077 −11.06547.986 32.610 1.00 22.56 B C ATOM 4429 O CYS B 1077 −11.830 47.25731.997 1.00 23.55 B O ATOM 4430 N TRP B 1078 −11.251 48.323 33.892 1.0023.18 B N ATOM 4431 CA TRP B 1078 −12.374 47.797 34.684 1.00 21.44 B CATOM 4432 CB TRP B 1078 −11.905 47.359 36.077 1.00 21.43 B C ATOM 4433CG TRP B 1078 −10.755 46.398 36.077 1.00 23.00 B C ATOM 4434 CD2 TRP B1078 −9.714 46.318 37.054 1.00 23.77 B C ATOM 4435 CE2 TRP B 1078 −8.83445.293 36.647 1.00 24.28 B C ATOM 4436 CE3 TRP B 1078 −9.438 47.01738.233 1.00 22.51 B C ATOM 4437 CD1 TRP B 1078 −10.478 45.437 35.1451.00 26.11 B C ATOM 4438 NE1 TRP B 1078 −9.322 44.772 35.478 1.00 25.75B N ATOM 4439 CZ2 TRP B 1078 −7.697 44.954 37.376 1.00 23.37 B C ATOM4440 CZ3 TRP B 1078 −8.314 46.679 38.950 1.00 22.43 B C ATOM 4441 CH2TRP B 1078 −7.455 45.656 38.520 1.00 22.90 B C ATOM 4442 C TRP B 1078−13.592 48.712 34.831 1.00 20.28 B C ATOM 4443 O TRP B 1078 −14.34848.621 35.798 1.00 15.97 B O ATOM 4444 N ALA B 1079 −13.772 49.59333.860 1.00 21.94 B N ATOM 4445 CA ALA B 1079 −14.918 50.480 33.844 1.0023.82 B C ATOM 4446 CB ALA B 1079 −14.838 51.408 32.645 1.00 21.74 B CATOM 4447 C ALA B 1079 −16.138 49.569 33.726 1.00 26.53 B C ATOM 4448 OALA B 1079 −16.111 48.555 33.027 1.00 26.44 B O ATOM 4449 N PRO B 1080−17.221 49.918 34.417 1.00 28.40 B N ATOM 4450 CD PRO B 1080 −17.37451.083 35.305 1.00 28.57 B C ATOM 4451 CA PRO B 1080 −18.441 49.11334.374 1.00 29.60 B C ATOM 4452 CB PRO B 1080 −19.463 49.997 35.088 1.0027.68 B C ATOM 4453 CG PRO B 1080 −18.624 50.737 36.086 1.00 27.42 B CATOM 4454 C PRO B 1080 −18.876 48.741 32.954 1.00 30.91 B C ATOM 4455 OPRO B 1080 −18.977 47.556 32.625 1.00 33.35 B O ATOM 4456 N SER B 1081−19.119 49.745 32.116 1.00 30.36 B N ATOM 4457 CA SER B 1081 −19.56849.498 30.749 1.00 30.13 B C ATOM 4458 CB SER B 1081 −20.373 50.68430.214 1.00 32.93 B C ATOM 4459 OG SER B 1081 −19.514 51.762 29.886 1.0037.08 B O ATOM 4460 C SER B 1081 −18.422 49.223 29.799 1.00 28.16 B CATOM 4461 O SER B 1081 −17.355 49.822 29.894 1.00 28.59 B O ATOM 4462 NPRO B 1082 −18.643 48.313 28.849 1.00 26.55 B N ATOM 4463 CD PRO B 1082−19.807 47.418 28.779 1.00 23.40 B C ATOM 4464 CA PRO B 1082 −17.63347.938 27.861 1.00 26.35 B C ATOM 4465 CB PRO B 1082 −18.315 46.80727.103 1.00 23.94 B C ATOM 4466 CG PRO B 1082 −19.214 46.207 28.152 1.0022.82 B C ATOM 4467 C PRO B 1082 −17.209 49.097 26.954 1.00 28.24 B CATOM 4468 O PRO B 1082 −16.021 49.294 26.681 1.00 27.35 B O ATOM 4469 NGLN B 1083 −18.184 49.866 26.493 1.00 28.90 B N ATOM 4470 CA GLN B 1083−17.897 50.992 25.629 1.00 32.63 B C ATOM 4471 CB GLN B 1083 −19.20851.615 25.163 1.00 36.33 B C ATOM 4472 CG GLN B 1083 −20.063 52.14026.290 1.00 44.10 B C ATOM 4473 CD GLN B 1083 −21.349 52.781 25.796 1.0047.98 B C ATOM 4474 OE1 GLN B 1083 −22.121 52.160 25.059 1.00 50.30 B OATOM 4475 NE2 GLN B 1083 −21.592 54.029 26.208 1.00 50.00 B N ATOM 4476C GLN B 1083 −17.012 52.050 26.318 1.00 33.60 B C ATOM 4477 O GLN B 1083−16.493 52.961 25.669 1.00 33.23 B O ATOM 4478 N ASP B 1084 −16.82151.926 27.626 1.00 34.03 B N ATOM 4479 CA ASP B 1084 −15.999 52.89528.341 1.00 35.82 B C ATOM 4480 CB ASP B 1084 −16.627 53.227 29.704 1.0038.13 B C ATOM 4481 CG ASP B 1084 −17.865 54.113 29.579 1.00 38.77 B CATOM 4482 OD1 ASP B 1084 −18.596 54.275 30.580 1.00 40.28 B O ATOM 4483OD2 ASP B 1084 −18.102 54.655 28.479 1.00 40.01 B O ATOM 4484 C ASP B1084 −14.549 52.438 28.521 1.00 35.43 B C ATOM 4485 O ASP B 1084 −13.64653.262 28.708 1.00 34.85 B O ATOM 4486 N ARG B 1085 −14.325 51.12928.460 1.00 33.57 B N ATOM 4487 CA ARG B 1085 −12.980 50.589 28.603 1.0031.02 B C ATOM 4488 CB ARG B 1085 −13.025 49.064 28.690 1.00 27.37 B CATOM 4489 CG ARG B 1085 −13.849 48.558 29.856 1.00 25.02 B C ATOM 4490CD ARG B 1085 −14.021 47.069 29.809 1.00 22.29 B C ATOM 4491 NE ARG B1085 −15.125 46.671 30.665 1.00 21.69 B N ATOM 4492 CZ ARG B 1085−15.985 45.702 30.374 1.00 20.52 B C ATOM 4493 NH1 ARG B 1085 −15.87345.015 29.246 1.00 17.94 B N ATOM 4494 NH2 ARG B 1085 −16.975 45.43831.210 1.00 20.52 B N ATOM 4495 C ARG B 1085 −12.194 51.012 27.375 1.0030.75 B C ATOM 4496 O ARG B 1085 −12.742 51.116 26.289 1.00 32.84 B OATOM 4497 N PRO B 1086 −10.897 51.280 27.532 1.00 30.76 B N ATOM 4498 CDPRO B 1086 −10.048 51.250 28.734 1.00 29.24 B C ATOM 4499 CA PRO B 1086−10.132 51.688 26.355 1.00 30.29 B C ATOM 4500 CB PRO B 1086 −8.80252.147 26.950 1.00 29.66 B C ATOM 4501 CG PRO B 1086 −8.654 51.27328.137 1.00 29.74 B C ATOM 4502 C PRO B 1086 −9.971 50.509 25.421 1.0029.51 B C ATOM 4503 O PRO B 1086 −10.398 49.407 25.732 1.00 32.54 B OATOM 4504 N SER B 1087 −9.364 50.742 24.270 1.00 29.78 B N ATOM 4505 CASER B 1087 −9.141 49.668 23.325 1.00 29.49 B C ATOM 4506 CB SER B 1087−9.447 50.139 21.906 1.00 26.96 B C ATOM 4507 OG SER B 1087 −8.41650.983 21.422 1.00 30.79 B O ATOM 4508 C SER B 1087 −7.664 49.300 23.4391.00 29.09 B C ATOM 4509 O SER B 1087 −6.864 50.087 23.936 1.00 30.95 BO ATOM 4510 N PHE B 1088 −7.303 48.108 22.987 1.00 28.19 B N ATOM 4511CA PHE B 1088 −5.919 47.679 23.038 1.00 27.93 B C ATOM 4512 CB PHE B1088 −5.809 46.252 22.509 1.00 26.98 B C ATOM 4513 CG PHE B 1088 −6.21745.204 23.510 1.00 26.32 B C ATOM 4514 CD1 PHE B 1088 −5.428 44.95724.627 1.00 23.88 B C ATOM 4515 CD2 PHE B 1088 −7.384 44.466 23.336 1.0023.74 B C ATOM 4516 CE1 PHE B 1088 −5.793 43.997 25.545 1.00 23.97 B CATOM 4517 CE2 PHE B 1088 −7.757 43.500 24.257 1.00 23.15 B C ATOM 4518CZ PHE B 1088 −6.961 43.264 25.362 1.00 24.05 B C ATOM 4519 C PHE B 1088−5.037 48.622 22.226 1.00 29.08 B C ATOM 4520 O PHE B 1088 −3.855 48.78622.517 1.00 30.69 B O ATOM 4521 N SER B 1089 −5.619 49.253 21.213 1.0029.50 B N ATOM 4522 CA SER B 1089 −4.867 50.177 20.381 1.00 31.30 B CATOM 4523 CB SER B 1089 −5.679 50.555 19.143 1.00 31.23 B C ATOM 4524 OGSER B 1089 −6.889 51.188 19.509 1.00 34.90 B O ATOM 4525 C SER B 1089−4.530 51.427 21.190 1.00 32.13 B C ATOM 4526 O SER B 1089 −3.568 52.14020.880 1.00 30.23 B O ATOM 4527 N ALA B 1090 −5.337 51.678 22.221 1.0031.60 B N ATOM 4528 CA ALA B 1090 −5.138 52.816 23.107 1.00 33.02 B CATOM 4529 CB ALA B 1090 −6.446 53.174 23.792 1.00 32.78 B C ATOM 4530 CALA B 1090 −4.064 52.521 24.157 1.00 33.92 B C ATOM 4531 O ALA B 1090−3.083 53.262 24.286 1.00 34.82 B O ATOM 4532 N LEU B 1091 −4.241 51.43024.895 1.00 33.05 B N ATOM 4533 CA LEU B 1091 −3.284 51.053 25.929 1.0032.35 B C ATOM 4534 CB LEU B 1091 −3.745 49.772 26.618 1.00 30.82 B CATOM 4535 CG LEU B 1091 −5.128 49.884 27.254 1.00 29.77 B C ATOM 4536CD1 LEU B 1091 −5.770 48.510 27.366 1.00 27.39 B C ATOM 4537 CD2 LEU B1091 −4.999 50.558 28.605 1.00 31.11 B C ATOM 4538 C LEU B 1091 −1.87950.858 25.366 1.00 32.88 B C ATOM 4539 O LEU B 1091 −0.893 51.290 25.9741.00 32.53 B O ATOM 4540 N GLY B 1092 −1.807 50.208 24.204 1.00 32.64 BN ATOM 4541 CA GLY B 1092 −0.540 49.928 23.538 1.00 32.84 B C ATOM 4542C GLY B 1092 0.515 51.017 23.583 1.00 32.38 B C ATOM 4543 O GLY B 10921.548 50.839 24.215 1.00 30.96 B O ATOM 4544 N PRO B 1093 0.293 52.15222.904 1.00 34.39 B N ATOM 4545 CD PRO B 1093 −0.890 52.468 22.089 1.0035.39 B C ATOM 4546 CA PRO B 1093 1.239 53.269 22.881 1.00 36.18 B CATOM 4547 CB PRO B 1093 0.530 54.305 22.000 1.00 36.68 B C ATOM 4548 CGPRO B 1093 −0.915 53.969 22.159 1.00 35.69 B C ATOM 4549 C PRO B 10931.557 53.779 24.284 1.00 35.73 B C ATOM 4550 O PRO B 1093 2.705 54.09324.583 1.00 34.76 B O ATOM 4551 N GLN B 1094 0.547 53.852 25.146 1.0037.32 B N ATOM 4552 CA GLN B 1094 0.783 54.301 26.516 1.00 39.11 B CATOM 4553 CB GLN B 1094 −0.526 54.389 27.309 1.00 39.49 B C ATOM 4554 CGGLN B 1094 −1.545 55.394 26.781 1.00 43.75 B C ATOM 4555 CD GLN B 1094−2.660 55.693 27.789 1.00 47.08 B C ATOM 4556 OE1 GLN B 1094 −2.39756.218 28.874 1.00 49.17 B O ATOM 4557 NE2 GLN B 1094 −3.903 55.36227.434 1.00 46.08 B N ATOM 4558 C GLN B 1094 1.740 53.335 27.222 1.0039.18 B C ATOM 4559 O GLN B 1094 2.728 53.758 27.817 1.00 40.18 B O ATOM4560 N LEU B 1095 1.452 52.038 27.154 1.00 39.55 B N ATOM 4561 CA LEU B1095 2.312 51.045 27.793 1.00 40.38 B C ATOM 4562 CB LEU B 1095 1.74049.637 27.607 1.00 38.68 B C ATOM 4563 CG LEU B 1095 0.575 49.259 28.5331.00 39.13 B C ATOM 4564 CD1 LEU B 1095 −0.133 48.024 28.010 1.00 37.02B C ATOM 4565 CD2 LEU B 1095 1.104 49.031 29.943 1.00 37.97 B C ATOM4566 C LEU B 1095 3.741 51.087 27.257 1.00 41.75 B C ATOM 4567 O LEU B1095 4.704 51.027 28.023 1.00 40.09 B O ATOM 4568 N ASP B 1096 3.87951.192 25.941 1.00 43.20 B N ATOM 4569 CA ASP B 1096 5.199 51.229 25.3361.00 45.21 B C ATOM 4570 CB ASP B 1096 5.086 51.289 23.814 1.00 47.28 BC ATOM 4571 CG ASP B 1096 6.277 50.658 23.127 1.00 50.41 B C ATOM 4572OD1 ASP B 1096 7.018 51.376 22.411 1.00 51.05 B O ATOM 4573 OD2 ASP B1096 6.471 49.434 23.317 1.00 51.68 B O ATOM 4574 C ASP B 1096 5.96952.432 25.857 1.00 44.84 B C ATOM 4575 O ASP B 1096 7.188 52.389 26.0141.00 43.07 B O ATOM 4576 N MET B 1097 5.240 53.506 26.132 1.00 46.20 B NATOM 4577 CA MET B 1097 5.839 54.722 26.655 1.00 47.53 B C ATOM 4578 CBMET B 1097 4.805 55.845 26.679 1.00 50.08 B C ATOM 4579 CG MET B 10975.362 57.174 27.161 1.00 53.76 B C ATOM 4580 SD MET B 1097 4.083 58.42127.455 1.00 59.09 B S ATOM 4581 CE MET B 1097 3.697 58.094 29.210 1.0056.01 B C ATOM 4582 C MET B 1097 6.378 54.482 28.069 1.00 47.41 B C ATOM4583 O MET B 1097 7.551 54.746 28.346 1.00 47.55 B O ATOM 4584 N LEU B1098 5.524 53.979 28.960 1.00 45.95 B N ATOM 4585 CA LEU B 1098 5.93453.703 30.340 1.00 46.87 B C ATOM 4586 CB LEU B 1098 4.808 53.000 31.1091.00 45.75 B C ATOM 4587 CG LEU B 1098 3.507 53.792 31.244 1.00 45.44 BC ATOM 4588 CD1 LEU B 1098 2.490 53.006 32.075 1.00 45.54 B C ATOM 4589CD2 LEU B 1098 3.809 55.143 31.891 1.00 45.95 B C ATOM 4590 C LEU B 10987.195 52.841 30.395 1.00 47.11 B C ATOM 4591 O LEU B 1098 8.103 53.09631.188 1.00 48.02 B O ATOM 4592 N TRP B 1099 7.240 51.821 29.547 1.0047.69 B N ATOM 4593 CA TRP B 1099 8.380 50.920 29.480 1.00 48.25 B CATOM 4594 CB TRP B 1099 8.231 49.990 28.279 1.00 47.18 B C ATOM 4595 CGTRP B 1099 9.403 49.114 28.085 1.00 45.90 B C ATOM 4596 CD2 TRP B 109910.442 49.287 27.124 1.00 46.24 B C ATOM 4597 CE2 TRP B 1099 11.36548.244 27.319 1.00 46.53 B C ATOM 4598 CE3 TRP B 1099 10.689 50.22926.126 1.00 46.72 B C ATOM 4599 CD1 TRP B 1099 9.720 48.004 28.800 1.0046.60 B C ATOM 4600 NE1 TRP B 1099 10.899 47.469 28.346 1.00 45.86 B NATOM 4601 CZ2 TRP B 1099 12.508 48.110 26.541 1.00 47.39 B C ATOM 4602CZ3 TRP B 1099 11.825 50.095 25.356 1.00 46.84 B C ATOM 4603 CH2 TRP B1099 12.723 49.047 25.570 1.00 47.41 B C ATOM 4604 C TRP B 1099 9.68251.707 29.361 1.00 49.00 B C ATOM 4605 O TRP B 1099 10.600 51.531 30.1601.00 48.96 B O ATOM 4606 N SER B 1100 9.757 52.575 28.358 1.00 49.38 B NATOM 4607 CA SER B 1100 10.943 53.395 28.149 1.00 50.99 B C ATOM 4608 CBSER B 1100 10.966 53.916 26.714 1.00 50.66 B C ATOM 4609 OG SER B 11009.892 54.814 26.492 1.00 50.60 B O ATOM 4610 C SER B 1100 10.975 54.57929.128 1.00 51.72 B C ATOM 4611 O SER B 1100 11.903 54.640 29.961 1.0052.69 B O ATOM 4612 OXT SER B 1100 10.071 55.437 29.060 1.00 52.10 B OTER 1 SER B 1100 B HETATM 4625 P1 AMP Y 1 26.248 46.926 4.305 1.00 28.91Y P HETATM 4626 O1 AMP Y 1 24.959 46.349 4.017 1.00 29.03 Y O HETATM4627 O2 AMP Y 1 26.471 48.087 3.460 1.00 23.13 Y O HETATM 4628 O3 AMP Y1 27.346 45.981 4.135 1.00 27.39 Y O HETATM 4629 P2 AMP Y 1 25.26048.053 6.796 1.00 28.00 Y P HETATM 4630 O4 AMP Y 1 24.100 47.197 6.8181.00 27.56 Y O HETATM 4631 O5 AMP Y 1 25.860 48.106 8.087 1.00 27.82 Y OHETATM 4632 N2 AMP Y 1 26.211 47.226 5.864 1.00 28.12 Y N HETATM 4633 P3AMP Y 1 23.678 50.169 5.602 1.00 24.33 Y P HETATM 4634 O6 AMP Y 1 24.10751.460 4.951 1.00 28.59 Y O HETATM 4635 O7 AMP Y 1 23.048 49.307 4.6521.00 25.29 Y O HETATM 4636 O8 AMP Y 1 25.027 49.513 6.240 1.00 26.20 Y OHETATM 4637 O9 AMP Y 1 22.642 50.469 6.693 1.00 23.79 Y O HETATM 4638 C1AMP Y 1 22.965 51.477 7.584 1.00 22.50 Y C HETATM 4639 C3 AMP Y 1 22.38151.189 8.968 1.00 23.70 Y C HETATM 4640 O10 AMP Y 1 20.972 51.326 8.9781.00 22.51 Y O HETATM 4641 C7 AMP Y 1 22.646 49.806 9.574 1.00 23.88 Y CHETATM 4642 O11 AMP Y 1 22.712 49.938 10.970 1.00 27.97 Y O HETATM 4643C9 AMP Y 1 21.390 49.035 9.243 1.00 23.07 Y C HETATM 4644 O12 AMP Y 121.146 48.025 10.175 1.00 20.17 Y O HETATM 4645 C10 AMP Y 1 20.31350.104 9.309 1.00 22.71 Y C HETATM 4646 N4 AMP Y 1 19.162 49.846 8.3971.00 23.97 Y N HETATM 4647 C8 AMP Y 1 19.211 49.660 7.018 1.00 23.33 Y CHETATM 4648 N5 AMP Y 1 17.986 49.386 6.524 1.00 23.11 Y N HETATM 4649 C5AMP Y 1 17.127 49.389 7.573 1.00 23.16 Y C HETATM 4650 C6 AMP Y 1 15.74149.186 7.842 1.00 23.60 Y C HETATM 4651 N6 AMP Y 1 14.807 48.895 6.8731.00 22.95 Y N HETATM 4652 N1 AMP Y 1 15.244 49.269 9.124 1.00 26.75 Y NHETATM 4653 C2 AMP Y 1 15.984 49.546 10.260 1.00 22.61 Y C HETATM 4654N3 AMP Y 1 17.313 49.758 10.097 1.00 23.12 Y N HETATM 4655 C4 AMP Y 117.889 49.687 8.808 1.00 23.32 Y C HETATM 4656 MG MG Y 2 22.965 47.1444.708 1.00 27.65 Y MG HETATM 4657 P1 AMP Z 1 −6.811 27.348 31.249 1.0029.75 Z P HETATM 4658 O1 AMP Z 1 −6.300 27.933 30.032 1.00 25.93 Z OHETATM 4659 O2 AMP Z 1 −7.551 26.124 30.969 1.00 24.41 Z O HETATM 4660O3 AMP Z 1 −7.613 28.224 32.090 1.00 26.59 Z O HETATM 4661 P2 AMP Z 1−4.222 26.039 31.829 1.00 26.40 Z P HETATM 4662 O4 AMP Z 1 −3.371 26.74230.880 1.00 26.33 Z O HETATM 4663 O5 AMP Z 1 −3.594 25.914 33.084 1.0027.90 Z O HETATM 4664 N2 AMP Z 1 −5.480 27.010 32.143 1.00 28.13 Z NHETATM 4665 P3 AMP Z 1 −4.457 23.966 29.840 1.00 26.27 Z P HETATM 4666O6 AMP Z 1 −5.338 22.775 29.725 1.00 28.28 Z O HETATM 4667 O7 AMP Z 1−4.637 24.880 28.724 1.00 27.16 Z O HETATM 4668 O8 AMP Z 1 −4.755 24.62631.283 1.00 25.90 Z O HETATM 4669 O9 AMP Z 1 −2.951 23.529 29.790 1.0025.56 Z O HETATM 4670 C1 AMP Z 1 −2.309 22.819 30.848 1.00 22.33 Z CHETATM 4671 C3 AMP Z 1 −0.795 23.071 30.857 1.00 23.34 Z C HETATM 4672O10 AMP Z 1 −0.234 22.965 29.547 1.00 22.37 Z O HETATM 4673 C7 AMP Z 1−0.408 24.496 31.335 1.00 23.19 Z C HETATM 4674 O11 AMP Z 1 0.745 24.34232.105 1.00 25.77 Z O HETATM 4675 C9 AMP Z 1 −0.090 25.231 30.042 1.0022.68 Z C HETATM 4676 O12 AMP Z 1 0.844 26.255 30.179 1.00 22.55 Z OHETATM 4677 C10 AMP Z 1 0.452 24.151 29.138 1.00 22.80 Z C HETATM 4678N4 AMP Z 1 0.396 24.436 27.666 1.00 24.01 Z N HETATM 4679 C8 AMP Z 1−0.742 24.730 26.933 1.00 24.62 Z C HETATM 4680 N5 AMP Z 1 −0.447 24.96625.604 1.00 25.25 Z N HETATM 4681 C5 AMP Z 1 0.891 24.823 25.461 1.0024.14 Z C HETATM 4682 C6 AMP Z 1 1.915 24.885 24.448 1.00 24.17 Z CHETATM 4683 N6 AMP Z 1 1.681 25.214 23.143 1.00 20.34 Z N HETATM 4684 N1AMP Z 1 3.266 24.622 24.771 1.00 25.74 Z N HETATM 4685 C2 AMP Z 1 3.69424.311 26.030 1.00 22.91 Z C HETATM 4686 N3 AMP Z 1 2.771 24.244 27.0431.00 21.55 Z N HETATM 4687 C4 AMP Z 1 1.437 24.478 26.810 1.00 22.73 Z CHETATM 4688 MG MG Z 2 −4.549 27.191 28.573 1.00 31.30 Z MG HETATM 4689 OHOH W 1 −2.475 30.329 15.504 1.00 11.40 W O HETATM 4690 O HOH W 2 12.41445.490 15.244 1.00 13.21 W O HETATM 4691 O HOH W 3 29.299 47.960 7.0151.00 20.72 W O HETATM 4692 O HOH W 4 −8.081 23.906 29.636 1.00 24.82 W OHETATM 4693 O HOH W 5 19.546 44.643 17.339 1.00 5.81 W O HETATM 4694 OHOH W 6 −5.932 29.329 7.200 1.00 26.30 W O HETATM 4695 O HOH W 7 13.33545.024 29.684 1.00 26.89 W O HETATM 4696 O HOH W 8 −2.722 34.331 39.7671.00 28.35 W O HETATM 4697 O HOH W 9 35.150 40.728 −7.044 1.00 32.32 W OHETATM 4698 O HOH W 10 −21.199 33.084 32.518 1.00 29.13 W O HETATM 4699O HOH W 11 1.946 41.700 15.699 1.00 17.00 W O HETATM 4700 O HOH W 12−4.135 15.706 24.394 1.00 26.37 W O HETATM 4701 O HOH W 13 18.978 58.2802.913 1.00 29.75 W O HETATM 4702 O HOH W 14 24.050 58.118 8.115 1.0033.81 W O HETATM 4703 O HOH W 15 8.875 64.811 12.194 1.00 32.66 W OHETATM 4704 O HOH W 16 48.673 31.147 15.865 1.00 19.28 W O HETATM 4705 OHOH W 17 51.031 42.556 6.078 1.00 39.02 W O HETATM 4706 O HOH W 1825.398 50.597 2.357 1.00 20.20 W O HETATM 4707 O HOH W 19 40.324 26.36116.008 1.00 27.85 W O HETATM 4708 O HOH W 20 33.653 51.255 1.318 1.0024.99 W O HETATM 4709 O HOH W 21 28.596 48.674 9.568 1.00 27.69 W OHETATM 4710 O HOH W 22 3.864 6.537 26.814 1.00 30.27 W O HETATM 4711 OHOH W 23 34.593 52.731 −2.102 1.00 21.01 W O HETATM 4712 O HOH W 243.459 12.452 32.479 1.00 16.68 W O HETATM 4713 O HOH W 25 21.173 61.85413.602 1.00 18.35 W O HETATM 4714 O HOH W 26 −9.899 40.661 21.126 1.0014.79 W O HETATM 4715 O HOH W 27 −6.606 26.300 34.986 1.00 26.71 W OHETATM 4716 O HOH W 28 31.882 37.812 13.934 1.00 24.97 W O HETATM 4717 OHOH W 29 5.767 35.379 −5.080 1.00 26.68 W O HETATM 4718 O HOH W 30−0.387 12.747 10.060 1.00 30.83 W O HETATM 4719 O HOH W 31 −2.871 16.14231.823 1.00 27.26 W O HETATM 4720 O HOH W 32 −11.338 17.892 21.567 1.0024.99 W O HETATM 4721 O HOH W 33 27.741 41.030 9.385 1.00 35.57 W OHETATM 4722 O HOH W 34 4.219 40.947 15.023 1.00 26.11 W O HETATM 4723 OHOH W 35 13.358 40.025 45.175 1.00 33.41 W O HETATM 4724 O HOH W 3610.178 43.642 −0.473 1.00 21.44 W O HETATM 4725 O HOH W 37 −5.670 25.83523.800 1.00 26.16 W O HETATM 4726 O HOH W 38 22.553 65.325 10.636 1.0035.15 W O HETATM 4727 O HOH W 39 −19.914 17.680 11.168 1.00 22.16 W OHETATM 4728 O HOH W 40 14.142 46.495 2.450 1.00 24.14 W O HETATM 4729 OHOH W 41 30.519 39.861 12.539 1.00 36.50 W O HETATM 4730 O HOH W 4219.597 33.906 −3.688 1.00 17.47 W O HETATM 4731 O HOH W 43 16.289 45.3563.477 1.00 17.51 W O HETATM 4732 O HOH W 44 21.782 43.355 −2.963 1.0020.88 W O HETATM 4733 O HOH W 45 −8.473 49.357 41.780 1.00 25.18 W OHETATM 4734 O HOH W 46 −14.467 25.593 49.502 1.00 36.38 W O HETATM 4735O HOH W 47 2.639 57.400 5.791 1.00 28.77 W O HETATM 4736 O HOH W 489.875 15.041 10.250 1.00 39.43 W O HETATM 4737 O HOH W 49 12.865 4.29811.454 1.00 42.78 W O HETATM 4738 O HOH W 50 −18.417 36.077 56.375 1.0034.15 W O HETATM 4739 O HOH W 51 −1.916 27.652 19.935 1.00 22.92 W OHETATM 4740 O HOH W 52 7.220 17.804 12.275 1.00 44.35 W O HETATM 4741 OHOH W 53 48.699 45.704 12.632 1.00 30.47 W O HETATM 4742 O HOH W 54−2.981 8.858 20.070 1.00 23.68 W O HETATM 4743 O HOH W 55 −4.013 26.39836.017 1.00 22.25 W O HETATM 4744 O HOH W 56 40.677 24.839 −3.765 1.0025.15 W O HETATM 4745 O HOH W 57 −20.509 33.232 20.262 1.00 42.21 W OHETATM 4746 O HOH W 58 18.916 63.958 14.464 1.00 33.09 W O HETATM 4747 OHOH W 59 6.936 41.796 15.875 1.00 31.02 W O HETATM 4748 O HOH W 6012.623 66.714 5.890 1.00 23.87 W O HETATM 4749 O HOH W 61 11.893 47.13439.605 1.00 23.05 W O HETATM 4750 O HOH W 62 7.474 40.610 3.914 1.0031.03 W O HETATM 4751 O HOH W 63 22.606 52.920 −12.732 1.00 42.64 W OHETATM 4752 O HOH W 64 2.426 54.692 4.984 1.00 26.28 W O HETATM 4753 OHOH W 65 48.775 30.973 5.752 1.00 25.77 W O HETATM 4754 O HOH W 66−11.173 53.513 23.526 1.00 41.70 W O HETATM 4755 O HOH W 67 23.52926.529 24.314 1.00 38.02 W O HETATM 4756 O HOH W 68 9.992 28.475 25.5941.00 34.12 W O HETATM 4757 O HOH W 69 3.366 44.401 −5.013 1.00 50.58 W OHETATM 4758 O HOH W 70 34.274 34.206 2.671 1.00 24.77 W O HETATM 4759 OHOH W 71 20.152 56.215 −4.144 1.00 22.22 W O HETATM 4760 O HOH W 72−8.710 24.835 37.208 1.00 27.50 W O HETATM 4761 O HOH W 73 32.146 41.42714.964 1.00 28.71 W O HETATM 4762 O HOH W 74 −19.018 31.978 53.014 1.0038.25 W O HETATM 4763 O HOH W 75 0.080 8.693 33.017 1.00 42.67 W OHETATM 4764 O HOH W 76 −7.947 47.660 19.560 1.00 23.76 W O HETATM 4765 OHOH W 77 36.529 54.767 10.120 1.00 28.79 W O HETATM 4766 O HOH W 78−12.852 35.028 17.783 1.00 25.41 W O HETATM 4767 O HOH W 79 −0.55947.749 21.052 1.00 24.10 W O HETATM 4768 O HOH W 80 −17.156 21.79234.959 1.00 42.68 W O HETATM 4769 O HOH W 81 −13.699 23.195 35.641 1.0033.42 W O HETATM 4770 O HOH W 82 −9.587 42.543 56.480 1.00 34.56 W OHETATM 4771 O HOH W 83 43.873 33.067 −8.277 1.00 39.60 W O HETATM 4772 OHOH W 84 5.761 57.407 37.269 1.00 45.64 W O HETATM 4773 O HOH W 8516.884 21.454 20.877 1.00 52.96 W O HETATM 4774 O HOH W 86 47.763 34.0491.316 1.00 36.54 W O HETATM 4775 O HOH W 87 −6.209 31.119 46.066 1.0044.92 W O HETATM 4776 O HOH W 88 40.750 51.712 5.730 1.00 33.72 W OHETATM 4777 O HOH W 89 −21.569 39.844 47.646 1.00 29.53 W O HETATM 4778O HOH W 90 26.302 31.299 25.877 1.00 24.97 W O HETATM 4779 O HOH W 91−7.619 56.473 35.928 1.00 33.44 W O HETATM 4780 O HOH W 92 19.370 29.016−3.829 1.00 36.95 W O HETATM 4781 O HOH W 93 22.912 21.947 20.348 1.0034.74 W O HETATM 4782 O HOH W 94 6.640 33.210 4.482 1.00 25.32 W OHETATM 4783 O HOH W 95 19.761 65.159 5.818 1.00 28.63 W O HETATM 4784 OHOH W 96 −2.429 28.740 22.618 1.00 17.06 W O HETATM 4785 O HOH W 97−3.064 31.778 42.427 1.00 42.96 W O HETATM 4786 O HOH W 98 −5.388 7.26811.141 1.00 30.44 W O HETATM 4787 O HOH W 99 −22.456 19.371 11.638 1.0031.53 W O HETATM 4788 O HOH W 100 4.576 39.683 11.824 1.00 34.42 W OHETATM 4789 O HOH W 101 −11.699 42.668 37.871 1.00 20.12 W O HETATM 4790O HOH W 102 −20.248 30.467 21.517 1.00 43.20 W O HETATM 4791 O HOH W 103−2.130 27.300 28.199 1.00 34.69 W O HETATM 4792 O HOH W 104 −28.85435.295 32.405 1.00 26.50 W O HETATM 4793 O HOH W 105 47.956 33.74415.640 1.00 34.20 W O HETATM 4794 O HOH W 106 9.854 66.277 −3.306 1.0036.84 W O HETATM 4795 O HOH W 107 24.030 38.651 −11.161 1.00 50.50 W OHETATM 4796 O HOH W 108 48.420 31.498 3.256 1.00 39.12 W O HETATM 4797 OHOH W 109 −1.253 45.553 15.262 1.00 38.50 W O HETATM 4798 O HOH W 11033.843 42.792 13.225 1.00 30.63 W O HETATM 4799 O HOH W 111 28.70342.535 −2.829 1.00 30.19 W O HETATM 4800 O HOH W 112 8.622 12.687 11.1021.00 29.60 W O HETATM 4801 O HOH W 113 20.128 67.529 1.352 1.00 33.55 WO HETATM 4802 O HOH W 114 −0.770 14.323 8.166 1.00 52.45 W O HETATM 4803O HOH W 115 −3.656 9.896 7.101 1.00 32.62 W O HETATM 4804 O HOH W 116−13.602 22.480 44.154 1.00 35.16 W O HETATM 4805 O HOH W 117 22.12820.904 −3.627 1.00 30.87 W O HETATM 4806 O HOH W 118 −5.070 15.04527.353 1.00 23.93 W O HETATM 4807 O HOH W 119 36.061 37.125 23.788 1.0024.47 W O HETATM 4808 O HOH W 120 −25.322 30.252 30.726 1.00 41.44 W OHETATM 4809 O HOH W 121 35.690 29.845 5.576 1.00 16.76 W O HETATM 4810 OHOH W 122 −24.680 19.112 17.711 1.00 37.84 W O HETATM 4811 O HOH W 12313.080 52.502 31.871 1.00 41.89 W O HETATM 4812 O HOH W 124 2.957 25.90131.930 1.00 19.65 W O HETATM 4813 O HOH W 125 39.312 38.534 −13.393 1.0031.38 W O HETATM 4814 O HOH W 126 38.067 33.591 −15.755 1.00 35.74 W OHETATM 4815 O HOH W 127 29.602 55.694 2.224 1.00 36.44 W O HETATM 4816 OHOH W 128 34.510 31.619 3.906 1.00 29.94 W O HETATM 4817 O HOH W 1299.989 23.860 20.084 1.00 32.28 W O HETATM 4818 O HOH W 130 −17.67135.139 20.740 1.00 51.29 W O HETATM 4819 O HOH W 131 36.267 31.168−11.638 1.00 51.65 W O HETATM 4820 O HOH W 132 −14.553 50.627 22.2531.00 36.45 W O HETATM 4821 O HOH W 133 −16.661 11.632 17.334 1.00 19.62W O HETATM 4822 O HOH W 134 23.273 35.371 −10.468 1.00 27.93 W O HETATM4823 O HOH W 135 −23.607 44.003 35.480 1.00 29.99 W O HETATM 4824 O HOHW 136 −11.964 57.410 34.233 1.00 59.88 W O HETATM 4825 O HOH W 137−19.087 51.552 39.458 1.00 34.48 W O HETATM 4826 O HOH W 138 6.01222.773 15.789 1.00 32.08 W O HETATM 4827 O HOH W 139 19.642 44.693−8.548 1.00 30.54 W O HETATM 4828 O HOH W 140 3.705 36.386 50.313 1.0038.47 W O HETATM 4829 O HOH W 141 1.298 37.283 7.120 1.00 51.13 W OHETATM 4830 O HOH W 142 −23.191 29.343 32.125 1.00 50.13 W O HETATM 4831O HOH W 143 46.067 49.093 7.670 1.00 42.60 W O HETATM 4832 O HOH W 14431.146 48.281 12.422 1.00 40.48 W O HETATM 4833 O HOH W 145 31.48033.377 27.417 1.00 40.50 W O HETATM 4834 O HOH W 146 −0.521 7.311 18.9651.00 40.93 W O HETATM 4835 O HOH W 147 4.938 47.003 20.293 1.00 35.68 WO HETATM 4836 O HOH W 148 2.572 56.018 12.990 1.00 38.20 W O HETATM 4837O HOH W 149 4.166 41.330 46.439 1.00 51.22 W O HETATM 4838 O HOH W 150−27.096 42.038 36.548 1.00 54.71 W O HETATM 4839 O HOH W 151 −9.60644.717 20.161 1.00 26.34 W O HETATM 4840 O HOH W 152 −12.543 24.53050.664 1.00 31.97 W O HETATM 4841 O HOH W 153 23.986 57.755 13.449 1.0041.58 W O HETATM 4842 O HOH W 154 4.142 48.610 −7.954 1.00 41.73 W OHETATM 4843 O HOH W 155 −8.571 34.493 10.496 1.00 35.68 W O HETATM 4844O HOH W 156 6.535 43.683 −0.301 1.00 28.35 W O HETATM 4845 O HOH W 1575.098 9.837 31.389 1.00 32.69 W O HETATM 4846 O HOH W 158 4.605 38.45146.567 1.00 44.80 W O HETATM 4847 O HOH W 159 −12.373 9.262 29.626 1.0043.00 W O HETATM 4848 O HOH W 160 21.944 64.392 14.788 1.00 43.27 W OHETATM 4849 O HOH W 161 8.410 42.221 0.553 1.00 38.42 W O HETATM 4850 OHOH W 162 −15.092 24.451 51.951 1.00 33.87 W O HETATM 4851 O HOH W 163−28.497 40.660 38.549 1.00 42.45 W O HETATM 4852 O HOH W 164 4.67756.197 15.176 1.00 39.88 W O HETATM 4853 O HOH W 165 9.008 31.037 17.6961.00 37.12 W O HETATM 4854 O HOH W 166 −13.943 48.188 19.442 1.00 51.59W O HETATM 4855 O HOH W 167 −16.372 52.024 18.619 1.00 30.94 W O HETATM4856 O HOH W 168 36.587 31.130 −14.714 1.00 37.59 W O HETATM 4857 O HOHW 169 40.198 33.790 −13.561 1.00 51.85 W O HETATM 4858 O HOH W 17011.326 50.791 32.880 1.00 41.20 W O HETATM 4859 O HOH W 171 24.82441.289 −12.891 1.00 48.97 W O HETATM 4860 O HOH W 172 −19.243 31.09423.985 1.00 65.07 W O HETATM 4861 O HOH W 173 22.235 20.511 18.399 1.0035.72 W O HETATM 4862 O HOH W 174 25.487 19.422 20.119 1.00 42.44 W OHETATM 4863 O HOH W 175 −0.531 31.883 14.385 1.00 36.04 W O HETATM 4864O HOH W 176 21.134 46.888 6.137 1.00 20.06 W O END

1. A crystal comprising a human Janus Kinase 3 kinase domain.
 2. Acrystal comprising a Janus Kinase 3 kinase domain homologue. 3-41.(canceled)
 42. A method of using the crystal of claim 1 or 2 in aninhibitor screening assay comprising: (a) selecting a potentialinhibitor by performing rational drug design with a three-dimensionalstructure determined for the crystal, wherein said selecting isperformed in conjunction with computer modeling; (b) contacting thepotential inhibitor with a kinase; and (c) detecting the ability of thepotential inhibitor for inhibiting the kinase.